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Abstract 
DNA replication is central to the propagation of life and initiates by the 
designation of genome sequences as origins, where synthesis of a copy of 
the genetic material begins once per cell division. Despite considerable 
progress in understanding mitochondrial (kinetoplast) DNA replication in 
kinetoplastid parasites, little is known about nuclear DNA replication. The 
mechanism and machinery of DNA replication initiation is well-conserved 
among characterised eukaryotes. The six protein origin recognition complex 
(ORC, Orc1-Orc6), Cdc6, and Cdt1 are recruited sequentially to DNA, and 
once bound, they load the replicative helicase (MCM, a heterohexamer; 
subunits Mcm2-7) to form a pre-replicative complex (pre-RC) at potential 
origins of replication. The largest subunit of ORC, Orc1, is related in 
sequence to Cdc6, indicative of derivation from a common ancestor. Such 
an ancestral molecule appears still to function in archaea. These 
prokaryotes lack Cdc6 and possess a protein named Orc1/Cdc6, which 
appears to provide all ORC functions, since orthologues of Orcs2-6 are 
absent. In addition to this, archaeal orthologues of Cdt1 have not been 
clearly described, though potentially related factor, named WhiP (winged 
helix initiator protein), has been found. Comparative genome analysis of 
Trypanosoma brucei and related trypanosomatids (Leishmania major and 
Trypanosoma cruzi) revealed, remarkably, only a single ORC protein that is 
equally related to eukaryotic Orc1 and Cdc6 (named here TbORC1/CDC6). In 
addition, no clear homologue of Cdt1 was found. These observations have 
been interpreted as suggesting that origin designation in trypanosomatids, 
although eukaryotic, may be archaeal-like, raising numerous mechanistic 
and evolutionary questions.  
To test this hypothesis, and to dissect the process of nuclear DNA 
replication, a   number of experiments are described in this thesis. We used 
RNA interference (RNAi) to demonstrate that knockdown of TbORC1/CDC6 in 
procyclic form (PCF) T. brucei cells inhibits nuclear DNA synthesis, as 
revealed by cell cycle analysis and a BrdU incorporation assay. 
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Immunofluorescence and GFP-tagging showed that in procyclic form (PCF) 
cells TbORC1/CDC6 is a nuclear protein. In PCF cells, based on the evidence 
gathered, we confirm that TbORC1/CDC6 acts in nuclear DNA synthesis. In 
contrast, RNAi knockdown of TbORC1/CDC6 in bloodstream form (BSF) T. 
brucei cells resulted in the rapid accumulation of cells with more than two 
nuclei and two kinetoplasts, indicating a deregulation of the cell cycle, 
which is then followed by cell rapid cell death. This RNAi result provides 
greater evidence that TbORC1/CDC6 provides an essential function in the 
parasite, since RNAi depletion of TbORC1/CDC6 in PCF cells has a less 
pronounced effect on growth. Nevertheless, attempts to generate 
TbORC1/CDC6 null mutants failed in PCF cells, consistent with an essential 
role in this life cycle stage also. 
To study the molecular interactors of TbORC1/CDC6, we performed 
immunoprecipitation analyses. From this, we have identified one protein 
(gene ID, Tb927.10.13380) that acts as a component of the T. brucei pre-
replicative machinery, and suggest that this is a previously unidentified 
orthologue of Orc4. We also indentified a further protein (gene ID, 
Tb927.10.7980) that may also act in T. brucei DNA replication, but whose 
identity and function are unclear. TbORC1/CDC6 appears not to interact 
directly with the TbMCM helicase (for which orthologues of all subunits can 
be identified), consistent with previous observations from a number of 
eukaryotic organisms, and contrary to reports in some archaeal species. 
MCM subunits in T. brucei form at least one subcomplex (TbMCM2/4/6/7) 
homologous to that previously observed for human, yeast, Drosophila, 
Xenopus and mouse MCM proteins. Taken together, these data appears to 
refute the hypothesis that the DNA replication pre-RC machinery in T. 
brucei is analogous to archaea. Rather, we propose that TbORC contains at 
least two components, TbORC1/CDC6 and Tb927.10.13380, more analogous 
to the eukaryotic model, suggesting that origin designation is not carried out 
by a single protein.  
To identify potential replication origin sequences, we performed chromatin 
immunoprecipitation with functional, epitope-tagged TbORC1/CDC6 in PCF 
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cells and, using a high-resolution tiling array (NimbleGen) for T. brucei, we 
have mapped TbORC1/CDC6 binding sites along all the megabase 
chromosomes in the genome. Analyses of chromosomes 1-10 showed that 
278 binding sites are sparsely located within the core of chromosomes, of 
which 114 loci (40%) co-localise with probable RNA Polymerase II 
transcription start sites, perhaps consistent with an origin function. In 
addition, a further 330 binding sites are present as high density clusters in 
subtelomeric VSG arrays, and 81 binding sites are associated with sub-
telomeric elements, perhaps consistent with a non-origin function. 
Consistent with these results, RNAi knockdown of TbORC1/CDC6 led to 
derepression of metacyclic Variant Surface Glycoprotein (VSG) genes, 
suggesting that TbORC1/CDC6 plays a role in the epigenetic silencing at VSG 
expression sites in PCF T. brucei. Similar analysis of VSG expression in BSF 
cells, and of BSF VSGs in PCF cells, was less conclusive, perhaps suggesting 
differential functions of TbORC1/CDC6 in different life cycle stages or at 
different VSG expression sites. These analyses shed new light on the 
architecture and potential function of TbORC1/CDC6 in T. brucei nuclear 
DNA replication in general, as well as a potential association between 
replication and antigenic variation in T. brucei. 
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1 General Introduction 
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1.1 Introduction to Trypanosoma brucei 
1.1.1 Phylogeny of Trypanosoma brucei 
Taxonomically, the species Trypanosoma brucei belongs to the eukaryotic 
supergroup Excavata, most of which are unicellular, flagellated organisms (Adl 
et al. 2005; Simpson & Roger 2004). The Excavate supergroup includes many 
other parasitic protozoan genera: Giardia, Trichomonas, Leishmania and 
Trypansonoma - Figure 1-1 (Dacks, Walker, & Field 2008). This new level 
classification of these eukaryotic organisms is based on a combination of 
molecular sequence data and morphological traits (Adl et al. 2005; Simpson & 
Roger 2004) and is based on what has been termed an “egalitarian” view of 
eukaryotic evolution - Figure 1-1 (Dacks et al. 2008). It suggests that parasitic 
protozoans such as Giardia, Trichomonas, Leishmania and Trypansonoma are not 
“early-diverging” eukaryotes, as they are frequently described (Dacks & 
Doolittle 2001; Sogin et al. 1989), but rather share a common ancestor and have 
specialised and adapted to their various niches (Dacks et al. 2008). Many studies 
consider there to be the five eukaryotic supergroups described in Figure 1-1, 
while others argue that that the Excavata should be considered as two distinct 
groups, perhaps without a common origin: the Jakobids, Euglenozoans (including 
T. brucei) and Heteroloboseans; and the Parabasalids (including Trichomonas 
vaginalis), the Oxymonads and the Diplomonads (including Giardia lamblia) 
(Fritz-Laylin et al. 2010). The sub-taxomic ranks for T. brucei are thus: phylum, 
Euglenozoa; order, Kinetoplastida; family, Trypanosomatidae; and Genus, 
Trypanosoma. 
A characteristic feature of members of the order Kinetoplastida is the presence 
of a mitochondrial-like organelle known as the kinetoplast, within which is a 
concatenated DNA network that assumes the role of more typical mitochondrial 
DNA present in higher eukaryotes (Liu et al. 2005; Maslov, Podtipaev, & Lukes 
2001). The family Trypanosomatidae has three closely related species known as 
the TriTryps: Trypanosoma cruzi, Leishmania major and Trypanosoma brucei. 
The genomes of each of these organisms, plus some further species, have been 
sequenced (Ivens et al. 2005; Berriman et al. 2005; El Sayed et al. 2005a) and 
show a high degree of gene conservation and gene synteny (Ghedin et al. 2004).  
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The trypanosomatids (derived from Trypansomatidae) are responsible for a 
variety of diseases of both human and veterinary importance. These diseases 
include Chagas' disease (caused by T. cruzi), Leishmaniasis (caused by several 
species of the genus Leishmania), Human African Trypanosomiasis (HAT) in 
humans and nagana in domestic livestock (both caused by several species of the 
genus Trypanosoma)(Garcia et al. 2006; Barrett et al. 2003). The most important 
Trypanosoma species for humans is T. brucei. Two sub-species, T. brucei 
rhodesiense and T. brucei gambiense, infect humans in central and western 
Africa, and in eastern and southern Africa, respectively.  Another subspecies, T. 
brucei brucei, is not human infective but infects livestock, causing huge 
economic misery. HAT disease is invariably fatal if untreated and is a menace to 
over 60 million people inhabiting over 36 sub-Saharan African countries (Fevre et 
al. 2006; Garcia et al. 2006; Barrett 1999). 
 
Figure 1-1 - The egalitarian view of eukaryotic phylogeny  
A phylogenetic tree showing the classification of eukaryotes into six supergroups: Amoebozoa, 
Opisthokonta, Excavata, Chromalveolata, Rhizaria, Archaeplastida. The tree, which is not rooted, 
is generated according the new level of classification by (Adl et al. 2005; Simpson & Roger 2004); 
Lm = Leishmania major, Tb = Trypanosoma brucei, Gi = Giardia intestinalis, Tv = Trichomonas 
vaginalis, Eh = Entamoeba histolytica, and Dd = Dictyostelium discoideum, Ec = Encephalitozoon 
cuniculi, Pf = Plasmodium falciparum, Tt = Tetrahymena thermophila, Tp = Thalassiosira 
pseudonana. T. brucei belongs to the supergroup Excavata. Taken from (Dacks et al. 2008) 
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1.1.2 Trypanosomiasis and disease control 
The two human infective Trypanosoma subspecies: T. b. rhodesiense and T. b. 
gambiense, cause different variants of HAT disease or African sleeping sickness. 
While T. b. rhodesiense causes an acute infection, T. b. gambiense causes a 
more chronic infection (Barrett et al. 2003). In acute infections, the parasites 
reside extracellularly in the lymphatic and vascular systems of the mammalian 
host and are more readily detected in blood, lymph, or tissue aspirates (Barrett 
et al. 2003). However, the infection is characterised by a rapid transition to the 
central nervous system and death occurs within weeks or months (Brun et al. 
2010). In chronic infections which can last around three years (Brun et al. 2010), 
the parasites cross the blood brain barrier and reside in the central nervous 
system where they cause motor and sensory disorders leading to alterations in 
sleep/wake patterns and seizures; hence the term sleeping sickness (Barrett et 
al. 2003). If untreated, HAT disease is invariably fatal.  
African sleeping sickness is among the most neglected diseases in the world. 
Because it affects the world’s poorest countries there is a lack of incentive from 
major pharmaceutical companies for investment in the development of new 
drugs (Barrett et al. 2007; Maudlin 2006; Ehrenberg & Ault 2005). It is a major 
public health problem and is a strong impediment to the socio-economic 
development of affected countries. Current control measures for trypanosome 
infections rely primarily on prevention of transmission and chemotherapy 
(Barrett et al. 2003). However, this is hindered by an increasing problem of drug 
resistance, slow progress in prevention approaches (such as vector and reservoir 
host controls), the lack of a preventive vaccine, limited access to essential 
medicines, lack of surveillance, and lack of clinical and diagnostic expertise 
especially in regions affected by conflict (Hotez et al. 2007; Ehrenberg & Ault 
2005). Other than being limited in supply, current drugs also suffer drawbacks of 
high levels of toxicity and an increasing incidence of treatment failures (Barrett 
et al. 2007), and hence there is a necessity for the identification and 
characterisation of new drug targets.  
Trypanosomatids display considerable divergence, both structurally and 
functionally, in basic biological processes. This may bring hope that novel 
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therapies can be developed that exploit these processes, as they show 
differences between the parasites and their hosts. Examples of such divergence 
in trypanosomatids include the kDNA structure, RNA editing in the 
mitochondrion, and nuclear polygenic transcription (see Section 4.1.1). Another 
biological process that is central and essential to the propagation of life is DNA 
replication. With the T. brucei genome sequence now available (Berriman et al. 
2005), an understanding of DNA replication and its associated characteristics can 
provide insights into both fundamentally conserved and fundamentally different 
aspects of this process. Indeed, unique aspects of the T. brucei DNA replication 
machinery may differ sufficiently from its host (see Section 4.1.1) to represent 
targets for future development of novel chemotherapeutic agents. 
1.1.3 Life Cycle of Trypanosoma brucei 
T. brucei has a complex digenetic life cycle (Figure 1-2), being transmitted 
between mammalian hosts by an insect vector (Glossina spp; commonly known 
as the tsetse fly)(Gull 2002). When the mammal-infective form of the parasite, 
known as the metacyclic trypomastigote, is introduced into its mammalian host 
by the bite of an infected tsetse fly, they multiply extravascularly at the site of 
the bite, and establish the infection. From there they migrate into the 
bloodstream and tissue fluids, and eventually find their way into the 
cerebrospinal fluid in chronic infections (Tetley & Vickerman 1985). In the 
bloodstream, trypomastigotes differentiate from the non-dividing metacyclic 
form cells into the proliferative long slender form. Both these life cycle forms 
express a variant surface glycoprotein (VSG) coat on the cell surface, which acts 
as ‘shield’ to prevent the immune system from recognising invariant surface 
antigens. Changes in the VSG coat in the longer slender cells provide for immune 
evasion, a process termed antigenic variation. Throughout infection in the 
bloodstream, the long-slender form cells differentiate into the non-dividing 
short ‘stumpy’ form (Tetley et al. 1987). This latter form is capable of infecting 
the tsetse fly. During a blood meal, short ‘stumpy’ trypomastigotes are ingested 
into the fly gut, where they differentiate into replicative procyclic 
trypomastigotes and then into the epimastigote form in the salivary glands. 
During the first of these differentiation processes the major outer membrane 
protein of the parasite changes from VSG to a distinct glycoprotein coat, 
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composed of procyclic acidic repetitive proteins (PARPs) or procyclins (Barry & 
McCulloch 2001; Roditi et al. 1998). In the salivary gland of the tsetse fly the 
replicative epimastigote cells differentiate into the mammal-infective 
metacyclic form cells, which are not attached to the gland wall and are capable 
of re-infecting during a blood meal, thereby closing the cycle (Barry et al. 1998). 
During this differentiation, the surface coat is changed back to VSG from 
procyclin, in preparation for confronting the mammal’s immune system. 
 
Figure 1-2 – The Life cycle of Trypanosoma brucei 
T. brucei proliferative and non-proliferative stages in mammalian and tsetse fly hosts are shown as 
scanning electron micrographs; shown to scale. Circular arrows represent replicative stages, 
whereas straight arrows represent differentiation and progression through the life cycle. Taken from 
(Barry & McCulloch 2001) 
 
1.2 Cellular and genome organisation of Trypanosoma 
brucei 
1.2.1 Trypanosoma brucei cell structure 
T. brucei has an elongated shape within which are single copy organelles (one 
kinetoplast, one Golgi, and one nucleus) precisely positioned between the 
posterior end and the centre of the cell (Figure 1-3). At the posterior end of the 
cell is an invagination of the plasma membrane known as the flagellar pocket, 
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since this is where the flagellum emerges (Matthews 2005). The single 
mitochondrion that T. brucei possesses runs the length of the cell and contains a 
unique matrix of concatenated DNA, termed kinetoplast DNA (kDNA) (Shapiro & 
Englund 1995). The kDNA consists of an interlocked network of large and small 
DNA rings known as maxicircles and minicircles, respectively. The kDNA 
maxicircles range in size from 20–40 kb, encode ribosomal RNA and several 
mitochondrial proteins and are present in tens of copies. The minicircles range 
in size from 0.5–2.9 kb, encode guide RNAs that regulate the RNA editing 
machinery for the formation of functional maxicircle mRNA, and are present in 
thousands of copies (Morris et al. 2001; Shapiro & Englund 1995). kDNA 
replication and segregation is independent of nuclear DNA replication and 
mitosis, although the events are coordinated (Woodward & Gull 1990). 
 
Figure 1-3 - Cartoon of a T. brucei cell showing single copy organelles  
Image taken from (Grunfelder et al. 2003) 
 
1.2.2 The nuclear genome structure 
The nuclear genome comprises 11 diploid megabase-sized chromosomes (0.9-6 
megabase in length), several intermediate-sized chromosomes (~200-900 kb in 
size) and approximately 100 mini-chromosomes (~50-150 kb in size) (El Sayed et 
al. 2000; Melville et al. 1998). The near-completed genome sequence of T. 
brucei strain TREU (Trypanosomiasis Research Edinburgh University) strain 927/4 
has been published (Berriman et al. 2005). Sequence analysis of the T. brucei 
megabase nuclear chromosomes revealed a haploid DNA content of ~26-
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megabases, containing 9068 predicted genes. The genetic repertoire includes 
~900 pseudogenes, primarily derived from variable surface glycoprotein genes 
(VSGs), and ~1700 further T. brucei-specific genes (Berriman et al. 2005). These 
figures are exclusive of some of the subtelomeric ends of the megabase 
chromosomes, the intermediate-sized chromosomes and the minichromosomes, 
whose genetic content are yet to be published. 
In general, a T. brucei megabase chromosome can be sub-structured into three 
main parts: a central core that harbours most of the ‘house-keeping’ genes, a 
proximal subtelomeric region that harbours tandem repeated units of VSG arrays 
and a distal subtelomeric region that harbours VSG expression sites (Hertz-
Fowler, Renauld, & Berriman 2007). The house-keeping genes within the central 
core have a highly unconventional structural organisation. The genes are 
arranged in closely packed clusters in which the ORFs face the same direction 
and are transcribed by RNA Polymerase II into, it appears,  a single pre-mRNA 
from which individual mRNAs are generated by coupled trans-splicing and 
polyadenylation (Martinez-Calvillo et al. 2010; Clayton 2002). These so-called 
directional gene clusters are reminiscent of bacterial operons, although the co-
transcribed genes are not normally functionally related. Adjacent directional 
gene clusters can be arranged head to head (convergent) or tail to tail 
(divergent), and are separated by gene-free regions called strand switch regions 
(SSRs) (Hall et al. 2003; El Sayed et al. 2003; Myler et al. 1999). Available 
evidence suggests that: (a) no consensus motifs exist for sequences present at 
SSRs (Hall et al. 2003), and (b) transcription initiation occurs bi-directionally in 
divergent strand switch regions. As a result, divergent SSRs represent 
transcription start sites in which no promoters have been described, though they 
are sites of accumulation of histone variants (H2AZ, H2BV, and H4K10ac). 
Transcription termination is thought to occur at convergent SSRs (Siegel et al. 
2009). In T. cruzi, as well as in T. brucei, some SSRs have repetitive DNA 
sequences, which have been shown to act as centromeres functioning to provide 
mitotic stability to chromosomes (Obado et al. 2007; Obado et al. 2005). 
Due to their repetitive nature, the subtelomeric ends of some megabase 
chromosomes of the genome strain are still being assembled, and when this 
information becomes available, more light will be shed on their organisation 
(Renauld, Kelly, & Horn 2007). However, available information suggest that 55 % 
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of the size of T. brucei megabase chromosomes is devoted to subtelomeres, 
harbouring 10 % of the total predicted gene repertoire (Hertz-Fowler et al. 2007). 
The majority of this subtelomeric repertiore are VSG and VSG-associated genes, 
involved in evasion of host immune destruction by antigenic variation (Marcello 
& Barry 2007; Barry & McCulloch 2001).  The minichromosomes also harbour a 
repertoire of VSGs, though these all appear to be directly telomeric. 
Minichromosomes have a characteristic central core region of 177-bp repetitive 
sequences arranged in large palindromes (Wickstead, Ersfeld, & Gull 2004) and 
this is shared with intermediate chromosomes. VSGs in the minichromosomes 
and in the subtelomeric VSG arrays in the megabase chromosomes are not 
expressed in-situ. Instead, they can only become transcribed if they are 
translocated by recombination to VSG expression sites (see Section 1.3) in the 
megabase and intermediate chromosomes (Taylor & Rudenko 2006; Barry & 
McCulloch 2001). 
1.3 Antigenic variation in T. brucei 
The biological relationship of host-pathogen interactions has intrigued scientists 
over the years in trying to unravel the evasion mechanisms pathogens utilise to 
overcome host innate and/or adaptive immunity. From simple prokaryotes to 
more complex single-celled eukaryotes, different strategies have been adopted 
by pathogens to ensure survival within a host organism. For example, Gram-
positive bacteria such as Streptococcus pneumoniae have a thick peptidoglycan 
cell wall layer, which prevents complement-mediated lysis by the membrane-
attack complex (Joiner et al. 1983). Alternatively, Gram-negative bacteria, such 
as members of the genus Salmonella, employ a mechanism known as phase 
variation, where they randomly switch phenotypes by varying the expression of 
specific antigenic factors either in an “on-state” or in an “off-state” (Tamura et 
al. 1988). Another mechanism by which pathogens such as viruses evade host 
immune attack is by a process known as molecular mimicry, whereby a protein is 
expressed that closely mimics the structure and function of a host protein (Zhao 
et al. 1998). An example is an epitope expressed on the coat protein of the 
herpes simplex virus-type 1 (HSV-1) KOS strain, which is analogous to corneal 
antigens expressed in a murine mouse model (Zhao et al. 1998). 
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Unicellular parasites such as T. cruzi and Leishmania, which are close relatives 
of T. brucei, escape host-immune surveillance by inhabiting intracellular 
environments, and hence become inaccessible (Sibley 2004). On the other hand, 
T. brucei proliferates extracellularly in the blood and tissue fluids of a 
mammalian host, where it is subject to continuous immune attack from host 
defence molecules such as antibodies. To thrive successfully in these 
environments and to subsequently establish a chronic infection the parasites 
utilise a protective mechanism known as antigenic variation (Pays, Vanhamme, & 
Perez-Morga 2004; Barry & McCulloch 2001). Antigenic variation involves 
continuously altering exposed surface antigens, thereby displaying to the host 
immunologically distinct antigens, meaning that the adaptive immune response 
cannot eradicate the infecting population (Morrison, Marcello, & McCulloch 
2009). In T. brucei, the variant antigen is VSG, which forms a protective ‘coat’ 
consisting of densely packed molecules (~5 x 106 dimers per cell) that protects 
invariant surface molecules from immune recognition. VSG is anchored to the 
cell membrane through a glycosylphosphatidylinositol (GPI) anchor (Masterson et 
al. 1989). The ability to continuously maintain the process of antigenic variation 
depends on the huge repertoire (~1500 VSGs) of silent VSG genes present in the 
subtelomeres of all T. brucei chromosomes (Marcello & Barry 2007; Berriman et 
al. 2005). At any one time, a trypanosome cell can only express a single VSG 
molecule on its surface, and this expression occurs from specialised sites at the 
distal subtelomeric ends of megabase or intermediate size chromosomes known 
as VSG expression sites (Becker et al. 2004). 
The life cycle of T. brucei (see above) involves distinct periods in either an 
insect host or a mammalian host. Prior to infection of a mammalian host, the 
expression of VSGs commences in the metacyclic form cells in the insect salivary 
glands and these VSGs are referred to as metacyclic VSGs (MVSGs), while in the 
bloodstream form (BSF) the expressed VSGs are referred to as bloodstream VSGs 
(BVSGs) (Barry & McCulloch 2001). MVSG genes are therefore expressed from 
metacyclic expression sites (MES), while BVSG genes are expressed from 
bloodstream expression sites (BES). The structure and organisation of these VSG 
expression sites are distinct and is discussed in Section 3.8.6. Fourteen distinct 
BESs have been characterised in the BSF stage of the T. brucei strain Lister 427 
(Hertz-Fowler et al. 2008). Of these, only one can be transcriptionally active at 
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any one time in a trypanosome cell. Fewer MES have been described in detail, 
but again only one is actively transcribed at a time (Ginger et al. 2002). The 
process of singular BES or MES transcription is not yet fully understood. 
Accumulating evidence suggest that epigenetic phenomena may be involved in 
maintaining transcriptionally silent chromatin at inactive BES, while little is 
known about MES (Molloy 2010; Rudenko 2010; Stockdale et al. 2008). Section 
3.8.6 discusses published work on the transcriptional regulation of BES in the 
context of new evidence we provide of how both BES and MES activation may be 
regulated. 
1.4 The T. brucei cell cycle 
The mammalian cell division cycle consists of four temporally distinct phases: 
G0/G1, S, G2, and M. G0/G1 is a gap phase marked by synthesis of proteins, 
nucleotides and nutrients that are required in S phase, where replication of DNA 
occurs. There is also significant protein synthesis in the G2 phase, another gap 
phase during which the cell prepares to enter mitosis (M-phase) or, in specific 
cases, meiosis. The M-phase is characterised by nuclear and cytoplasmic 
division. T. brucei broadly follows a typical mammalian cell cycle, although it is 
characterised by unique features and unusual complexities compared with higher 
eukaryotes (Mckean 2003). For example, whereas in mammalian cells 
mitochondrial DNA is replicated throughout the cell cycle, kDNA replication in T. 
brucei occurs in S-phase and division of the kDNA network precedes, but 
overlaps, with nuclear division (Mckean 2003; Woodward & Gull 1990). The T. 
brucei cell cycle has been extensively studied in procyclic form (PCF) cells 
(Figure 1-4). In this life cycle stage, the cell cycle takes 8.5 hours to complete 
(compared to ~6 hours in the BSF) and can be followed chronologically by the 
duplication of specific organelles in the following order: basal body, golgi, 
endoplasmic reticulum (ER), flagellum, kinetoplast, and nucleus (though, again, 
kinetoplast division overlaps with nuclear division) (Hammarton, Wickstead, & 
Mckean 2007). The replicated nucleus then undergoes mitosis, which is followed 
by the division of the cell into two daughter cells in a process known as 
cytokinesis, which commences prior to the completion of mitosis (Hammarton et 
al. 2007). 
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As mentioned above, kDNA and nuclear DNA replication are distinct steps in the 
cell cycle and, although they overlap, the duration of kDNA replication and 
segregation (~3 hrs) is slightly shorter than that of nuclear DNA replication and 
nuclear mitosis (4 hrs) - Figure 1-4 (Hammarton et al. 2007). This time difference 
has been exploited to study the progress of cell cycle events in both PCF and BSF 
cells in T. brucei, as shown in Figure 1-4 (Hammarton et al. 2005; Hammarton et 
al. 2003). This is described in detail in Section 3.3.5. 
 
Figure 1-4 – The cell division cycle in procyclic form T. brucei 
Upper panel: Relative timings of the nuclear and kinetoplast division cycles during the cell cycle 
phases: G1 and G2 represent gap phases, SN and SK represent nuclear and kinetoplast DNA 
synthesis, respectively, M represents Mitosis, C represents cytokinesis, D represents kinetoplast 
division and A represents kinetoplast segregation. Lower panel: The trypanosome cell is depicted 
by a white oval; basal body is indicated by a green-shaded circle; flagellum is indicated by black 
line that emerges from basal body; kinetoplast is indicated by smaller blue-shaded circle; and 
nucleus is indicated by larger blue-shaded circle. Arrow heads indicate direction of progression of 
cell cycle; the onset of SK is indicated by smaller red-shaded oval while the onset of SN is indicated 
by red-shaded circle. The organelle configuration of nucleus and kinetoplast at each phase of the 
cell cycle is denoted below: 1N1K for one nucleus and one kinetoplast, 1N2K for one nucleus and 
two kinetoplasts, and 2N2K for two nuclei and two kinetoplasts. Adapted from (Hammarton et al. 
2007) 
 
The molecular machinery of kDNA replication and the mechanisms involved in 
copying this complex genome have been widely studied in T. brucei and are 
discussed in Section 3.1. Much of the T. brucei kDNA replication machinery 
appears to be substantially distinct from that used in nuclear DNA replication 
(e.g. specialised DNA polymerases and DNA ligases). In stark contrast to this, and 
despite the central role of this process, nuclear DNA replication still remains a 
very poorly studied process in T. brucei, or indeed in any trypanosomatid, and is 
the subject of this PhD project. 
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1.5 Origins of DNA replication 
The blueprint of every cell in an organism is its DNA. The information encoded in 
DNA must be faithfully duplicated before it is passed from parent(s) to progeny 
to ensure the propagation of life. Despite the central nature of this process, DNA 
replication mechanisms show considerable variation in organisation in 
prokaryotes and eukaryotes (Robinson & Bell 2005). The foundation for our 
understanding of DNA replication regulation began in 1963 when Jacob, Brenner 
and Cuzin published a paper “On the regulation of DNA replication in bacteria” 
and in it proposed the replicon model (Jacob, Brenner, & Cuzin 1963).  This 
model proposed that DNA replication is closely similar to gene transcription, 
whereby its initiation involves interactions between trans-acting regulators, 
known as initiator factors, and cis-acting elements in the genome, known as the 
replicator sequences (replicons), that determine the initiation of DNA replication 
(Jacob et al. 1963). Over the years this model has proved to be accurate, and 
much has been learned about the structure, function and organisation of the 
initiator factors and replicator sequences (elements that determine the origin of 
DNA replication) in both simple and complex model organisms [for reviews see 
(Masai et al. 2010; Sun & Kong 2010; Mott & Berger 2007; Robinson & Bell 
2005)]. Below, we discuss DNA replication sequences (origins) in bacteria, 
archaea and eukaryotes and their associated initiator factors 
1.5.1 Bacterial origins 
In the bacterium Escherichia coli, DNA replication of the single, circular 
chromosome initiates at a specific locus known as Origin of Chromosomal 
replication (oriC), and the replication from this site proceeds bidirectionally 
(Bird et al. 1972). By integrating Phage Mu-I into the different chromosomal 
locations in E. coli K-12, establishing a synchronous cycle of replication of the 
genome, and in vivo radialobelling the genomic DNA with radioactive thymidine 
and then using DNA-DNA hybridisation to determine the rate of duplication of 
the integrated markers in the genome, Bird et al (1972) were able to 
experimentally map the positions of the origin and terminus of replication in E. 
coli (Bird et al. 1972). They reported that the origin was located near the dnaA-
ilv locus present at 74 min on the genetic map of the chromosome (Bird et al. 
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1972). Over time, biochemical and genetic studies have been carried out to 
further characterise this locus. Yasuda and Hirota (1977) were able to clone the 
locus into a plasmid, pSYR211, and showed that this molecule was only able to 
replicate in the presence of the origin sequence (Yasuda & Hirota 1977). This 
study refined the location of the origin to 83 min on the genetic map, and later 
on, a minimum region of 245 bp was shown to be conserved in five enteric 
bacteria (Zyskind et al. 1983). 
The origin region (OriC) has been partitioned into sub-domains known as DnaA 
boxes or R-boxes, which promote DNA-initiator protein (DnaA) interaction 
(Fuller, Funnell, & Kornberg 1984). The exact number of DnaA boxes varies 
between different bacterial species (Yoshikawa & Ogasawara 1991). In E. coli, 
for example, there are five DnaA boxes (numbered R1-R5; Figure 1-5) that 
contain a highly conserved consensus 9 bp sequence; 5' - TTATCCACA - 3' (Fuller 
et al. 1984). Thirteen DnaA boxes are found in Thermus thermophilus, fifteen in 
Bacillus subtilis, and nineteen in Streptomyces lividans (Messer 2002). 
Interspersed within the DnaA boxes are additional DnaA binding sites termed I-
sites (I1, I2, and I3; Figure 1-5); consensus, 5’-AGATCT (McGarry et al. 2004; 
Sekimizu, Bramhill, & Kornberg 1987). Located between DnaA box R1 and R5 is a 
single binding site for Integration Host Factor (IHF; Figure 1-5), which is 
necessary for facilitating DnaA-mediated unwinding of OriC by introducing a 
bend into the DNA backbone (Polaczek et al. 1997). Immediately adjacent to 
DnaA box R2 is a binding site for Factor for Inversion Stimulation (Fis), a protein 
that inhibits DNA melting at OriC (Wold, Crooke, & Skarstad 1996). Upstream of 
DnaA box R1 are three upstream 13-mer AT-rich repeat elements that facilitate 
melting of duplex DNA [Figure 1-5; (McGarry et al. 2004)]. The concerted 
interactions of DnaA-ATP to the DnaA boxes and I-sites, and of IHF to its binding 
site, cause the AT-rich sequence upstream to become negatively supercoiled, 
facilitating unzipping of local DNA (Speck & Messer 2001; Crooke et al. 1991). 
Several other proteins are recruited via the polymerisation of DnaA, thereby 
initiating DNA replication (Fang, Davey, & O'Donnell 1999) - see Section 1.6.1. 
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Figure 1-5 – Architecture of the bacterial origin of chromosomal replication (OriC)  
Schematic representation of DNA sequence elements present at E. coli OriC showing five DnaA 
boxes depicted as by boxes [R1-R5 (M)], interspersed by I-sites depicted by boxes (I1, I2, and I3); 
a site bound by integration host factor (IHF) is depicted by IHF; a 13-mer duplex unwinding element 
is depicted by 13-mer; and a site bound by FIs protein is depicted by Fis. Taken from (McGarry et 
al. 2004) 
 
1.5.2 Eukaryotic origins 
Unlike most prokaryotes, which have circular chromosomes, in eukaryotes 
chromosomes are linear, larger in size and replication fork progression is slower. 
To ensure that the entire genome is duplicated within the time allocated during 
the cell cycle (termed S-phase), initiation of DNA replication requires multiple 
origins of replication on each chromosome (Kelly & Stillman 2006). In the well-
studied single-celled eukaryote, Saccharomyces cerevisiae, initiation of DNA 
replication involves the recognition (by the Origin Recognition Complex, ORC; 
see below) of a consensus 11 bp AT-rich sequence within an ~200 bp region 
known as an autonomously replicating sequence (ARS) (Weinreich, Debeer, & Fox 
2004; Newlon 1996; Bell & Stillman 1992). Origin sequences in budding yeast are 
named ARS because of their capacity to confer stability to extrachromosomal 
DNA molecules and direct their autonomous replication (Hsiao & Carbon 1979). 
Within the ARS consensus sequence are four distinct regions: an ARS-consensus 
element (ACS, or A element) and three B elements (B1, B2, and B3) - Figure 1-6A 
(Marahrens & Stillman 1992). The A element consists of a highly conserved motif 
(5'- T/ATTTAYRTTTT/A -3', where Y corresponds to a cytosine or thymine base 
and R to adenine or guanine base) that is absolutely required for recognition by 
ORC in vitro, and mutation within the sequence leads to loss of origin function 
(Theis & Newlon 1997; Marahrens & Stillman 1992). Although B elements 
constitute more divergent motifs, collectively they are also required for origin 
recognition as mutations in their sequences abrogates ORC recognition (Rao & 
Stillman 1995). Collectively, A and B elements act co-operatively to provide a 
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landing pad for interaction with specific replication proteins to facilitate the 
initiation of DNA replication (Bell & Stillman 1992).  
This strict requirement for a well conserved DNA sequence element to function 
as an origin of replication is recognisable only in the budding yeast S. cerevisiae. 
In Schizosaccharomyces pombe, clusters of asymmetric AT-rich intergenic 
sequences with a size range of 0.5 - 1 kb function as budding yeast ACS element 
analogues - Figure 1-6B (Clyne & Kelly 1995; Dubey et al. 1994). Like their 
budding yeast counterparts, fission yeast asymmetric AT-rich clusters are also 
able to confer extrachromosomal stability to plasmids and are characterised by A 
residues on one strand and Ts on the complementary strand (Okuno et al. 1999). 
This sequence, however, displays a degree of heterogeneity in different 
locations compared with the very well defined budding yeast ARS sequences 
(Segurado, de Luis, & Antequera 2003; Dubey et al. 1994). 
 
Figure 1-6 – Budding and fission yeast origin of replication map 
(A) The first origin locus to be characterised in budding yeast, denoted by ARS1, is shown; it 
comprises an 11-bp consensus element (ACS) and less conserved B elements downstream (B1, 
B2, B3). ORC high-affinity binding sites are denoted by a horizontal line above ACS and B1; 
bidirectional replication site is denoted by OBR and AT-rich duplex unwinding elements are 
denoted by B2 and B3. The approximate size of the locus is shown beneath. (B) In fission yeast, 
the origin locus ars1 is shown; the chromosome is depicted by a black horizontal line, white boxes 
indicate AT-rich ORC binding sites; box sizes reflect affinity of binding sites (the bigger the box, the 
higher the binding affinity). Figure adapted from (Aladjem, Falaschi, & Kowalski 2006) 
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In metazoans, it has been shown that replication origins are rarely defined 
sequence elements, but rather are organised within a broad initiation zone from 
which there are a number of initiation origins, one or a few of which are capable 
of firing within S-phase (Aladjem et al. 2006). Within the proposed broad 
initiation zones, in Xenopus egg extracts, initiation site selection is dependent 
on the presence of closely clustered AT-rich asymmetric sequences (Stanojcic et 
al. 2008), which have also been reported for mammalian origins such as the CHO 
Dihydrofolate reductase (DHFR) gene, human β-globin locus  and Lamin B2 
origins - Figure 1-7 (Aladjem et al. 2006). Apart from AT-rich clusters, in HeLa 
cells, ORC preferentially localises with GC-rich tracks and is found sparsely in 
GC-poor regions; such GC-rich tracks tend to coincide with CpG islands in the 
genome (Cadoret et al. 2008). The AT-rich eukaryotic origins tend to replicate 
late and/or are inefficient initiation sites, while GC-rich regions are early 
replicating regions (MacAlpine & Bell 2005). Examining DNA sequence element 
requirements from higher eukaryotes therefore indicates that there is more 
flexibility in selection of origins of replication. 
 
Figure 1-7 – Architecture of the two metazoan chromosomal origins of replication 
DNA sequence elements present at the human β-globin origin locus (Hs β-globin) and the human 
Lamin B2 origin locus (Hs laminB2). Locations of AT-rich origin loci are indicated by “AT”; 
asymmetric purine-pyrimidine tracks are indicated by “AG”; and CpG islands are indicated by 
“CpG”; promoters are indication by arrows with arrow heads pointing in the direction of 
transcription; bulk arrows indicate an  “initiation zone”, while filled triangle indicates a precise 
initiation site, and sizes of initiation zones are indicated within arrows; Taken from (Aladjem et al. 
2006) 
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1.5.3 Archaeal origins 
Beyond bacterial and eukaryotic systems for understanding the molecular 
mechanisms that define sequence elements for selection as origins of DNA 
replication, the archaeal DNA replication machinery has recently emerged as an 
interesting model system to understand this vital process (Kelman & Kelman 
2003). It appears that archaea utilise a blend of both eukaryotic and bacterial 
systems (Robinson & Bell 2005; Kelman & Kelman 2003). While initiator factors 
in archaea appear to be a somewhat simplified eukaryotic machine, the 
sequence elements appear to be well-defined (Robinson et al. 2004). In the 
archaeon Sulfolobus solfataricus, Robinson et al (2004) identified two origins of 
replication in its single chromosome and demonstrated that Orc1/Cdc6 protein 
(see below) is able to bind a motif within the origin sequence termed an origin 
recognition box (ORB) element, which is also conserved at the positions of 
characterised origins in a number of Pyrococcus species: P. abyssi, P.furiosus, 
and P. horikosii (Robinson et al. 2004; Matsunaga et al. 2003). Based on this 
finding they proposed that ORB-like consensus motifs (5’-GTTCCAGTGGAAAC-
AAA----GGGGG-3’ for Crenarchaeal species, and 5’-GTTCCAGTGGAAAC-AAA----
GGGGG-3’ for Euryarchaeal species) may be a characteristic of archaeal origins 
(Robinson et al. 2004). Subsequently, by measuring the copy numbers of specific 
markers located close to origin loci relative to markers located at termination 
sites (a technique known as marker frequency analysis), Lundgren and colleagues 
were able to show that two Sulfolobus species (S. acidocaldarius and S. 
solfataricus) actually have three origins of replication, two of which located in 
close proximity to the locus of the initiator protein gene (orc1/cdc6), while no 
replication-associated gene appeared to be in the vicinity of the third origin 
(Lundgren et al. 2004). Further work by Robinson et al (2007) afterwards 
identified a distantly related eukaryotic Cdt1-like factor, which they named the 
winged-helix initiator protein (WhiP) (Robinson & Bell 2007). Using two-
dimensional gel electrophoresis, they later showed that the third archaeal origin 
was located in the vicinity of the whip gene locus - Figure 1-8 (Duggin, 
McCallum, & Bell 2008). Like eukaryotes, and unlike bacteria, the multiple origin 
paradigm seems to be conserved in archaea (Duggin et al. 2008; Robinson & Bell 
2007; Lundgren et al. 2004). 
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Figure 1-8 – Diagram of S. acidocaldarius origins of replication  
Map of three S. acidocaldarius origin loci indicated by OriC1 region, OriC2 region, and OriC3 
region. Horizontal line depicts segments of chromosomes; square boxes above and below the 
horizontal line depict direction of transcription; circles indicate the predicted location of origins, 
which are located either upstream of an initiator factor gene (Orc1-1) or downstream of initiator 
factor genes (Orc1-3 and Whip); grey shaded regions indicate loci for initiator factors (Orc1-1, 
Orc1-3, and Whip). (Duggin et al. 2008) 
 
1.5.4 Trypanosomatid origins 
Unlike the much-studied mitochondrial genome replication, nuclear DNA 
replication initiation in T. brucei remains a largely unexplored subject (El Sayed 
et al. 2005a). In fact, the latter is not only true for T. brucei but also true for its 
close relatives, L. major and T. cruzi (El Sayed et al. 2005a), and for protists in 
general. The first attempt geared towards finding origins of nuclear DNA 
replication in T. brucei was made by Patnaik and colleagues (Patnaik, Kulkarni, 
& Cross 1993). In this study, random DNA segments from T. brucei chromosomes 
were cloned into bacterial circular plasmids and tested for their ability to confer 
autonomous replication on these extrachromosomal DNA molecules, which are 
otherwise unable to survive as an episome (Patnaik et al. 1993). The study 
identified two plasmids (pT13-11 and pT13-41) that were able to be maintained 
as single copy episomes in PCF cells, and one plasmid (pT11-bs) that was 
extrachromosomally stable in BSF cells. The region that conferred their 
extrachromosomal stability was attributed to a large inserted gene fragment, 
which they termed the plasmid maintenance sequence (PMS), and deletion of 
this region abrogated the ability of the plasmids to survive as an episome 
(Patnaik et al. 1993). Further work by the same group later characterised pT13-
11 in an attempt to identify the specific region of the genome that played a role 
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in its ability to survive as an episome (Patnaik, Fang, & Cross 1994). Here, they 
showed that an interaction between the PMS and a 108 bp region encompassing 
the PARP gene promoter region were both necessary for stable 
extrachromosomal existence. If the PARP gene region was replaced with a rRNA 
promoter region, the ability of pT13-11 to survive as an episome was 
incapacitated, suggesting that this region played a role in successful propagation 
of the plasmid in PCF T. brucei (Patnaik et al. 1994). Although the authors failed 
to physically map the specific location of the origin(s) either within the plasmids 
or in their natural chromosomal context, an important finding from both studies 
(Patnaik et al. 1994; Patnaik et al. 1993) was the demonstration of a possible link 
between the ability of the PARP gene promoter region to confer episome 
stability and its additional role in the same plasmid to drive the transcription of 
a selectable marker, thereby supporting a close relationship between DNA 
replication and transcription regulatory elements in T. brucei; a phenomenon 
that is now emerging as a paradigm in higher eukaryotes, including yeasts and 
humans (Maric & Prioleau 2010; Hiratani et al. 2009; Zappulla, Sternglanz, & 
Leatherwood 2002). 
Although the focus of this thesis is on nuclear DNA replication in T. brucei, it is 
worth mentioning that prior to the work by Patnaik and colleagues (1993, 1994), 
the lab of P.T. Englund had reported the presence of a conserved region (100 – 
200 bp in length) in mitochondrial (kDNA) minicircles that contained a 
replication origin in T. equiperdum (Ntambi et al. 1986). Within this region is a 
consensus dodecameric sequence 5’-GGGTTGGTGTA-3’ [known as the universal 
minicircle sequence (UMS)] and a hexameric sequence 5’-ACGCCC-3’ that are 
both present in all minicircles examined from virtually all trypanosomatid 
species (T.  brucei,  T. Equiperdum, L. Tarentolae,  T.lewisi,  T. cruzi, and 
Crithidia fasciculata) (Ray 1989). The UMS is associated to minicircle replication 
initiation in the leading strand while the hexameric sequence is the initiation 
site for the first okazaki fragment (Morris et al. 2001). Unlike minicircles, much 
less is known about maxicircle replication initiation in T. brucei (Morris et al. 
2001). 
In parallel with the work by Patnaik and colleagues (1993, 1994) and the work by 
the lab of P.T Englund described above, another laboratory identified a 1 kb 
mitochondrial kDNA minicircle fragment that permitted autonomous replication 
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of a plasmid (pTbo-1) in the nuclei of PCF T. brucei cells (Metzenberg & Agabian 
1994). This 1 kb minicircle kDNA fragment had within it the consensus UMS 
motif, and was maintained as a supercoiled concatemer of approximately nine 
monomeric units (Metzenberg & Agabian 1994). Although pTbo-1 was maintained 
stably as a concatemer in the nucleus under hygromycin selection, it was lost in 
the absence of drug selection, suggesting that the minicircle DNA fragment alone 
was necessary but not sufficient for plasmid maintenance. Also worthy of note is 
the fact that the organisation (concatenated multimers) of pTbo-1 in the nucleus 
is very reminiscent of minicircle organisation in the mitochondrion of T. brucei 
(Liu et al. 2005). This may imply that the presence of the UMS within the 1 kb 
mitochondrial DNA fragments could impose some mitochondrial properties in the 
nucleus, although its maintenance is likely to be driven by nuclear-specific DNA 
replication proteins, since the UMS binding proteins that have been shown to 
bind the UMS are not localised to the nucleus (Milman et al. 2007). It had been 
proposed in two earlier papers (Papadopoulou, Roy, & Ouellette 1994; Patnaik et 
al. 1993) that the existence of episomes as multimers (rather than as single copy 
molecules) suggests that multiple weak or adventitious origins are likely to fire 
from the plasmid within the cell cycle, which might therefore facilitate the 
random selection of an origin within the plasmid sequence. This proposition 
lends support to the notion that pTbo-1’s stability is unlikely to be driven by a 
single bona fide origin of DNA replication. However, if it does, could this 
mitochondrial DNA fragment function as a nuclear DNA replication origin? This 
remains to be investigated, though it seems unlikely that mitochondrial and 
nuclear chromosome would naturally share DNA replication origin sequences. 
Whereas in T. brucei both the PARP promoter gene region and the PMS are 
required for extrachromosomal stability (Patnaik et al. 1994), in related 
trypanosomatids such as L. major and T. cruzi, bacterial plasmids entirely 
deficient in trypanosomatid-derived sequences can be maintained as stable 
episomes (Kelly 1995; Papadopoulou et al. 1994). These bacterial plasmids could 
only replicate autonomously in T. brucei if they had undergone rearrangements 
or acquired sequences from the genome by a process of recombination (Patnaik 
1997). These findings led to the assertion that in L. major and T. cruzi, but not 
in T. brucei, the initiation of DNA replication is likely to occur at loci that do not 
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have specific sequence requirements (Kelly 1995; Papadopoulou et al. 1994; 
Patnaik et al. 1993). 
Apart from studying autonomously replicating circular plasmids in 
trypanosomatid species, other studies have focused on autonomously replicating 
linear DNA molecules, otherwise known as artificial linear mini-chromosomes 
(Patnaik et al. 1996; Lee, E, & Axelrod 1995). In both studies (Patnaik et al. 
1996; Lee et al. 1995), the authors used constructs bearing the PMS and the PARP 
gene promoter (derived from pT13-11 described above), but this time added 
telomeric repeats and subtelomeric T. brucei-derived sequences at the ends of 
the constructs. The linear constructs, when transfected into PCF T. brucei cells, 
could be maintained as stable extrachromosomal elements only after extensive 
rearrangements with additional sequences present at subtelomeric and 
telomeric loci (Patnaik et al. 1996; Lee et al. 1995). The authors asserted that the 
additional sequences which were located were most likely of minichromosomal 
origin acquired through recombination events, although they were not fully 
characterised (Patnaik et al. 1996; Lee et al. 1995). As these additional sequences 
remain unidentified and uncharacterised, it still remains unclear whether they 
conferred the ARS activity to these artificial linear molecules, or whether the 
sequences will display ARS activity in a natural chromosomal context. 
Prior to experiments to investigate the stability of artificial linear DNA 
molecules in T. brucei, the structure and DNA nucleotide sequence of naturally 
occurring minichromosomes had been studied (Weiden et al. 1991). Using 
sucrose gradient fractionation, minichromosomes were isolated from T. brucei 
cells and visualised by electron microscopy (EM). The authors reported the 
identification of a variety of putative replication intermediates in the 
minichromosomes, including various bubble and replication fork structures. A 
more remarkable observation was the identification of a single replication 
bubble on all minichromosomes analysed, suggesting the presence of a single 
origin of DNA replication in each molecule (Weiden et al. 1991).  For five 
molecules (with a size range of 47.6 kb to 110.5 kb) the analysed bubble length 
ranged from 7.2 kb to 18.2 kb, giving a mean position of the replication bubble a 
distance of ~ 35 % from one end of the molecules (Weiden et al. 1991). In the 
same study, structural analyses of minichromosomes also revealed that most of 
their content comprises AT-rich sequence, which was subsequently shown to be 
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organised as repeats (termed 177 bp repeats) reminiscent of viral, or perhaps 
even yeast, origins (Wickstead et al. 2004) and found also in intermediate 
chromosomes. Whether these AT-rich repeats are present on T. brucei megabase 
chromosomes and behave in the same way as observed in the minichromosomes 
remains to be investigated. 
In an attempt to define the structure and organisation of centromeres in T. cruzi 
megabase chromosomes, telomere-associated chromosome fragmentation 
studies mapped centromeric DNA for chromosome (Chr) 3 to a 16 kb GC-rich 
region that separates two directional gene clusters (the SSR discussed above) 
(Obado et al. 2005). In a follow-up study by the same group, etoposide-mediated 
Topoisomerase II cleavage mapping demonstrated that an analogous 40 kb SSR 
region on Chr. 1 functions as a centromere in T. cruzi (Obado et al. 2007). Using 
the same method in T. brucei, centromeres were also mapped to SSRs (Obado et 
al. 2007). However, the latter were composed of arrays of AT-rich repeats, as 
opposed to the GC-rich sequences observed for T. cruzi (Obado et al. 2007; 
Obado et al. 2005). In both T. cruzi and T. brucei, these centromeres contained 
degenerate retrotransposon elements that conferred mitotic stability to the 
chromosomes (Obado et al. 2007; Obado et al. 2005). However, the lack of 
sequence conservation of the similarly mapped SSRs in both T. cruzi and T. 
brucei does not allow us to state if the regions also act as replication origins. 
This claim is supported by evidence from the SSR on Chr. 1 of L. major, which 
has been shown not to be essential for mitotic stability of the chromosome 
(Dubessay et al. 2002).  
To summarise, for all the attempts that have been made to define sequences 
that confer replicative stability to extrachromosomal DNA molecules, no clear 
consensus sequences have been reported. In addition, no studies in 
trypanosomatids (T. cruzi, T. brucei and L. major) have directly examined the 
presence of replication origins in the megabase chromosomes, although these 
chromosomes contain most of the parasite’s genetic content (Berriman et al. 
2005). Here, we have interrogated the T. brucei genome in a search for 
TbORC1/CDC6 binding sites (see below), with the ultimate goal of delineating 
DNA replication origins in all 11 megabase chromosomes. 
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1.6 The DNA replication initiation machinery; a synopsis 
DNA replication is central to the propagation of life and initiates by the 
designation of genome sequences as origins, where synthesis of a copy of the 
genetic material begins once per cell division. In all organisms studied (bacteria, 
archaea and eukaryotes), DNA replication requires a chronological sequence of 
events: the definition of replication start site, termed an origin of DNA 
replication, by binding of specific factor(s) (see below); the recruitment of 
regulatory factors (see below), which then guide the recruitment of a replicative 
helicase complex to locally unwind the double helical structure of DNA at the 
origin locus; the recruitment of primases to provide a 3’-OH group for extension 
of nascent strand DNA by DNA polymerases; and finally termination of leading 
strand replication and filling-in of okazaki fragments on the lagging strand (these 
final steps need also be co-ordinated with replication of the linear chromosome 
ends (telomeres) via telomerase). 
The establishment of a competent start site is known as the initiation step and 
this is the key point of DNA replication regulation, which determines which 
origins are fired, as well as the rate of replication (Sclafani & Holzen 2007). For 
example, in Drosophila and Xenopus embryos where cells are dividing more 
rapidly, origins occur and fire randomly without a defined initiation point, 
whereas in somatic cells origins becomes more defined and are fired distinctly 
(Sasaki et al. 1999; Hyrien, Maric, & Mechali 1995). Since this work only 
investigates DNA replication initiation events in T. brucei, we only focus on the 
molecular machinery used for the initiation process and its associated regulatory 
events in bacteria, archaea and eukaryotes. We will then consider our current 
understanding of the conservation of this process in trypanosomatids. Although 
the process of DNA replication is well conserved among characterised 
eukaryotes, it is surprising that there is considerable diversity in the modes of 
recognition and regulation used to ensure the correct duplication of genomes in 
bacteria, archaea and eukaryotes (Kawakami & Katayama 2010), given the 
essential nature of this process. 
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1.6.1 DNA replication initiation factors in bacteria 
In bacteria DNA replication initiates from a single well-characterised origin of 
replication in its circular chromosome termed OriC (Fuller et al. 1984). 
Pioneering in vitro work on DNA replication initiation in Escherichia coli in the 
Kornberg laboratory shed light on our understanding of the process in bacteria; 
for comprehensive review see (Mott & Berger 2007; Messer 2002). The 
fundamentals of the process are conserved throughout the bacterial kingdom, 
and here we focus on the molecular players involved in DNA replication initiation 
in E. coli. 
In E. coli the main initiator protein of DNA replication is DnaA and the initiation 
process begins with the recognition and binding of DnaA-ATP to five 9-bp repeat 
elements known as DnaA boxes, followed by a DnaA-ATP interaction with a 
second class of DNA sequences termed I-sites, which are interspersed among the 
DNA boxes (McGarry et al. 2004; Schaper & Messer 1995). Once bound to the 
DnaA boxes and I-sites, DnaA-ATP binds a further 13-bp AT-rich repeat element 
known as DUE (DNA unwinding element) located upstream of the DnaA boxes 
(Speck, Weigel, & Messer 1999; Bramhill & Kornberg 1988). These interactions of 
DnaA induce cooperative loading of more DnaA monomers, which facilitates a 
conformational distortion at the intrinsically less stable AT-rich DUE, thereby 
causing it to melt (Speck & Messer 2001). A consequence of the melting event is 
the facilitated loading of two hexamers of the replicative helicase DnaB, 
mediated by its loader, DnaC (Carr & Kaguni 2001). The presence of all three 
factors (DnaA, DnaB and DnaC) licenses OriC for recruitment of downstream 
factors: single-stranded DNA binding proteins (SSBPs), which bind each parent 
DNA template to prevent premature re-annealing; a primase (DnaG), which 
synthesises 10-12 nucleotide RNA primers for priming of each template 
indicating the end of initiation and the onset of elongation; and finally 
elongation by DNA polymerases (DNA polymerase-III holoenzyme) (Fang et al. 
1999). 
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Figure 1-9 – Model of DNA replication initiation in bacteria 
The assembly of DnaA, DnaB and DnaC at OriC: OriC is represented by parallel horizontal lines; 
black boxes represent DnaA boxes; I-sites are interspersed between DnaA boxes; yellow shaded 
area represents 13-mer AT-rich DUE; six white balls represented DnaC which loads DnaB 
represented by green shaded ovals; Upon loading of DnaB onto melted DUE, DnaC is released 
from DnaB. Figure taken from (Messer, 2002) 
 
Structurally, based on homology sequence alignment and functional biochemical 
characterisation, four domains have been identified in DnaA that are crucial for 
its replication function: an N-terminal domain (amino acid residues 1-86) 
essential for its interaction with DnaB and homo-oligomerisation (Weigel et al. 
1999; Messer et al. 1999); a linker domain (amino acid residues 87-134), which is 
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variable in sequence among bacterial species and appears not to be essential for 
DnaA function (Messer et al. 1999); a AAA+ ATPase domain (amino acid residues 
135-373), which confers its ATPase activity necessary for unwinding of the DUE 
element (Sekimizu et al. 1987); and a C-terminal helix-turn-helix domain, which 
specifically binds OriC (Roth & Messer 1995). The ability of DnaA to bind and 
hydrolyse ATP serves as a key regulatory step of DNA replication initiation in E. 
coli. Although the energy from ATP hydrolysis is not required for co-operative 
DnaA-OriC interactions, as a non-hydrolysable ATP analogue does not abrogate 
these interactions, the allosteric modifications induced by the binding event has 
been shown to be essential for melting the DUE (McGarry et al. 2004; Sekimizu et 
al. 1987). The helicase loader DnaC is also belongs to the family of AAA+ ATPases 
(Iyer et al. 2004), and here, hydrolysis of ATP is essential for DnaC to be 
released from DnaB after it has been loaded onto DnaA (Fang et al. 1999). To 
limit replication to occur only once per cell cycle, at least two other modes of 
regulation have been described, among others (see below). 
One mode of regulating re-initiation of DNA replication in E. coli involves a 
protein known as SeqA. This protein co-operatively and preferentially binds 
hemimethylated GATC repeats (the recognition sequence of Dam 
methyltransferase) interspersed among the DnaA-boxes at OriC, thereby 
sequestering the newly replicated OriC from DnaA and preventing re-initiation of 
replication (Nievera et al. 2006). A second system used by E. coli to control DNA 
replication initiation occurs by titration of available DnaA by a locus called the 
datA locus (Ogawa et al. 2002). This locus has a high affinity for DnaA and null 
mutants have been shown to undergo several rounds of re-replication, while 
additional copies leads to incomplete replication, suggesting that it is necessary 
to adjust the concentration of available DnaA (Kitagawa et al. 1998).  
1.6.2 DNA replication initiation factors in eukaryotes 
In contrast with the bacterial DNA replication initiation machinery, the initiation 
of DNA replication in all eukaryotes examined to date, including a number of 
yeast species, Drosophila, Xenopus and mammals (including humans) requires 
the binding of at least four different proteins: a six protein complex known as 
the origin recognition complex (ORC; composed of factors named Orc1-Orc6), 
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Cdc6, Cdt1, and the Mcm2-7 helicase complex (Bell & Dutta 2002). Once ORC has 
bound, Cdc6 is recruited onto the ORC-origin complex, prompting the 
recruitment of the replicative helicase via a preformed heptameric complex 
composed of Cdt1 bound to the Mcm2-7 complex (Tsakraklides & Bell 2010). 
ORC, Cdc6, Cdt1 and Mcm2-7 together form a larger complex known as the pre-
replication complex (pre-RC) at the origin of replication (Figure 1-10). Pre-RC 
formation and activation is tightly regulated by the cell so that only pre-existing 
pre-RCs formed during the G1 phase are activated in S-phase (Bell & Dutta 2002). 
S-phase-promoting cyclin-dependent kinases facilitate loading of additional 
initiator factors (MCM10, Cdc45 and GINS) to ensure that the cell only replicates 
its DNA once per cell cycle. Each component of the pre-RC seems to play a well-
defined role in this regulation and activation process (see Section 1.6.3). Despite 
this mechanistic similarity between bacteria and eukaryotes, no evidence has 
suggested that the proteins involved are conserved. 
The precise way that ORC designates origins shows remarkable plasticity, 
meaning that it is not feasible to predict replication origins by sequence alone. 
For example, the budding yeast S. cerevisiae uses a limited set of origins each 
with a conserved DNA sequence element, while in metazoans, no consensus DNA 
sequence has been found to function at DNA replication initiation sites (see 
Section 1.5).  
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Figure 1-10 – Model of Pre-RC assembly as currently understood in budding yeast 
The assembly of the pre-RC complex in eukaryotes requires the recruitment of ORC (Orc1-6) on to 
a specific locus of a chromosome (horizontal grey line) known as an origin of replication (striped 
box). Origin-bound ORC recruits Cdc6 and this DNA-protein complex then triggers helicase loading 
in the presence of a pre-formed Cdt1-Mcm2-7 complex. Binding of regulatory factors (Mcm10, 
replication factor A (RPA), Cdc45, GINS, and cyclin-dependent kinases) following helicase loading 
triggers the release of ORC, Cdc6 and Cdt1 from origin DNA. Binding of Cdc45 promotes binding 
of primases (Pri) and DNA polymerase- α (Pol- α), and initiation of DNA replication begins with the 
formation of a replication bubble.  Notice that some MCM subunits are shown to bind origin DNA. 
Model is adapted from (Francon, Maiorano, & Mechali 1999) and includes modification based on 
recent in vitro work by (Tsakraklides & Bell 2010) 
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1.6.3 Components of eukaryotic DNA replication initiation 
machinery 
1.6.3.1 The origin recognition complex (ORC) proteins 
The origin recognition complex (ORC) is a six component protein consisting of 
five related proteins (Orc1-Orc5) that share a similar modular domain 
architecture (Figure 1-11), and another protein that lacks this structural 
organisation; Orc6. ORC proteins were first purified thanks to their ability to 
specifically recognise and bind ARS sequences in S. cerevisiae; DNA sequences 
present at S. cerevisiae origins of replication (Bell & Stillman 1992). Initially, the 
well-characterised budding yeast origin locus ARS1 was used as ‘bait’ to affinity 
purify proteins that were specifically bound to origins from a yeast nuclear 
extract (Bell & Stillman 1992). Using glycerol gradient centrifugation coupled 
with SDS-PAGE on the purified nuclear extracts, a multi-protein complex was 
identified that specifically recognised ARS sequences. This multi-protein 
complex was shown to protect ARS1 from DNaseI nuclease activity in vivo. 
Similar experiments using ARS307 and ARS121 suggested a universal role of ORC 
to bind yeast origin sequences in an ATP-dependent manner (Bell & Stillman 
1992). Over the years, greater progress has been made to understand the 
evolutionary conservation of ORC proteins across species, its role in DNA 
replication, as well as its functions beyond DNA replication (Duncker, Chesnokov, 
& McConkey 2009). 
As in budding yeasts, all six subunits have been shown to be conserved in other 
eukaryotic species: Drosophila melanogaster, Xenopus laevis, Mus musculus, 
Arabidopsis thaliana and Homo sapiens (Dutta & Bell 2006). Orc1 through to 
Orc6 are thus numbered (in descending order of their molecular weight) based 
on their migration on SDS-PAGE, with Orc1 being the largest subunit and Orc6 
being the smallest subunit. The assembly of ORC in S. cerevisiae occurs in a 
stepwise fashion, with specific interactions occurring between different subunits 
in the following order: Orc2 and Orc3 interact, Orc4 and Orc5 interact, and the 
dimeric Orc4-Orc5 is capable of interacting with dimeric Orc2-Orc3 and 
separately with Orc1 with to form a pentameric Orc1-Orc5 (Chen et al. 2008). 
Pentameric Orc1-Orc5 is fully functional in S. cerevisiae (Lee & Bell 1997), 
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although Orc6 has been shown to interact with this complex to form the ORC 
hexamer (Chen, de Vries, & Bell 2007). In humans, Baculovirus expression of 
recombinant ORC proteins in insect cells and subsequent purification revealed 
that Orc2 interacts with Orc3, which then recruits Orc4-Orc5 to form a core 
complex. This core complex of Orc2-Orc5 then recruits Orc1 and Orc6 (Dhar, 
Delmolino, & Dutta 2001), consistent with the budding yeast model (Chen et al. 
2008). 
 
Figure 1-11 – Structural domain organisation of Orc1-Orc5 and Cdc6 from S. cerevisiae 
Orc1, Orc4, Orc5, and Cdc6 each contain an AAA+ domain indicated by AAA+ (orange; 
ORC/Cdc6). Orc2 and Orc3 are shown to have the AAA+ domain but lack the associated ATPase 
activity. Amino acid sequence motifs within the AAA+ domain: Walker A (WA), Walker B (WB), 
Sensor-1 (S1) and Sensor-2 (S2) are shown. ORC and Cdc6 posses a winged-helix domain (WH), 
involved in DNA binding. Orc1 contains an additional BAH (bromo-adjacent homology) domain 
(pink); Orc1 and Orc2 have regions of disorder (yellow); a DNA-binding AT-hook motif (here 
PRKRGRPRK) is identified in S. cerevisiae Orc2, and several of these have also been identified in 
disordered regions in S. pombe Orc4.The number of amino acids for each protein is indicated at 
the right. Taken from (Duncker et al. 2009) 
 
All ORC subunits, with the exception of Orc6, have been shown to associate 
specifically with the A and B1 elements (~50 bp in length) of ARS at replication 
origins in S. cerevisiae (Lee & Bell 1997; Rao & Stillman 1995). Later, based on 
secondary structure conservation, it was proposed that that the interaction 
between the Orc1-5 complex with DNA occurs via a winged-helix DNA binding 
domain, which is present either at the C-terminus or internally (Speck et al. 
2005) of each ORC subunit. Apart from the budding yeast paradigm, where the 
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ORC-DNA interaction is dependent on the presence conserved ARS motifs, its 
interactions with origin DNA in other eukaryotic systems is less well defined. In 
S.pombe, for example, under mild salt extraction conditions (0.3 M NaCl) Orc4 
remains associated with chromatin while the other five subunits (Orc1, Orc2, 
Orc3, Orc5, and Orc6) could be purified from the extract (Moon et al. 1999).  
Further biochemical analysis of the Orc4 subunit revealed the presence of nine 
AT-hook motifs at its N-terminal domain that preferentially recognised the high 
AT-rich clusters present at S. pombe origins (Lee et al. 2001), and it was later 
shown that this Orc4-specific interaction was the key event that directed the 
recruitment of the other five subunits (Kong & DePamphilis 2001b). In 
D.melanogaster and X. laevis embryos, where cells are dividing more rapidly, 
DNA sequence recognition by ORC proteins occurs randomly, whereas in somatic 
cells ORC’s DNA-sequence recognition becomes more defined (Sasaki et al. 1999; 
Hyrien et al. 1995), although any consensus is yet to be identified. 
A functional and stable ORC-DNA complex is a prerequisite to carry on and 
complete pre-RC assembly. Mutational and biochemical analyses show that there 
is considerable variability in the interplay and involvement of ORC subunits in 
ATP binding and hydrolysis in different organisms. Structurally, three of the six 
ORC subunits (Orc1, Orc4, and Orc5) belong to the AAA+ family of ATPases, based 
on consensus Walker A and B motifs in their primary amino acid sequences 
(Speck et al. 2005; Neuwald et al. 1999). This suggests that ORC function, like 
DnaA in bacteria, is tightly regulated by binding and/or hydrolysis of ATP, 
reminiscent of a common evolutionary origin (Iyer et al. 2004). Studies in S. 
cerevisiae have shown that Orc2 and Orc3 lack the key conserved α-helix and β-
sheet secondary structure elements of the ATP binding site, and thus appear to 
be more distant relatives of the AAA+ family of ATPases (Speck et al. 2005). In S. 
cerevisiae the stability of the ORC complex appears to be mediated by the Orc5 
ATP-binding motif, since a mutation in the Walker A motif (K43E) leads to 
overexpression of the Orc4 subunit and a slower growth rate at 37 ◦C due to ORC 
dissociation (Takahashi et al. 2004). In another study by Klemm at al (1997), a 
mutation in the Walker A motif (K485T) of Orc1 led to impaired ORC binding to 
ARS1, suggesting that ATP-binding to the Orc1 subunit is essential for ARS 
interaction (Klemm, Austin, & Bell 1997). The role of the Walker B motif has 
been established in S. cerevisiae by mutating a key conserved Aspartate to 
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Tyrosine (D569Y) in Orc1 (Klemm & Bell 2001). Overexpression of this dominant 
negative mutant allele is lethal and the D569Y mutant in Orc1 cannot hydrolyse 
ATP, suggesting an important role of Orc1-ATP binding and hydrolysis (Klemm & 
Bell 2001; Klemm et al. 1997). Mutations of a conserved arginine residue in the 
so-called “arginine finger” in S. cerevisiae Orc4 have been shown to impair 
loading of the replicative helicase (Mcm2-7) (Bowers et al. 2004), suggesting an 
essential role for the Orc4 subunit in pre-RC assembly. Although Orc6 lacks the 
aforementioned functionally conserved AAA+ domains (Speck et al. 2005) and 
shows no affinity for ARS sequences, it still remains essential for cell viability in 
budding yeasts (Lee & Bell 1997) and is required for recruitment of the 
downstream factor Cdc6 in S. cerevisiae, the next essential step in pre-RC 
assembly (Chen et al. 2007). This scenario is contrary to observations in D. 
melanogaster, where all six subunits are required for origin recognition and DNA 
replication (Chesnokov, Remus, & Botchan 2001). 
The subcellular localisation of ORC, and its eventual fate post-replication 
initiation, still remains debatable from eukaryotic DNA replication studies. 
Depending on the visualisation technique, the results obtained from localising 
ORC proteins not only do not agree for different cell cycle stages and across 
species, but also depend on the specific subunit of ORC that is being localised. 
For example, in D. melanogaster embryos, imaging of a green fluorescent 
protein (GFP)-tagged Orc2 revealed a temporal association with chromatin, 
where it is excluded from chromosomes until anaphase (when mitotic cyclin 
activity is depleted)(Baldinger & Gossen 2009). Earlier studies in D. 
melanogaster larval neuroblasts, which used anti-Orc2 antibody and indirect 
immunofluorescence (Loupart, Krause, & Heck 2000), and studies on X. laevis 
Orc1 and Orc2 by the same method, showed that these subunits are also 
excluded from metaphase chromatin (Romanowski et al. 1996). In Hela cells, 
using chromatin fractionation experiments, human Orc1 appears to be 
dissociated from chromatin during S-phase to M-phase transition (Kreitz et al. 
2001). It has been suggested that in Chinese hamster Ovary (CHO) cells Orc1 and 
not Orc2 is targeted for degradation via a 26S proteasome ubiquitination 
pathway (Li & DePamphilis 2002). Together these findings suggest that Orc1 does 
not permanently associate with chromatin throughout the cell cycle in these 
organisms. On the contrary, in other studies in CHO cells (McNairn et al. 2005) 
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and D. melagonaster embryos (Pak et al. 1997), Orc1 and Orc2 subunits localised 
to chromatin throughout the cell cycle, including metaphase. In S. cerevisiae 
imaging YFP-tagged Orc6 and Myc-tagged Orc2 showed that ORC localised to 
punctate subnuclear foci throughout the cell cycle, consistent with a role in DNA 
replication (Semple et al. 2006; Pasero et al. 1999).  
Using polyclonal anti-Orc6 antiserum, localisation of human Orc6 to kinetochores 
and to a reticular-like structure around the cell periphery in a cleavage furrow 
has been reported (Prasanth, Prasanth, & Stillman 2002). In another report, 
human Orc2 subunit localises to centrosomes and centromeres during mitosis 
(Prasanth et al. 2004). More recently, in human cells Orc1 has been shown to be 
involved in regulating centriole copy number, which is consistent with a 
localisation at centromeres (Hemerly et al. 2009). These results are indicative of 
a role for ORC in chromosome segregation and hence cell cycle progression in 
human cells. Given that individual ORC subunits display differential subcellular 
localisation in different species, further work is therefore needed to reach a 
consensus of the localisation of the ORC. However, in all of these studies, 
nuclear localisation seems to be common across species. 
Apart from the other non-replication roles of ORC that have been reported from 
sub-cellular localisation studies, the first non-replication role of ORC proteins to 
be reported arose from the discovery that ORC in S. cerevisiae protected all four 
silent mating-type loci, HMR-E, HMR-I, HML-E, and HML-I, from DNaseI digestion 
in foot-printing experiments, suggesting that it mediates the establishment of 
transcriptionally silent chromatin (Bell, Kobayashi, & Stillman 1993). Further 
experimental work on the transcriptional regulatory role of ORC showed that 
deletion of an N-terminal region (235 amino acids) of Orc1 from S. cerevisiae 
derepresses the HMR locus (Bell et al. 1995). In addition, S. cerevisiae Orc1 was 
shown to contain a Bromo-adjacent homology (BAH) and the full length protein 
was 50 % identical and 63 % similar to Silent Information Regulator 3 (Sir3), a 
protein that has been shown to play a role in transcriptional silencing, 
confirming that the N-terminus of Orc1 was required for epigenetic silencing at 
this locus (Bell et al. 1995). This finding is supported by subsequent work, which 
showed that Orc1 interacts with Sir1 (Triolo & Sternglanz 1996). Here, the 
authors propose a model for the establishment and spreading of heterochromatin 
at the HM loci orchestrated by an interaction between Orc1 with Sir1 (Triolo & 
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Sternglanz 1996). This interaction recruits Sir4, Sir3 and Rap1 in a complex that 
interacts with histone H3 and H4 tails, leading to chromatin compaction (Triolo 
& Sternglanz 1996). It is now well established that apart from a direct 
interaction of Orc1 with Sir1, Orc1 also interacts with the transcription factors 
Rap1 and Abf1, and after recruitment of Sir3, Sir4 and Sir2, the latter 
deacetylates adjacent histone tails, facilitating the methylation of H3 at lysine 
79 by Dot1, among other histone modifications [reviewed in (Burgess, Guy, & 
Zhang 2009)]. While the aforementioned are true for S. cerevisiae, Orc1’s role in 
transcriptional regulation has also been described in a number of eukaryotes, for 
example D. melanogaster and humans.  
In Drosophila and human cells, Orc2 has been shown to co-localise with the 
Heterochromatin Protein 1 (HP1) (Prasanth et al. 2004; Pak et al. 1997), while in 
Xenopus and humans, Orc1 co-localises with HP1 (Lidonnici et al. 2004; 
Romanowski et al. 1996). Both these findings support a role for ORC in 
heterochromatin formation and hence epigenetic silencing, though what genes 
may be targeted is unknown. It has been proposed that a possible rationale for 
ORC’s interaction with HP1 is to facilitate progression of a replication fork 
through heterochromatin (Mechali 2010). This hypothesis is supported by the 
observation that architectural remodelling of chromatin mediated by ISW1 
facilitates progression of a replication fork (Mechali 2010; Collins et al. 2002). 
Since the discovery of ORC’s role in silencing, studies on ORC proteins have 
established its involvement in ribosome biogenesis, sister chromatid cohesion, 
cytokinesis, among others [see (Sasaki & Gilbert 2007) for a comprehensive 
review]. 
How is ORC recruited to chromatin? Like ORC’s localisation, this subject still 
remains controversial. Several mechanisms have been suggested: a non-coding 
RNA-dependent mechanism in Tetrahymena thermophila (Donti et al. 2009; 
Mohammad et al. 2007) and in yeasts and mammalian cells (Deng et al. 2009); 
and via interactions with other proteins, for example EBNA1 in Epstein-Barr virus 
(Norseen et al. 2008). This topic is discussed in more depth in Section 4.10.6 
where preliminary interactions studies of T. brucei ORC1/CDC6-interacting 
proteins suggest a possible RNA-binding protein-dependent recruitment of 
TbORC1/CDC6 to chromatin in trypanosomatids.  
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ATP-dependent ORC recognition and binding to origins of replication serves to 
provide a platform to load a functional pre-RC, which involves the recruitment 
of downstream factors: Cdc6, Cdt1 and the minichromosome maintenance 
proteins (Mcm2-Mcm7). These are discussed below. 
1.6.3.2 Cell division cycle 6 (Cdc6) protein 
The Cell division cycle 6 (Cdc6) protein was first identified in S. cerevisiae as a 
factor essential for re-initiation of DNA synthesis (Hartwell 1976). At non-
permissive temperatures, Hartwell (1976) showed that S. cerevisiae mutants in 
the cdc6 gene were only able to complete a single round of replication and were 
unable to re-initiate a second round, suggesting an essential role of the protein 
in DNA replication (Hartwell 1976). In S. cerevisiae, Cdc6 has been shown be cell 
cycle dependent; it is transcribed only in late G1 and early S-phase (Piatti, 
Lengauer, & Nasmyth 1995), after which it is rapidly degraded by a Cdc4/34/53 
ubiquitin-mediated pathway (Drury, Perkins, & Diffley 1997). Beyond cell cycle 
dependent regulation of Cdc6 availability, its activity is also regulated by ATP 
binding and hydrolysis. Cdc6 (named Cdc18 in S. pombe) is closely related to 
Orc1 in primary amino sequence - Figure 1-11 (Duncker et al. 2009), possessing 
the characteristic Walker A and B motifs typical of the AAA+ family of ATPases, 
which have been shown to be involved in ATP binding or hydrolysis,thereby 
regulating Cdc6 activity (Speck & Stillman 2007; Iyer et al. 2004). In S. 
cerevisiae, mutation of the Cdc6 Walker A motif (K114A) is lethal. However, the 
mutant is still able to bind chromatin, but prevents Mcm2-7 recruitment, 
suggesting that ATP hydrolysis by the Walker A motif mediates structural 
changes that lead to helicase binding (Weinreich, Liang, & Stillman 1999). In the 
same study a double alanine mutation in the Walker B motif [DE(223,244)AA] 
was fully functional (Weinreich et al. 1999). In humans (Herbig, Marlar, & 
Fanning 1999), mutations in the Walker A motif (K208A) and Walker B motif 
(E285Q) have been described, and similar mutations in Xenopus (Frolova et al. 
2002)[Walker A mutation (K202E) and Walker B mutation (E277G)], all supporting 
an essential role of ATP binding and hydrolysis by Cdc6 in these organisms. Based 
on primary sequence homology comparison, the C-terminus of Cdc6 is predicted 
to have a winged helix-turn-helix domain capable of binding DNA, as observed 
for Orcs1-5 (Duncker et al. 2009), although evidence that this domain directly 
binds DNA is still lacking (Kawakami & Katayama 2010). Rather, a KRKK motif 
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(amino acid residues 29-32) present in S. cerevisiae Cdc6 has been shown by 
site-directed mutagenesis to be essential for DNA recognition in vivo and in vitro 
(Feng et al. 2000). The collective function of ORC and Cdc6 is to load a pre-
formed heptameric complex of Cdt1 and Mcm2-Mcm7 complex onto origin DNA 
(Tsakraklides & Bell 2010). 
1.6.3.3 Cdc10-dependent transcript 1 (Cdt1) 
A third factor involved in the formation of pre-RC is Cdt1, essential for 
recruitment of the MCM helicase (Tsakraklides & Bell 2010; Chen et al. 2007). 
Cdt1 was originally identified in S. pombe in a screen to isolate novel targets of 
the Cdc10 gene, which encodes a cell cycle regulated DNA binding protein 
(Hofmann & Beach 1994). Like Cdc6 (Cdc18 for S. pombe), Cdt1 in S. pombe is 
transcribed in a cell cycle dependent manner (by Cdc10-dependent 
transcriptional regulation), with expression peaking at G1/S transition and 
absent from the rest of the cell cycle (Nishitani et al. 2000; Hofmann & Beach 
1994). Homologues of Cdt1 exist in higher eukaryotes, including Drosophila 
(named double parked or Dup) (Whittaker, Royzman, & Orr-Weaver 2000), 
Xenopus (named XCDT1) (Maiorano, Moreau, & Mechali 2000), humans 
(Wohlschlegel et al. 2000), and S. cerevisiae (also known as Tah11/Sid2) (Tanaka 
& Diffley 2002). Sequence similarity between Cdt1 eukaryotic homologues is very 
low, and hence a single BLAST search using S. pombe Cdt1 alone was insufficient 
to confidently identify a budding yeast homologue (Tanaka & Diffley 2002). 
Rather, a three-way multiple sequence alignment of a weak candidate from 
BLAST searches showed that Cdt1 from budding yeast and fission yeast were 32 % 
similar and 18 % identical in amino acid sequence, while both proteins were only 
12 % identical to the Xenopus homologue (Tanaka & Diffley 2002). 
The primary structure of Cdt1 lacks motifs associated with enzymatic properties. 
Thus, Cdt1 has been suggested to function as an adaptor protein that holds the 
MCM helicase and the ORC-Cdc6 complex together (Tada 2007). Functionally, 
Cdt1 has a poorly conserved N-terminal consensus motif with a phosphorylation 
site possibly recognised by CDK for regulation of its activity (Senga et al. 2006; 
Sugimoto et al. 2004). Like Cdc6, in mammalian cells Cdt1 is degraded at late S-
phase and G2, when CDK activity is high and where it is phosphorylated and 
degraded by an Skp2-dependent mechanism (Sugimoto et al. 2004). To prevent 
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re-initiation of DNA-synthesis, the activity of Cdt1 is negatively regulated by an 
interacting factor (Geminin), whose expression increases at late S and G2 phase 
of the cell cycle, binding Cdt1 and blocking its interaction with MCM, thereby 
preventing re-licensing (Tada et al. 2001; Wohlschlegel et al. 2000; McGarry & 
Kirschner 1998). Although Cdt1 has been shown to interact with Cdc6 in 
mammalian and yeast cells (Cook, Chasse, & Nevins 2004; Nishitani et al. 2000), 
there is still controversy in the literature as to whether Cdt1 binds directly to 
chromatin, or is able to trigger the recruitment of Mcm2-7 with or without Cdc6 
in Drosophila and Xenopus extracts (Maiorano et al. 2000; Whittaker et al. 2000). 
However, more recent studies in Xenopus suggest that Cdt1 associates with 
chromatin and only in the presence of Cdc6 can it mediate loading of the 
helicase Mcm2-7 for DNA licensing to occur (Tsuyama et al. 2005). Other studies 
have also confirmed that all three components (ORC, Cdc6 and Cdt1) are 
essential for loading of the helicase to form the pre-RC (Randell et al. 2006). 
Even more recently, in S. cerevisiae, Cdt1 has been shown to play a direct role 
in recruiting the MCM complex via its interaction with specific motifs (N-
terminus residues 1–185 and C-teriminus residues 270–435) of Orc6 (Chen et al. 
2007).  
1.6.3.4 Minichromosome maintenance (MCM) proteins  
The Mini Chromosome Maintenance (MCM) proteins were first identified in S. 
cerevisiae mutants which were defective in the maintenance of mitotically 
stable circular plasmids with a functional ARS and centromeric sequence (Maine, 
Sinha, & Tye 1984). Subsequently, it was independently shown that mutations in 
mcm2 affected the replication of a plasmid but not its segregation (Maiti & Sinha 
1992). In all eukaryotes studied so far, the prime candidate for duplex DNA 
unwinding during initiation and progression of DNA replication is a complex 
composed of six closely related paralogues, named Mcm2 through Mcm7 (Mcm2-
Mcm7) (Liu, Richards, & Aves 2009b; Tye 1999). Functional MCM in eukaryotes 
forms a hetero-hexameric complex involving all six proteins and this organisation 
is conserved in all eukaryotes examined (Bochman & Schwacha 2009; Liu et al. 
2009b; Forsburg 2004). However, various MCM subcomplexes have been 
detected, suggesting that formation of the hexameric complex occurs in a 
stepwise fashion; for a comprehensive review see (Bochman & Schwacha 2009). 
Using a chromatographic fractionation assay in Xenopus laevis egg extracts, it 
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has been shown that Mcm4, Mcm6 and Mcm7 are first assembled into a stable 
hexameric complex (two trimers), which then binds two Mcm2 homodimers to 
form two tetramers of Mcm2/4/6/7. Each of the Mcm2/4/6/7 tetramers then 
interacts with a heterodimer of Mcm3/5 to form the complete heterohexameric 
complex (Prokhorova & Blow 2000). In human cells, a stable trimeric subcomplex 
of Mcm4/6/7, with a loose interaction to Mcm2, forms the same tetramer 
observed in Xenopus (Schulte et al. 1996; Musahl et al. 1995). Mcm2/4/6/7 and 
Mcm3/5 subcomplexes have also been described in yeasts (both budding and 
fission), mouse, Drosophila, human cells and Xenopus, suggesting the mechanism 
of hexamer formation is also conserved (Schwacha & Bell 2001; Prokhorova & 
Blow 2000; Ishimi 1997; Schulte et al. 1996; Musahl et al. 1995; Kimura et al. 
1995). In vivo and in vitro studies from various eukaryotes have demonstrated 
that the dimeric subcomplex comprised of  Mcm4/6/7 forms a ring-shaped 
structure, with a high level of 3′ → 5′ DNA-dependent helicase activity, and is 
capable of binding single-stranded DNA (Sato et al. 2000). Addition of Mcm2, 
Mcm3, and Mcm5 modulates this helicase activity, suggesting that Mcm4/6/7 is 
the functional helicase subcomplex while Mcm2, Mcm3, and Mcm5 play a 
regulatory role within the heterohexamer (Kanter, Bruck, & Kaplan 2008; 
Schwacha & Bell 2001; Lee & Hurwitz 2000; Sato et al. 2000; Schulte et al. 1996).  
It has been suggested that MCM is loaded onto ORC and Cdc6 as a hexameric ring 
composed of Mcm2-Mcm7 and this loading event, mediated by Cdt1, is regulated 
by hydrolysis of ATP by Cdc6 (Randell et al. 2006; Machida, Hamlin, & Dutta 
2005). In vitro experiments using S. cerevisiae support this model and further 
propose that Mcm3 and Mcm5 are stabilised in the hexameric complex by Cdt1 
(Tsakraklides & Bell 2010). A stable interaction between ORC and MCM has not 
previously been described in unmodified eukaryotes; only when Cdt1 is tethered 
to Orc1-5 has this interaction been described (Chen et al. 2007).  In S. cerevisiae, 
once the MCM complex is recruited onto chromatin-bound ORC and Cdc6, ORC 
and Cdc6 can be washed from the complex by high salt, suggesting that MCM is 
the key licensing factor that is needed to prime pre-RC for DNA elongation 
(Donovan et al. 1997). This licensing is regulated by post-translation 
modifications, such as phosphorylation of bound MCM subunits [for example the 
Mcm4 subunit (Sheu & Stillman 2010)] by Dbf4–Cdc7 kinase (DDK, Dbf4-
dependent protein kinase). The regulatory pathways that are involved in 
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replication licensing post pre-RC formation is beyond the scope of this thesis, 
and hence are not covered.  
1.7 DNA replication initiation in archaea 
In archaea the DNA replication initiation machinery is fundamentally related to 
that of Eukarya, indicative of their descent from a common (and presumably 
archaeal-like) ancestral machinery (Dionne et al. 2003). Eukaryotes typically 
have large numbers of linear chromosomes, each of which possess multiple 
replication origins (see above). In contrast, in archaea with circular 
chromosomes, some have single replication origins [e.g. Pyrococcus abyssi; 
(Matsunaga et al. 2001)] and others have three origins [e.g. S. solfataricus and 
Sulfolobus acidocaldarius; (Lundgren et al. 2004)]. In both systems, licensing of a 
replication initiation site involves the loading of a series of different factors. 
ORC in all archaea studied (except three methanogenic archaeal species where 
the protein is not been identified) is not a multi-component complex as observed 
in eukaryotes (see above), but is instead composed of a protein that is related to 
both eukaryotic Orc1 and Cdc6 (referred to as Orc1/Cdc6) - Figure 1-12 (Barry & 
Bell 2006). Some archaeal species encode a single Orc1/Cdc6 protein (e.g 
members of the Pyrococcus spp), while others encode greater numbers: for 
example, two for Aeropyrum pernix and Methanobacterium 
thermautotrophicum; three for Sulfolobus Spp; five for Natronomonas 
pharaonis; seventeen for Haloarcula marismortui; and none for Methanococcus 
jannaschii, M. maripaludis, and M. kandleri (Barry & Bell 2006). It remains 
unknown what the initiator protein is in these latter organisms that do not 
encode an ORC or a Cdc6 homologue (Barry & Bell 2006). 
Archaeal Orc1/Cdc6s that have been characterised bind specifically to origins of 
replication in vivo and in vitro and, in some cases, as observed in Solfolobus spp 
(similar to bacteria for dnaA  gene locus and OriC), the origin is located in close 
proximity to the orc1/cdc6 gene (Duggin et al. 2008; Duggin & Bell 2006; 
Matsunaga et al. 2001). More recently, the structure of Orc1/Cdc6 from 
Sulfolobus solfataricus bound to a replication origin has been determined to 3.4 
angstrom–resolution, showing DNA distortion and protein conformation changes 
that are likely to allow the recruitment of further factors, suggesting they 
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designate replication origins in a manner related to their eukaryotic orthologues 
(Dueber et al. 2007). Like eukaryotic ORC proteins, archaeal Orc1/Cdc6 proteins 
have a C-terminal winged helix domain, which is conserved for a number of 
archaeal species (Singleton et al. 2004) and functions as a DNA binding domain, 
as observed from structural and mutational analysis in Pyrobaculum aerophilium 
(Liu et al. 2000). The N-terminal domain contains an AAA+ ATPase domain 
indicative of a regulatory role imposed by ATP binding and hydrolysis; a 
phenomenon that is observed as structural conformational changes induced 
when Orc1/Cdc6-2 (the second Orc1/Cdc6 protein) of A. pernix is crystallised 
with ADP (Singleton et al. 2004).  The downstream factors in archaea that 
constitute the pre-replication complex also appear simpler than those in 
eukaryotes.  
Cdt1 is a critical factor in eukaryotic pre-replication complex formation, 
functioning with ORC and Cdc6 to recruit the MCM helicase (see above). Very 
recently, a factor in archaea, named WhiP (winged helix initiator protein), has 
been identified that bears 34 % sequence similarity and 21 % identity to the C-
terminal region of S. cerevisiae Cdt1 (Robinson & Bell 2007). Further 
bioinformatic analyses and alignment with four other archaeal homologues 
revealed the presence of two highly conserved N-terminal and C-terminal 
regions which consist of a winged helix-turn-helix (wHTH) DNA binding domain 
reminiscent of the RepA plasmid initiator protein from the bacterium 
Pseudomonas (perhaps suggesting the likely evolutionary descent of Cdt1) 
(Robinson & Bell 2007). As mentioned above, S. solfataricus has three origins, 
two of which are located upstream of the orc1/cdc6-1 and orc1/cdc6-3 genes. 
Following identification of the WhiP protein, Duggin et al (2008) found that the 
third origin was located in close proximity to whip locus (Duggin et al. 2008).  
The presumptive DNA unwinding element, MCM, observed to be a 
heterohexameric protein in eukaryotes, is a homohexamer in archaea. Unlike 
eukaryotic MCMs, all archaea have at least a single MCM homologue (for example 
in Pyrococcus spp and Solfolobus spp), although some have more than one MCM 
homologue (for example two in Methanopyrus kandleri and three in Haloarcula 
marismortui) (Barry & Bell 2006). Structural studies on archaeal MCM proteins 
have produced diverse results, depending on the species studied. For example, 
in vitro characterisation of S. solfataricus MCM showed that the protein forms 
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homohexamers in solution (Carpentieri et al. 2002), while electron microscopic 
reconstruction studies of Methanobacterium thermoautotrophicus have shown a 
ring-shaped dodecameric complex (Kasiviswanathan et al. 2004; Chong et al. 
2000). Like eukaryotic MCM, the archaeal MCM proteins also possess 3′ → 5′ DNA-
dependent helicase activity and bind both single-stranded DNA and double-
stranded DNA (De Felice et al. 2003; Chong et al. 2000). Direct interactions have 
been reported for archaeal MCM and Orc1/Cdc6 in S. solfataricus by gel 
filtration analyses (De Felice et al. 2003) and in M. thermautotrophicus by yeast 
two-hybrid analysis (Shin et al. 2003), and by pull-down and co-
immunoprecipitation experiments (Kasiviswanathan, Shin, & Kelman 2005). From 
the results above, it was suggested that Orc1/Cdc6 may function as a helicase 
loader in the absence of a clear Cdt1 archaeal homologue (De Felice et al. 2003). 
 
1.8 DNA replication initiation in T. brucei 
In T. brucei previous work on DNA replication have examined sequences likely to 
function as replication origins (see above) rather than consider initiator factors 
that are required to carry out the process. With the publication of the genome 
sequence for T. brucei in 2005 (Berriman et al. 2005), it is now possible to use 
web-based algorithms to predict the function of T. brucei genes based on amino 
acid sequence homology with those of other organisms. Surprisingly, based on in 
silico searches, kinetoplastids (though eukaryotes) appear to possess an 
archaeal-like, simplified machinery for origin designation. Notably, T. brucei, T. 
cruzi and Leishmania contain a single identifiable ORC homologue, which 
appears to be related to both eukaryotic Orc1 and Cdc6 and is thus predicted to 
provide the functions of both Orc1 and Cdc6 (El Sayed et al. 2005b), as reported 
for archaea (Robinson & Bell 2005). Given this, the protein has been named 
ORC1/CDC6 (named hereafter TbORC1/CDC6 for the T. brucei protein), 
following the archaeal nomenclature.  
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Figure 1-12 – Comparison of the DNA replication initiation factors in Eukarya, 
Trypanosomatids, and Archaea 
A comparison of the identified factors that generate the DNA pre-replication complex, and their 
presumptive order of action, in those eukaryotes that have been studied (‘standard’), 
trypanosomatids (e.g. T. brucei) and in the archaea. Homologues of eukaryotic Cdt1 have not been 
identified in any archaea or in the trypanosomatids (cross); the replicative helicase, MCM, is a 
hexamer composed of 6 distinct polypeptides in eukaryotes, which are conserved in the 
trypanosomatids, whilst it is normally a homomeric double or single hexamer in the archaea 
 
In support of this nomenclature, T. brucei ORC1/CDC6 appears to be as closely 
related to its archaeal relatives as to eukaryotic Orc1 and Cdc6 proteins (Figure 
1-13A), suggesting it assumes both roles. It also lacks the N-terminal extensions 
found in the Orc1 and Cdc6 proteins of other eukaryotes, instead possessing the 
N-terminal AAA+ domain and C-terminal winged-helix-turn-helix architecture 
characteristic of the archaeal proteins (Liu et al. 2000) (Figure 1-13B).  
In addition to the finding of only ORC1/CDC6, no clear homologue of Cdt1 could 
be found by BLAST searches of the kinetoplastid genomes. Though this may not 
be surprising, given the sequence divergence of Cdt1 in those eukaryotes in 
which it has been characterised, this may lend support to the idea that the very 
early steps of replication intitiation in T. brucei is archaeal-like. Recently, what 
appeared to be a distant homologue of archaeal WhiP was identified by 
bioinformatic searches of the kinetoplastid genomes (gene ID Tb927.6.5070, 
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referred to here as TbWhiP/CDT1). However, TbWhiP/CDT1 functional analysis 
by RNAi and BrdU incorporation to assess in vivo the effect of knockdown on DNA 
replication showed that this protein is unlikely to be involved in DNA replication 
in T. brucei. These data, being negative, are not presented in this thesis, and 
the protein is not considered further, except for in one experiment (see Section 
3.3.6).   
The absence of homologues of Orc2-Orc6 has not been described for any other 
eukaryotic organism, raising numerous mechanistic and evolutionary questions. 
If, indeed, these eukaryotic parasites utilise an archaeal-like, streamlined 
machinery (Figure 1-12) for replication origin licensing, this would be wholly 
novel for a eukaryote. However, this is complicated by the fact that the MCM 
helicase in kinetoplastids looks conventionally heterohexameric, with all six 
components readily identified bioinformatically. Nevertheless, a recent 
publication (Godoy et al. 2009) has begun to examine this question, and showed 
that T. brucei ORC1/CDC6 can complement an S. cerevisiae cdc6 mutant, 
providing evidence for CDC6-related activity and support for hypothesis that the 
trypanosome pre-replication machinery may be similar to the archaeal system. 
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Figure 1-13 – A phylogenetic comparison of complete Orc1 and Cdc6-related proteins 
A phylogenetic comparison of complete Orc1 and Cdc6-related proteins in those eukaryotes that 
have been studied (‘standard’), trypanosomatids and in the archaea; the length corresponding to 
10 amino acid (aa) changes per 100 residues is indicated. B. A diagram of sequence homology 
between Orc1 and Cdc6 proteins from S. cerevisiae, and Orc1/Cdc6 proteins from A. pernix and T. 
brucei (numbers indicate lengths in aa). Regions of homology are boxed grey; Walker A and B 
boxes, which define the AAA+ domain along with sensor motifs I and II, are shown as black bars 
and the the C-terminal winged-helix domain (W-H) involved in DNA binding is indicated. N-terminal 
sequence not conserved in trypanosomatid or archaeal proteins is in white 
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1.9 Project aims 
To the best of our knowledge, at the outset of this project, the process of 
nuclear DNA replication initiation in T. brucei and related kinetoplastids (L. 
major and T. cruzi) had not been studied. Our overall objective was therefore to 
elucidate the mechanism and machinery of nuclear DNA replication in T. brucei, 
and, as you will see, we have begun to develop a clearer picture of the process 
than was previously understood. 
1.9.1 Specific aims 
This project had three specific aims: 
 
1. To characterise TbORC1/CDC6 function in T. brucei (Chapter 3) 
2. To identify TbORC1/CDC6 molecular partners (Chapter 4) 
3. To identify and dissect replication origins in T. brucei (Chapter 5) 
To address Aim 1, Chapter 3 describes RNAi analysis of T. brucei ORC1/CDC6 
function that was performed prior to the publication of Godoy et al (2009), and 
will discuss similarities and differences in the findings. Using the TbORC1/CDC6 
RNAi lines, non-replication functions of TbORC1/CDC6 are also presented. 
To address Aim 2, Chapter 4 describes the generation of functional epitope-
tagged TbORC1/CDC6, and its application in co-immunoprecipitation 
experiments coupled with mass spectrometry to uncover TbORC1/CDC6 binding 
partners. 
To address Aim 3, Chapter 5 describes the application of the functional epitope-
tagged TbORC1/CDC6 to identify TbORC1/CDC6 binding sites by chromatin 
immunoprecipitation coupled with microarray technology. 
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2 Material and Methods 
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2.1 Trypanosome Strains, Cell Culture, & Genetic 
Modification 
2.1.1 T. brucei strains 
In this thesis, three strains of T. brucei and their genetically modified 
derivatives were used: Lister427, TREU (Trypanosomiasis Research Edinburgh 
University) 927, and EATRO (East African Trypanosomiasis Research Organisation) 
795. For RNA interference (RNAi), T. brucei procyclic form strain 427 pLew29-
pLew13, bloodstream form strain 427 pLew90-pLEW13, or procyclic form 795 
pLew13-pLew29 were used. The pLew90-pLEW13 or pLew29-pLew13 parasite 
lines developed by Wirtz et al (Wirtz et al. 1999) constitutively co-expresses T7 
RNA polymerase (T7RNAP) and the Tet repressor (TetR). Integration of the 
T7RNAP and TetR constructs were selected, respectively, by neomycin (G418) 
and hygromycin B selectable markers. Where necessary, selection of RNAi 
parasite lines expressing the T7RNAP, TetR and the RNAi construct was achieved 
by addition of hygromycin B, G418, and zeocin (for procyclic form cells) or 
phleomycin (for bloodstream form cells). Apart from RNAi experiments, the 
TREU927 wild type cell line was used for all other experiments except where 
specific genetically modified lines are indicated to have been used. 
2.1.2 Procyclic-form cell culture 
The term “procyclic form” (PCF) refers to the replicative tsetse fly midgut stage 
of T. brucei. In vitro, PCF T. brucei cultures were grown at 27 °C in a derivative 
of semi-defined medium (SDM-79, see recipe below) (Brun 1992), supplemented 
with 10 % (v/v) heat inactivated foetal calf serum (FCS) and 0.2 % (v/v) haemin 
[diluted from a 2.5 mg.mL-1 in NaOH (Gibco)]. Typically, PCF cells were 
maintained by a 1:10 dilution every 3 – 4 days of a culture that was usually at a 
density of ~8 x 106 cells. 
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SDM79 recipe (5 L) 
One sachet SDM79 Cat#  07490916N, Gibco 
NaHCO3 (BDH Ltd) 24 mM final concentration 
Distilled H2O up to to 5 L 
pH adjusted with 5 M NaOH 7.3 
 
2.1.3 Bloodstream-form cell culture 
‘Bloodstream form’ (BSF) refers to the replicative stage of T. brucei that resides 
extracellularly in the blood and tissue fluids of mammals. In vitro, BSF cultures 
were grown in petri dishes at 37°C, 5 % CO2 in a humified incubator (Heraeus 
Instruments). BSF cells were grown in HMI-9 medium supplemented with 20 % 
(v/v) heat inactivated FCS; see recipe below (Hirumi & Hirumi 1994). Except 
where stated, BSF cells were harvested at densities of 3 – 5 x 106 cells.mL-1 for 
all experiments or for cryo-preservation. BSF cultures were maintained by a 
1:100 dilution of a culture of density 3 – 5 x 106 cells.mL-1 every 3 – 4 days. 
HMI-9 recipe (5 L) 
One sachet HMI9 powder (Gibco) Cat#  07490915N, Gibco 
NaHCO3 (BDH Ltd) 36 mM final concentration 
β-mercaptoethanol (Sigma) 1.4 % 
Penicillin/Streptomycin (Cat# 15140, Gibco) 50 mL 
Distilled H2O up to 5 L 
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2.1.4 Routine growth and maintenance of trypanosomes 
Cell density was determined microscopically using an improved Neubauer 
haemocytometer (Weber Scientific). In a 10 µl aliquot, the number of parasites 
under a 1 mm square area was counted. This was repeated for three 
independent 1 mm squares and the average of three counts was multiplied by 
104 to get the number of cells per millilitre of culture. For long-term 
preservation, T. brucei cells were cryo-frozen in liquid nitrogen with unique 
identification numbers, known locally as “stabilate numbers”. Log-phase PCF or 
BSF cells were supplemented with 10 % glycerol in SDM79 or HMI-9 medium, 
respectively, aliquoted  in 1 ml volumes into cryo-vials, wrapped with cotton 
wool and frozen overnight at – 80 C. After the overnight period, the labelled 
cryo-vials were transferred to liquid nitrogen at a specific location and 
electronically recorded into a database. Recovery of stabilates was achieved by 
gradually thawing to room temperature (RT) and supplementing with 5 ml of 
warm medium without any drug selection. After a few days (2 – 3 days) in 
culture, the medium was supplemented with drugs and lines re-tested for any 
previous modification before further analyses. 
2.1.5 Stable transfection of T. brucei procyclic form cells 
All centrifugation steps were performed at 600 x g. PCF cells at a density of 5-10 
x 106 cells.mL-1 were centrifuged for 10 min at RT and the supernatant removed 
and preserved for use as “conditioned medium”. ~ 2.5 x 107 cells were 
resuspended in 0.5 ml of ice-cold Zimmerman medium (‘ZMnoG’; 132 mM NaCl, 
8 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, 0.5 mM MgAc2, and 0.06 mM CaAc2, pH 
7.5), known as electroporation buffer. 10 µg of linearised DNA (prepared as 
described below), in a maximum volume of 10 ul of sterile double-distilled 
water, was added to the cells resuspended in ZMnoG. After mixing to 
homogenise, two pulses were delivered using a Bio-Rad Gene Pulser II set at 
1.5 kV and 25 μF capacitance. After electroporation, the delivered voltage was 
usually ~ 1.40 to 1.60 kV and a time constant of ~ 0.30 to 0.50 ms was recorded. 
The cells were then transferred into 10 ml of pre-warmed SDM79 medium and 
incubated at 27 ºC overnight (usually 12 – 24 hrs)  to allow recovery before being 
subjected to drug selection. After overnight recovery, cells were selected in 
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medium supplemented with antibiotics at concentrations described below (Table 
2-1). 
Table 2-1 - Antibiotics used for selection of genetically modified parasites  
Antibiotics Stock 
concentration 
Final 
concentration 
Phleomycin (Cayla) 20 mg.mL-1 2.5 μg.mL-1 (BSF) 
Zeocin (Invitrogen) 100 mg.mL-1 10 μg.mL-1 (PCF) 
Hygromycin B (CALBIOCHEM) 50 mg.mL-1 5 μg.mL-1 (BSF) 
50 μg.mL-1 (PCF) 
Neomycin or G418 (SIGMA) 50 mg.mL-1 2.5 μg.mL-1 (BSF) 
10 μg.mL-1 (PCF) 
Blastidicin (CALBIOCHEM) 10 mg.mL-1 10 μg.mL-1 (BSF) 
15 μg.mL-1 (PCF) 
Puromycin (CALBIOCHEM) 10 mg.mL-1 0.2 μg.mL-1 (BSF)   
1 μg.mL-1 (PCF) 
Tetracycline (CALBIOCHEM) 5 mg.mL-1 1-2 μg.mL-1 (BSF) 
1-2 μg.mL-1 (PCF) 
 
 “Conditioned medium” was prepared by adding 10 % (v/v) FCS, 15 % (v/v) 
sterile filtered medium from a dense culture (up to 107 cells/ml), and 75 % (v/v) 
SDM79 medium supplemented with appropriate selection antibiotics. 100 ul and 
1 ml of the population of electroporated and recovered parasites was added 
separately to 20 ml of conditioned medium and distributed in all welsl of a 96 
well plate (175 µl in each well). The growth of antibiotic-resistant transformants 
was monitored by looking for wells containing growing cells 10 – 14 days later. 
The transformants were considered to be clonal if growing cells arose in 10 or 
less wells of the 96 well plates. This procedure was used for all PCF transfections 
except for antibiotic selection of clones which depended on the resistance 
marker present in the vectors used which are shown in Table 2-2 and the drug 
concentrations used are shown in Table 2-1.  
DNA to be transfected was linearised using appropriate restriction enzymes as 
described in Section 2.3.3; except that this time the reaction was scaled up to a 
final reaction volume of 300 μl containing ~ 100 μg of DNA, the reaction mixture 
was incubated overnight, ethanol precipitated as described in Section 2.2.3 and 
resuspended in sterile double-distilled H20. The DNA concentration was 
measured using a Nanodrop spectorphotometer (ThermoScientific). 
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2.1.6 Stable transfection of T. brucei bloodstream form cells 
DNA preparation and all steps up to electroporation were essentially the same as 
described for PCF cells, except for the following. Transformation used the 
AMAXA Nucleofactor kit, optimised for Human T-cells according to the 
manufacturer’s protocol (Cat# VPA-1002, Amaxa Biosystems). For each 
transfection, 1-2 x 106 cells.mL-1 BSF cells were used with 10 μg of DNA. After 
electroporation, the cells were serially diluted 1:10 in three consecutive tubes 
containing 30mL, 27mL, and 27 mL of HMI-9, without antibiotic. Each dilution 
was then distributed in 24 well plates (1.0 ml per well) and incubated at 37 0C 
for 6 – 12 hrs for recovery. After recovery, 1 ml of HMI-9 medium containing 
double the concentration of antibiotic used for selection of transformants (Table 
2-1) was added to each well and incubated for 7 – 10 days at 37 0C. Plates in 
which at most 6 out of 24 wells contained growing T. brucei cells were 
considered clones and were used for further experiments. 
2.2 General methods for DNA analysis 
2.2.1 Primer design 
A necessary first step in primer design for PCR in plasmid construction was 
retrieval of DNA sequences from genome sequence databases. DNA sequences 
were retrieved from TriTryDB (http://tritrypdb.org/tritrypdb/) using gene IDs 
for any gene of interest. All oligonucleotides used were designed using the 
primer design software supplied by Invitrogen® with the vectorNTI® package. 
Suitable restriction enzyme recognition sites were appended to the 5’ end of 
each primer, along with a further four G residues at the 5’ terminus. Also, 
restriction sites within the target gene were avoided and caution was taken to 
ensure in-frame fusion of the gene for any tags that were necessary in the final 
vector. All oligonucleotides were synthesised by Eurofins MWG Operon® 
(Germany). The sequences of oligonucleotides, destination vectors, and 
restriction sites used are shown in Table 2-2.  
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2.2.2 DNA Isolation  
Plasmid purification from Escherichia coli and DNA extraction from agarose gels 
used the Qiagen Miniprep kit and the Qiagen Gel Extraction kit, respectively, 
following the manufacturer’s protocols. Genomic DNA (gDNA) isolation from T. 
brucei cells was carried out using the Qiagen DNeasy Kit according to 
manufacturer’s instructions.  
2.2.3 Ethanol precipitation 
To purify and concentrate DNA from solution, three volumes of ice cold ethanol 
(Fisher) was added to the DNA solution and, subsequently, sodium acetate 
(CH3COONa, pH 5.2) (BDH) was added to a final concentration of 0.3 M.  The 
mixture was incubated at - 80 oC for 30 minutes and then centrifuged at 20,000 x 
g for 30 minutes at 4 oC. The supernatant was carefully decanted and the pellet 
was washed twice with 1 mL 70 % ethanol. After the washes, the pellet was air 
dried and re-suspended in Tris-EDTA (TE) buffer (see recipe below) or distilled 
water depending on the subsequent application. 
TE buffer 
Tris-HCl 10 mM (pH 7.5) 
EDTA 1 mM 
 
2.3 Molecular cloning 
2.3.1 Polymerase chain reaction (PCR) 
A typical 50 ul PCR reaction was constituted as follows: 1 U of either Taq (New 
England Biolabs, NEB) or Phusion (NEB), 2.5 μl (10 μM stock) of each primer, the 
required buffer concentration (manufacturer’s recommendation), 4 μl (2.5 mM 
stock) dNTPs, 10-50 ng of template DNA and distilled water (dH20) to a final 
volume of 50 μl per reaction. DNA from T. brucei strain TREU927 was used as 
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DNA template for all cloning of ORFs and gene fragments, except for cloning of 
inserts for RNAi experiments where gDNA of the Lister427 strain was used. PCR 
amplification was carried out using a TC-3000 thermocycler (Techne), under the 
following PCR conditions: denaturation at 94 oC for 5 minutes, followed by 25 - 
30 cycles of denaturation at 94 oC for 1 minute, annealing of primers at 55 oC for 
1 minute and extension at 72 oC for 1 minute per kilobase (kb) amplified. A final 
extension time of 10 minutes at 72  oC was included at the end to ensure 
complete PCR amplification. After PCR cycling, samples were checked by 
running a 1 % agarose gel and the PCR product was cleaned from primer dimers 
and contaminating salt and enzymes using the PCR purification kit from Qiagen® 
according to manufacturer’s instructions. 
2.3.2 Agarose Gel Electrophoresis 
DNA was separated on 1 % (w/v) agarose (Invitrogen) gels in 1X Tris Acetate-
EDTA (TAE) buffer (40 mM Tris-HCl, 1 mM EDTA, pH 8.0, 0.11 % Acetic acid) 
containing 0.2 μg.mL-1 ethidium bromide (Sigma) or 1:20,000 dilution of 
SYBRSafe (Invitrogen). Using a Bio-Rad PowerPac Mini, agarose gels were run at 
100 – 120 V for 30 – 45 min depending on the sizes of the DNA fragments 
resolved. Visualisation was done with a U.V. transilluminator (Bio-Rad) and 
digitised using QuantityOne software v4.6 (Bio-Rad). A commercial 1 Kb size 
marker (NEB) was used to determine the size of DNA fragments resolved by 
agarose gel electrophoresis.  
2.3.3 Restriction endonuclease digestion 
All restriction enzyme digests for cloning were carried out as follows: e.g. 1 – 2 
μl (typically 10 – 20 units. μl-1 ) of appropriate enzyme (NEB), 1 - 10 μg total 
DNA, the required NEB buffer at the appropriate concentration (10X stock 
provided), and dH20 to a final volume of 20 μl per reaction. In cases where DNA 
was being prepared for transfection of trypanosome cells, a total reaction 
volume of 300 μl was prepared, with buffer and enzymes scaled up 
appropriately. A standard 20 μl reaction was incubated at the optimum 
temperature required for the particular enzyme for 1 – 2 h. For DNA to be used 
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in transfection, incubation was performed overnight at the manufacturer’s 
specified temperature of the restriction enzyme. 
2.3.4 DNA ligation 
To insert digested PCR products or DNA fragments into plasmids, DNA ligation 
was carried out. A typical 20 μl reaction contained the following: 2.5 units of T4-
DNA ligase (NEB), molar ratios of vector to insert was typically 1:3 (typically 50 
ng linearised dephosporylated plasmid vector to 150 ng digested insert DNA), 2 
μl of 10X ligation buffer (NEB provided) and dH20 to a final volume of 20 μl. The 
reaction mix was incubated at RT for 2 h prior to bacterial transformation. 
2.3.5 Bacterial transformation 
E. coli XL1-Blue MRF [Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 
recA1 gyrA96 relA1 lac [F´ proAB lacIqZΔM15]; Stratagene] competent cells were 
used for plasmid propagation. For ligation reactions, 5 μl was mixed with a 50 – 
100 μl aliquot chemically competent E. coli XL1-Blue, purchased commercially 
from Stratagene. The DNA/E. coli mix was first incubated on ice for 30 minutes 
and then heat shocked at 42 oC for 40 seconds. 750 μl of LB (see recipe below) 
was added to the cells and the mix was incubated for 45 minutes at 37 oC in a 
shaker. After incubation, 200 μl of cells were plated onto antibiotic selective LB 
agar plates (see recipe below) with appropriate drugs for positive selection of 
plasmids (Section 2.4.1). LB agar plates were incubated at 37 oC overnight. 
Colonies were picked, screened by colony PCR (described below) and plasmids 
from positive colonies were sent for sequencing by the University of Dundee DNA 
sequencing service. Primers used for sequencing were usually the same primers 
used to amplify the gene from gDNA. After sequencing, contigs were assembled 
using the ContigExpress tool in Vector NTI Suite 10 (Invitrogen) or CLC genomics 
(CLC Bio). 
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Luria Bertani (LB) Medium  LB Medium + Agar = LB Agar 
Tryptone 10 g/L LB Medium  
Yeast extract  5 g/L Bacto-Agar 15 g/L 
NaCl 10 g/L  
…………....... 
 
 
2.4 Selection of bacterial transformants 
2.4.1 Drug selection 
Positive colonies selected on LB agar plates were carried out at concentrations 
shown below: 
Antibiotics Stock 
concentration 
Final 
concentration 
Ampicillin (SIGMA) 100 mg.mL-1 100 μg.mL-1 
Kanamycin (CALBIOCHEM) 30 mg.mL-1 30 μg.mL-1  
Chloramphenicol (CALBIOCHEM) 34 mg.mL-1 34 μg.mL-1  
 
2.4.2 Colony PCR 
The PCR mix for bacterial colony screening and conditions were the same as the 
standard PCR described in Section 2.3.1, except for the following. Template DNA 
was obtained from a single colony picked from the LB agar plate and 
resuspended in 20 μl of dH2O. Twenty-four colonies were picked for each round 
of screening and primers used for PCR-amplifying DNA fragments from gDNA 
were used for colony PCRs. After PCR, a 1 % (w/v) agarose gel was run alongside 
a positive control; where gDNA had been used as the template for the PCR and 
dH2O as a negative control. Positive clones identified were grown overnight in LB 
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medium, plasmids were purified from overnight cultures and sent for 
sequencing. 
2.5 Southern blot, hybridisation and detection  
The NEBlot Kit protocol was used for Southern blot analysis (Cat No. N1500S, 
NEB). 5 - 10 μg of DNA was digested (as described in Section 2.3.3) overnight in a 
total volume of 100 μl with appropriate units of enzyme(s). After digestion, the 
DNA was ethanol precipitated, resuspended in a final volume of 20 μl, and 
loaded onto a 0.8 % agarose gel. The gel was run overnight at 30 V (350 m/s) in 
1X TAE. The gel was then photographed under UV light alongside a ruler to allow 
calculation of the size of fragments after hybridisation and detection. After 
electrophoresis, the gel was incubated in 0.25 M HCl for 10 min with gentle 
agitation. The DNA in the gel was then denatured by soaking the gel in a 
denaturing solution (0.5 M NaOH, 1.5 M NaCl) for 30 min. The gel was neutralised 
by soaking first in a neutralising solution (1 M Tris-HCl pH 8.0, 1.5 M NaCl, 1mM 
EDTA) for 30 min, and then into 20X SSC solution (3 M NaCl + 0.3 M Na Citrate). 
The DNA was transferred overnight to a nylon membrane (Hybond-N+, 
Amersham) by capillary blotting. After the transfer, the blotting apparatus was 
dismantled; the membrane was rinsed in 20X SSC for 5min, air-dried and UV-
crosslinked twice to bind DNA to membrane (UV Stratalinker 2400, Stratagene).  
PCR-amplification for generation of DNA probes used primers CT_OL9/CT_OL10 
for the 5’ UTR probe and primers CT_OL47/CT_OL48 for the TbORC1/CDC6 ORF 
probe. PCR-amplification was carried out as described in Section 3.1. The DNA 
probes were radiolabelled using the random priming method according to 
manufacturer’s protocol (NEBlot protocol). After labelling, probes were purified 
by gel filtration on Sephadex® G-50, Spin Column Elutips® (GE Healthcare) to 
reduce non-specific background and limit exposure of lab personnel to high 
levels of radioactivity during hybridization experiments. Following purification, 
labelled DNA probes were prepared for hybridization as follows: denatured by 
heating in boiling H2O bath 95–100°C for 5 minutes and quickly placed in ice bath 
for 5 minutes. The denatured DNA was either used directly in hybridisation 
experiment or stored at –20°C. 
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After crosslinking the DNA to membrane, the blot was pre-hybridised in 50 ml (to 
cover membrane) pre-warmed Church-Gilbert solution (0.342 M Na2HPO4, 
0.158 M NaH2PO4.2H2O, 0.257 M SDS and 1 mM EDTA) for 2 h at 60 ºC. Then, 
100ng of radiolabelled, purified, and denatured DNA probe was added and 
hybridisation was performed at 60 °C overnight in pre-warmed Church-Gilbert 
solution. After hybridisation, post hybridisation washes were carried as follows: 
the blot was washed twice at 60°C, initially for 5 min, then again for 15 min 
with: (a) 50 ml of 2X SSC + 0.1% SDS and (b) 50 ml 0.2X SSC + 0.1% SDS. The blot 
was then sealed in transparent cling film and visualised by exposure to an x-ray 
film in an autoradiography cassette at - 70°C for 15 min to 7 days. 
2.6 RNA interference and analysis of samples 
2.6.1 RNA isolation and analysis 
2.6.1.1 Generation of cDNA and semi quantitative RT-PCR 
Total RNA was prepared according to the manufacturer’s protocol from the 
Qiagen® RNeasy mini kit. A total of 2 – 4 x 107 cells from cultures with densities 
between 1 - 2 x 106 cells.mL-1 (BSF) or 3 - 4 x 106 cells.mL-1 (PCF) was used for 
each RNA preparation. To digest any contaminating DNA, the RNA preparation 
was treated on column with RNase-free DNase as described by the manufacturer 
(Qiagen®). 
For first strand cDNA synthesis, the SuperScript™ First-Strand Synthesis System 
for RT-PCR (Invitrogen) was used as described by the manufacturer. 1 µg of total 
RNA was used with 50 µM oligo (dT) primers, as per manufacturer’s instructions. 
Identical reactions were set up for each cDNA sample with reverse transcriptase 
(RT) or without RT (to act as a control for gDNA contamination). PCRs were set 
up according to manufacturer’s instructions (Invitogen) using 1 µl of 
cDNA/reaction and primers for TbORC1/CDC6 (CT_OL3/CT_OL4, Table 2-2). The 
conditions for PCR were: 1 cycle of 95 °C for 5 min, either 26 or 30 cycles of 95 
°C for 30 s, 55 °C for 30 s, 72 °C for 60 s, and a final 1 cycle of 72 °C for 10 min.  
RNA Polymerase I largest subunit (Tb927.8.5090) PCR-amplified using primers 
CT_OL5/CT_OL6 (Table 2-2) as a loading control.  
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2.6.1.2 Real-Time PCR 
To quantify levels of mRNA knockdown, primers for real-time PCR of 
TbORC1/CDC6 (CT_OL7/CT_OL8, Table 2-2) were designed using Primer 
Express® software (Applied Biosystems). The SYBR® Green PCR Master Mix 
(Applied Biosystems) was used for PCR amplification in 96 well plates. A master 
mix for 30 reactions was made according to the following recipe: 12.5 µl of SYBR 
mix (provided in kit), 1.0 µl of each primer (300 nM stock), 9.5 µl of dH2O, and 
1.0 µl cDNA (from Section 3.8). GPI8 primers (CT_OL27/CT_OL28) were used as 
an internal control, and dH2O was used for non-template primer controls. The 
ABI Prism 7000 thermocycler conditions for all reactions were 50°C for 2 min, 
95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 1 min. 
Amplification plots generated were used for quantification of mRNA levels as 
described in the Applied Biosystems manual. 
2.6.2 4, 6 - Diamidino-2-phenylindole (DAPI) Staining  
For DAPI staining of T. brucei DNA, 5 x 105 cells were centrifuged at 600 x g, 
washed twice in PBS and resuspended in 100 μl of PBS. 50 μl was spread on a 
glass microscope slide, air-dried, and fixed for 5 min in methanol at RT. The 
slides were then removed from the methanol, which was allowed to evaporate 
at RT, and DAPI with Vectashield (VectorLabs) was added to the slide and spread 
by the addition of a coverslip. Slides were sealed with nail varnish and examined 
under UV light on a Zeiss Axioplan microscope. Images were captured using a 
Hamamatsu ORCA-ER digital camera and Openlab version 3.0.3 software was 
used for processing images. 
2.6.3  Fluorescent Activated Cell Sorting (FACS) Analysis  
For FACS analysis, 106 cells were pelleted by centrifugation at 600 x g, washed 
once in PBS, and resuspended in 70% methanol, 30% PBS. The cells were 
incubated at 4 °C overnight. After fixation overnight, cells were washed in 10 ml 
of ice cold PBS, resuspended in 1 ml of PBS containing 10 μg ml-1 propidium 
iodide (SIGMA) and 10 μg ml-1 RNase A (SIGMA), and incubated at 37 °C for 45 
min. FACS was performed with a Becton Dickinson FACSCalibur using detector 
FL2-A and an AmpGain value of 1.75. 
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2.6.4 In vivo Bromo-2-deoxyuridine (BrdU) labelling, detection and 
quantitation 
After RNAi for 96 hrs, 108 PCF T. brucei cells were labelled with 50 μM BrdU and 
50 μM 2’-deoxycytidine in SDM-79 and incubated at 27°C for 60 mins. After 
incubation, the cells were harvested by centrifugation at 600 x g for 10 minutes, 
and total DNA was extracted using the Qiagen DNeasy Kit according to 
manufacturer’s instructions.  DNA samples were then incubated for 1 hr at 37 °C 
with 33 µg.mL-1 RNase A (Sigma R4642). The amount of purified DNA was 
determined using a NanoDrop (Thermo Scientific) and 2 µg of total DNA was 
incubated with 10 volumes of 0.4 N NaOH solution for 30 min at RT and kept on 
ice to prevent re-annealing.  The DNA solution, kept on ice, was then neutralised 
with an equal volume of 1 M Tris·HCl (pH 6.8). The single-stranded, neutralized 
DNA was next dot-blotted (50 ng in 5 µl) onto a nitrocellulose membrane 
(Amersham) and allowed to air dry. The DNA was fixed twice on the membrane 
using an ultraviolet cross-linker Stratalinker (Stratagene). After the fixation step, 
the membrane was incubated with mouse anti-BrdU monoclonal antibody 
(1:2,000 dilution, B2531, Sigma) in buffer containing TBST (20 mM Tris·HCl, pH 
7.6, 136 mM NaCl, and 0.05% Tween 20) containing 1 % non-fat milk for 1 hr at 
RT. After incubation with the primary antibody, the membrane was washed with 
TBS-T three times for 10 mins each at RT, and then incubated with horseradish 
peroxidase-conjugated anti-mouse IgG antibody (1:5,000 dilution) for 1 h at RT. 
After incubation with the secondary antibody, the membrane was washed three 
times again with TBS-T for 20 min at RT. Detection of the BrdU signal used an 
enhanced chemiluminescence detection system using the QuantityOne software 
(BioRad). Dot intensity on the membrane was quantified by measuring 
chemiluminescent signal relative a neutral spot on the membrane (background) 
using the same software. 
2.7 Protein analysis 
2.7.1 Preparation of whole cell T. brucei extracts  
To prepare whole cell extracts from T. brucei, 108 cells were pelleted at 2000 x 
g for 10 minutes and washed twice in ice cold Phosphate buffered Saline (PBS).  
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The cells were then re-centrifuged and resuspended in 200 μl SDS lysis buffer [63 
mM Tris HCl (pH 6.8), 10 % glycerol, 2 % SDS, 5 % β-mercaptoethanol, 0.0025 % 
bromophenol blue (Sigma)]. This sample was ready for SDS-PAGE 
electrophoresis. 
2.7.2 Sodium-dodecyl-sulphate–polyacrylamide gel 
electrophoresis (SDS-PAGE) 
To separate proteins by electrophoresis, protein samples were loaded into 
precast polyacrylamide gels (Invitrogen) depending on the sizes of the proteins. 
Normally, the gels contained 10 % polyacrylamide, but for higher molecular 
weight proteins (usually > 175 kDa) 5 % gels were used. 20 μl of the T. brucei 
whole cell extract (above) was loaded and separated by electrophoresis at 200 V 
for 60 min. After electrophoresis, the gel was either stained with Coomassie Blue 
or colloidal coomassie for visualisation of all proteins, or specific proteins were 
detected by immunoblotting (Section 3.9.5) after transfer to a nitrocellulose 
membrane. 
2.7.3 Coomassie blue staining of SDS gels 
After electrophoresis, protein gels were visualised by Coomassie blue staining or 
in specific instances where low abundant proteins were visualised, colloidal 
Coomassie staining was used instead. 
For Coomassie staining, gels were immersed in Coomassie stain solution [0.25 g 
Coomassie brilliant blue R [Sigma] in 90 ml of methanol: water [1:1 v/v] and 10 
mls glacial acetic acid] and placed on a rocker for 1 – 4 hours. After staining, the 
gel was destained by immersing gel in a destaining solution [10 % glacial acetic 
acid, 40 % methanol] for 1 hour. 
For colloidal Coomassie staining, protein gels were fixed for 1 hour in fixing 
solution (40% v/v methanol, 7% v/v acetic acid). Immediately before staining, 
gel staining solution was prepared by mixing and then vortexing 4 parts of the 1X 
working solution (1X Brilliant Blue G-Colloidal Coomassie, SIGMA) and 1 part 
methanol. The gel was then incubated in the staining solution overnight. After 
staining, the gel was placed in a destaining solution 1 (10% v/v acetic acid, 25% 
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v/v methanol) for 60 seconds while rocking. The gel was then rinsed with 25% 
v/v methanol, and destained again in 25% v/v methanol for up to 24 hours. To 
visualise bands, the gel was scanned at 600 nm wavelength using a trans-UV 
illuminator (BioRad). Bands were then excised from the gel and sent for mass 
spectrometry for protein identification. 
2.7.4 Identification of proteins by liquid chromatography mass 
spectrometry [LC-MS/MS] 
After colloidal coomassie staining, specific bands were excised directly from SDS 
gels, and sent to The University of Glasgow, Sir Henry Wellcome Functional 
Genomics facility for liquid chromatography mass spectrometry (LC-MS/MS). The 
resulting MS/MS were used to interrogate the TritryDB database using the 
MASCOT software. The MASCOT output resulting from the queries were used to 
analyse potential interacting partners. Potential interactors were further 
confirmed by co-immunoprecipitation experiments.  
To identify TbORC1/CDC6 interacting partners, samples were treated as 
described above but this time the samples were sent to the University of Dundee 
proteomics facility for mass spectrometry. This is described further in Section 
4.7.  
2.7.5 Immunoblotting 
After separation of proteins by SDS-PAGE, the proteins were transferred to 
nitrocellulose membrane (GE Healthcare) in transfer buffer [25 mM Tris pH 8.3, 
192 mM Glycine and 20% v/v methanol] for acidic proteins or CAPS buffer 
(SIGMA) pH 11.0 for basic proteins. The transfer was carried out at 100 V for 70 
minutes using the Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad). Blots 
were blocked for 1 hour with PBS containing 5% w/v powdered Milk (Marvel, 
Chivers Ireland Ltd) and 0.05% v/v Tween 20 (PBST). After blocking, blots were 
incubated with primary antibody in PBST for 1 hour at RT. Excess antibody was 
washed off with PBST three times for 5 mins each. Blots were then incubated for 
1 hour with horseradish peroxidise (HRP) – conjugated secondary antibody 
(Invitrogen) in PBST. To detect protein, blots were washed 3 times in PBST and 
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detected by enhanced chemiluminescence (following the manufacturer’s 
protocols; Piercenet) by exposure to an x-ray film.  The x-ray film was 
developed using a Kodak Ex-omat system (KODAK). 
2.7.6 Immunofluorescence  
The immunocytochemistry protocol provided with anti-Myc Tag, clone 4A6, Alexa 
Fluor® 488 Conjugate antibody (Millipore) was used for IFA.  Briefly, T. brucei 
cells were grown to a density of ~ 106 cells.mL-1, the culture medium was 
removed after centrifugation at 600 x g for 10 mins and the cells washed twice 
with PBS. 1 mL of 3.7% (v/v) formaldehyde/PBS was added to the cells and the 
solution was incubated for 60 minutes at RT. The cells were washed twice with 
PBS for 5 mins each, resuspended in 1 mL of PBS and permeabilized by addition 
of Triton X 100 to a final concentration of 0.5 % (v/v) for 5 mins. The cells were 
washed, again twice, with PBS for 5 mins and incubated with 2 μg.mL-1 of anti-
Myc Tag, clone 4A6, Alexa Fluor® 488 Conjugate antibody in 5 % BSA in PBS for 1 
hr. TREU927 wild type (not TbORC1/CDC6-myc tagged) samples were incubated 
with the same antibody to serve as a negative control sample. After incubation 
with antibody, the cells were washed twice with PBS for 5 mins, pelleted, 
resuspended in 100 μl of PBS and spread evenly onto a glass slide (Menzel-
glaser). The slide was then air-dried, counter-stained with DAPI (VectorLabs) and 
sealed with a cover slip using nail varnish. Cells on the slides were examined 
using an Axioskop 2 microscope and Openlab 3.00 software was used for analysis 
of images. 
For T. brucei cells in which TbORC1/CDC6 had been tagged with Green 
fluorescent Protein (GFP) at the amino-terminus (see Section 3.5.1), these cells 
were harvested and fixed with formaldehyde as described above. After fixing 
with formaldehyde, 10 μl was smeared onto a glass slide, allowed to air dry, 
counter-stained with DAP and visualised as described above.  
2.7.7 Co-immunoprecipitation (co-IP) 
For co-IP, whole cell extracts from T. brucei were prepared. 108 cells were 
pelleted at 2000 x g for 10 minutes and washed twice in ice cold Phosphate 
buffered Saline (PBS).  The cells were then re-centrifuged (2000 x g for 10 
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minutes) and resuspended in 2 mL of WCE buffer below. This was incubated on 
ice for 1 – 2 hours while magnetic beads were prepared as described below.  
2.7.7.1 Preparing magnetic beads 
50 μl of M-280 IgG-coated magnetic Dynalbeads (Invitrogen) was pre-blocked by 
washing the beads with 1 ml of block solution [0.05% Bovine Serum Album (BSA), 
PBS]. The beads were collected using a magnetic rack and the supernatant 
removed with a pipette. This step was repeated twice and the beads were 
resuspended in 250 μl block solution. 5 μg of antibody specific to the targeted 
epitope tag was added to the beads/block solution and incubated at 4°C 
overnight on a rotor. After incubation overnight, the beads were washed 3 times 
in 1 ml block solution and resuspended in 100 μl block solution. The antibody-
beads were for ready for IPs. 
2.7.7.2 Immunoprecipitation (IP), washes and elution  
108 PCF cells were pelleted by centrifugation (600 x g), washed once in ice cold 
PBS pH 7.4 and lysed by incubating in 2 mL of Whole Cell Extract buffer (WCE 
buffer, see recipe below) at 4 ºC for 1 hr. The lysate was then centrifuged at 
15000 x g at 4 ºC for 30 mins. 20 μl from supernatant was aliquoted; protein SDS 
loading dye was added to it and stored at – 20 ◦C. This served as the input 
sample for western blotting. The supernatant was added to the beads prepared 
in Section 2.7.7.1 and incubated for 2 hrs. After incubation, the samples were 
washed with 1.0 mL of ice cold wash buffer (see recipe below). The beads were 
collected and the supernatant was discarded. Wash steps were repeated seven 
times, after which the samples were washed with 1 mL of TE wash buffer (see 
recipe below). After the TE wash step, the samples were centrifuged for 3 mins 
at 1000 x g at 4 ºC and any residual TE wash buffer was carefully removed. 220 
μl of Elution buffer (see recipe below) was then added to the samples and 
incubated in a 65°C water bath for 30 min with intermittent vortexing every 2-5 
mins. The beads were then centrifuged for 1 min at 16,100 g at RT. 200 μl of the 
supernatant was removed after the spin step and transferred to new 
microcentrifuge tube. This served as the eluate. An aliquot of 20 μl was taken 
and used for western blot analysis (Section 2.7.5).  
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Solution Stock solution concentration Final Concentration  
WCE buffer 1 M HEPES pH 7.55 50 mM 
 1 M NaCl 100 mM 
 0.5 M EDTA pH 8.0 1.0 mM 
 0.5 M EGTA pH 8.0 1.0 mM 
 50 % glycerol 10 % 
 10 % Triton X100 1 % 
 *50 X complete protease inhibitor mix 1 X 
   
Wash buffer 1 M HEPES pH 7.55 50 mM 
 1 M LiCl 500 mM 
 0.5 M EDTA pH 8.0 1.0 mM 
 0.5 M EGTA pH 8.0 1.0 mM 
 10 % Na deoxycholate 0.7 % 
 10 % NP40 1 % 
 *50 X complete protease inhibitor mix 1 X 
   
TE Wash Buffer 50 mM Tris pH 8 10 mM 
 10 mM EDTA pH 8.0  1.0 mM 
 1M NaCl  50 mM 
   
Elution buffer 1M Tris pH 8 50 mM  
 0.5M EDTA pH 8.0  10 mM  
 10% SDS 1% 
   
 
2.8 Chromatin immunoprecipitation (chIP) 
ChIP protocol was obtained from the G.A.M. Cross Lab (Rockerfeller Institute, 
New York). 108 PCF cells were used for each ChIP experiment. To prepare cells 
for cross-linking, the concentration of cells was adjusted thus: 1.0 X 108 PCF 
cells/40 mL in SDM79 medium. These cells were cross-linked by incubating them 
for 20 min at RT in formaldehyde solution (see recipe below).  After cross-
linking, Glycine was added to the mix at a final concentration of 125 mM and 
centrifuged at 4000 x g for 20 min at 4 °C. The cells were then washed with 30 
mL ice cold PBS and centrifuged again at 4000 x g for 20 min at 4 °C. After the 
wash step, cells were resuspended in Lysis buffer 1 (see recipe below), vortexed 
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thoroughly and rocked on a platform rocker for 10 min. After rocking, the cells 
were centrifugedat 4000 x g for 20 min at 4 °C and the supernatant was 
decanted. The previous procedure was repeated with Lysis buffer 2 (see recipe 
below) but this time the pellet was resuspended in 2 mL of Lysis buffer 3 (see 
recipe below).  Prior to the IP step (below), the whole cell lysates prepared in 
this way were sonicated for 60 cycles (30 sec on/30 sec off) using a Bioruptor 
(Diagenode). After sonication, the material was centrifuged at 16,100 x g for 10 
min at 4 °C. A 20 µl aliquot of the material was removed before the IP step to 
serve as the “input sample”. IPs were then performed overnight with 10 μg of 
anti-Myc monoclonal antibody (Millipore) coupled to M-280 IgG magnetic 
Dynalbeads (Invitrogen). Beads were washed seven times with Wash buffer and 
eluted as in Section 2.7.7.2. The eluted DNA was prepared for sequencing or 
hybridisation to a microarray as described below. 
After IP, the eluted DNA was reverse cross-linked from proteins. First, 3 volumes 
of Elution buffer (recipe above; Section 3.9.7.2) was added to the ‘input sample’ 
and mixed thoroughly. From here, the ‘input sample’ was treated like the eluted 
IP material. Both samples were reverse crosslinked by incubating at 65°C for ~ 9 
hours (not more than 15 hours). After incubation, 8 μl of RNaseA (from a stock of 
10 mg.mL-1) was added to each sample and mixed by inverting the tubes several 
times and this was incubated at 37°C for 2 hours. Next, 4 μl of Proteinase K 
(from a stock of 20 mg.mL-1) was added to each sample and mixed by inverting 
tube several times and incubated at 55°C for 2 hours. The DNA was then purified 
using a Qiagen gel extraction kit and eluted with 60 μl kit elution buffer, as 
recommended by manufacturer’s protocol. The purified DNA was repaired (from 
nicks introduced during the sonication step) using the Quick Blunting kit (NEB) 
according to manufacturer’s protocol. After the repair step, DNA was purified 
using the QIAquick PCR Purification Kit (Qiagen) according to manufacturer’s 
instructions and eluted with 41 μl of dH2O. The purified DNA was then amplified 
using the Whole Genome Amplification kit (SIGMA) and purified using PCR 
purification Kit from Qiagen®. 5 μl of the eluted DNA was run on a 1.5 % agarose 
gel, and the remaining material was quantified using a NanoDrop.  
For microarray analysis, ~ 5 μg of input and eluted DNA was sent to Roche 
Diagnostics (NimbleGen, USA) for differential labelling and hybridisation to a 
custom-designed microarray. For Solexa sequencing, ~ 100 ng was sent to 
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GenePool at Edinburgh University, UK for sequencing. The ChIP-chip data was 
analysed by L. Marcello (University of Glasgow), a collaborator on the project. 
The ChIP-seq data is still being analysed by N. Dickens, the resident 
Bioinformatician at the department, and is not considered in this thesis.  
Solution Stock solution concentration Final Concentration 
Formaldehyde Solution 1 M HEPES pH 7.55 50 mM 
 1 M NaCl 100 mM 
 0.5 M EDTA pH 8.0 1 mM 
 0.5 M EGTA pH 0.5 mM  
 37% formaldehyde (Fisher) 11% 
   
Lysis Buffer 1 1 M HEPES pH 7.55 50 mM 
 1 M NaCl 140 mM 
 0.5 M EDTA pH 8.0 1.0 mM 
 0.5 M EGTA pH 8.0 1.0 mM 
 50 % glycerol 10 % 
 10 % Triton X100 0.25 % 
 10% NP-40 0.5 % 
 *50 X complete protease inhibitor mix 1 X 
   
Lysis buffer 2 1 M Tris-HCl pH 7.8.0 50 mM 
 1 M NaCl 200 mM 
 0.5 M EDTA pH 8.0 1.0 mM 
 0.5 M EGTA pH 8.0 1.0 mM 
 *50 X complete protease inhibitor mix 1 X 
   
Lysis buffer 3 1 M Tris-HCl pH 7.8.0 10 mM 
 1 M NaCl 100 mM 
 0.5 M EDTA pH 8.0 1.0 mM 
 1 % Na-Deoxycholate  0.1 % 
 10 % N-lauroylsarcosine 0.5 % 
 *50 X complete protease inhibitor mix 1 X 
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Table 2-2 – Table of primers used throughout this thesis 
 
Chapter 3
Name Gene ID/Gene Description Primer Sequence (5 '- 3') Restriction site/Loci description Final vector
CT_OL1 Tb11.02.5110 /TbORC1/CDC6 RNAi 5' CCCGGATCCGAAGCCCACAGCTGTCTTTC BamH1 pZJM_dual T7
CT_OL2 3' CCCAAGCTTTTCTCCGGCAACTTGTAACC HindIII
CT_OL3 TbORC1/CDC6 cDNA semi-qPCR 5' GGCTTGCTAACTGTAAAGGA
CT_OL4 3' ATCCCCGTACCAAAGTCATC
CT_OL5 PolI primers 5' GTGACGGTTCAGGGAACACT
CT_OL6 3' GCACCGAAATTTGACTTGGT
CT_OL7 TbORC1/CDC6_qPCR 5' TTCACCCTGTCATGCAGGTTT
CT_OL8 3' GGTTCACTGACGCTGTCTTTCC
CT_OL9 TbORC1/CDC6_ KO 5' UTR 5' CCCGAGCTCCATCCGCCTGGTTACAGCCA SacI pBlu2KS
CT_OL10 3' CCCTCTAGATGGAGCACGAACACGGTAAA XbaI
CT_OL11 TbORC1/CDC6_KO 3' UTR 5' CCCTTAATTAACCGTCTTAGGACGTGTGTGC PacI pBlu2KS
CT_OL12 3' CCCCTCGAGCCTTCTTTCGGCTTTGGCTT XhoI
CT_OL13 TbORC1/CDC6 +/- PUR integration test 5' CCCGTTTGGCGTGAGATATA
CT_OL14 3' ATGTGGCGGTCCGGGTCGACG
CT_OL15 TbORC1/CDC6 +/- BSD integration test 5' CCCGTTTGGCGTGAGATATA
CT_OL16 3' GCCCTCCCACACATAACCAG
CT_OL17 BSD Primers 5' GGCCAAGCCTTTGTCTCAAG
CT_OL18 3' GCCCTCCCACACATAACCAG 
CT_OL19 TbORC1/CDC6_eGFP integration test 5' GGCCAAGCCTTTGTCTCAAG 
CT_OL20 3' CTTGAGCTCAGGCAGACTAT
CT_OL21 MVSG 1.22 (GFP)_qPCR 5' CACAGACCTGCAGATGCACTTTAT 
CT_OL22 3' TGCCTTTATCTTTGCTAAATTTGCT 
CT_OL23 MVSG 1.61 (GFP)_qPCR 5' GGCGGTTTGTCTTTGTTTTTG
CT_OL24 3' TGACTCCTCTTTGTTGTCGTCTTC
CT_OL25 MVSG 1.64 (GFP)_qPCR 5' CTGCTGCCCGACAACCA 
CT_OL26 3' TGTGATCGCGCTTCTCGTT 
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Chapter 3/4
Name Gene ID/Gene Description Primer Sequence (5 '- 3') Restriction site/Loci description Final vector
CT_OL27 GPI8_qPCR 5' TCTGAACCCGCGCACTTC 832 bp downstream of start codon
CT_OL28 3' CCACTCACGGACTGCGTTT
CT_OL29 Actin-qPCR 5' CGGACGAGGAACAAACTGC 4 bp downstream of start codon
CT_OL30 3' TTTCCATGTCATCCCAATTGG
CT_OL31 Tubulin_qPCR 5' TTCAGGCTGGCCAATGCG 18 bp downstream of start codon
CT_OL32 3' TACGGAGTCCATTGTACCTG
CT_OL33 VSG221_qPCR 5' AGCAGCCAAGAGGTAACAGC 338 bp downstream of start codon
CT_OL34 3' CAACTGCAGCTTGCAAGGAA
CT_OL35 VSG13_qPCR 5' ATAACGCATGGCCATCTTGAC 572 bp downstream of start codon
CT_OL36 3' GTCGTTGCTGTGGATTGCTC
CT_OL37 VSGV02_qPCR 5' CAGCGCAAGTACAGGACG 393 bp downstream of start codon
CT_OL38 3' TGCTTCGTCGTCGCTTAC
CT_OL39 VSG224_qPCR 5' GACGCAGCAGAATCAACAC 1.1 kb downstream of start codon
CT_OL40 3' GCTTATTTTGTGTCTGTCGC
CT_OL41 VSG800_qPCR 5' ACAGACCGCCGACAGTATC 161 bp downstream of start codon
CT_OL42 3' GTATCTTTGTAGGCCGCTGC
CT_OL43 TbORC1/CDC6_12Myc 5' CCCAAGCTTGCATGGAACTGGCAGCTGAT HindIII pNAT-12Myc
CT_OL44 3' CCCTCTAGATATCGAAAACAGTGGGCATATCCC Xba1
CT_OL45 TbORC1/CDC6-12Myc integration test 5' TGTCGTGATTCCCATGTTAA
CT_OL46  3' AATGACGAACGGGAAATGCC
CT_OL47 TbORC1/CDC6_ORF Probe 5' ATGAAACGAAGGAGGGACAG
CT_OL48 3' AGACAGCTGTGGGCTTCGAC
CT_OL49 6HA_Tag 5' CGATCCGGACCAAGTTCTAGATACCCCTACGACGTT Xba1
CT_OL50 3' AAATGGGCAGGATCTGGATCCTTACCTTGAGGCATA BamH1
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Chapter 4/5
Name Gene ID/Gene Description Primer Sequence (5 '- 3') Restriction site/Loci description Final vector
CT_OL51 Tb11.01.3510 / MCM6_HA 5' CCCAAGCTTCCTGAGTGAGGATGTTGAAG HindIII pNAT-6HA
CT_OL52 3' CCCTCTAGACTGCTTCGTAATATCTGGGT Xba1
CT_OL53 Tb11.01.7810 / MCM7_HA 5' CCCAAGCTTCGAGTGAGAATGTAAATTTACC HindIII pNAT-6HA
CT_OL54 3' CCCTCTAGACTCCAGTGAAAAGTGAACAG Xba1
CT_OL55 Tb11.02.5730 / MCM2_HA 5' CCCAAGCTTCGAACGCAACAGGAGAGCCG HindIII pNAT-6HA
CT_OL56 3' CCCTCTAGACACCAGGGAGTGCTCTATTT Xba1
CT_OL57 Tb11.02.3270 / MCM5_HA 5' CCCGAGCTCGGGGGTAGTGCTCGTCATTC SacI pNAT-6HA
CT_OL58 3' CCCTCTAGAACGTAACCGATGAATTTGGGG Xba1
CT_OL59 Tb11.02.4070 / MCM4_HA 5' CCCAAGCTTGCCACCAGTCGTGCCCCCAT HindIII pNAT-6HA
CT_OL60 3' CCCTCTAGACGAAAGCCTACCGGCGAAAC Xba1
CT_OL61 Tb927.2.3930 / MCM3_HA 5' CCCAAGCTTGAAGCAATTGTGCGACTAGC HindIII pNAT-6HA
CT_OL62 3' CCCTCTAGAAATGAACTGAACCCATTCAT Xba1
CT_OL63 Tb927.10.13380 / Tb13380_RNAi 5' CCCGGATCCCACGTTGTATCCCCTTGCTT BamH1 pZJM_dual T7
CT_OL64 3' CCCAAGCTTTTCAGTTTCGGCGAAGTTCT HindIII
CT_OL65 Tb927.10.13380 / Tb13380_HA 5' CCCAAGCTTCGTTTCTGCTGTCTTTGGGG HindIII pNAT-6HA
CT_OL66 3' CCCTCTAGACACGAGGCTGCGTAATC Xba1
CT_OL67 Tb927.10.7980/Tb7980_RNAi 5' CCCAGATCTAGTGTGGCTCCGGTTACATC BglII pZJM_dual T7
CT_OL68 3' CCCAAGCTTTTGTTGCAAAGAGCGTGTTC HindIII
CT_OL69 Tb927.10.7980/Tb7980_HA 5' CCCAAGCTTCGAGCAAGTATCGTCACACAGGA HindIII pNAT-6HA
CT_OL70 3' CCCTCTAGATCGTGGAATGAGGTCGT Xba1
CT_OL71 Tb01_281401_1 5' CGATGAATGCAAAGACATGTGA
CT_OL72 3' CGATGAATACGCGAAATGGA
CT_OL73 Tb01_281401_4 5' TGAACTACCCTCCGTGGACAA
CT_OL74 3' GATCCCATAGTGCCGTTGAAA
CT_OL75 Tb01_281401_5 5' TTTATTCTTAGCACATTGCGGAGTA
CT_OL76 3' AGGACGTTCAAAGCAGAATAAGCT
CT_OL77 Tb01_281421_13 5' GAACTCTCATCTGCCCTTGGTT
CT_OL78 3' GCAGTCTCAACACGGGTATTTTG
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3 Functional characterisation of TbORC1/CDC6, a 
putative Trypanosoma brucei replication 
initiation protein 
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3.1 Introduction  
T. brucei is a unicellular eukaryotic parasite responsible for sleeping sickness 
disease in humans and nagana in livestock. The parasite is characterised by the 
presence of two genomes: (i) a mitochondrial DNA network that comprises 
topologically interlocked minicircles ( ~1 kb in size) and maxicircles (~ 23 kb in 
length), collectively known as the kinetoplast or mitochondrial genome (Liu et al. 
2005); and (ii) a nuclear genome which comprises 11 diploid megabase-sized 
chromosomes (0.9-6 Mb in length), several intermediate-sized chromosomes 
(200-900 kb in size) and approximately 100 mini-chromosomes (~50-150 kb in 
size) (Melville et al. 1998; Gottesdiener et al. 1990). Due to the unique and 
unconventional composition and organisation of the kinetoplast DNA (kDNA), a 
distinct repertoire of specialised proteins is dedicated to its replication and 
segregation to ensure cell propagation and maintain diversity. First isolated and 
characterised from Leishmania by the lab of Larry Simpson in 1971 (Simpson & 
Dasilva 1971), the kDNA replication machinery has been the subject of immense 
scientific research for well over 40 years in trypanosomes and Crithidia by the 
labs of P. Englund, M. Klingbeil, D. Ray and J. Shlomai, amongst others [for 
reviews see: (Liu et al. 2005; Shlomai 2004; Klingbeil & Englund 2004; Klingbeil et 
al. 2001; Shapiro & Englund 1995). From initiation to termination, kDNA 
replication involves the concerted participation of ~30 characterised proteins. 
For minicircle replication, p38, the universal minicircle binding protein (UMSBP), 
TbPIF1, at least one primase, DNA polymerases (pols) IB and IC, and 
Topoisomerase II are just a few factors involved in the initiation events.  TbPIF5, 
structure-specific endonuclease-I (SSE 1), DNA pol β and DNA ligase kβ are 
involved in later steps (Liu et al. 2010; Bruhn et al. 2010; Liu et al. 2009a; 
Milman et al. 2007; Liu et al. 2006; Liu et al. 2005). Although much less is known 
about maxicircle replication, it is estimated that both sets of interlocked DNA 
classes require ~100 proteins for a complete duplication and segregation (P.T. 
Englund, personal communication). 
Despite the increasing clarity in our understanding of the machinery and 
mechanism of kDNA replication, until the publication of the sequences of the T. 
brucei, T. cruzi and L. major genomes in 2005 (Ivens et al. 2005; Berriman et al. 
2005; El Sayed et al. 2005a) the components needed for trypanosomatid nuclear 
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DNA replication remained relatively uncharacterised. Bioinformatic analysis and 
gene annotation suggested that the replication initiation machinery may be 
atypical of eukaryotes (El Sayed et al. 2005b).  
The DNA replication initiation machinery in higher eukaryotes is covered 
extensively in Section 1.6.3. The mechanism and machinery of DNA replication 
initiation is well-conserved among characterised eukaryotes (Dutta & Bell 2006). 
The six protein origin recognition complex (ORC, Orc1-Orc6), Cdc6, and Cdt1 are 
recruited sequentially to DNA, and once bound, they load the replicative 
helicase (MCM, a heterohexamer; subunits Mcm2-7) to form a pre-replicative 
complex (pre-RC) at potential origins of replication (Dutta & Bell 2006). The 
largest subunit of ORC, Orc1, is related in sequence to Cdc6, indicative of 
derivation from a common ancestor (Duncker et al. 2009). Such an ancestral 
molecule appears still to function in archaea (Barry & Bell 2006). These 
prokaryotes lack Cdc6 and possess a protein named Orc1/Cdc6, which appears to 
provide all ORC functions, since orthologues of Orcs2-6 are absent. In addition to 
this, archaeal orthologues of Cdt1 have not been clearly described, though a 
potentially related factor, named WhiP (winged helix initiator protein), has been 
found (Robinson & Bell 2007). Comparative genome analysis of Trypanosoma 
brucei and related trypanosomatids (L. major and T. cruzi) revealed, 
remarkably, only a single ORC protein that is equally related to eukaryotic Orc1 
and Cdc6 (named here TbORC1/CDC6) (El Sayed et al. 2005b). In addition, no 
clear homologue of Cdt1 was found. These observations have been interpreted 
as suggesting that origin designation in trypanosomatids, although eukaryotic, 
may be archaeal-like, raising numerous mechanistic and evolutionary questions. 
Beyond a core function in origin designation, there is evidence for additional 
non-replication roles of at least the largest subunit of the ORC complex, Orc1, in 
higher eukaryotes. First characterised in S. cerevisiae, Orc1 has been shown to 
mediate the formation of transcriptionally silent chromatin domains at silent 
mating loci, HMR and HML. Once bound to DNA, S. cerevisiae Orc1 interacts with 
the transcription factors Rap1 and Abf1 via an N-terminal Bromo-adjacent (BAH) 
domain. This interaction then recruits Silent Information Regulator proteins (Sir 
1 – 4), allowing the formation and spreading of heterochromatin. The formation 
of heterochromatin mediated by ORC proteins appears to be a conserved 
eukaryotic role reported in yeasts, Drosophila and mammals (Sasaki & Gilbert 
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2007). Bearing in mind the obvious similarity between TbORC1/CDC6 and its 
eukaryotic Orc1 counterpart (albeit lacking the N-terminal BAH domain), and the 
high density of localisation of the T. brucei protein at subtelomeres (see chapter 
5), we hypothesised that TbORC1/CDC6 might play a role in the regulation of 
VSG expression. This hypothesis, if correct, would lend support to the growing 
data suggesting that epigenetic phenomena are closely associated with antigenic 
variation and VSG transcriptional control in T. brucei (Elias & Faria 2009; Siegel 
et al. 2009; Yang et al. 2009; Stockdale et al. 2008; Figueiredo, Janzen, & Cross 
2008). 
3.2 Results 
3.3 RNA interference of ORC1/CDC6 in procyclic form T. 
brucei 
To investigate the role of TbORC1/CDC6 in T. brucei, an RNAi approach was 
taken. The construction of an RNAi vector (Figure 3-1) that uses two opposing 
tetracycline-inducible T7 promoters to controllably drive the expression of 
double-stranded RNA to target a specific gene of interest has facilitated the 
rapid screening of genes essential for viability in T. brucei (Motyka & Englund 
2004; Wang et al. 2000). The construct stably integrates in a ribosomal locus in 
the T. brucei genome after it has been digested with NotI and transfected by 
electroporation (see Materials and Methods) into a transgenic T. brucei Lister 
427 pLew13 pLew29 cell line constitutively expressing T7 RNA polymerase and 
the tetracycline repressor (TetR)(Wirtz & Clayton 1995). Upon addition of 
tetracycline, expression of double stranded RNA (ds-RNA) is induced and this is 
processed by the RNAi machinery of the parasite, thereby reducing transcript 
levels of a target gene (Ullu, Tschudi, & Chakraborty 2004; Ullu et al. 2002; Ngo 
et al. 1998).  
3.3.1 Cloning of TbORC1/CDC6 RNAi constructs 
For RNAi of TbORC1/CDC6, oligonucleotides were designed for amplification of 
an 579-bp region (positions 252 – 831 relative to the start codon) of 
TbORC1/CDC6 using an automated web-based tool for the selection of RNAi 
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targets in T. brucei (http://trypanofan.path.cam.ac.uk/software/RNAit.html) 
(Redmond, Vadivelu, & Field 2003). The primers (CT_OL01/CT_OL02, Table 2-2) 
contained BamHI (forward primer) or HindIII (reverse primer) recognition 
sequences. The fragments were amplified by polymerase chain reaction (PCR) 
from T. brucei PCF Lister427 strain genomic DNA (gDNA) using Phusion® Taq DNA 
polymerase (New England Biolabs ®) – see Materials and Methods. After PCR 
amplification, the gene fragment was cloned into BamHI/HindIII site of the pZJM 
dual T7 vector shown in Figure 3-1. The vector was linearised at the rRNA spacer 
using the restriction enzyme NotI and transfected into the T. brucei Lister427 
pLew13-pLew29 cell line. Selection of positive clones was carried out using 
Zeocin at a concentration of 10 μg.mL-1.  
 
Figure 3-1 - The pZJM dual T7 RNAi vector for TbORC1/CDC6 RNAi 
A fragment of TbORC1/CDC6 (579 bp) that was cloned into BamHI and HindIII sites in the plasmid, 
after PCR amplification, is shown; this is surrounded by T7 promoter sequences and by operator 
sequences (tet operators) that bind the Tetracycline repressor, together allowing the controlled 
expression of ORC1/CDC6 dsRNA. The NotI site used for vector linearization to allow integration 
into the rRNA spacer sequence is also shown. Selection of T. brucei transfectant clones was 
perfomed using the phleomycin resistance gene (BLE), whose expression is derived from an rRNA 
promoter, as indicated. All features shown on the vector map are designed using the VectorNTI 
resource (Invitrogen). The vector is originally from (Wang et al. 2000). 
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3.3.2 Effect of TbORC1/CDC6 RNAi knockdown on growth 
After transfection of the TbORC1/CDC6 RNAi construct and drug selection, three 
independent clones were selected and growth curves were generated in the 
absence or presence of 1.0 μg.ml-1 tetracycline, which induces expression of the 
TbORC1/CDC6 dsRNA thus initiating RNAi. Growth of the trypanosomes was 
followed for 144 hours, and induction of TbORC1/CDC6 RNAi resulted in a growth 
defect clearly visible from 84 hrs post induction (Figure 3-2), relative to the non-
RNAi induced cells. Cell counts were carried out in triplicate for each clone and 
all growth curves appeared similar for both RNAi-induced and non-induced 
samples (Figure 3-2). A single clone was selected at random for further analysis. 
First, we sought to investigate whether the growth defect was specifically due to 
knockdown of TbORC1/CDC6 expression. 
 
Figure 3-2 - Effect of TbORC1/CDC6 RNAi on the growth of procyclic form T. brucei 
Cell counts of T. brucei Lister 427 pLew13-pLew29 cells transformed with a TbORC1/CDC6 RNAi 
construct are shown over time for 3 independent clones in the absence of TbORC1/CDC6 RNAi 
induction (Tet-; solid lines) or following RNAi induction by the addition of 1 μg.ml-1 tetracycline 
(Tet+; broken lines). The cumulative cell numbers reflect correction of the cell densities following 
dilution after 72 hrs. 
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3.3.3 mRNA levels after TbORC1/CDC6 RNAi knockdown 
To determine if the above growth impairment was due to a decrease in 
TbORC1/CDC6 mRNA levels after RNAi induction by addition of tetracycline, 
semi-quantitative reverse transcription-polymerase chain reaction (semi-qPCR) 
was first used to examine TbORC1/CDC6 mRNA levels 96 hrs post induction of 
RNAi compared with a non-induced sample. Using the single clone selected, total 
RNA was extracted before and after induction with tetracycline. 1 µg of total 
RNA was used for cDNA synthesis with 50 µM oligo (dT) primers, as per 
manufacturer’s instructions (SuperScript™ kit, Invitrogen). Identical reactions 
were set up for each RNA sample with either reverse transcriptase added (RT +) 
or without reverse transcriptase (RT -) to act as a control for genomic DNA 
contamination. Using 1 µl of cDNA synthesised per reaction, PCRs were set up for 
26 cycles with primers for TbORC1/CDC6 (CT_OL3/CT_OL4, Table 2-2); a 0.5 kb 
fragment outside of the fragment cloned into the pZJM vector. As a control, 
mRNA levels of RNA Pol I, an unrelated transcript, were also examined. Using 
the same cDNA sample from above with primers (CT_OL5/CT_OL6, Table 2-2), a 
0.5 kb fragment of RNA Pol I was amplified. Both the induced and non-induced 
samples (RT- and RT+) were resolved on a 1 % agarose gel. The results showed 
that while less TbORC1/CDC6 PCR product was generated from the RNAi-induced 
cDNA relative to the uninduced, the PolI RNA control was unaffected (Figure 
3-3A).  
To quantify levels of mRNA knockdown, quantitative real time PCR (qPCR) was 
carried out (See Materials and Methods) using a Prism7500 real time PCR 
machine (Applied Biosystems). Oligonucleotides CT_OL7/CT_OL8 (Table 2-2) for 
TbORC1/CDC6 was used to amplify a ~70-bp fragment of the gene distinct from 
the RNAi vector insert. Glycosylphosphatidylinositol-8 (GPI8), an unrelated 
transcript, was amplified as an internal control using primers CT_OL23/CT_OL24 
(Table 2-2). Distilled H2O was used as non-template control. All PCRs were set up 
in triplicate and the data analysed using Applied Biosystems 7500 system 
software. qPCR of cDNA from the same samples used in the semi-qPCR revealed 
that, 96 hrs post RNAi induction, TbORC1/CDC6 mRNA levels were reduced by 
~90 % when compared with non-induced samples and with GPI8, an unrelated 
transcript used as endogenous control (Figure 3-3B).  
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These data demonstrate that knockdown of TbORC1/CDC6 mRNA by RNAi was 
efficient by 96 hrs, and that the growth phenotype observed in Section 3.3.2 
after this time was in all likelihood associated with specific depletion of 
TbORC1/CDC6 mRNA. 
 
Figure 3-3 - Measurement of TbORC1/CDC6 transcript levels 96 hrs post induction of RNAi 
(A) Semi-quantitative reverse transcriptase PCR (semi-qPCR) was performed by 26 cycles of PCR 
using oligonucleotide primers for amplification of a region of TbORC1/CDC6 distinct form that 
cloned into the pZJM RNAi vector. PCR products are shown from cDNA substrate generated from 
RNA derived from cells induced for RNAi (+Tet) and uninduced (-Tet); RT+ indicates that reverse 
transcriptase was used to generate cDNA, while RT- indicates control samples generated in the 
absence of reverse transcriptase enzyme.  The same PCR is shown for an unrelated transcript, 
RNA Polymerase I (PolI) as loading control. (B) Quantitative PCR (qPCR) to determine 
TbORC1/CDC6 mRNAi knockdown levels. The abundance of TbORC1/CDC6 cDNA from RNAi-
induced cells (Tet +, black bar) is shown to relative to control cells without TbORC1/CDC6 RNAi 
(tet -, grey bar). The concentration of PCR product in the non-induced sample is normalised to 1. 
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3.3.4 FACS analysis after TbORC1/CDC6 RNAi knockdown  
To measure the relative DNA content of cells, and to analyse the cell distribution 
during the various phases of the cell cycle before and after RNAi of 
TbORC1/CDC6 in procyclic form T. brucei Fluorescent-Activated Cell Sorting 
(FACS) was performed on propidium-iodide (PI) - stained RNAi induced and non-
induced control cells.  In this analysis, cells were examined 72 hrs and 120 hrs 
after RNAi induction (Figure 3-4). A total of 104 cells were sorted for DNA 
content with Becton Dickinson FACSCalibur using detector FL2-A and an AmpGain 
value of 1.75. In such FACS plots, cells in the G1 phase of the cell cycle appear at 
position 200 (labelled 2C, where C represents a haploid DNA content); cells with 
double DNA content (labelled 4C), in G2, appear at position 400; while S-phase 
cells are in-between G1 and G2 (Figure 3-4). Aberrant cells can also be detected: 
those with DNA content < 2C (normally anucleate cells, or zoids) appear on the 
far left of the plot at approximately position zero on the PI-axis; cells with >4C 
content are found to the right of position 400. 
After knockdown of TbORC1/CDC6 for 72 hrs, there was an accumulation of 
putative zoids with a corresponding decrease in the population of 2C cells 
(Figure 3-4A). This became more pronounced after 120 hours, with an increase in 
zoids of ~ 15 fold relative to a non-induced sample (Figure 3-4B). After 120 hrs 
of inducing TbORC1/CDC6 RNAi there was also a marked reduction in 4C cells, 
and potentially of 2C cells, with greater staining of S-phase cells (between 2C 
and 4C). This suggests that cells appear unable to progress beyond S-phase after 
RNAi, perhaps due to impaired G1/S and/or G2/M transition. This observation 
correlates with an inability of TbORC1/CDC6 RNAi-induced cells to synthesise 
new nuclear DNA (see below). 
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Figure 3-4 - FACS profiles of PI-stained cells after TbORC1/CDC6 RNAi  
Histograms show propidium iodide-stained T. brucei procyclic-form cells after FACS sorting, 
sampled 72 hrs (A) or 120 hrs (B) pre- and post - induction of RNAi for TbORC1/CDC6 (- Tet and + 
Tet ,respectively). The peaks corresponding with cells containing 2C and 4C DNA content are 
indicated, as is the peak position for cells with 8C content; where C represents a haploid DNA 
content.  
 
3.3.5 Cell morphology after TbORC1/CDC6 RNAi knockdown 
In order to get a clearer picture of the cell cycle distribution of cells, and to 
distinguish between cell debris (which co-localise with zoids in FACS analyses) 
and genuine anucleate cells, a quantification of the various cellular 
morphologies throughout the period of RNAi induction was carried out by 
sampling the cells and staining them with 4,6-Diamidino-2-phenylindole (DAPI) – 
see Materials and Methods. DAPI-staining of DNA in trypanosomes provides a tool 
to monitor cell cycle progression since the number of kinetoplasts and nuclei in 
an individual cell enables cell cycle stage-specific classification (see below). 
Approximately 200 cells were classified into various subgroups, depending on the 
number of nuclei (N) or kinetoplast (K) DNA that could be detected 
microscopically. Without TbORC1/CDC6 RNAi induction, cells appeared normal 
with the expected distribution of N-K DNA configuration (Woodward & Gull 1990) 
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(Figure 3-5A): cells with one kinetoplast and one nucleus (1K1N) made up ~ 80 % 
of the total population; cells with two kinetoplasts and a single nucleus (2K1N, 
having divided the kDNA but not nDNA) comprised ~10 %; and, after nuclear 
division but before completion of mitosis, cells with two nuclei and two 
kinetoplasts (2K2N) made up ~5 % of the total population. Aberrant cells, not 
corresponding to these N-K configurations, represented only ~3 % of cells in the 
absence of TbORC1/CDC6 RNAi. In a typical scenario, 2K2N cells will undergo 
cytokinesis to produce two daughter progeny each with a 1K1N configuration and 
the cycle continues. However, aberrant cells can also be present in the 
population and these usually constitute ~3.5 % (Woodward & Gull 1990), similar 
to that observed here. Thus, without induction of RNAi up to the 144 hrs 
sampled, the N-K distribution was as expected. In contrast, from 48 -144 hrs 
after TbORC1/CDC6 RNAi there was a steady decrease in the numbers of 1N1K 
cells, falling from ~70% - to ~35 % of the population. The drop in 1N1K cells was 
accompanied by an increase in the population of anucleate cells (0N1K; Figure 
3-5C), rising from ~5% of the entire population at 48 hrs to ~50% at 144 hrs 
(Figure 3-5B). There was no apparent increase in other forms of aberrant cells 
(grouped here as ‘unclassified’). These DAPI data appear to correspond with the 
FACS data and, taken together, suggest that knockdown of TbORC1/CDC6 in 
procyclic-form T. brucei cells prevents nuclear DNA synthesis but has no 
observable effect on kinetoplast DNA synthesis or on cytokinesis. 
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Figure 3-5 – Microscopic quantitation of nuclear (N) and kinetoplast (K) DNA content after 
DAPI staining 
Procyclic form T. brucei cells were counted (N = 200) at each time point for non RNAi-induced 
control cells (A), or cells depleted in TbORC1/CDC6 by RNAi (B).  Examples of cells of differing 
DNA content are shown stained with DAPI, and as an overlay with a phase contrast image (C).  
 
3.3.6 Quantitative assessment of DNA Synthesis during 
TbORC1/CDC6 RNAi knockdown 
So far, we have proposed, based on FACS and DAPI analyses, that RNAi 
knockdown of TbORC1/CDC6 mRNA results in the generation of cells which can 
no longer synthesise nuclear DNA. To examine this directly, we used a 
quantitative dot blot assay to assess in vivo DNA synthesis (Ueda et al. 2005). 
After induction of RNAi for 96 hrs, induced and uninduced cells were incubated 
with 5-Bromo-2’-Deoxyuridine (BrdU) for 60 minutes, total genomic DNA was 
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purified from the cells, denatured, 50 ng spotted onto a nitrocellulose 
membrane, and the incorporated 5-bromo-2-deoxyuridine triphosphate (BrdUTP) 
was detected with a monoclonal antibody against BrdUTP by western blotting 
(see Materials and Methods). Using this approach, there was very little visibly 
detectable BrdUTP signal after TbORC1/CDC6 RNAi, compared with un-induced 
samples where signal was readily detected (Figure 3-6A). In contrast, there was 
no visible difference in the signal intensity of dot-blotted DNA after silencing 
TbWhiP/CDT1, an unrelated gene that also induces zoid formation upon RNAi 
(Figure 3-6C). Quantifying the signal intensities by densitometry showed a > 4 
fold difference in intensity between samples where TbORC1/CDC6 was RNAi 
depleted compared with samples where RNAi was not induced (Figure 3-6B), 
while quantifying TbWhiP/CDT1 showed no significant difference in intensities 
between induced and un-induced samples. These data strongly support our 
previous observations that cells which lack ~ 90% of TbORC1/CDC6 transcript fail 
to synthesis new nuclear DNA. 
 
Figure 3-6 - Assaying DNA synthesis by BrdUTP incorporation after RNAi of TbORC1/CDC6 
Dot-blots are shown of T. brucei DNA probed with anti-BrdUTP antibody. In (A) the cells were 
incubated with BrdU after TbORC1/CDC6 RNAi was induced by tetracycline (+Tet) for 96 h, and 
are compared with control cells in which RNAi was not induced (-Tet). In (C) dot blots are shown 
for a similar analysis performed for TbWhiP/CDT1. (B); (D) show quantitative densitometric 
analysis of the dot-blot samples, calculated relative to a background spot on the membranes.  
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3.4 Is TbORC1/CDC6 essential for viability of T. brucei? 
3.4.1 Design of TbORC1/CDC6 knockout constructs and 
generation of null mutants  
The above RNAi data are consistent with TbORC1/CDC6 being an essential gene, 
as would be expected for a core factor of replication initiation, but are 
inconclusive as the extent of protein knockdown and longevity of the knockdown 
have not been examined. To try and determine more clearly if the gene is 
essential, attempts were made to make TbORC1/CDC6 homozygous (null) 
mutants. To generate a TbORC1/CDC6 null mutant cell line, constructs were 
made in which the 5’ and 3’ flanks (Untranslated Regions; UTRs) of the ORF were 
cloned into a modified pBluescript KS vector (vector was a Gift from M. 
Swiderski, WTCMP University of Glasgow). This pBluescript KS vector had 
antibiotic resistance cassettes encoding resistance to either puromycin (PUR) or 
blasticidin (BSD) cloned into it. The PUR or BSD cassette present in this vector 
was flanked upstream by a sequence derived from the processing signal in-
between β and α tubulin (βα), and downstream by a sequence derived from the 
actin intergenic region (Act) (Figure 3-7A). The 5’ UTR region used for targeting 
TbORC1/CDC6 was PCR-amplified using primers CT_OL9/CT_OL10, while the 3’ 
UTR region of TbORC1/CDC6 used was PCR-amplified using primers 
CT_OL11/CT_OL12, (Table 2-2). The 5’ UTR and 3’ UTR PCR fragments, of 348 bp 
and 237 bp respectively, were PCR-amplified from genomic DNA extracted from 
strain TREU927 using Phusion® Taq (NEB) DNA polymerase enzyme, and were 
digested with SacI/XbaI, and PacI/XhoI, respectively. The two fragments were 
cloned sequentially into SacI/XbaI (5’ UTR) and PacI/XhoI (3’UTR) restriction 
sites of the pBluescript KS vector (Figure 3-7B). Restriction mapping and DNA 
sequencing of the final constructs confirmed correct insertion of both UTRs and 
both drug resistance cassettes. Once both constructs were confirmed, they were 
called ΔORC1/CDC6::BSD or ΔORC1/CDC6::PUR (Figure 3-7B). Transfection of 
ΔORC1/CDC6::BSD or ΔORC1/CDC6::PUR in T. brucei should allow integration of 
the drug resistance cassettes by homologous recombination, targeting the 5’ and 
3’ UTRs of TbORC1/CDC6, and deleting the ORF (Figure 3-7 A, B). 
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Figure 3-7 – TbORC1/CDC6 knockout construct and knockout strategy 
(A) TbORC1/CDC6 knockout strategy: the 5' and 3' Untranslated Regions (UTR; sky blue boxes) of 
TbORC1/CDC6 that were used for targeted integration of a puromycin resistance gene (PUR) or 
Blasticidin S Deaminase (BSD) gene are shown flanked 5’ by a Tubulin UTR (βα) and 3’ by an 
Actin UTR (Act). Integration of the linearised construct is meant to occur by homologous 
recombination (indicated by black crosses) using the 5’ and 3’ UTRs of TbORC1/CDC6 ORF.  
(B) The resulting locus after integration is represented schematically (ΔORC1/CDC6::PUR or 
ΔORC1/CDC6::BSD). Numbers shown represent length of DNA fragments (in bp) Location of 
restriction sites used for digestion and cloning the 5’ and 3’ UTRs, and linearization are shown by 
vertical lines. 
 
3.4.2 Confirmation of TbORC1/CDC6 gene disruption by PCR 
Once the ΔORC1/CDC6::PUR construct was generated and linearised with 
SacI/XhoI, it was transfected into wild type TREU927 procyclic form T. brucei 
and puromycin-resistant clones recovered. Total genomic DNA was prepared 
from five drug resistant clones and tested by conventional PCR for accurate 
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integration at the TbORC1/CDC6 locus. All five clones selected indicated correct 
integration of the ΔORC1/CDC6::PUR construct using the primer pair 
(CT_OL13/CT_OL14, Table 2-2) indicated by red arrows (Figure 3-8 B, C). As 
expected, an ~800 bp PCR product was seen when primer CT_OL14 (reverse 
primer) hybridised 153 bp downstream of the 5’ end of the PUR gene and primer 
CT_OL13 (forward primer) hybridised at a sequence 38 bp upstream of the 5’ 
end of the 5’ UTR region cloned (Figure 3-8 B, C; red arrows). Figure 3-8C shows 
that we were able to delete one allele of TbORC1/CDC6 to generate a 
heterozygote null mutant; since only in the presence of the ΔORC1/CDC6::PUR 
cassette can we get a PCR product.  
To attempt to mutate both alleles of TbORC1/CDC6, one of the puromycin-
resistant heterozygote mutant clones generated was transfected with the 
ΔORC1/CDC6::BSD construct. Three independent transfection experiments each 
failed to delete the second allele of TbORC1/CDC6. Figure 3-8 B and D show that 
no PCR products were generated using primers CT_OL15/CT_OL16 (Table 2-2), 
indicated by blue arrows. The forward primer hybridised upstream of the 5’ UTR 
cloned and the reverse primer hybridised within the blasticidin cassette. 
However, all five clones selected were blasticidin resistant, suggesting that the 
ΔORC1/CDC6::BSD construct had indeed integrated in the genome. To check if 
the second TbORC1/CDC6 allele had been affected by the ΔORC1/CDC6::BSD 
construct integration, we used primers CT_OL1/CT_OL2 indicated by purple 
arrows (Figure 3-8A) to PCR-amplify the TbORC1/CDC6 ORF. As seen on Figure 
3-8E, the second allele of TbORC1/CDC6 was unaffected by the 
ΔORC1/CDC6::BSD construct integration. Using primers CT_OL17/CT_OL18, 
indicated by green arrows (Figure 3-8A), to the BSD ORF, PCR confirmed that 
indeed the cells were resistant to blasticidin due to the presence of the 
Blasticidin S Deaminase gene present in the genome (Figure 3-8F). 
The results observed from all experiments described in this section are 
consistent with TbORC1/CDC6 being an essential gene as we could not generate 
a homozygous null mutant. Using blasticidin at the same concentration, we were 
able to tag the endogenous TbORC1/CDC6 locus with a myc epitope (see chapter 
4) in the puromycin-resistant heterozygous clone, meaning that second allele is 
accessible for genetic manipulation. Though we have not formally shown that 
the BSD null mutant construct is capable of integrating into the TbORC1/CDC6 
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locus in these conditions, it is equivalent to the PUR construct in all regards 
except the antibiotic resistance ORF.  
 
Figure 3-8 - Attempt to generate null mutants of TbORC1/CDC6 in procyclic form T. brucei 
by targeted gene replacement 
(A) Described in Figure 3-8; purple and green arrows indicate position of primers to PCR amplify 
either TbORC1/CDC6 ORF (purple arrows) or the BSD ORF (green arrows). (B) Linearised 
schematic map after integration at the TbORC1/CDC6 locus. Arrows indicate position of primers to 
check for correct integration by PCR either for the ΔORC1/CDC6::PUR construct (red arrows) or 
for the ΔORC1/CDC6::BSD construct (blue arrows). (C) Agarose gel showing PCR products 
generated by PCR amplification using primers indicated by red arrows in (B) on genomic DNA 
isolated from 5 puromycin-resistant clones. A band is visible at ~800 bp (red arrow) corresponding 
to red arrow positions in (B). (D) Agarose gel shows that no PCR product was generated when 
PCR amplification using primers indicated by blue arrows in (B) is carried out. (E) Agarose gel 
shows a ~1.3 kb product (purple arrows) which corresponds to the size of a full length wild type 
TbORC1/CDC6 allele, derived from primers indicated by purple arrows in (A). (F) Agarose gel 
shows the presence of a 0.4 kb PCR product which corresponds to the size of full length BSD ORF 
when primers indicated by green arrows (A) are used. 
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3.5 Localisation of TbORC1/CDC6  
3.5.1 Generation of eGFP-tagged TbORC1/CDC6 construct 
Procyclic form T. brucei cells expressing TbORC1/CDC6-eGFP were generated 
using a PCR-based approach as described in (Shen et al. 2001). Briefly, 
constructs were designed with oligonucleotides: forward primer [5’-
UTR(5’primer)] 5’ - 
ATACGCTCAGCGCTGCCACCCCAGCCCTAAGTGCCGCAATGGACTTACCGTTACTGTCCC
TCCTTCGTTTCTTGTACAGCTCGTCCATGC -3’ and reverse primer [5’-ORF (3’ 
primer)] 5’ - ATACGCTCAGCGCTGCCACCCCAGCCCTAAGTGCCGCAATGGACTTA 
CCGTTACTGTCCCTCCTTCGTTTCTTGTACAGCTCGTCCATGC – 3’. The sequences 
underlined are the 5’ UTR immediately upstream of the start codon of 
TbORC1/CDC6 ORF (“ATG”) and the 5’ TbORC1/CDC6 ORF immediately 
downstream of its “ATG”, for the forward and reverse primers respectively (see 
Figure 3-9 for strategy). The primers, which consist of 70 nucleotides of the 5’ 
UTR plus 20 nucleotides of the drug resistance marker (BSD) for the forward 
primer, and  70 nucleotides of the TbORC1/CDC6 ORF plus 20 nucleotides of the 
Green fluorescent protein (GFP) ORF sequence for the reverse primer, were used  
for PCR-amplification as shown in Figure 3-9. The template for the PCR was a 
plasmid, PGL1464 (a gift from Tansy Hammarton, University of Glasgow). 
PGL1464 has the 3’ end of the TY1 epitope tag and eGFP ORF subcloned into it 
to generate a TY1:eGFP fusion construct. The TY1 epitope tag corresponds to 10 
amino acids from the immunologically well-characterised major structural 
protein of S. cerevisiae TY1 virus-like particle (Shen et al. 2001). Just upstream 
(5’ end) of the TY1:eGFP fusion is an intergenic region to provide RNA processing 
signals for trans-splicing and polyadenylation, and a BSD gene upstream (5’ end 
of intergenic region) to serve as a selectable marker for stable transfectants. 
After PCR, as shown in Figure 3-9, the product was subcloned into pCR2.1 Topo 
(Invitrogen). The pCR2.1 construct was sequenced to check for mutations in the 
oligonucleotide primers incorporated during synthesis or mutations incorporated 
by the PCR. The pCR2.1 construct was digested with EcoR1, ethanol precipitated 
and T. brucei strain TREU927 wild type parasites were transfected as described 
in Materials and Methods. Selection of positive transfection was achieved at 10 
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µg.ml-1 Blasticidin. Two clones were selected for TbORC1/CDC6 tagged to eGFP 
and checked for correct integration of the construct by PCR.  
 
Figure 3-9 - Strategy for in vivo eGFP tagging of TbORC1/CDC6 ORF in T. brucei 
Key: [5’ UTR (5’ primer)] = 70 nucleotides (ntds) of 5’ UTR immediately upstream of the start codon 
(“ATG”) of TbORC1/CDC6 gene + 20 ntds of DrugR gene (BSD gene); [5’ ORF (3’ primer)] = 70 
ntds of ORF immediately downstream of TbORC1/CDC6 “ATG” + 20 ntds of Green fluorescent 
protein (xFP) ORF, xFP = Green fluorescent protein, Tag = TY. Adapted from (Shen et al. 2001) 
 
3.5.2 Confirmation of in vivo eGFP-TbORC1/CDC6 tagging by PCR 
and western blot analysis  
The construct generated in Section 3.5.1 was transfected into wild type TREU927 
line and positive clones were recovered after drug selection with 10 μg.mL-1 
Blasticidin. To check for correct integration two independent clones were 
selected and PCR was carried out using oligonucleotides CT_OL19/CT_OL20 
(Table 2-2), indicated by red arrows (Figure 3-10A and Figure 3-10B). Western 
blot analyses of whole parasite extracts using anti-GFP antibody (SIGMA) and BB2 
monoclonal antibody (anti-TY antibody from T. Hammarton) was used to check 
expression of TY-GFP to determine if they have been translationally fused to 
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TbORC1/CDC6. In all experiments, untransfected T. brucei strain 927 parasite 
whole extracts was used as a negative control to exclude non-specific bands in 
the western blots and non-specific PCR products. 
The results showed a PCR product size of ~ 2.4 kb as expected (Figure 3-10A, B) 
if the forward primer (CT_OL19) hybridised at the 5’ end of the BSD ORF and the 
reverse primer (CT_OL20) hybridised 629 bp downstream of the TbORC1/CDC6 
ORF. This PCR indicated that TY-GFP was fused to full length TbORC1/CDC6 at 
its genomic locus. Western blot with anti-GFP and anti-TY also confirmed that 
full length protein was expressed with a band visible at ~ 65 kDa (Figure 3-10 C, 
D). 
Since the TREU927 line used was not a heterozygote null for TbORC1/CDC6, we 
could not claim that the tagged TbORC1/CDC6 protein was fully functional, as 
the other allele remains untagged. However, confirmation of expression by 
western blot implied that the protein was not targeted for degradation. 
Therefore we used this line for immunofluorescence to localise TbORC1/CDC6 in 
T. brucei.      
 
Figure 3-10 – TbORC1/CDC6-eGFP at the endogenous locus 
(A) Linearised schematic map after integration at the TbORC1/CDC6 locus. Red arrows indicate 
position of primers to check for correct integration by PCR; forward primer binds at the 5’ end of 
BSD ORF while reverse primer binds at middle of TbORC1/CDC6 ORF.  (B) Agarose gel shows 
PCR product at ~ 2.4 kb for two clones corresponding to position of red arrows in (A), with no band 
present in an untransfected line (927 WT). (C) Western blot of whole cell parasite extract of two 
independent clones using anti-TY antisera show a band at ~ 65 KDa with no band present in whole 
parasite extract from an untransfected line (927 WT). (D) Western blot of whole cell parasite extract 
of two independent clones using anti-GFP antisera show a band at ~ 65 KDa with no band present 
in whole parasite extract from an untransfected line (927 WT). 
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3.5.3 Confirmation of TbORC1/CDC6 localisation by Immuno-
fluorescence  
Procyclic form T. brucei cells generated expressing TbORC1/CDC6-eGFP or 
TbORC1/CDC6-12Myc was used for localisation of TbORC1/CDC6 by fluorescent 
microscopy or immuno-fluorescence, respectively. The generation and 
confirmation of TbORC1/CDC6-12Myc construct and cells is described in detail in 
Section 4.5. DNA in the cell was stained with DAPI. For cells in which 
TbORC1/CDC6 had been tagged with eGFP at the endogenous locus, microscopic 
visualisation was carried out using either a DAPI filter to see the  DNA staining, a 
FITC filter for the eGFP signal and phase contrast microscopy for DIC imaging of 
the whole cell. AlexaFluor488 conjugated anti-myc antibody (Millipore®) at 
1:1000 dilution was used to localise TbORC1/CDC6 in a fixed cell line expressing 
12-Myc tagged to TbORC1/CDC6 at the endogenous locus (see Materials and 
Methods, Section 2.7.6). In both cases, TbORC1/CDC6 was localised to the 
nucleus and nowhere else in the cell (Figure 3-11).  
 
Figure 3-11 - Subcellular localization of TbORC1/CDC6 
Top Panel: An example of a T. brucei cell expressing endogenous TbORC1/CDC6 C-terminally 
tagged with 12Myc. Localisation of the protein is shown by immuno-fluorescence using monoclonal 
anti-myc antibody and alexafluor-conjugated anti-mouse secondary antiserum (FITC); DNA is 
shown by DAPI stain (DAPI); and a phase contrast image (PHASE) shows the intact cell.  
Bottom Panel: Examples of T. brucei cells expressing endogenous TbORC1/CDC6-eGFP; 
localisation of the protein is shown by fluorescent microscopy (FITC); DNA is shown by DAPI stain 
(DAPI); and a phase contrast image (PHASE) shows the intact cells. 
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3.6 RNA interference of TbORC1/CDC6 in bloodstream 
form T. brucei 
3.6.1 Generation of TbORC1/CDC6 RNAi construct for BSF 
analysis 
To investigate the role of TbORC1/CDC6 in vivo in T. brucei BSF cells, the same 
approach described in Section 3.3 was adopted, except that the TbORC1/CDC6 
pZJM dual T7 vector with the same RNAi gene fragment was transfected into the 
bloodstream form 427 pLew13 pLew90 cell line. This cell line has the same 
tetracycline inducible properties already described in Section 3.3. After stable 
transfection and drug recovery with 2.5 μg.mL-1 of Phleomycin, two independent 
clones were selected and growth curves were generated in the absence or 
presence of 1 μg.ml−1 tetracycline, which induces expression of TbORC1/CDC6 
RNAi.  
3.6.2 Effect of TbORC1/CDC6 RNAi knockdown on growth  
In the bloodstream form (BSF), cell numbers were counted for two clones for 30 
hrs with or without tetracycline induction of RNAi. The results showed growth 
retardation from 12 hrs and an almost complete disappearance of cells after 30 
hrs, as seen in the decrease in cell numbers (Figure 3-12A). TbORC1/CDC6 RNAi 
effect on growth in BSF cells was significantly more rapid than was observed in 
PCF cells, where growth arrest was seen only after ~84 hrs (Section 3.3.2). For a 
single clone, we asked if the growth defect was accompanied by a reduction in 
TbORC1/CDC6- specific transcript levels. Surprisingly, this greater growth arrest 
was accompanied by a smaller, though still significant, RNAi-induced knockdown 
in TbORC1/CDC6 transcript than seen in PCF cells. Where RNAi in the former 
caused an ~90 % reduction in TbORC1/CDC6 transcript, this reduction was only ~ 
40 % in BSF cells, as judged by quantitative RT-PCR of RNAi-induced cDNA 
compared with non-RNAi sample, and using GPI8 as a control (Figure 3-12B).  
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Figure 3-12 - Effect of TbORC1/CDC6 RNAi in bloodstream cells 
(A) Growth was monitored in bloodstream cell lines in which TbORC1/CDC6 RNAi was induced (+ 
Tet, solid line) or without induction (-Tet, broken line) for 2 clones; C3 and C4. (B) mRNA levels 
was measured by quantitative PCR before (-Tet, grey bar) and after (+ Tet, black bar) tetracycline 
addition for TbORC1/CDC6 relative to GPI8 as an endogenous control. 
 
3.6.3 Effect of TbORC1/CDC6 RNAi knockdown on cell 
morphology  
To examine the phenotype of TbORC1/CDC6 RNAi in BSF cells, nucleus (N) and 
kinetoplast (K) configurations were monitored for 24 hours in the absence and 
presence of tetracycline. Analysis of the N and K DNA configuration of the BSF 
cells after TbORC1/CDC6 RNAi revealed a drastic contrast to PCF observations 
described above (Section 3.3.5). 
As the two clones responded, by growth, nearly identically, one clone was 
analysed in this way. ~100 cells were counted after DAPI staining to examine 
their DNA content. Given the severity of the growth impairment after RNAi, 
these analyses were conducted only up to 24 hrs after RNAi induction.  Unlike in 
PCF cells, where the most abundant abnormal N-K configuration after 
TbORC1/CDC6 RNAI was zoids (0N1K), in the BSF cells most abnormal cells had 
greater than 2N and 2K DNA configurations by DAPI staining and, in most cases, 
were unclassifiable. These data are shown in Figure 3-13. Non RNAi-induced cells 
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displayed the expected ratios of ‘normal’ N-K configurations (1N1K, 1N2K and 
2N2K) for the length of the experiment, and only a minor proportion of aberrant 
cells (~3-4 %) were seen (Figure 3-13A). In contrast, multi-kinetoplast and multi-
nucleate cells accumulated rapidly after RNAi, with ~70 % of cells being aberrant 
and most (~ 60 %) having >2N>2K DNA content by 18 hrs, which increased to >80 
% by 24 hrs, at which time the increased nuclear DNA material was mainly (~80 % 
of cells) a single condensed mass (Figure 2-8). 
 
Figure 3-13 – Analysis of nuclear and kinetoplast DNA configuration of TbORC1/CDC6 RNAi 
cells for a single clone 
(A) DNA DAPI staining and microscopic counting of nuclear (N) and kinetoplast (K) DNA content 
after DAPI staining.  ~ 100 bloodstream form T. brucei cells were counted at each time point for 
non RNAi-induced control cells (A: 8, 18, 24 hrs; Tet -), or cells depleted in TbORC1/CDC6 by 
RNAi (A: 8, 18, 24 hrs; Tet +). (B) Images of normal cells (Tet –, 24 hrs) and abnormal cells after 
RNAi induction (Tet +; 18 and 24 hrs) 
 
3.6.4 Effect of TbORC1/CDC6 RNAi knockdown on cell cycle  
To further characterise the effect of depleting TbORC1/CDC6 on the T. brucei 
DNA content, and to understand its possible consequences for cell cycle 
regulation, flow cytometry was performed on PI-stained RNAi-induced versus 
non-induced cells for up to 18 hrs (Figure 3-14). FACS profiles of these cells 
showed that TbORC1/CDC6 RNAi in the BSF resulted in a decrease in the 
proportion of cells with 2C and 4C DNA content (the former being depleted more 
rapidly), with a concomitant increase in the proportion of cells with 8C DNA 
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content. The increase in the 8C peaks implied that these cells re-replicated their 
nuclei following induction of TbORC1/CDC6 RNAi. This observation seems 
consistent with the accumulation of multinucleate cells observed from DNA DAPI 
staining above. Again consistent with the lack of observable 0N1K zoids observed 
in the DAPI staining, and contrasting with their pronounced accumulation in PCF 
cells, no significant accumulation of cells of <2C content was seen in the BSF 
RNAi FACS.  
 
Figure 3-14 - FACS analysis of BSF TbORC1/CDC6 RNAi cells 
FACS analysis was performed on a single clone at 8 hrs, 10 hrs, and 18 hrs post induction. Left 
panel = non-induced cells and Right panel = tetracycline- induced cells. 
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3.7 Does TbORC1/CDC6 have broader functions beyond 
DNA replication? 
Because Orc1 has been reported to initiate and maintain the formation of 
heterochromatin and hence transcriptionally silent loci in budding yeasts (Foss 
et al. 1993; Bell et al. 1993), we next used the RNAi cell lines generated and 
examined the possibility that TbORC1/CDC6 might play a similar role in 
regulation of VSG gene expression in procyclic and bloodstream form 
trypanosomes. 
3.7.1 Effect of TbORC1/CDC6 RNAi on BVSG expression in Lister 
427 PCF T. brucei 
According to Hertz-Fowler et al, there are 14 different VSG genes present in 15 
unique telomeric bloodstream expression sites (BES) in the Lister427 strain of T. 
brucei (Hertz-Fowler et al. 2008). Out of the 15 BES, only 1 is transcriptionally 
active in the BSF cells, and it is not fully understood how the cell selects only 
one BES out of the many. In the Lister 427 cell line used for RNAi analysis, the 
active BES (BES1) contains VSG221 (VSG221/427-2) (Hertz-Fowler et al. 2008). In 
PCF cells, all the BES are transcriptionally silenced to an equivalent level and 
the VSG coat is replaced with procyclin (Chaves et al. 1999) 
We first investigated whether depletion of TbORC1/CDC6 by RNAi results in 
activation of transcription from the BES in PCF cells. To do this, we used 
quantitative real time RT-PCR to measure mRNA levels for 5 silent BES VSGs: 
VSG13 (VSG427-13), VSG224 (VSG224/427-3), VSG800 (VSG800/427-18), VSGV02 
(VSGVO2/427-9) and VSG221 (VSG221/427-2). This was performed 96 hours after 
RNAi induction using oligonucleotides CT_OL35/CT_OL36, CT_OL39/CT_OL40, 
CT_OL41/CT_OL42, CT_OL37/CT_OL38, and CT_OL33/CT_OL34, respectively. 
Oligonucleotides CT_OL07/CT_OL08 and CT_OL31/CT_OL32 were used for 
TbORC1/CDC6 and Tubulin qPCRs. In two biologically independent experiments, 
with RNAi knockdown resulting in a reduction in TbORC1/CDC6 mRNA levels by 
~70 %, we detected a statistically significant (P < 0.05) increase between 
induced and non-induced samples in mRNA levels for VSG221 (~2 fold increase), 
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VSG800 and VSGv02 (each ~1.5 fold increase), but no significant differences for 
VSG13, VSG224 and the chromosome-internal gene tubulin (Figure 3-15). 
 
Figure 3-15 - Bloodstream VSG expression in procyclic form T. brucei after TbORC1/CDC6 
RNAi 
Expression levels of genes were measured by quantitative real time RT-PCR, comparing mRNA 
levels for each relative to GPI8 as endogenous control, before (Tet -, grey bar) and after induction 
(Tet +, black bar) of TbORC1/CDC6 RNAi. In each case the level of mRNA of the uninduced 
sample is shown as 1 and the mRNA level in the RNA-induced sample shown relative to that. 
TbORC1/CDC6 is indicated by Orc1 and VSGs are described in the results. Vertical lines indicate 
standard deviation from triplicates within the same biological sample. 
 
3.7.2 Effect of TbORC1/CDC6 RNAi on BVSG gene expression in 
Lister 427 BSF T. brucei 
During a tsetse blood meal metacyclic trypomastigotes are transmitted from the 
salivary glands of the fly to the bloodstream of the mammalian host, where the 
parasites differentiate to replicative long slender bloodstream forms.  
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Metacyclic form T. brucei express MVSG surface coat molecules until a few days 
post-entry into the mammalian bloodstream at which time, by a process that is 
not well understood, MVSG expression becomes attenuated with a concomitant 
activation of a single BVSG (Tetley et al. 1987). With the observation that some 
silent VSG genes are modestly derepressed in PCF cells upon RNAi depletion of 
TbORC1/CDC6 (see above), we investigated whether the inactive BES also 
become activated after RNAi in established BSF cells expressing a single BVSG. 
To do this, we used to Lister 427 (90-13) bloodstream form TbORC1/CDC6 RNAi 
cells described above (Section 3.6), and used quantitative RT-PCR to measure 
mRNA levels of the BVSG genes previously examined in Lister 427 PCF cells 
(Section 3.6). The same oligonucleotides used in Section 3.7.1 were used for this 
experiment. Of these BVSGs, VSG221 is found in the single actively transcribed 
BES, and the others are found in silent BES. mRNA levels were compared in 
TbORC1/CDC6 RNAi-induced versus non-induced samples relative to Actin as 
endogenous control, and 12 hours after RNAi induction (Figure 3-16), a shorter 
time relative to PCF cells given the severity of the RNAi growth phenotype in the 
bloodstream (see Section 3.6.3). Perhaps surprisingly (at P < 0.05), we detected 
a significant increase in transcript levels, of only 1.5 fold, for only one of the 
silent VSGs out of the five tested (expression of the housekeeping genes GPI8 
and Tubulin were also not significantly affected). The single gene with 
significantly greater expression was VSG221, in the actively transcribed BES. As 
before, RNAi depletion of TbORC1/CDC6 transcript levels was lower than in 
procyclic form cells, at ~40 % of uninduced levels.  
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Figure 3-16 - Bloodstream VSG expression in bloodstream form T. brucei after 
TbORC1/CDC6 RNAi 
Expression levels of genes were measured by quantitative real time RT-PCR, comparing mRNA 
levels for each relative to Actin as endogenous control, before (Tet -, grey bar) and after induction 
(Tet +, black bar) of TbORC1/CDC6 RNAi. In each case the level of mRNA of the uninduced 
sample is shown as 1 and the mRNA level in the RNA-induced sample shown relative to that. 
TbORC1/CDC6 is indicated by Orc1 and VSGs are described in the results. Vertical lines indicate 
standard deviation from triplicates within the same biological sample 
 
3.7.3 Effect of TbORC1/CDC6 RNAi on MVSG expression in 
EATRO 795 PCF T. brucei 
VSGs are expressed on the surface of T. brucei in metacyclic stage cells in the 
salivary gland of the tsetse fly prior to a mammalian infection: these are known 
as metacyclic VSGs (MVSGs).  Like all surface coat molecules in trypanosomes 
MVSGs are expressed in a life-cycle stage-specific manner. Like BVSG genes, 
MVSG transcription is also controlled by RNA Pol I, but differs in that it is 
monocistronic, since the MVSG ESs do not contain ESAGs (Alarcon et al. 1994). 
The complete repertoire of MVSG ESs is not fully known as they require targeted 
cloning and sequencing, which thus far has been limited to the BVSG ESs (Hertz-
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Fowler et al. 2008; Taylor & Rudenko 2006). So far, the promoter elements of  
MVSG ESs containing four VSGs have been characterised in the EATRO795 T. 
brucei strain: MVSG1.22, MVSG1.61, MVSG1.63 and MVSG1.64 (Ginger et al. 
2002). Having observed statistically significant derepression of some BVSG 
transcripts in PCF cells upon RNAi knockdown of TbORC1/CDC6, we therefore 
extended this analysis to these MVSGs in the same life cycle stage. To do this, 
we utilised an EATRO795 pLew29pLEW13 RNAi line developed by M. Swiderski 
(WTCMP, University of Glasgow). This was transfected with the TbORC1/CDC6 
RNAi construct (Section 3.3) and two clones isolated. To determine if the RNAi 
effect was equivalent to that seen in Lister427 procyclic form cells, we analysed 
one clone by measuring growth for 144 hours. Although the TbORC1/CDC6 RNAi 
EATRO795 cell line had almost equal growth with the uninduced samples (Figure 
3-17A), qPCR showed that RNAi in this line resulted in a ~70 % knockdown of 
TbORC1/CDC6 mRNA after 96 hours (Figure 3-17B), compared with a 90% 
knockdown observed in the Lister 427 cell line (Section 3.3.3). To then ask about 
the effect of TbORC1/CDC6 RNAi knockdown on MVSG expression, we performed 
quantitative RT-PCR on three of the four MVSGs, 96 hours after induction (Figure 
3-17C). This showed a statistically significant increase in mRNA levels of 6 – 12 
fold for MVSG 1.22, 5 – 10 fold for MVSG 1.61 and 6 – 13 fold for MVSG 1.64, 
when comparing RNAi-induced and non-induced samples relative to GPI8 as an 
endogenous control. Thus, TbORC1/CDC6 RNAi appears to have a greater 
derepression effect on MVSG genes than on BVSG genes in this life cycle stage. It 
is worth mentioning that more clones need to be tested with Tubulin run as an 
unrelated control relative to GPI8 as an endogenous control. 
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Figure 3-17 - Metacyclic VSG expression in procyclic form T. brucei after TbORC1/CDC6 
RNAi 
(A) Cell counts of T. brucei Lister 427 pLew13-pLew29 cells transformed with a TbORC1/CDC6 
RNAi construct are shown over time for 3 independent clones in the absence of TbORC1/CDC6 
RNAi induction (Tet-; solid lines) or following RNAi induction by the addition of 1 μg.ml-1 tetracycline 
(Tet+; broken lines). Expression levels of MVSG genes were measured by quantitative real time 
RT-PCR, comparing mRNA levels for each relative to GPI8 as endogenous control, before (Tet -, 
grey bar) and after induction (Tet +, black bar) of TbORC1/CDC6 RNAi. In each case the level of 
mRNA of the uninduced sample is shown as 1 and the mRNA level in the RNA-induced sample 
shown relative to that. TbORC1/CDC6 mRNA knockdown levels is shown in (B) and MVSGs in (C). 
Vertical lines indicate standard deviation from triplicates within the same biological sample 
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3.8 Discussion 
This chapter presents the results of functional characterisation of T. brucei 
ORC1/CDC6 by RNAi, showing a role in nuclear DNA replication, and preliminary 
data that suggest a further role beyond DNA replication. 
3.8.1  RNAi of TbORC1/CDC6 defines an essential role in PCF  
First reported in Caenorhabditis elegans as a mechanism to specifically interfere 
with endogenous gene function by injection of RNA into cells, RNAi has evolved 
as a powerful tool that has been widely used in a variety higher eukaryotes as 
well as parasitic pathogenic protozoa to rapidly assess gene function (Ullu et al. 
2004; Fire et al. 1998). Since its inception in T. brucei RNAi has become the 
method of choice, in the first instance, to functionally characterise the effect of 
partial depletion of target genes. In this chapter, we have exploited this tool to 
investigate the function of a newly identified protein thought to control DNA 
replication in T. brucei. Before work in this chapter was begun, Michele Klingbeil 
and colleagues at the University of Massachusetts in Amherst had already 
performed RNAi of TbORC1/CDC6 and presented her data at the Kinetoplastid 
Molecular and Cellular Biology meeting II (2007) in Woods Hole, USA. Being a 
collaborator of Richard McCulloch and Dave Barry (my supervisors), Michele 
Kinglbeil kindly shared her unpublished data with us, and it was agreed that 
corroboration of this data, by performing the same initial PCF RNAi analysis in 
Glasgow, was valuable. Unknown to us, a group in Brazil headed by Caroline 
Elias was working on the same project, and have since published their findings in 
2009 (Godoy et al. 2009), Given this set of circumstances, I discuss below the 
overlapping data from all three labs, as well as unique aspects of my work, 
which suggest TbORC1/CDC6 is a key nuclear DNA replication factor. For the 
purposes of coherence, I provide a brief summary of the findings from Michele 
Klingbeil and colleagues and from Godoy et al (2009), and then focus the rest of 
my discussion on my data. 
Klingbeil and colleagues showed that: (i) a TbORC1/CDC6-GFP C-terminal fusion 
was a nuclear protein; (ii) TbORC1/CDC6 RNAi resulted in growth inhibition from 
4 days after induction in PCF T. brucei; (iii) the pre-dominant population of cells 
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post TbORC1/CDC6 RNAi induction was zoids (0N1K cells); (iv) BrdU 
incorporation, assayed microscopically, after TbORC1/CDC6 RNAi led to a 
decrease in nuclear DNA synthesis with a subset of zoids still capable of 
synthesising kDNA. Based on these findings, Klingbeil et al concluded that 
TbORC1/CDC6’s main role is in nuclear DNA synthesis. Godoy et al (2009) 
characterised ORC1/CDC6 from T. cruzi and T. brucei and showed that: (i) both 
proteins possess ATPase activity [a typical property of eukaryotic ORC proteins 
(Speck et al. 2005)] that increased in the presence of non-specific DNA; (ii) 
TbORC1/CDC6 and TcORC1/CDC6 were able to complement S. cerevisiae Cdc6 
mutants,  but not S. cerevisiae Orc1 mutants; (iii) TbORC1/CDC6 depletion by 
RNAi resulted in zoid formation in T. brucei PCF cells; (iv) using antiserum 
against TcORC1/CDC6 and TbORC1/CDC6, both proteins localised to the nucleus 
and remained attached to chromatin throughout the cell cycle. Based on these 
data Godoy et al concluded that, unlike higher eukaryotes (yeasts and humans, 
for example), trypanosomes utilise a simplified pre-replication machinery as 
previously described for archaea (Godoy et al. 2009).  
Based on database mining and phylogenetic analyses, we (Godoy et al, Klingbeil 
et al, and us) all hypothesise that T. brucei, T. cruzi and L. major possess a 
single protein that is homologous to eukaryotic Orc1 and Cdc6 proteins, and 
defines nuclear DNA replication origins by providing the activities of each. It is 
important to stress, however, that although BLAST searches using all ORC 
subunit homologues from yeast, humans and Arabidopsis have been unable to 
find trypanosomatid proteins with domains that match other members of the 
eukaryotic ORC family of proteins, such proteins might be present, but severely 
evolutionarily divergent and hence only identifiable through direct experiments, 
such as immunoprecipitation (see chapter 4). However, what is clear is that the 
ORC1/CDC6 homologues in each trypanosomatid show synteny across the fully 
sequenced genomes (Aslett et al. 2010), consistent with a critical function 
within the group. Given the homology between ORC1 and CDC6 in all eukaryotes 
(Kawakami & Katayama 2010; Duncker et al. 2009), and the ability to detect only 
trypanosomatid ORC1/CDC6 by BLAST searches with either gene, it seems likely 
that, like in archaea (De Felice et al. 2006; Grabowski & Kelman 2003), this 
singular trypanosomatid gene encodes a protein with ORC1 and CDC6 functions. 
Indeed, this may not be unique to trypanosomatids as a single ORC1/CDC6 gene 
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has also been described in Giardia lamblia (Morrison et al. 2007), and we detect 
the same in Entamoeba histolytica (see chapter 4). Whether this reflects an 
ancestral eukaryotic state remains unknown, but the ability of TcORC1/CDC6 to 
complement the absence of CDC6 when expressed in yeast CDC6 mutants (Godoy 
et al. 2009) provides evidence of Cdc6 function in the trypanosomatid protein. 
If the hypothesised nuclear DNA replication function for ORC1/CDC6 is true, the 
gene should be essential in trypanosomatids and RNAi knockdown should result in 
a complete block of nuclear DNA synthesis and rapid cell death. This has been 
tested now in T. brucei, and our work and others (Klingbeil et al, unpublished; 
and Godoy et al, 2009) show, surprisingly, that depletion of TbORC1/CDC6 mRNA 
in procyclic form cells does not immediately lead to cell death, but instead 
normal growth continues for up to 3-4 days post induction of RNAi. Why could 
this be the case? For any cell to be successfully propagated, its DNA content 
must be duplicated in S-phase, segregated in M-phase and then during 
cytokinesis passed onto its progeny. In budding and fission yeasts to ensure that 
DNA is replicated only once per cell cycle and to avoid re-replication, sites of 
initiation of DNA replication are licensed in G1 and only at these sites does DNA 
synthesis occur in S-phase (Ogawa, Takahashi, & Masukata 1999; Aparicio, 
Weinstein, & Bell 1997; Santocanale & Diffley 1997). We know from experiments 
by Godoy et al that, like yeast Orc1, TbORC1/CDC6 remains bound to chromatin 
throughout the cell cycle (Godoy et al. 2009). It also known that ORC in yeasts is 
not targeted for degradation after S phase, but rather its activity is regulated by 
post-translational modification events that release it from chromatin in mitosis 
and, upon mitotic exit, it is able to re-bind origins (Tsakraklides & Bell 2010; 
DePamphilis 2005).  Any such modifications have not been explored in T. brucei. 
Nevertheless, based on these observations, we can speculate that the equal 
growth observed before 72 hrs (approximately 6-8 cell divisions in vitro) for both 
TbORC1/CDC6 RNAi-induced and non-induced cells results from incomplete 
depletion of TbORC1/CDC6 protein in the cell, meaning that there is sufficient 
protein in these cell divisions to bind all origins, or sufficient numbers of origins 
defined to continue effective replication. Only once all, or most, TbORC1/CDC6 
is depleted does a growth defect become apparent, because the cell can no 
longer initiate sufficient DNA synthesis. Consistent with this, Godoy et al (2009) 
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show that TbORC1/CDC6 protein is still detectable up to 7-8 days post-RNAi 
induction (we have not examined this in our cell lines).  
Our FACS data, and that of Godoy et al (2009) and Klingbeil et al (unpublished), 
showed that TbORC1/CDC6 RNAi depleted cells have an altered nuclear DNA 
content (the contribution of kinetoplast DNA to the PI-stained population in FACS 
is considered negligible), consistent with a perturbation in cell cycle 
progression. T. brucei follows the conventional G1-S-G2-M cell cycle transition, 
with the replication of kinetoplast DNA occurring in temporal and partial 
synchrony with the replication of the nuclear genome (Woodward & Gull 1990), 
although all the events co-ordinating this cell division are not completely 
understood (Hammarton 2007). From Figure 3-4, the population of cells labelled 
2C are in G1, 4C cells with double nuclear DNA content are in G2, and S-phase 
cells are between the G1 and G2 peaks. Like wild type cells, non RNAi-induced G1 
cells transit nuclear DNA synthesis in S-phase to enter G2 and, following mitosis 
and cytokinesis, revert to G1. In the case of TbORC1/CDC6 RNAi cells, we infer 
that this routine is interrupted, since an almost complete disappearance of 4C 
cells is observed 120 hrs post-RNAi induction. In addition to this, there is an 
obvious reduction in 2C cells, and ultimately a majority of the cells have less 
than 2C nuclear DNA content 5 days post-RNAi. These data suggest that 
TbORC1/CDC6 depletion leads to inhibition of G1 to S transition, consistent with 
loss of TbORC1/CDC6 leaving origin DNA sites free from pre-licensing and hence 
no subsequent replication in S-phase. The additional loss of 2C cells and 
accumulation of <2C cells suggest further cell cycle abnormalities, discussed 
below.  
To complement the FACS data and further understand the potential role of 
TbORC1/CDC6 in the regulation of nuclear DNA replication in procyclic form T. 
brucei, microscopic counting of DAPI-stained DNA was carried out and quantified 
by us and by Godoy et al (2009) and Klingbeil et al (unpublished). Progression of 
the cell cycle in T. brucei involves the ordered and coordinated duplication of 
two genomes; the kinetoplast and the nuclear genomes. However, in cases of 
aberrant DNA synthesis and/or segregation of either genome, progeny could 
inherit unusual N-K configurations, such as 0N1K (anucleate cells, or zoids), 
1N0K, 2N1K, or >2N1K cells. Such aberrant cells usually maximally constitute 
~3.5 % of a wild type population (Woodward & Gull 1990). RNAi of TbORC1/CDC6 
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had a deleterious effect on nuclear synthesis, but no effect on kDNA synthesis, 
since cells lacking kDNA DAPI staining were never seen. In contrast, 
TbORC1/CDC6 RNAi virtually exclusively resulted in the generation of 0N1K 
zoids. In agreement with the growth phenotype and FACS analysis, zoids did not 
appear in the TbORC1/CDC6 RNAi-induced cell population until 72 hrs. Zoid 
appearance was primarily concomitant with a reduction of 1N1K cells, though 
2N2K cells appeared less prevalent relative to non-RNAi induced parasites, 
whereas 1N2K cells numbers appeared unchanged. Put together, these data 
support previous reports that there is apparently little coordination between 
nuclear DNA synthesis and cell division in PCF T. brucei (discussed below). 
Hence, we suggest that TbORC1/CDC6 RNAi inhibits nuclear but not kinetoplast 
DNA synthesis, but the cells can still proceed through to cytokinesis, resulting in 
the accumulation of zoids from division of 1N2K cells. 
The dissociation of nuclear DNA synthesis, nuclear mitosis and cytokinesis in T. 
brucei has been reported for a number of cell cycle proteins silenced by RNAi or 
following drug treatment of PCF cells. RNAi of cyclins CycE1/CYC2 and Cyc B2, a 
polo-like kinase, PLK, and cdc2-related kinase-1s, CRK1 and CRK3, all result in 
the production of anucleate cells in PCF T. brucei (Kumar & Wang 2006; 
Hammarton, Engstler, & Mottram 2004; Hammarton et al. 2003; Li & Wang 2003). 
Studies by Ploubidou et al (1999) used 60 μM aphidicolin to inhibit DNA synthesis 
by DNA Pol α (hence nuclear DNA synthesis) and showed that cells become 
blocked in S-phase, leading to the formation of zoids. This treatment also 
resulted in the complete absence of 2N2K cells in the population and an increase 
in 1N2K cells, suggesting that the zoids were the products of division of the IN2K 
population. In the same study, an anti-microtubule polymerisation inhibitor, 
rhizoxin, also resulted in the formation of zoids. From both experiments 
Ploubidou et al concluded that neither inhibition of nuclear DNA synthesis nor 
inhibition of mitosis has any effect on T. brucei cytokinesis (Ploubidou et al. 
1999).  Given that zoid formation also resulted from RNAi of all the above cell 
cycle regulators, the question arises if a general cell death pathway initiates in 
PCF cells once nuclear DNA synthesis or nuclear mitosis is inhibited, or does the 
data indicate a role of the cell cycle proteins in nuclear DNA synthesis?  It seems 
possible that once procyclic form cells sense a perturbation with cell cycle 
progression, nuclear DNA synthesis and consequently mitosis are shut down, 
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although progression to cytokinesis is not: hence the common production of 
anucleate cells. Therefore, the suggestion by Godoy et al (2009) that zoid 
formation upon RNAi of TbORC1/CDC6 implies a singular involvement of the 
protein in nuclear DNA synthesis may be flawed, and other roles cannot be ruled 
out. Godoy et al showed that the protein has ATPase activity, is localised to the 
nucleus and binds chromatin. Does that mean every protein with ATPase activity 
(at least ~ 135 in T. brucei identified in the TritrypDB database), that binds 
chromatin (at least ~ 110 in T. brucei by Tritryp DB), or that produces zoids after 
RNAi is involved in nuclear DNA replication? Like in Klingbeil et al’s analysis of 
TbORC1/CDC6 work and Ploubidou et al (1999) an assay, such as BrdUTP 
incorporation, is necessary to measure DNA synthesis and distinguish between 
cells which die by zoid formation because of cell cycle inhibition and death by 
the same route because nuclear DNA replication is inhibited. 
3.8.2 Assaying BrdU incorporation shows that TbORC1/CDC6 
RNAi inhibits nuclear DNA synthesis 
Having established by FACS and microscopy that RNAi knockdown of 
TbORC1/CDC6 led to inhibition of nuclear DNA replication and led to zoid 
formation in PCF cells, we wondered if the persistence of some normal cells (for 
instance, 40 % of cells were 1N1K) even 120 hrs post RNAi induction was due to 
incomplete TbORC1/CDC6 depletion, and so tested this by BrdUTP incorporation. 
Incorporation of the thymidine synthetic analogue 5-bromo-2′-deoxyuridine 
(BrdU) has become a common route to study S-phase events in living cells 
(Nowakowski, Lewin, & Miller 1989; Gratzner 1982).  Cells that are actively 
replicating their DNA, when incubated with BrdU and deoxycytidine, can be 
visualised by immunofluorescence using fluorescently-labelled monoclonal 
antibodies specific for BrdU. Variations in fluorescent intensities due to different 
immunofluorescent detection methods, the requirement of high magnification 
microscopes, and the time-consuming process of fixing and labelling cells are 
limitations in assessing and discriminating BrdU positive and negative cells by 
such approaches.  We therefore used a novel dot blot technique to assess and 
quantify DNA synthesis by BrdU incorporation in whole genomic DNA isolated 
from parasite populations before and after induction of TbORC1/CDC6 RNAi 
(Ueda et al. 2005). This approach demonstrated that 96 hrs post induction of 
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TbORC1/CDC6 RNAi, all living cells in the population could not make new DNA, 
since the amount of BrdU incorporated was essentially indistinguishable from 
background. This is consistent with our FACS and microscopic analyses, and 
suggests that TbORC1/CDC6 depletion was sufficient for abrogation of T. brucei 
DNA replication. 
3.8.3 TbORC1/CDC6 seems to be an essential gene 
Although RNAi has become the primary forward genetic tool to analyse gene 
function in trypanosomes, classical reverse genetic approaches such as targeted 
replacement of genes still remain the ultimate proof to test essentiality of genes 
for viability. Being a diploid organism, for single copy T. brucei genes both 
alleles must be deleted using conventional homologous recombination of regions 
flanking the gene of interest, which are replaced by selectable drug resistance 
markers. From a wild type cell line, a heterozygote null is first generated with 
one drug resistance marker, and using this line, a second marker is then used to 
attempt to delete the second allele. If the second allele cannot be deleted, this 
may suggest that the gene has an essential function, since both copies cannot be 
lost. A TbORC1/CDC6 heterozygous PCF cell line, with one allele replaced by a 
PUR cassette, was successfully generated. However, three separate attempts 
aimed at removing the second allele of TbORC1/CDC6 failed. In all three 
attempts, using a PCR-based approach, no PCR products could be generated for 
correct integration of the BSD cassette at the TbORC1/CDC6 locus when the PUR 
cassette was also present. Collectively, these results establish that there are, as 
expected, two alleles of TbORC1/CDC6 and that one can be disrupted without 
effecting cell viability. Here, we have only shown a PCR-based approach to 
verify that the TbORC1/CDC6 locus was targeted, but Southern blot analyses 
have also been carried out to confirm the results from the PCR (see chapter 4).  
A definitive technique to confirm essentiality would be to carry out a conditional 
gene knock-out strategy, first established in T. brucei by the lab of G.A.M Cross 
(Wirtz et al. 1999). Here, after one allele of the target gene has been replaced 
by a drug resistant cassette, the wild type copy of the gene is tetracycline-
inducibly expressed ectopically from the rRNA spacer. Once the heterozygote 
null recombinant parasites of the gene is obtained that can conditionally restore 
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expression of the wild type copy, then the second allele of the gene can be 
deleted with a second drug resistant marker. Removal of tetracycline to shut 
down ectopic expression of the gene in a homozygous null background should 
lead to cell death, if the gene is essential for viability. This approach has been 
used to test the essentiality of a number of genes in T. brucei (Martin & Smith 
2006; Martin & Smith 2005; Helfert et al. 2001; Wirtz et al. 1999; Ochatt et al. 
1999). With hindsight, this would have been the approach adapted to ultimately 
prove that TbORC1/CDC6 is an essential gene.   
3.8.4 TbORC1/CDC6 is a nuclear protein 
Immunolocalisation and fluorescent imaging of C-terminally GFP– or Myc– tagged 
TbORC1/CDC6 localises the signal to the nucleus, consistent with data from 
Klingbeil et al (unpublished) and Godoy et al (2009). In later work, furthermore, 
we show that the Myc-tagged variant is functional (see chapter 4).  In 
conjunction with FACS and DAPI-staining microscopy data, and attempted 
knockout experiments, these data are consistent with an essential role for 
TbORC1/CDC6 in procyclic form nuclear DNA synthesis. 
3.8.5 TbORC1/CDC6 is important for BSF T. brucei life cycle 
progression 
In the above analyses, and in the work of Klingbeil et al and Godoy et al, the 
effect of TbORC1/CDC6 RNAi was limited to insect stage T. brucei procyclic form 
cells and demonstrated clearly that it is an essential gene involved in nuclear 
DNA synthesis. What about the mammalian-infective stages, the bloodstream 
form cells, which are clinically relevant in terms of drug discovery? Does 
TbORC1/CDC6 perform the same function in both life cycle stages? As shown in 
the Section 3.6.2, induction of TbORC1/CDC6 RNAi inhibits parasite growth very 
rapidly in the BSF, since after 8 hrs (~1 cell division) post-induction no increase 
in cell density was observed. This was followed by an accumulation of post-S 
cells with no apparent manifestation of a cleavage furrow to indicate the onset 
of cytokinesis. The impairment of cytokinesis in these cells appeared to be 
associated with continued synthesis and replication of kinetoplast and nuclear 
DNA, since multi-nucleate, multi-kinetoplast cells accumulated from 8 hrs 
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onwards, with the nuclei eventually becoming condensed and non-discrete 24 hrs 
post RNAi induction. However, despite the rapid effect of RNAi on DNA content, 
knockdown levels measured by quantitative RT-PCR only revealed a 40 % 
depletion of TbORC1/CDC6 transcripts 12 hrs post-induction. Even at this level 
of RNAi, >80 % of the cells in the RNAi-induced population after 24 hrs had 
aberrant DNA configurations. The rapidity of the onset of growth arrest, the 
extent of aberrant cells observed and the lack of anucleate cells in the BSF all 
appear to contrast with the TbORC1/CDC6 RNAi phenotypes seen in PCF cells. 
Looking at the literature there is substantial evidence to support the concept 
that there are differences in the regulation of cell cycle events between BSF and 
PCF T. brucei. A few examples of proteins whose RNAi knockdown show 
differences between bloodstream and procyclic forms are described below. 
In all studied eukaryotes, Mob proteins are known to bind and up-regulate the 
activity of members of the NDR (nuclear Dbf2-related) subfamily of kinases 
(Hergovich et al. 2006). In budding yeasts, they have been shown to control 
mitotic exit and entry into cytokinesis via their interaction with Dbf2/Dbf20 
(Mah, Jang, & Deshaies 2001). In T. brucei there are two Mob1 proteins: MOB1-A 
and MOB1-B. When depleted by RNAi both proteins exhibit an increase in 
abnormal cells (Hammarton et al. 2005), usually seen as >2N>2K configurations in 
the BSF 24 hrs post RNAi induction. The MOB1 RNAi-induced cells also showed 
prematurely terminated cytokinesis, as observed by a block in the later stages of 
cytokinesis which occurred in a subset of post-mitotic cells (Hammarton et al. 
2005). It is worthy of note that MOB1 in BSF T. brucei cells does not localise to 
the nucleus at any stage in the cell cycle. Although the same localisation 
experiments were not done in PCF cells, RNAi of MOB1-A and MOB1-B in this life 
cycle stage resulted in the production of zoids. The authors concluded that there 
is differential regulation of the cell cycle in the two life cycle stages. How do 
these findings compare with TbORC1/CDC6 RNAi? Clearly, there are broad 
similarities in terms of RNAi phenotypes of both TbORC1/CDC6 and TbMOB1; 
indeed, in both studies very similar time points were used for examination of 
samples, implying that the results are very comparable. However, localisation of 
MOB1 proteins was analysed in BSF cells and not in PCF cells, while localisation 
of TbORC1/CDC6, in all 3 studies, was done in PCF cells and not in the BSF. Due 
to time constraints in this project we have not looked at the localisation of 
 
 111
TbORC1/CDC6 in the BSF. Although it is possible that TbORC1/CDC6 might have 
other roles in BSF cells that may not restrict it to the nucleus, without 
experimental proof this is speculation.  
Structural Maintenance of Chromosome (SMC) proteins are known in eukaryotes 
to play essential roles in DNA repair and recombination, as well as in 
chromosome segregation (for review see (Schubert 2009)). An example of the 
SMC class of proteins is the cohesin complex, whose function is to hold 
duplicated sister chromatids together until segregation. The cohesin complex 
proteins are conserved in T. brucei and characterisation of the cohesin subunit I 
(SCC1) by RNAi has been carried out by Gluenz and colleagues (Gluenz et al. 
2008). In BSF cells, TbSCC1 localises to the nucleus during S-phase and G2 and is 
absent in G1 and M-phases of the cell cycle. Although phenotypes arise much 
slower than observed for TbORC1/CDC6, RNAi of TbSCC1 also results in zoid 
formation in PCF cells and in multikinetoplast, multinuclei and multi-flagellated 
cells in the BSF. Here, therefore, is a protein that is localised to the nucleus at 
least for part of the cell cycle and whose RNAi phenotypes are analogous to that 
observed for TbORC1/CDC6 RNAi in both BSF and PCF cells. 
In higher eukaryotes the function of cyclin-dependent kinases (CRK) as key 
regulators of cell cycle progression is well established [for review see (Pines 
1995) and references therein]. Recently, in T. brucei, RNAi studies on a number 
of cyclins and their corresponding kinases has begun to shine a light on our 
understanding of their roles as key cell cycle regulators in both PCF and BSF T. 
brucei cells (Hammarton et al. 2004; Tu & Wang 2004; Li & Wang 2003).  In two 
independent studies the cyclin CYC6 and its corresponding kinase CRK3 have 
been shown to show stage-specific differences in cell cycle controls when 
analysed by RNAi (Tu & Wang 2004; Hammarton et al. 2003). Although in both 
studies the localisation of the proteins are not established in any of the parasite 
life cycle stages, it is very likely that at least for part of the cell cycle these 
proteins will be in the nucleus if they are bona fide cell cycle regulators. With 
this assumption in mind, depletion of TbCYC6 by RNAi generates zoids in PCF 
cells, whereas in BSF cells multikinetoplast and multinucleat cells are formed. 
Not surprisingly, the same phenotypes are observed upon RNAi knockdown of 
TbCRK3, except that the multiple nuclei in BSF cells remain condensed to each 
other. Both papers conclude that there are fundamental differences in cell cycle 
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regulation in PCF and BSF cells. Again, these phenotypes are broadly similar to 
the observed differences for TbORC1/CDC6 RNAi in the two life cycle stage 
forms, though not directly comparable due to lack of localisation experiments.  
Taking the above data together, we can propose that in T. brucei cells, BSF- 
specific cell cycle checkpoints become activated in a number of contexts that 
halt cell division, or at least cytokinesis. For TbORC1/CDC6 such a response 
occurs quickly after RNAi, even before TbORC1/CDC6 levels are reduced 
sufficiently to halt DNA replication. Three alternative hypotheses are possible. 
One is that T. brucei expresses a BSF-specific factor that is accidently targeted 
by the TbORC1/CDC6 RNAi, initiating an off-target effect that exceeds the small 
depletion of TbORC1/CDC6 (40 % decrease in mRNA levels). Second, there may 
be a BSF-specific factor that interacts with TbORC1/CDC6, or a direct BSF-
specific function of TbORC1/CDC6, whose importance to T. brucei growth in this 
life cycle stage supersedes the role of TbORC1/CDC6 as the orchestrator of 
nuclear DNA replication. Thirdly, might depletion of essential proteins by RNAi in 
BSF cells always produce a stereotyped phenotype of multinucleate and 
mutikinetoplast cells, implying a general cell death phenomenon in BSF? 
Examples of protein depletion by RNAi that fail to induce these phenotypes 
appear to rule out this last possibility (see below).  
In a quest to understand the mechanisms that lead to cell death in BSF T. 
brucei, Worthen et al (2010) used RNAi to knockdown the large and small 
subunits of topoisomerase IB (TOP1BS and TOPIBL respectively), mitochondrial 
topoisomerase II (TOPIImt) and a nucleolus localised protein, NOPP44/46. 
Knockdown of TOP1BS and TOPIBL resulted in zoid formation, knockdown of 
TOPIImt resulted in accumulation of 1N0K cells, while knockdown of nuclear 
NOPP44/46 resulted in loss of 2N cells and accumulation of >4N cells. Coupled 
with a variety of drug treatments, the authors suggest that there is a limited 
number of pathways that lead to cell type in BSF cells, and whether this involves 
the disruption of biochemical pathways and/or depends on underlying genetic 
variation still remains to be investigated (Worthen, Jensen, & Parsons 2010). 
Nevertheless, it is clear that the formation of multinucleate and 
multikinetoplast cells, as seen following RNAi of TbORC1/CDC6 and a number of 
cell cycle regulators, is not a default RNAi phenotype.  
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The differences in TbORC1/CDC6 RNAi phenotypes between PCF and BSF cells 
may, of course, have simpler explanations. It may simply be down to differences 
in metabolic rates or in generation times (~ 6 hrs for BSF cells, and ~ 11 hrs for 
PCF). Differences in protein abundance is also possible, though no significant 
difference in mRNA expression levels of TbORC1/CDC6 between BSF and PCF T. 
brucei have been reported, at least based on RNA-Seq data available on TriTryDB 
(Aslett et al. 2010; Siegel et al. 2010). Further work will therefore be needed to 
explain this, but one non-DNA replication function of TbORC1/CDC6 that may be 
key to this is discussed below. 
3.8.6 Regulation of BSVG and MSVG gene expression by 
TbORC1/CDC6 
ORC proteins mediate the formation of heterochromatin, for instance at the 
silent mating loci HML and HMR in yeasts, and at telomeres and subtelomeres via 
interactions with Telomere repeat binding factor 2 (TRF2), heterochromatin 
protein 1 (HP1), and histone H3 trimethyl K9 (H3 K9me3) in Drosophila and 
mammalian cells (Deng et al. 2009; Sasaki & Gilbert 2007; Lidonnici et al. 2004). 
Also, in the malaria parasite Plasmodium falciparum, where only 1 out of ~ 50 
var genes is expressed at one time, Orc1 in conjunction with Sir2 has been 
shown to be involved in telomeric silencing (Mancio-Silva et al. 2008). Except in 
P. falciparum, eukaryotic Orc1’s role in silencing is thought be orchestrated by 
the presence of an N-terminal BAH domain (reviewed in [Sasaki & Gilbert 2007)]. 
Although T. brucei ORC1/CDC6 lacks the BAH domain, sub-telomeric localisation 
revealed by chIP-chip data (see Chapter 5) prompted us to investigate if 
TbORC1/CDC6 played additional roles in PCF and BSF cells beyond DNA 
replication.  
Mapping TbORC1/CDC6 binding along the T. brucei megabase chromosomes 
showed high density clusters of binding sites at telomeric and subtelomeric loci, 
overlapping with sites which are known to contain BVSG and MVSG expression 
sites (see Chapter 5). To investigate the potential function of TbORC1/CDC6 
binding at these loci we asked if depletion of the protein by RNAi had an effect 
on BVSG or MVSG expression. In Lister 427 PCF cells, RNAi had limited effect on 
BVSG mRNA levels (3/5 genes tested showed derepression, of 1.5-2.7 fold), and 
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no discernible effect on BVSGs in Lister 427 BSF cells (no silent genes showed 
derepression). In contrast, in EATRO795 PCF T. brucei, RNAi of TbORC1/CDC6 led 
to substantial (5-13 fold) derepression of all MVSGs tested. On first look this is 
an interesting observation, but upon closer scrutiny several questions arise; why 
is the effect of TbORC1/CDC6 RNAi different at BES and MES, and perhaps in 
different life cycle stages? Are these due to differences in the structure of the 
two ES classes, or due to differential regulatory mechanisms acting on them or 
in the two life cycle stages? 
Recently, Hertz-Fowler and colleagues used transformation–associated 
recombination cloning (TAR clone) to analyse the complete collection of BES 
from the Lister 427 strain of T. brucei (Hertz-Fowler et al. 2008). Their results 
confirm a number of differences from the MES (Ginger et al. 2002). Figure 3-18 
highlights the major differences in the architecture of the MES and BES. Briefly, 
Hertz-Fowler showed that BVSGs are located 40 – 60 kb downstream of their 
promoters, between which are located a number of expression site-associated 
genes (ESAGs) and pseudogenes that are co-transcribed with the VSG. ESAG 7, 
ESAG6, and ESAG5 are located closest to the promoter and are thus furthest 
from the VSG ORF. Between the most telomere-proximal ESAG (ESAG1) and the 
VSG ORF is an array of 70 bp repeats whose length is variable depending on the 
BES (Hertz-Fowler et al. 2008). On the other hand, the MES show a much simpler 
design than the BES (Ginger et al. 2002; Kim & Donelson 1997; Son et al. 1989). 
Eight MES characterised showed gross architectural similarities amongst each 
other with a number of differences compared to BES (Figure 3-18 A and B). The 
differences include: (a) much reduced numbers, and even absence, of 70-bp 
repeats between the promoter and the MVSG ORF; and (b) the complete absence 
of ESAGs between the promoter and the MVSG ORF (though some ESAGs are 
located upstream of the MVSG promoter, alongside a number of ESAG 
pseudogenes and ingi retrotransposons) (Ginger et al. 2002).  
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Figure 3-18 – Architecture of T. brucei expression sites 
(A) Metacyclic VSG expression site (MES) and (B) bloodstream VSG expression site (BES) show 
structural differences in: (i) location of the promoter relative to the VSG; (ii) number of 70 bp 
repeats between promoter and VSG; and (iii) position and number of expression site associated 
genes (ESAGs).  Functional ESAGs are shown by black boxes, pseudigenes are shown as grey 
boxes, arrow heads indicate the position of the promoter, and coloured boxes show the ORF of 
either BVSG or MVSG shown below it. Figure made by R. McCulloch – copied with permission. 
BES structure originally in (Hertz-Fowler et al. 2008) 
 
Like BVSGs in the mammal bloodstream, MVSGs are expressed in a monoallelic 
fashion in the tsetse salivary glands (Alarcon et al. 1994), and in neither case is it 
fully understood how this is achieved. Unlike protein coding genes, which are 
transcribed by RNA Pol II, both types of VSG gene are transcribed by RNA Pol I 
(Gunzl et al. 2003), though the BES and MES promoters are not significantly 
homologous to each other (Ginger et al. 2002). Navarro and Gull showed that RNA 
Pol I localises to a single, extranucleolar site in the nucleus of BSF cells, termed 
the expression site body (ESB), and thus they postulate that this is limited to 
containing one BES and therefore drives monoallelic expression (Navarro & Gull 
2001). It is unknown if an equivalent structure is found in metacyclic cells and 
associated with MES expression, but it is not observed in PCF cells, when no VSG 
are normally expressed (Navarro & Gull 2001). If the ESB hypothesis is true, is 
the single ESB primarily necessary and sufficient to render the other 14 sites 
transcriptionally silent? There is accumulating evidence in the literature to 
suggest that epigenetic phenomena are also involved in maintaining 
transcriptionally silent chromatin at inactive BES. Deletion of TbDOT1B, and 
RNAi of TbISWI, TbSCC1 and TbRAP1, have all been shown to cause derepression 
of silent BES to varying extents in PCF and BSF (Yang et al. 2009; Landeira et al. 
2009; Figueiredo et al. 2008; Hughes et al. 2007). 
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The first experiments to show that derepression of BES could involve changes in 
local chromatin structure came from the lab of G. Rudenko, by studying the 
chromatin remodelling protein TbISWI through RNAi. Using fluorescent gene 
reporter assays integrated downstream of BES promoters they showed that 
depletion of TbISWI in PCF cells led to 10 -17 fold depression of the reporter,  
while in BSF depletion resulted in 30 – 60 fold derepression. Silent BES activation 
was measured either by the reporter gene or by measuring transcript levels for 
ESAGs located downstream of the reporter. Interestingly, in both PCF and BSF 
cells RNAi caused derepression of the reporter gene and ESAGs proximal to the 
promoter (ESAG 5, 6, and 7), while those genes distant from the promoters, 
including the BVSGs, were not derepressed. They concluded that BES 
activation/silencing is a multi-step process that involves regulation of the 
activity of the promoter occurring separately from regulation at the level of 
transcription, which involves regulation of termination/progression of 
transcription through the BES (Hughes et al. 2007).  These data may be consistent 
with the lack of BVSG derepression after TbORC1/CDC6 RNAi, particularly in BSF 
cells. If some BES control is indeed exerted at the level of the promoter, with 
transcription gradually attenuated in silent sites as you move further from it, 
then the level of derepression following TbORC1/CDC6 RNAi for BVSG 
transcription in PCF might be stronger than reported here; i.e. there may be 
significant derepression of promoter proximal genes (which was not examined), 
but little increase in VSG mRNA levels (which corresponds with what was 
observed). The slightly greater evidence for BVSG derepression in PCF cells may 
reflect some life cycle stage differences in the balance between promoter and 
transcription elongation controls. To test this, transcript levels for ESAG5, ESAG6 
and ESAG7 would need to be assessed. In contrast to the work of Hughes et al 
(2007), Yang et al (2009) showed that RNAi depletion of TbRAP1 causes 
derepression of VSGs from silent BESs in BSF T. brucei, but the extent of this 
derepression is reduced in genes more proximal to the telomere. TbRAP1, like its 
homologues in other eukaryotes, associates with telomeres (Yang et al. 2009) and 
may be part of a trypanosome shelterin complex that protects chromosome ends 
from repair and can mediate heterochromatin-silencing (Dreesen, Li, & Cross 
2007). It is known that in mammals ORC can also associate with telomeres, 
where it is recruited via two other telomere binding components of the shelterin 
complex, TRF1 and TRF2, and can also interact with HP1, which can bind 
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methylated histone H3 at telomeres (Deng et al. 2009). Given that TbRAP1 RNAi 
causes telomere-proximal BES derepression in BSF cells, and TbORC1/CDC6 does 
not, this might be consistent with TbORC1/CDC6 acting at promoters, and not at 
telomeres. This could be addressed by chIP, which has not been done. However, 
this is complicated by that fact that BSF TbTRF2 RNAi appears not to result in 
VSG de-repression (Li, Espinal, & Cross 2005). 
Despite the lack of a clear role for TbORC1/CDC6 in determining BES monoallelic 
expression, we found compelling evidence that TbORC1/CDC6 RNAi results in 
derepression of MVSGs in PCF cells. Using an EATRO 795 RNAi strain developed 
by M. Swiderski, we observed a significant derepression of all MVSGs tested. 
RNAi depletion of PLK, Clathrin and an ATPase factor as control experiments 
clearly demonstrate that the observed derepression is not a stress response 
caused by RNAi of essential genes, since none of these experiments led to MVSG 
expression (M. Swiderski, personal communication). To date, no genes involved 
in MVSG silencing in PCF cells have been reported, but M. Swiderski has revealed 
others in addition to TbORC1/CDC6 (M.Swiderski and J.D.Barry, unpublished). 
The level of derepression observed following TbORC1/CDC6 RNAi is comparable 
to that observed for a nuclear envelope protein, TbNUP-1 (6 – 16 fold increase in 
MVSG mRNA levels; M. Swiderski, personal communication). Interestingly, MVSGs 
are derepressed to an even greater extent by RNAi of TbRAP1 and TbTRF2 (16 – 
80 fold) (M. Swiderski, personal communication), which was not reported to 
affect BES silencing. Why, then, does TbORC1/CDC6 appear to have a role in 
MVSG silencing, but not BVSG? This may be consistent with TbORC1/CDC6 
exerting its influence at the promoter, since in MES the promoter is much closer 
to the VSG than in the BES and any alleviation of promoter-proximal silencing 
could encompass the MVSG. This is complicated by the lack of homology 
between MES and BES promoters, however. An alternative explanation is that 
the monoallelic regulatory factors and mechanisms that operate on the MES and 
BES are quite different. Indeed, this may be consistent with the observed role 
for TRF2 in MES silencing in PCF cells, but not in BES silencing in BSF cells (Li et 
al. 2005). Answering this would require the demonstration that TbORC1/CDC6 or 
TRF2 RNAi in BSF cells causes MES derepression, and this is not currently 
technically possible as MESs in Lister427 T. brucei have not been identified and 
EATRO795 T. brucei do not grow in culture as BSF cells. Nevertheless, the 
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localisation of TbORC1/CDC6 at MVSG loci (see chapter 5), coupled with known 
functions of Orc1 as mediators of heterochromatin (Deng et al. 2009; Sasaki & 
Gilbert 2007), could provide a potential broad explanation of how TbORC1/CDC6 
functions at telomeric loci in this parasite, which deserve to be followed up.  
A final complication in analysing the above data may provide yet another 
explanation for the lack of observable effect of TbORC1/CDC6 RNAi on BVSG 
expression in BSF cells. It could simply be that the TbORC1/CDC6 RNAi-induced 
cells die so quickly that any changes in transcript levels are masked by switching 
off the transcription and translation machinery. The rapidity of TbORC1/CDC6 
BSF RNAi-induced cell death is faster than that of either TbISWI (Hughes et al. 
2007) or TbRAP1 (Yang et al. 2009), which caused BES up-regulation, but may be 
closer to that following RNAi of TbTRF2 (Li et al. 2005). However, previous 
observations do suggest there are fundamental differences in the way BSF and 
PCF cells regulate ES promoter activity, perhaps arguing against this technical 
explanation. In BSF cells, an rDNA promoter integrated in the BES behaves 
exactly like the endogenous promoter, whereas in PCF cells integration of an 
rDNA promoter prevents repression of BES activity (Rudenko et al. 1995; Horn & 
Cross 1995; Rudenko et al. 1994). Thus, changes in sequence could mediate 
differences in TbORC1/CDC6 occupancy at these loci, leading to differential 
behaviour in terms of regulating ES activation.  
The last, and perhaps most critical question, especially given the genome-wide 
binding of TbORC1/CDC6 (see chapter 5), is how widespread is TbORC1/CDC6 
RNAi effect on gene expression? Is it limited only to telomeric VSGs? Using our 
TbORC1/CDC6 427 PCF RNAi strain, RNA-seq was carried out to ask if there are 
any genome-wide or VSG-specific changes in transcript levels between RNAi- 
induced and non-induced samples. Analysis of RNA-Seq data and quantification 
of genome-wide RNA levels in two samples (tet – and tet +) is still been 
performed. The results may also answer the questions on changes in ESAG 
transcript levels upon TbORC1/CDC6 RNAi induction discussed above.  
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3.9 Highlight of major findings  
To summarise this chapter, the major findings are: (i) TbORC1/CDC6 is essential 
for nuclear DNA synthesis in T.brucei as revealed by BrdUTP incorporation in PCF  
cells; (ii) TbORC1/CDC6 is essential in BSF cells, where its knockdown results in 
accumulation of multinucleate and multikinetoplast cells with an absence of 
cytokinesis, a distinct phenotype to the accumulation of zoids in PCF cells; (iii) 
TbORC1/CDC6 is a nuclear protein; (iv) several failed attempts to generate 
TbORC1/CDC6 null mutants, despite being able to generate a heterozygote null 
and tag the second allele at the endogenous locus, are consistent with it being 
an essential gene; and (v) TbORC1/CDC6 is involved in the silencing of telomeric 
MVSG loci in PCF cells; whether this role extends more widely to antigenic 
variation in the BSF remains to be shown.  
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4 Identification of putative novel components of 
the Trypanosoma brucei Pre-Replication 
machinery 
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4.1 Introduction 
4.1.1 Is DNA replication initiation in T. brucei atypical of 
eukaryotes? 
Trypanosoma brucei and related species (such as L .major and T. cruzi) are 
single cell eukaryotic parasitic protozoa that display several unique biological 
features. These organisms have been studied for over a century not only because 
they cause clinically important diseases in humans and a variety of animals, but 
also because aspects of their fundamental biology are remarkably distinct from 
other eukaryotes and therefore shed new light on basic eukaryotic processes. 
Obviously, if basic biological processes can be shown to be significantly 
divergent from the eukaryotic hosts that trypanosomatids parasitize they could 
be exploited for rational drug design to treat the diseases caused by these 
organisms. A number of divergent biological aspects in trypanosomatids have 
already been characterised. A few examples include: (a) the sequestration of 
glycolytic enzymes into a peroxisome-like organelle known as the glycosome; (b) 
the apparently non-regulated polycistronic transcription initiation of mRNA 
genes by RNA Pol II; (c) the lack of restriction of RNA Pol I transcription to rRNA 
genes, since the enzyme also drives expression of several mRNA genes, e.g. 
MVSG and BVSG genes; (d) trans-splicing of nearly all mRNA transcripts; (e) the 
presence of a hypermodified base, beta-d-glucopyranosyloxymethyluracil (base 
J), in repetitive DNA sequences; and (f) the presence of an unusual 
mitochondrial (kinetoplast) DNA, which consists of a catenated network of 
minicircles and maxicircles with extensive editing of its RNA products (Borst & 
Sabatini 2008; Lukes, Hashimi, & Zikova 2005; Lukes et al. 2002; Clayton 2002; 
Simpson et al. 2000). Broadly, therefore, aspects of energy metabolism, gene 
expression and regulation and, of particular note, mitochondrial DNA replication 
seem to be atypical of eukaryotes. So, is trypanosomatid nuclear DNA 
replication, or at least its initiation, also unusual?  
Annotation of putative DNA replication factors using protein homology search 
algorithms suggests that trypanosomatid parasites, though eukaryotic, possess 
aspects of their replication initiation machinery that may be archaeal-like in 
organisation. This is supported by some experimental work, which reinforces the 
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hypothesis that only a single protein constitutes the pre-RC machinery in T. 
brucei and T. cruzi (Godoy et al. 2009).This chapter seeks to test this hypothesis 
further. Here, we focus on the events of DNA replication occurring from the 
point of recognition of T. brucei origins of replication by the ORC complex (or, 
putatively, simply by TbORC1/CDC6) up to the point at which the origin becomes 
licensed and is rendered competent for replication firing. The chapter describes 
a bioinformatic comparison of the pre-replication initiator proteins across a few 
eukaryotic lineages, and transgenic approaches to examine functional 
interactions amongst DNA replication proteins in T. brucei. The generation of a 
functional TbORC1/CDC6 epitope – tagged cell line, and lines co-expressing 
TbMCMs and TbORC1/CDC6 fusion proteins, will be described. Experiments to 
test for direct interactions between TbMCMs and TbORC1/CDC6, and 
subsequently using TbORC1/CDC6 as ‘bait’ to probe for potentially novel 
interactors, are discussed.  
4.2 Results 
4.3 A Bioinformatic screen for ORC and Cdc6 
components in protozoa relative to higher eukaryotes 
Chromosomal DNA replication initiation in “standard” eukaryotes, such as yeasts 
and metazoans, requires the Origin Recognition Complex (composed of six 
proteins, Orcs1-6), and Cdc6 to recognise and bind a number of DNA sequences 
per chromosome, known as origins of replication (Speck et al. 2005; Bell & Dutta 
2002). This event is a fundamental early requirement for the establishment of 
replication initiation. The experiments until now have considered the potentially 
novel circumstances found in kinetoplastid parasites where only a single protein, 
indistuguishable between Orc1 and Cdc6, can de identified from the above seven 
proteins. To ask if this is unique to these organisms amongst eukaryotes, we 
decided to examine the distribution of ORC components, plus CDC6, in a number 
of protozoans whose genomes have been sequenced. In doing so, we can ask if 
there is a clear evolutionary picture of how conserved these factors are amongst 
eukaryotes beyond simply yeasts, Drosophila, Xenopus, and humans where most 
work has been done [reviewed in (Gerbi, Strezoska, & Waggener 2002; Bell & 
Dutta 2002)]. To do this, we performed BLAST searches of all the genomes 
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detailed in Figure 4-1 with Orc1, Orc2, Orc3, Orc4, Orc5, Orc6 and Cdc6 from H. 
sapiens, S. cerevisiae and from Arabidopsis thaliana. 
From Figure 4-1, it is clear that bioinformatic examination of a wide range of 
eukaryotic genomes reveals that the absence of clear homologues of each of the 
six ORC components is not uncommon, and that a single protein related to both 
Orc1 and Cdc6 is not limited to kinetoplastids. Within the Opisthokonts and 
Amoebozoa, yeasts, metazoans and the social amoeba Dictyostileum discoidieum 
have six ORC proteins, and Cdc6 as a separate protein, the ‘standard’ for all 
higher eukaryotes studied so far (Bell & Dutta 2002). This complement of factors 
is also found in plants belonging to the Archaeplastida supergroup. However, two 
members of the Opisthokont supergoup, Encephalitozoon cuniculi and 
Entamoeba histolytica, appear not to have this composition: in the former, Orc1 
and Cdc6 are separate proteins, but Orcs 3, 4 and 6 are not found; in the latter, 
Orc2 alone is identified and a single Orc1/Cdc6 protein. The case of E. cuniculi is 
perhaps illuminating. This is an intracellular microsporidian parasite, related to 
fungi such as yeast, and might therefore be expected to display greater 
sequence homology, including in the ORC subunits, with Opisthokont eukaryotes. 
Considerable evidence suggests E. cuniculi is undergoing a process of genome 
reduction (Gill & Fast 2007; Katinka et al. 2001), and the absence of ORC 
components may then be a relatively recent evolutionary loss, illustrating that 
eukaryotic ORC function can be adapted to a streamlined version lacking some 
components. In the Excavata supergroup, all genomes examined appeared to 
encode Orc1 and Cdc6 as a single protein, and none had all six ORC components: 
G. Intestinalis and Trichomonas vaginalis encoded recognisable orthologues of 
the Orc4 subunit, and the Orc2 and Orc4 subunits, respectively. On the other 
hand, the Chromalveolates, which include members of the Apicomplexan taxon, 
appear to encode Orc1 and Cdc6 as separate proteins, and a variable number of 
other Orc subunits were present. Trypanosomatids belong to the taxon 
Euglenozoa, in the supergroup Excavata. From this genome-wide screen 
trypanosomatids appear to be the only organisms examined that possess Orc1 
and Cdc6 as a single protein, with no other subunits of ORC identified. As such, 
they may have the most simplified eukaryotic machinery involved in the 
initiation of DNA replication. To summarise, this genome-wide screen could not 
reveal a clear evolutionary trend for the conservation or absence of ORC 
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proteins or Cdc6 across the selected examples of eukaryotes for which genome 
sequences were available.  
 
Figure 4-1 – Comparison of ORC complex components and Cdc6 across eukaryotes with full 
genome sequences published or available 
The tree generated according the new level of classification by Adl et al (2005), shows the 
presence of the ORC complex components (Orcs 1-6) and Cdc6 revealed by database mining of 
genome sequences. Each species and the presence or absence of  Orcs1-6 or Cdc6 within each 
supergroup is indicated by a corresponding broken or solid line; Orc1/Cdc6 indicates a single 
protein related to both Orc1 and Cdc6, while Orc1 and Cdc6 indicates the presence of both 
proteins; two copies of a protein is indicated by (2). Lm = Leishmania major, Tb = Trypanosoma 
brucei, Gi = Giardia intestinalis, Tv = Trichomonas vaginalis, Eh = Entamoeba histolytica, and Dd = 
Dictyostelium discoideum, Ec = Encephalitozoon cuniculi, Pf = Plasmodium falciparum, Tt = 
Tetrahymena thermophila, Tp = Thalassiosira pseudonana.  
 
4.4 Are typical eukaryotic Pre-RC components conserved 
in Trypanosomatids? 
In budding yeasts (S. cerevisiae), the pre-RC is established at DNA replication 
origins by the regulated binding of four different proteins:  ORC, Cdc6, Cdt1, and 
the MCM complex (Diffley et al. 1994). With no specific pattern observed for 
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retention or loss of ORC and Cdc6 initiator proteins in the selected eukaryotes 
described above, a further BLAST was carried out to examine the extent of 
conservation of the downstream pre-RC factors, Cdt1 and the MCM complex. The 
molecular events that regulate and follow pre-RC formation are beyond the 
scope of this thesis and are not explored. Using CLC Genomics Workbench v4 
(CLC Bio, Denmark), with a local database of the 9068 predicted ORFs of T. 
brucei from TriTrypDB (http://tritrypdb.org/tritrypdb), pre-RC proteins from 
other organisms available in the NCBI protein database were used to carry out a 
local BLAST search for homologues in T. brucei.   The BLAST search results 
summarised in Table 4-1 revealed no clear homologue of the eukaryotic helicase 
recruiter Cdt1 (Randell et al. 2006; Tanaka & Diffley 2002). Bearing in mind the 
previously reported potential analogy of TbORC1/CDC6 to archaea (Godoy et al. 
2009)(chapter 3), the proteins were then compared to archaeal components. 
Sequence BLAST using seven archaeal WhiP proteins [Sulfolobus acidocaldarius 
(GenBank accession no. YP_256028); Metallosphaera sedula (GenBank accession 
no. ZP_01600793); Solfolubus solfataricus (GenBank accession no. NP_342366); 
Aeropyrum pernix (GenBank accession no. NP_148313); Hyperthermus butylicus 
(GenBank accession no. YP_001013395)] were used to query local database using 
CLC Genomics workbench. Again, the BLAST results revealed 13 hits all with E-
values >1. Therefore, we concluded that there was no obvious homologue of a 
helicase recruiter protein, since T. brucei orthologues of WhiP (Robinson & Bell 
2007) were not identified  (Table 4-1). Using the same approach but this time 
using eukaryotic MCM proteins as query (20 versions of each protein from 
eukaryotes available in the NCBI database – see Appendix 1), all six subunits of 
the MCM complex were found in T. brucei. The hits identified corresponded to 
annotations present in the T. brucei database, TriTrypDB 
(http://tritrypdb.org/tritrypdb). The gene IDs and corresponding T. brucei MCM 
subunits are shown in Table 4-2. 
 
 126
Table 4-1 – Comparison of Pre-RC components in archaea, “standard” eukaryotes, and T. 
brucei  
 
 
The in silico database mining experiments above and in Section 4.3 suggest that 
a number of factors of T. brucei DNA replication initiation are not recognisable: 
Orc2-6 and Cdt1. This means that either (a) T. brucei lacks eukaryotic 
homologues of these proteins, or (b) that these proteins are present but 
significantly diverged in sequence such that they cannot be identified by 
conventional bioinformatic approaches. A putative absence that can be tested 
experimentally is the lack of a helicase recruiter, Cdt1. If this is truly lacking, T. 
brucei replication initiation may be unusual, at least for a eukaryote, in that 
TbORC1/CDC6 functions alone as the initiator and at the same time as the 
recruiter of the helicase, which should be detectable as direct interaction 
between TbORC1/CDC6 and one or more subunits of the MCM heterohexamer. 
This hypothesis is tested below (Section 4.6). 
4.5  TbORC1/CDC6-Myc expressed at the endogenous 
locus is functional 
4.5.1 Cloning of TbORC1/CDC6-Myc construct 
For Myc tagging of TbORC1/CDC6, oligonucleotides were designed for 
amplification of a 752-bp region excluding the STOP codon (positions 557 – 1308 
relative to the start codon) of TbORC1/CDC6 using VectorNTI software 
(Invitrogen®). The primers (CT_OL43/CT_OL44, Table 2-2) contained restriction 
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sites HindIII (forward primer) or XbaI (reverse primer). The fragments were 
amplified by polymerase chain reaction (PCR) from T. brucei PCF TREU927 strain 
genomic DNA (gDNA) using Phusion® Taq DNA polymerase (NEB ®). After PCR 
amplification, the gene fragment was cloned into HindIII/XbaI site of the 
pNAT12MYC vector shown in Figure 4-2. The vector was linearised within the 
TbORC1/CDC6 C-terminal fragment cloned using the restriction enzyme XhoI and 
transfected into the T. brucei TREU927 procyclic heterozygote cell line 
(TbOrc1/Cdc6 +/-).  The strategy for integration of the linearised vector is 
described below. Selection of positive clones was carried out using blasticidin at 
a concentration of 15 μg.ml-1. 
  
Figure 4-2 – The pNAT12MYC vector for TbORC1/CDC6-Myc epitope tagging 
A C-terminal coding sequence of TbORC1/CDC6 (752 bp) that was cloned into HindIII and XbaI 
sites in the plasmid after PCR amplification is shown; the C-terminal TbORC1/CDC6 fragment was 
cloned fused to 12 tandem repeats of Myc (12Myc) to allow the expression of ORC1/CDC6 inframe 
with the 12Myc epitope tag. The XhoI site used for vector linearization to allow integration into the 
TbORC1/CDC6 locus is also shown. Selection of T. brucei transformant clones was performed 
using the blasticidin resistance gene (BSD) flanked by Actin and tubulin 3’ and 5’ mRNA 
processing regions (Actin UTR) and (βα tubulin UTR). All features shown on the vector map are 
designed using the VectorNTI resource (Invitrogen). The vector is originally from the lab of David 
Horn (Alsford & Horn 2008) 
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4.5.2 Strategy for C-terminal tagging of TbORC1/CDC6 
The strategy for C-terminal tagging using the pNAT12MYC employs the same 
strategy previously described for PTP-tagging (Alsford & Horn 2008; Schimanski, 
Nguyen, & Gunzl 2005). The TbORC1/CDC6 ORF is targeted using the C-terminal 
coding region of the gene (grey bar) which has a unique restriction site (XhoI) 
that is indicated by arrowheads (Figure 4-3 A and B). As illustrated in Figure 4-3 
A, B and C, after linearization of the construct (B) with XhoI, there is homology-
directed integration with the concomitant displacement of a fragment the 3’ 
end of the ORF disrupted (C). The resulting target gene (TbORC1/CDC6; C) 
becomes modified, fused at the C-terminus inframe with the epitope tag 
(12Myc), as demonstrated in Figure 4-3. 
 
Figure 4-3 – Strategy for C-terminal Myc-tagging of TbORC1/CDC6 
(A) Wild type open reading frame of TbORC1/CDC6 (TbORC1/CDC6 ORF) showing the presence 
of a unique restriction site (XhoI) depicted by an arrow head; (B) schematic representation of 
pNAT12MYC TbORC1/CDC6 C-term vector showing: unique linearization site (XhoI) depicted by an 
arrow head; HindIII and XbaI restriction sites for cloning of the C-terminal fragment of 
TbORC1/CDC6 are also shown; the Blasticidin S Deaminase gene cassette for selection of positive 
transformants is shown (BSD); integration occurs by recombination of the c-terminal homologous 
sequences post linearization (indicated by cross) and (C) illustration of the resulting 12Myc C-
terminally tagged TbORC1/CDC6 locus post integration. Illustration adapted from (Schimanski et 
al. 2005) 
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4.5.3 Confirmation of TbORC1/CDC6-Myc tagging by PCR  
We have previously shown that both alleles of TbORC1/CDC6 cannot be deleted 
to yield a TbOrc1/Cdc6 null (-/-) mutant. We also know that one allele can be 
successfully deleted (Chapter 3). Using the TbOrc1/Cdc6 heterozygote line in 
TREU927 strain procyclic form cells (TbOrc1/Cdc6 +/-, see Chapter 3) we 
generated transgenic lines that express TbORC1/CDC6 tagged with 12 tandem 
repeats of Myc at the C-terminus. Six transformant clones resistant to both 
puromycin (PUR; selecting for TbOrc1/Cdc6 +/-) and blasticidin (BSD; selecting 
for TbORC1/CDC6-Myc) were selected and analysed for correct integration of 
both constructs (Figure 4-4 A and B). 
To confirm that the TbORC1/CDC6::PUR knockout allele was still intact in these 
transformants, primers indicated in blue (Figure 4-4 A) were used to carry out a 
diagnostic PCR. The forward primer was located upstream of the 5’ UTR used in 
the knockout construct, while the reverse primer was located 362 bp from the 5’ 
end of the PUR gene ORF. As expected a PCR product size of ~800 bp was 
generated from each transformant, and no band in the wildtype (WT) TREU927 
cells that lacked the PUR gene (Figure 4-4 C). This confirmed that the construct 
had integrated in the TbORC1/CDC6 locus. PCR to test for integration of the 
TbORC1/CDC6-myc-tag construct was also carried out. Using a forward primer 
that binds to the TbORC1/CDC6 ORF upstream of the gene fragment cloned into 
the tagging construct and a reverse primer downstream (after the stop codon) of 
12 Myc ORF (CT_OL45/CT_OL46; Table 2-2), five clones out of the six gave a PCR 
product of the expected size, while the WT cells showed no band (Figure 4-4 B 
and D). Both PCR reactions validated the correct integration of both constructs 
at the TbORC1/CDC6 loci, generating cell lines expected to encode 
TbORC1/CDC6-Myc at the endogenous locus in a TbORC1/CDC6+/- background. 
These data cannot, however, exclude that a WT TbORC1/CDC6 allele has been 
retained, perhaps because the myc-tagged protein is non-functional. 
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Figure 4-4 –Analysis of TbORC1/CDC6-Myc expressing procyclic form cells 
(A) Cartoon representation of TbORC1/CDC6 loci after integration of a puromycin knock out 
cassette. Blue arrows indicate position of primers used to check correct integration of construct at 
the TbORC1/CDC6 locus. (B) Cartoon representation of TbORC1/CDC6-12Myc loci after 
integration of myc-tagging construct. Red arrows indicate the position of primers for checking 
correct integration into the TbORC1/CDC6 locus. (C) Image of a 1% agarose gel to show PCR 
products from 6 clones checked for integration of construct in (A) with an expected size of 791 bp; 
a control is shown of PCR from untransformed TREU927 wild type (927 wt) cells. (D) Image of a 
1% agarose gel to show PCR products of 6 clones checked for integration of construct in (B) with 
an expected size of 1.8 kb (E) Western blot of cell extracts from procyclic form cells expressing 
TbORC1/CDC6-Myc (Orc1-Myc) probed with anti-myc monoclonal antibody; with control lane (WT) 
showing no cross-reacting band. (F) Ponceau stained membrane used for western blot to 
demonstrate equal loading of whole cell extracts prior to western blot.  
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4.5.4 Confirmation of TbORC1/CDC6-Myc tagging by Western blot 
Western blot analysis was carried using an anti-Myc monoclonal antibody 
(Millipore®) to check if TbORC1/CDC6-Myc was expressed in these transformant 
cell lines. To do this, one clone was examined (Figure 4-4 E). On western 
blotting, anti-myc antibody recognised a band of ~65 kDa, corresponding to the 
expected size of a TbORC1/CDC6-Myc fusion (66.3 kDa; 48.6 kDa for 
TbORC1/CDC6 and 17.7 kDa for 12Myc), absent from WT cells. No further cross-
reacting bands were detected in either the TbORC1/CDC6-Myc or WT extracts 
(Figure 4-4 E).  Equal loading of extracts from the both TbORC1/CDC6-Myc and 
WT cells was checked by Ponceau staining of the membrane (Figure 4-4 F). 
4.5.5 Confirmation of TbORC1/CDC6-Myc tagging by Southern 
blot 
Having shown that TbORC1/CDC6-Myc is expressed in this cell line, and that the 
anti-Myc antibody does not cross-react with other antigens in the parasite whole 
cell extract, Southern blot analysis was carried out to test whether or not only 
the TbORC1/CDC6-Myc and TbORC1/CDC6::PUR alleles were present, as shown in 
the schematic illustration in Figure 4-5 A. One allele of TbORC1/CDC6 was 
replaced by homologous recombination with the puromycin resistance cassette, 
while the second allele was tagged at the C-terminus with 12 repeats of Myc. 
Using EcoRV to digest genomic DNA prepared from the transformant and WT 
cells, Southern blotting was used with a probe hybridising to the 5’ end of the 
ORF of TbORC1/CDC6 (Figure 4-5 A, B). This showed that both alleles of this loci 
are identical in size, and that the gene is single copy, as indicated by a single 
band at 4.1 kb in the WT lane (Figure 4-5 B). The same size band was seen in the 
TbORC1/Cdc6 +/- cells, indicating that at least one allele is intact. In the 
puromycin and blasticidin-resistant transformant, with the TbORC/CDC6-Myc 
allele, a single band of 3.1 Kb was seen, due to modification of the locus caused 
by the introduction of an EcoRV site during integration of the tagging construct. 
The absence of the 4.1 kb band seen in the WT and +/- lanes indicates that the 
TbORC/CDC6 ORF is only present as a TbORC/CDC6-Myc allele.  
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To confirm that the antibiotic resistance cassettes were integrated as expected 
in the TbORC1/CDC6-Myc line, we used the same Southern blot and a probe 
recognising the 5’ UTR of TbORC1/CDC6. Since there is an EcoRV site within the 
PUR resistance cassette, using the 5’ UTR probe we can distinguish the WT 
TbORC1/CDC6 and TbORC/CDC6::PUR alleles, and these in turn can be 
distinguished from the TbORC/CDC6-Myc allele. Digestion of genomic DNA from 
all three lines with EcoRV and probing with a 5’ UTR probe showed a 1.9 kb band 
corresponding to the TbORC/CDC6::PUR allele only in the TbOrc1/Cdc6 +/- and 
TbORC1/CDC6-Myc cells, and no band in WT (Figure 4-5 C). In addition, a 3.1 kb 
band was seen in the TbORC1/CDC6-Myc cells, where there was no evidence of a 
4.1 kb band corresponding to WT TbORC1/CDC6 seen in the WT and +/- cells.   
 
Figure 4-5 – Southern blot confirmation of TbORC1/CDC6-myc expressing lines 
(A) Cartoon representation of the gene disruption strategy from a wild type line (TbOrc1/Cdc6 +/+) 
where both alleles are intact: first, to heterozygote null line where one allele has been replaced with 
a transfected puromycin cassette (TbOrc1/Cdc6 +/-) is generated; and then, after a second round 
of transfection, a TbOrc1/cdc6 +/- and TbORC1/CDC6-Myc line is generated where one allele has 
been replaced with the PUR cassette and the other allele is tagged to 12 tandem repeats of Myc. 
The Blue triangle indicates the position of a probe to the 5’ UTR of TbORC1/CDC6 and the green 
triangle indicates the position of a probe to the 5’ end of the ORF of TbORC1/CDC6. EcoRV was 
used to digest genomic DNA prepared from each of the three lines WT = TbOrc1/Cdc6 +/+, +/- = 
TbOrc1/Cdc6 +/-, and Orc-Myc = TbOrc1/Cdc6 +/- and TbORC1/CDC6-Myc. (B) Autoradiogram 
using a probe to the 5’ end of TbORC1/CDC6 ORF (green triangle) to confirm loss of the wild type 
allele, and retention of a modified allele (C) Autoradiogram using a probe to the 5’ UTR of 
TbORC1/CDC6 (blue triangle) to confirm loss of the wild type TbORC1/CDC6 allele with a 
concomitant retention of the heterozygote allele at the endogenous locus. 
 
 133
Southern blot analysis was also carried out with a HindIII digest of genomic DNA 
from these cell lines and the results revealed a similar pattern after probing 
with the same probes (data not shown). Given that both alleles of TbORC1/CDC6 
could not be deleted (Chapter 3), the loss of WT TbORC1/CDC6 when the gene 
was Myc-tagged at the C-terminus in a heterozygote mutant clearly 
demonstrates that the locus is accessible and amenable to genetic manipulation 
and that TbORC1/CDC6-Myc is functional. 
4.6 Does TbORC1/CDC6 interact with TbMCM? 
In eukaryotes both Cdc6 and Cdt1 function in conjunction with the ORC complex 
to provide a platform at the origin of replication to recruit the Mcm2-7 helicase 
complex for local DNA unwinding (Bell & Dutta 2002). As explained above, T. 
brucei bioinformatically lacks Cdc6 as a distinct replication initiation 
component, lacks a clear eukaryotic Cdt1 homologue, and lacks an obvious 
archaeal WhiP homologue, which may provide Cdt1 functions (Robinson & Bell 
2007). On the other hand all six MCM subunits, named Mcm2-7 (named here as 
TbMCM2-7) are unambiguously present in the genome of T. brucei. To ask if 
TbORC1/CDC6 directly interacts with the MCM helicase, we generated cell lines 
that co-express TbORC1/CDC6-Myc with C-terminally tagged variants of each of 
the MCM subunits.  
4.6.1 Cloning of TbMCM-HA constructs 
To HA-tag the endogenous genes of each TbMCM subunit, six constructs were 
generated, each as described below in Figure 4-6, possessing a C-terminal 
fragment of a TbMCM ORF translationally fused with 6 tandem repeats encoding 
HA (Figure 4-6 A – F). The same principle used for construction of the pNAT12MYC-
TbORC1/CDC6-Myc construct (Section 4.5.2) was used for the TbMCM-HA 
constructs. A derivative of the pNAT12MYC-TbORC1/CDC6-Myc vector in which the 
BSD gene had been replaced with a bleomycin gene (BLE) was obtained from M. 
Swiderski (WTCMP, University of Glasgow). Using the latter, the 12Myc fragment 
in this vector was replaced with a 6HA fragment using primers CT_OL49/ 
CT_OL50 (Table 2-2). A 201 bp 6HA fragment was amplified by PCR from plasmid 
PGL1728 (Gift from T. Hammarton, University of Glasgow) using Phusion® Taq 
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DNA polymerase (NEB ®). After PCR-amplification, the PCR product was cloned 
into XbaI/BamHI site of the BLE resistant pNAT12MYC-TbORC1/CDC6-Myc vector to 
obtain the vector pNAT6HA-TbORC1/CDC6-HA. The latter was used as a template 
to clone all six TbMCMs C-terminal regions using the same strategy described in 
Section 4.5.2. The primers used (for sequences see Table 2-2), C-terminal 
fragment sizes used for each TbMCM, the restriction sites, and the sites for 
linearization sites are shown in Table 4-2. 
Table 4-2 – Construction of TbMCM-HA tagging vectors  
 
 
Each plasmid has the Bleomycin resistance gene (BLE) that confers resistance to 
phleomycin and can be used to select for TbMCM-HA transformants after 
transfection into the TbORC1/CDC6-Myc line, described above (which is 
blasticidin- and puromycin-resistant). Each TbMCM construct was transfected 
and phleomycin-resistant clones selected with 10 μg.ml-1 zeocin. 
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Figure 4-6 – TbMCM-HA constructs for C-terminal tagging 
Plasmids for tagging TbMCMs at the C-terminus of their endogenous loci: (A) = TbMCM2-HA, (B) = 
TbMCM3-HA, (C) = TbMCM4-HA, (D) = TbMCM5-HA, (E) = TbMCM6-HA, and (F) = TbMCM7-HA. 
The C-terminal coding sequence size of each TbMCM that was cloned into the plasmid after PCR 
amplification is shown; the C-terminal fragments of each TbMCM was cloned fused to 6 tandem 
repeats of HA (6HA) to allow the expression of TbMCMs inframe with the 6HA. The sites used for 
vector linearization to allow integration into the TbMCM loci are also shown within the C-terminal 
fragment of each gene. Selection of T. brucei transformant clones was performed using the 
phleomycin resistance gene (BLE) flanked by Actin and tubulin 3’ and 5’ mRNA processing regions 
(Actin UTR) and (βα tubulin UTR). All features shown on the vector map are designed using the 
VectorNTI resource (Invitrogen). The vector is originally from the lab of David Horn (Alsford & Horn 
2008) 
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4.6.2 Confirmation of TbORC1/CDC6-Myc and TbMCM-HA co-
expression cell line  
After transfection, clones were obtained for all TbMCMs (except for TbMCM5), 
co-expressing TbORC1/CDC6-Myc, represented by cartoon in Figure 4-7 A and B. 
Western blots were carried out with anti-HA monoclonal antibody to confirm 
expression of individually HA-tagged TbMCM subunits in two clones for TbMCM2. 
three clones for TbMCM3, one clone for TbMCM4, one clone for TbMCM6, two 
clones for TbMCM7 and, using the same cell extracts, co-expression of 
TbORC1/CDC6-Myc was also confirmed by western blot and hybridisation with 
anti-Myc antibody (Figure 4-7 C and D). From the western blots it is evident that 
the individual HA-tagged TbMCM subunits were expressed at different levels in 
T. brucei procyclic form cells, if TbORC1/CDC6-Myc is considered as a loading 
control. Visual inspection indicated that TbMCM2 was least expressed, followed 
by TbMCM7, and TbMCM3, 4 and 6 were probably expressed at the same, higher 
levels (Figure 4-7 C and D). 
 
Figure 4-7 – Western blot confirms procyclic TREU 927 cell lines co-expressing TbMCMs-HA 
and TbORC1/CDC6-Myc 
(A) and (B), respectively, show cartoon representations of an MCM subunit tagged at the C-
terminus with HA, and TbORC1/CDC6 tagged at the C-terminus with Myc. (C) and (D) show 
TbMCM-HA expression in whole cell extracts of transformant clones, detected on a western blot 
using anti-HA antibody (top panel), and TbORC1/CDC6-Myc from the same whole cell extracts 
detected using anti-Myc antibody (bottom panel). Single clones are shown for TbMCM4-HA and 
TbMCM6-HA, two clones for TbMCM2-HA and TbMCM7-HA, and three clones for TbMCM3-HA. 
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4.6.3 Co-immunoprecipitation of TbMCM-HA and TbORC1/CDC6-
Myc using anti-HA antibody 
To investigate if any of the TbMCM subunits directly or indirectly interact with 
TbORC1/CDC6 in vivo, the doubly tagged procyclic form cell lines described 
above were used to carried out co-immunoprecipitation (co-IP) experiments with 
anti-HA to precipitate TbMCM3-HA, TbMCM6-HA, or TbMCM7-HA. Anti-HA 
antibody was coupled to magnetic anti-mouse conjugated Dynalbeads 
(Invitrogen; see Materials and Methods for details) and whole cell extracts 
(input) from 108 cells were incubated with anti-HA coupled beads for two hours. 
After several washes and then elution in high salt, the precipitates from each 
cell line (eluates) were immunoblotted using either anti-HA (to detect the HA 
tagged TbMCM subunit) or anti-Myc antibody (to detect TbORC1/CDC6-Myc). The 
anti-HA blotting determined if IPs were successful, while the anti-myc antibody 
asked if there were any detectable interactions between the individual TbMCM-
HA subunits and TbORC1/CDC6-Myc. Figure 4-8 A shows inputs and eluates from 
double expressor lines and a cell line expressing TbORC1/CDC6-Myc only (i.e. not 
transformed with any TbMCM tag construct). The TbORC1/CDC6-Myc cell line 
served as a control for non-specific binding of TbORC1/CDC6-Myc protein to the 
anti-HA coupled beads used for IPs. The anti-HA probed western blot confirms 
that it was possible to IP TbMCM3-HA (96.5 kDa), TbMCM6-HA (104 kDa), and 
TbMCM7-HA (88.8 kDa) (Figure 4-8 A). However, immunoblotting for 
TbORC1/CDC6-Myc with anti-myc antibody did not detect co-IP of any of the 
TbMCM subunits and TbORC1/CDC-6Myc (Figure 4-8 B), suggesting they do not 
interact, at least in these conditions. Clearly, we cannot rule out interaction 
between TbORC1/CDC6-Myc and either or both of TbMCM2-HA, TbMCM4-HA and 
TbMCM5-HA, as these were not analysed. However, if the proteins form part of 
stable helicase complex, direct interaction between TbORC1/CDC6 and these 
components of the helicase would allow co-IP of the ORC factor and the three 
tested MCM subunits. To test this, interactions between the TbMCM subunits is 
examined below. 
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Figure 4-8 – Western blot analysis of the inputs and eluates following co-
immunoprecipitation using anti-HA antibody 
(A) The input and eluate from co-IPs from whole cell extracts of a control cell line (Orc1-Myc, 
expressing TbORC1/CDC6-Myc), and from co-expressor cell lines (expressing TbMCM3-HA, 
TbMCM6-HA, or TbMCM7-HA and TbORC1/CDC6-Myc), were separated on a 10 % SDS-PAGE 
gel and then transferred to a nylon membrane. This was then probed with anti-HA antibody (A) or 
with anti-Myc antibody (B). 
 
4.6.4 Identification of TbMCM subcomplexes from co-IP of 
TbMCM-HA and Mass spectrometry 
Since IP of HA-tagged TbMCM3, TbMCM6, and TbMCM7 were successful, yet no 
interaction with Myc-tagged TbORC1/CDC6 was identified by anti-Myc blotting, 
we wondered if the IP eluates, when separated on an SDS-PAGE gel, could reveal 
discreet bands in the co-expressor cell lines relative to each other and to the 
TbORC1/CDC6-Myc alone control. Such bands may indicate interacting factors 
that are not HA- or Myc-tagged, and would not therefore have been seen in the 
blots. The eluate from the IP of each TbMCM subunit examined in Figure 4-8, and 
from the TbORC1/CDC6-Myc control, was therefore separated on a 10 % SDS-
PAGE gel and stained with colloidal coommassie. Imaging of the gel revealed 
distinct patterns of bands for TbMCM7-HA (4 bands), TbMCM6-HA (3 bands), and 
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TbMCM3-HA (1 band) that were absent from the control (Figure 4-9 A). Each 
band was excised and analysed by protein fingerprinting by Liquid 
Chromatography-Electrospray Tandem Mass Spectrometry (LC-ES MS/MS) at the 
University of Glasgow Proteomics facility. The resulting MS/MS spectra were 
used to interrogate the TritryDB database using the MASCOT software 
(http://www.matrixscience.com/). All protein hits identified had at least 11 
unique peptides that confidently matched a single ORF within the database. Only 
protein hits with an overall MASCOT score of greater than 30 (p < 0.05) were 
considered significant. A summary of the results from the mass spectrometry is 
shown in Figure 4-9 B. 
These data show the following: IP of TbMCM6-HA also immunoprecipitated 
TbMCM2 and TbMCM4; IP of TbMCM7-HA also immunoprecipitated TbMCM2, 
TbMCM4, and TbMCM6; and the single band excised from the IP of TbMCM3-HA 
was identified as TbMCM3 itself. Thus, we find that a subcomplex can be 
detected containing TbMCM2, TbMCM4, TbMCM6 and TbMCM7, which is likely to 
represent biologically significant in vivo protein-protein interactions as the co-
IPs were performed from procyclic form whole cell extracts and no cross-linking 
agents were used prior to the experiment. We did not detect interaction 
between the above subcomplex and TbMCM3 or TbMCM5, nor did IP of TbMCM3-
HA reveal interaction with TbMCM5. 
 
 140
 
Figure 4-9 – Mass spectrometric characterisation of TbMCM-HA precipitates reveals TbMCM 
subcomplexes 
(A) Eluates are shown from immunoprecipitations (IP) using anti-HA antibody from T. brucei cell 
lines expressing TbMCM3-HA, TbMCM-6HA, TbMCM7-HA or TbORC1/CDC6-Myc (Orc1-Myc 
ONLY) as a control; proteins were separated by SDS-PAGE and visualised by colloidal commassie 
staining. Bands that were excised and analysed by mass spectrometry are numbered; the results 
of the analysis of these bands is shown in (B). The number of peptides indicated for each band 
(No. of peptides) are unique peptides.  
 
4.6.5 Co-immunoprecipitation of TbORC1/CDC6-Myc and TbMCM-
HA using anti-Myc antibody 
In other eukaryotes, it is known that once the ORC complex binds origin DNA, 
two further factors, Cdc6 and Cdt1, are required to recruit the MCM complex 
(Mcm2-7) for local unwinding of DNA at the origin (Bell & Dutta 2002). Since 
there is no clear Cdt1 homologue in T. brucei and IP assays of TbMCM subunits 
did not reveal any interaction with TbORC1/CDC6, we considered it possible that 
TbORC1/CDC6 must first bind to chromatin prior to recruitment of TbMCM. 
Therefore a substantial portion of the cellular pool of TbMCM may be unbound to 
DNA/TbORC1/CDC6, masking any interactions being detected by IP of an MCM 
subunit. We therefore sought to carry out the reciprocal IP from that performed 
 
 141
in Section 4.6.3, using anti-Myc antibody; in this case, TbORC1/CDC6-Myc will be 
immunoprecipitated and co-IP of TbMCM-HA tested using anti-HA antibody. The 
same experimental procedures described above and the same co-expression cell 
lines were used. In this case, single-tagged cell lines expressing only TbMCM6-HA 
or TbMCM7-HA were used as co-IP controls. IP of TbORC1CDC6-Myc was 
successful when co-expressed with either TbMCM6-HA or TbMCM7-HA (Figure 
4-10 A), and the control cell lines showed no bands, as expected. This 
demonstrated that IP of TbORC1/CDC6-Myc is successful with the anti-Myc 
antibody used. However, immunoblotting for TbMCM6-HA or TbMCM7-HA using 
anti-HA antibody did not detect the proteins in the eluate from any of the IPs 
(Figure 4-10 B), suggesting that interaction with TbORC1/CDC6-Myc is 
undetectable in these conditions. This result complements the previous 
observations made in Section 4.6.3. As before, we cannot exclude from this 
analysis that TbORC1/CDC6-Myc IP would reveal interaction with TbMCM3, 
TbMCM4 or TbMCM5, but deem it unlikely.  
 
Figure 4-10 – Western blot analysis of the inputs and eluates following co-
immunoprecipitation using anti-Myc antibody 
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(A) The input and eluate from co-IPs from whole cell extracts of control cell lines (MCM6-HA and 
MCM7-HA, expressing TbMCM6-HA and TbMCM7 respectively), and from co-expressor cell lines 
(expressing TbMCM6-HA, or TbMCM7-HA and TbORC1/CDC6-Myc), were separated on a 10 % 
SDS-PAGE gel and then transferred to a nylon membrane. This was then probed with anti-Myc 
antibody (A) or with anti-HA antibody (B). 
 
4.7 Identification of putative novel pre-RC components in 
T. brucei  
So far, we have shown that amongst the pre-RC replication machinery of T. 
brucei, only TbORC1/CDC6 can be identified bioinformatically, and may 
represent the functional analogue of the six protein ORC complex in higher 
eukaryotes. Also, all subunits of the MCM complex in higher eukaryotes are 
represented in T. brucei and some have been shown to interact, while 
interactions between TbORC1/CDC6 and three members of the TbMCM complex 
have eluded detection. We therefore wondered if T. brucei contains novel 
proteins, or highly divergent ORC subunits, that form part of the pre-RC 
machinery. To attempt to identify any such factors, we adopted a proteomic 
approach. Whole cell extracts were prepared from PCF TbORC1/CDC6-Myc cells 
and from untagged (TREU927 WT) cells and subjected to IP using Dynalbeads 
coupled with anti-myc antibody. The WT cell line served as a control for proteins 
that non-specifically bind to the magnetic beads. A further control cell line, 
expressing a distinct myc-tagged protein, to allow identification of T. brucei 
proteins that interact with the myc epitope and not TbORC1/CDC6, was not 
available and could not therefore be used. After several washes (see material 
and methods), eluates were run on a 10 % SDS PAGE gel, proteins throughout the 
lanes excised in 5 distinct bands for each cell line, and analysed by LC-ES MS/MS. 
The resulting MS/MS spectra were used to interrogate the TritryDB database 
using the MASCOT software (http://www.matrixscience.com/). In total, 405 
proteins were identified from the TbORC1/CDC6-Myc IP and 285 hits from the 
WT IP. These data were first filtered by excluding all proteins (using the 
Microsoft Excel VLOOKUP function) which were common in both IP samples. 
From this, proteins unique to the TbORC1/CDC6 IP tallied ~150 protein IDs, 
which were absent from the WT control IP. To further filter these proteins, as a 
rudimentary gauge of abundance, we used the number of unique peptide hits 
recovered for each protein to rank them. The bait, TbORC1/CDC6 itself, was 
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identified by 10 unique peptides hits in the TbORC1/CDC6-Myc IP, none of which 
were found in the IP from the WT control. This “proof of principle” 
demonstrated that the IP was successful, and that at least some of the filtered 
proteins are likely to be significant. Table 4-3 shows protein IDs for proteins with 
3 unique peptide hits or greater that were recovered from this filtering and are 
putative TbORC1/CDC6-interacting factors. They are described via their 
annotation in TriTryDB, where each is considered a hypothetical protein.  
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Table 4-3 – Potential TbORC1/CDC6-interacting proteins, showing the number of peptide 
hits for each from mass spectrometry analysis and a summary of bioinformatic analysis of 
potential function; TbORC1/CDC6 is not included in the list, but was identified by 10 
peptides  
 
>Tb927.6.1120   hypothetical protein,  
Peptide hits: 14 peptides
CLC PFAM search: Zinc finger (zf - C2H2 type) - PF00096, Tetratricopeptide repeat - PF07719
NCBI psi BLAST: No clear hits; very weak homology to NTPase (DNA PolIII protein) on psi BLAST
PHYRE search: 70% precision hit to virion RNA polymerase
>Tb09.160.3120   hypothetical protein,  
Peptide hits: 10 peptides
CLC PFAM search: No clear hits
NCBI psi BLAST: No clear hits; very weak homology to NTPase (mismatch repair and DNA Pol III proteins) 
PHYRE search: low precision 5% to archaeal Orc1/Cdc6 protein (2/3 top hits)
>Tb10.389.0050 tbrucei_v5:Tb10.389.0050/Tb927.10.13380 hypothetical protein, 
Peptide hits: 10 peptides
CLC PFAM search: AMP binding enzyme - PF00501, Tetratricopeptide repeat - PF00515
NCBI BLAST: very low level homology to D. melonogaster Orc4 (E-value = 0.055), and to Ploop NTPase (E-value = 0.002)
PHYRE search: top hits to archaeal Orc1/Cdc6
>Tb11.46.0009 tbrucei_v5:Tb11.46.0009 hypothetical protein,
Peptide hits: 5 peptides
CLC PFAM search: Helicase conserved C-terminal domain - PF00271
NCBI BLAST: DEAD box helicase; Zn finger
PHYRE: Very high precision hits to ATP-dependent RNA helicases
>Tb927.2.5810/1F7.275 tbrucei_v5:Tb927.2.5810/1F7.275 hypothetical protein, 
Peptide hits: 4 peptides
CLC PFAM search: Zinc Knuckle (zf-CCHC) - PF00098
NCBI BLAST: Transcription accessory factor, Tex
PHYRE search (N-term 1200aa): 100% precision hit to Pseudomonas Tex RNA binding factor; ARM (armadillo/HEAT) repeats
>Tb927.10.7980 hypothetical protein,  (Tb10.6k15.2570)
Peptide hits: 4 peptides
CLC PFAM search: ATPase associated family - PF00004, ABC transporter - PF00005, ATP synthase alpha/beta family - PF00006
NCBI psi BLAST: replication factor C, and polymerases on 1st and 2nd iterations
PHYRE: top hits to archaeal ORC1/Cdc6
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>Tb11.02.5725 hypothetical protein, 
Peptide hits: 3 peptide hits
CLC PFAM search: No hits
psiBLAST: No strong hits
PHYRE: No convincing hits
>Tb927.2.5130 hypothetical protein, 
Peptide hits: 3 peptides
CLC PFAM search: Glycosyl transferase group 1 - PF00534, Short chain dehydrogenase - PF00106
NCBI BLAST: Very low homology to plasmid replication proteins (top hits)
PHYRE: High precision (90-95%) hits to ARM (armadillo/HEAT) repeats, and archaeal topoisomerase V
>Tb10.389.1520 (Tb927.10.12220) hypothetical protein, 
Peptide hits: 3 peptides
CLC PFAM search: No hits
NCBI BLAST: No strong hits
PHYRE: no strong hits (5% precision to alpha actinin)
>Tb10.6k15.1050 (Tb927.10.9350) hypothetical protein,  
Peptide hits: 3 peptides
CLC PFAM search: ATPase associated family - PF00004, Helix-turn -helix -PF00512, GGDEF domain - PF0090
NCBI BLAST: No strong hits
PHYRE: High precision (60-70%) hits, mainly to ARM (armadillo/HEAT) repeats, including in virion RNA polymerase
>Tb927.7.1060 hypothetical protein, 
Peptide hits: 3 peptides
CLC PFAM search: alpha/beta hydrolase fold -PF00561, ATP synthase family -PF00006, CBS domain pair -PF00571
psiBLAST: Very weak BLAST homology; helicases, including MCM4
PHYRE: low precision to Pleckstrin homology (PH) domain
>Tb927.6.3190   hypothetical protein,  | protein  | length=548
Peptide hits: 3 peptides
CLC PFAM search: Radical SAM superfamily -PF04055, protein Kinase domain -PF00069, Glycosyl transferase family -PF00535
NCBI BLAST: No clear hits in BLAST
PHYRE: low precision (5%) to viral capsid protein (short polypeptide), and to virion RNA polymerase (long polypeptide)
 
 
To attempt to gain further insight into the potential functions of the above “top 
mass spec hits” from the TbORC1/CDC6-Myc IP, position-specific iterative BLAST 
(PsiBLAST; http://blast.ncbi.nlm.nih.gov/Blast.cgi), Protein Homology/analogY 
Recognition Engine Search (PHYRE search; 
http://www.sbg.bio.ic.ac.uk/~phyre/) and PFAM searches (using CLC genomics 
Workbench v4) were carried out for each. Based on these protein primary amino 
acid sequence and/or protein structural or domain predictive algorithms, 
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similarities could be associated to two classes of proteins (Table 4-3). First, 
three of the proteins provided evidence that they could potentially be related to 
eukaryotic ORC components or Cdc6. Second, at least four of the others 
provided evidence that they may be RNA-associated factors. T. brucei protein 
IDs Tb927.6.1120 (14 peptides), Tb11.46.009 (5 peptides), Tb927.2.5130 (3 
peptides) and Tb927.10.9350 (3 peptides) belonged to the putative RNA-
associated group, while Tb09.10.3120 (10 peptides), Tb927.10.13380 (10 
peptides) and Tb927.10.7980 (4 peptides) were putative ORC- or Cdc6-like 
proteins. Table 4-3 summarises the basis for this these assertions.  
Given the ORC-focus of this project, further characterisation of the above 
proteins was limited to those that have ORC-like characteristics. To do this, 
Tb927.10.13380 and Tb927.10.7980 were chosen to test if they directly or 
indirectly interact with TbORC1/CDC6, and RNAi was used to examine their 
functions in BSF cells. Tb927.10.13380 and Tb927.10.7980 were chosen because 
using the CLC Workbench PFAM domain search algorithm and PHYRE these two 
proteins appeared to be more closely related to ORC proteins (see below for a 
detailed analysis). 
4.8 Characterisation of Tb927.10.13380; a putative novel 
component of the pre-RC machinery in T. brucei 
This section provides further experiments that illuminate the role of 
Tb927.10.13380 (referred to hereafter as Tb13380 for the purpose of brevity) as 
a putative member of the T. brucei pre-RC machinery; if not a divergent T. 
brucei ORC member.  
4.8.1 Confirmation of interaction between Tb13380 and 
TbORC1/CDC6 
4.8.1.1 Cloning of Tb13380 C-terminal HA tagging construct 
 Using the Tb13380 sequence information derived from the TriTrypDB database 
(http://tritrypdb.org/tritrypdb/), a construct was generated that allows 
Tb13380 to be expressed as a C-terminal fusion with six copies of the HA eptiope 
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after integration into the endogenous locus. The strategy for this is as described 
in Section 4.5.2, and a 628 bp C-terminal fragment of Tb13380 was PCR-
amplified with primers CT_OL65/CT_OL66 (Table 2-2) for this purpose. The PCR 
product was cloned into the restriction sites HindIII and XbaI of the pNAT6HA 
vector (Figure 4-11). The construct was linearised with PvuII and transfected 
into the TbORC1/CDC6-Myc tagged line cell line (Section 4.5) and two 
phleomycin-resistant clones selected that should co-express TbORC1/CDC6-Myc 
and Tb13380-HA (see Figure 4-12 A and B for cartoon representation). As a 
control, the construct was also transfected into WT TREU927 procyclic form cells 
and two clones recovered. In each case, single clones validated for expression of 
the expected proteins were taken for further analysis.  
 
Figure 4-11 – The pNAT6HA vector for Tb13380-HA epitope tagging 
A C-terminal coding sequence of Tb13380 (628 bp) that was cloned into HindIII and XbaI sites in 
the plasmid after PCR amplification is shown; the C-terminal Tb13380 fragment was cloned fused 
to 6 tandem repeats of HA (6HA) to allow the expression of Tb13380 inframe with the 6HA. The 
PvuII site used for vector linearization to allow integration into the Tb13380 locus is also shown. 
Selection of T. brucei transformant clones was performed using the phleomycin resistance gene 
(BLE) flanked by Actin and tubulin 3’ and 5’ mRNA processing regions (Actin UTR) and (βα tubulin 
UTR) respectively. All features shown on the vector map are designed using the VectorNTI 
resource (Invitrogen). The vector is originally from the lab of David Horn (Alsford & Horn 2008) 
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4.8.1.2 Co-immunoprecipitation of Tb13380-HA and TbORC1/CDC6-Myc  
To test directly whether or not there is an interaction between TbORC1/CDC6 
and Tb13380 in T. brucei PCF cells, we asked whether the two proteins could be 
co-immunoprecipitated. Whole cell extracts were prepared (as described 
previously, Section 4.6.3) from the TbORC1/CDC6-Myc/Tb13380-HA double 
expressor cells, and from Tb13380-HA and TbORC1/CDC6-Myc single expressors. 
Expression of both tagged proteins was checked by western blot using the 
corresponding antibodies (Figure 4-12, input lanes). To test for interaction, co-IP 
was then performed. Firstly, anti-Myc antibody was used to immunoprecipitate 
TbORC1/CDC6-Myc and Tb13380-HA interaction was checked by western blotting 
using anti-HA antibody. The reciprocal experiment was then carried using anti-
HA antiserum to precipitate Tb13380-HA and checking for TbORC1/CDC6-Myc 
interaction with anti-Myc antiserum.  
As shown on Figure 4-12 (TbORC1/CDC6-Myc IP box), anti-Myc IP of 
TbORC1/CDC6-Myc was successful from the TbORC1/CDC6-Myc/Tb13380-HA 
double expressor cells, as seen by a band of the expected size in the eluate that 
was absent from the Tb13380-HA control. Probing the same eluate with anti-HA 
antibody confirmed interaction between the proteins, as a band of the size 
expected for Tb13380-HA was also present in the eluate from the double 
expressor cell. No such band was seen in the control Tb13380-HA expressor lane, 
showing that the interaction is not an artefact of Tb13380-HA non-specifically 
binding to the anti-Myc antibody-coupled beads. The reciprocal experiment, 
where IP was used to ‘pull-down’ Tb13380-HA using anti-HA antibody from 
TbORC1/CDC6-Myc/Tb13380-HA double expressor or TbORC1/CDC6-Myc single 
expressor cells, confirmed interaction between the two proteins. In Figure 4-12 
(Tb13380-HA IP box), the anti-HA western blot confirmed IP of Tb13380-HA from 
the double expressor, while the anti-Myc blot revealed a band of the expected 
size for TbORC1/CDC6-Myc, with no such band in the control lane (IP from the 
TbORC1/CDC6-Myc expressor cell). 
These data support the previous IP-mass spectrometry data of interaction 
between these proteins and indicate that TbORC1/CDC6 and Tb13380 can be 
found in the same complex in procyclic T. brucei cells. Whether TbORC1/CDC6 
and Tb13380 directly or indirectly interact is unknown, as is whether they 
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constitutively or transiently associate. Nevertheless, this may suggest the 
presence of a putative divergent subunit of ORC. To further understand the role 
of Tb13380 in T. brucei, we performed RNAi experiments in BSF cells and 
bioinformatic analyses to try to define a role for Tb13380. 
 
Figure 4-12 – Western blot analysis of the inputs and eluates following co-
immunoprecipitation using anti-HA and anti-myc antibodys 
(A) and (B) show cartoon of epitope-tagged constructs of Tb13380 and TbORC1/CDC6. Whole cell 
extracts from cell lines expressing proteins from both constructs were subjected to co-IP using 
antibodies to the Myc or HA tags. “TbORC1/CDC6-Myc IP Box”: The input and eluate from co-IPs 
from whole cell extracts of a control cell line (13380-HA, expressing Tb13380-HA), and from co-
expressor cell lines expressing Tb13380-HA (13380-HA), and TbORC1/CDC6-Myc (Orc1-Myc), 
were separated on a 10 % SDS-PAGE gel and then transferred to a nylon membrane. This was 
then probed with anti-Myc antibody (anti-myc) or with anti-HA antibody (anti-HA). “Tb13380-HA IP 
Box”: The input and eluate from co-IPs from whole cell extracts of a control cell line (Orc1-myc, 
expressing TbORC1/CDC6-Myc), and from co-expressor cell lines expressing Tb13380-HA 
(13380-HA), and TbORC1/CDC6-Myc (Orc1-Myc), were separated on a 10 % SDS-PAGE gel and 
then transferred to a nylon membrane. This was then probed with anti-HA antibody (anti-HA) or 
with anti-Myc antibody (anti-myc). 
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4.8.2 Amino acid sequence and structural analysis of Tb13380 
Tb13380 (also named Tb10.389.0050) is annotated as a hypothetical protein in 
TritrypDB (http://tritrypdb.org). The protein is predicted to be 713 amino acids 
long and 77.3 kDa in size. Second iteration psiBLAST searches of the NCBI 
database using the Tb13380 sequence from TriTrypDB as query retrieved D. 
melanogaster Orc4 (DmeOrc4) as a top hit (E-value = 9e-14) and a series of other 
Orc4 subunits from other organisms (0.003 ≤ E-value ≤ 1e-13). This provided a 
hint that this protein could be related to eukaryotic Orc4. The reciprocal BLAST 
search, using DmeOrc4 sequence to query TritryDB and asking if any meaningful 
hits emerged, was then conducted. To our surprise, considering that previous 
searches for ORC subunits had not yielded consistent results, the top hit (E-value 
0.0021) was Tb13380. Tb13380 shows 34 % amino acid identity to DmeOrc4 for 
the region for which alignment was recovered by BLAST. To examine if broader 
sequence homology to eukaryotic Orc4 subunits was apparent, the complete 
predicted sequence of Tb13380 was aligned with a range of Orc4 polypeptides 
(see Figure 4-13).  Overall this protein displays limited amino acid sequence 
homology to Orc4 subunits from the organisms in Figure 4-13 (for example: 33% 
similarity and 16% identity to DmeOrc4; and 33% similarity and 15% identity to 
Arabidopsis thaliana Orc4).  Based on primary amino acid sequence homology to 
Orc4 proteins from higher eukaryotes, Tb13380 appears to possess homology to 
Walker A and B boxes, and a sensor 1 motif, found with AAA+ ATPase proteins 
(Neuwald et al, 1999). However, Tb13380 lacks a crucial lysine residue 
(conserved Lysine at position 62 of DmeOrc4; position 108 of S. cerevisiae Orc4 
replaced by Alanine at position 114 in Tb13380) in the Walker A motif (Figure 
4-13), which binds the nucleotide, and may also have a degenerate Walker B box 
(Figure 4-13), which binds Mg++, suggesting it may not possess ATPase or a 
GTPase activity, a critical regulatory function of members of the ORC family of 
proteins and AAA+ ATPases in general (Speck et al. 2005; Neuwald et al. 1999). 
Despite this, there is quite considerable sequence homology between the T. 
brucei protein and eukaryotic Orc4 proteins, in particular around the Walker B 
box and Box VII motif, perhaps indicative of Orc4 orthology (Figure 4-13). The 
Box VII motif possesses a key arginine residue at position 281 of E. coli DnaA that 
has been proposed to interact with the γ-phosphate of the adenine nucleotide to 
sense its bound state (Erzberger, Pirruccello, & Berger 2002b; Neuwald et al. 
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1999). This interaction is meant to coordinate ATP hydrolysis with a 
conformational change of the ATPAse protein (Erzberger, Pirruccello, & Berger 
2002a). It is worth mentioning that although Tb13380 lacks the canonical Walker 
A and Walker B boxes, the Box VII motif appears to be conserved with other 
eukaryotic Orc4 proteins (Figure 4-13).  
Tb13380 is also conserved and syntenic across the sequenced kinetoplastids: 
orthologues exist in all the Tritryps, are annotated as hypothetical proteins and 
are of a similar size. T. cruzi has two proteins (Tc00.1047053506357.20 and 
Tc00.1047053511277.92) that are 97.1 % identical to each other and 54% 
identical to “Tb13380”, while L. major encodes a protein (LmjF18.0720) with 
38% identity to Tb13380. 
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Figure 4-13 – Amino Acid sequence alignment of eukaryotic Orc4 sequences with Tb13380 
Sequence alignment of eukaryotic Orc4 proteins from Hsa, Homo sapiens; Dme, Drosophila 
melanogaster; Ath, Arabidopsis thaliana; Sce, Saccharomyces cerevisiae; Pfa, Plasmodium 
falciparum; Ddi, Dictyostelium discoideum; Cpa, Cryptosporidium parvum; Tan, Theileria annulata;; 
Tth, Tetrahymena thermophila; Gla, Giardia lamblia;  Ecu, and Encephalitozoon cuniculi; with 
Tb13380. The alignment was generated using Clustal X and was coloured (in black and grey) in 
boxshade (http://www.ch.embnet.org/software/BOX_form.html). Black bars indicate conserved 
sequence motifs: Walker A; Walker B; and Box VII signature sequence. Black indicates identical 
residues in 50% of sequences; grey indicates conserved in 50% of sequences. Genbank accession 
numbers are provided Appendix 2. 
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To ask if further functional elements of Tb13380 could be identified, domain 
prediction using a PFAM prediction tool in CLC Genomics workbench v4 
(www.clcbio.com) was performed. This confirmed that Tb13380 belongs to the 
AAA+ superfamily of proteins, a critical feature of the ORC family of proteins, 
except for Orc6 which lacks the domain (Erzberger & Berger 2006; Speck et al. 
2005; Neuwald et al. 1999). The PFAM domain searches also revealed that 
Tb13380 belonged to the tetratricopeptide repeat (TPR) family of proteins, 
which are known to mediate protein-protein interactions and are often involved 
in the assembly of multi-protein complexes (Das, Cohen, & Barford 1998; Lamb, 
Tugendreich, & Hieter 1995). When Orc4 subunit PFAM domain searches were 
done in CLC using the same tool, the TPR repeat was predicted in P. falciparum 
Orc4 family, while A. thaliana, H. sapiens also showed conservation of the AAA+  
motif (Figure 4-14). These observations may support a role for Tb13380 in ORC 
complex formation in T. brucei. 
A Phyre search (web-based prediction algorithm for PDB-derived protein fold 
recognition using Psi-BLAST) revealed two predictions of Tb13380 being 
structurally similar to archaeal Orc1/Cdc6 (Aeropyrum pernix and Solfolobus 
Solfataricus). This lent further support for Tb13380 being a T. brucei ORC-
related factor. 
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Figure 4-14 – PFAM domain prediction of Tb13380 compared with selected eukaryotic Orc4p 
Using the “PFAM 100 most common” domain prediction tool in CLC Genomics Workbench v4, 
putative functional domain organisation of Tb13380 (Tb13380 box) is shown relative to the same 
analysis of A. thaliana Orc4 (AthOrc4 box), P. falciparum Orc4 (PfOrc4 box) and Homo sapiens 
Orc4 (HsaOrc4 box). An ATPase motif is indicated by AAA (PFAM no. PF00004); tetratricopeptide 
repeats are indicated by TPR1 and TPR2 (PFAM no. PF07719); Zinc-binding dehydrogenase 
indicated by ADH_zinc_N (PFAM no. PF00107); Radical SAM superfamily is indicated by Radical 
SAM (PFAM no. PF04055); ABC transporters indicated by ABC_tran (PFAM no. PF00005); 
GTPase motif indicated by MMR_HRS1 (PFAM no. PF01926); RNA recognition motif indicated by 
RRM_1 (PFAM no. PF00076); DEAD/DEAH box helicase indicated by DEAD (PFAM no. 
PF00270); Zinc finger, C3HC4 type indicated by zf-C3HC4 (PFAM no. PF00097); PFAM numbers 
(PFAM no.) obtained from the Sanger Institute webpage available at (http://pfam.sanger.ac.uk/). 
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Finally, having potentially identified Tb13380 domains indicative of an ORC-like 
protein, we questioned if the protein has structural motifs that may implicate it 
having a nucleic acid binding role. An example is seen in Schizosacchomyreces 
pombe where its Orc4 subunit has been shown to bind to specific sites within its 
DNA replication origins (Kong & DePamphilis 2001a). PsiPred 
(http://bioinf.cs.ucl.ac.uk/psipred/) and CLC Genomics predicted structural 
folds for Tb13380 that are also found in winged helix proteins, typical of all ORC 
members (Orc1, Orc4, and Orc5) which are nucleic acid binding proteins.  
4.8.3 RNAi of Tb13380 results in phenotypes analogous to 
TbORC1/CDC6 RNAi in BSF T. brucei 
4.8.3.1 Cloning of Tb13380 RNAi construct 
In order to understand the role played by Tb13380 in T. brucei, we carried out 
targeted depletion of Tb13380 transcript by RNAi in BSF cells. T. brucei Lister 
427 pLew90-pLew13 BSF cells were transfected with the pZJM vector containing 
a 562 bp fragment of Tb13380. The selection of RNAi target region, primer 
design and cloning procedure was performed as described in Section 3.3.1. The 
primers CT_OL63/CT_OL64 (Table 2-2) containing restriction sites BamHI 
(forward primer) or HindIII (reverse primer) were used to clone the Tb13380 
RNAi fragment into the pZJM vector (Figure 4-15). Linearization, transfection 
procedures and selection of clones are same as described in Section 3.3.1.  
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Figure 4-15 – The pZJM dual T7 vector for Tb13380 RNAi 
A fragment of Tb13380 (562 bp) that was cloned into BamHI and HindIII sites in the plasmid, after 
PCR amplification, is shown; Vector properties are same as described previously in Figure 3-1
 
4.8.3.2 Effect of Tb13380 RNAi on growth in bloodstream form cells 
After selection with phleomycin, two antibiotic-resistant clones were selected 
and growth was monitored up to 36 hrs post induction of RNAi with 2 μg.ml-1 of 
tetracycline. Comparing the growth curves of RNAi-induced and uninduced cells 
showed that each clone exhibited a severe growth defect, with reduced cell 
density visible as early as 8 hrs post induction of RNAi (Figure 4-16). After 18 hrs, 
the RNAi-induced cell numbers dropped, indicating the cells were dying. 
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Figure 4-16 – Effect of Tb13380 RNAi in bloodstream form cells 
Growth was monitored in bloodstream cell lines in which Tb13380 RNAi was induced (+ Tet, 
broken line) or without induction (-Tet, solid line) for 2 clones; C5 and C7 
 
4.8.3.3 Effect of Tb13380 RNAi on cell cycle and cell morphology in 
bloodstream form cells 
DAPI-staining of RNAi induced and non-induced cells (Figure 4-17) showed the 
accumulation of multi-nucleate and multi-kinetoplast cells 18 and 26 hrs post 
induction of RNAi, with a concomitant loss of 1N1K cells. In contrast, the 
distribution of 1N1K, 1N2K and 2N2K cells remained normal in non-induced 
samples up to 26 hrs, and aberrant cells represented only a small fraction of the 
population. To further understand the effect of Tb13380 RNAi on the cell cycle, 
flow cytometry was performed on PI-stained RNAi-induced versus non-induced 
cells. FACS of Tb13380 RNAi BSF cells revealed a decrease in the proportion of 
cells with 2C and 4C DNA content with a concomitant increase in the proportion 
of cells with 8C DNA content (Figure 4-18). This observation is in agreement with 
the accumulation of multinucleate cells observed from DNA DAPI staining 
experiments. 
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Figure 4-17 – Analysis of nuclear and kinetoplast DNA configuration of Tb13380 RNAi cells 
for a single clone 
(A) Microscopic of counting nuclear (N) and kinetoplast (K) DNA content after DAPI staining.  ~ 100 
bloodstream form T. brucei cells were counted at each time point for non RNAi-induced control 
cells (A: 18, 26 hrs; Tet -), or cells depleted in Tb13380 by RNAi (A: 8, 18, 26 hrs; Tet +). (B) 
Images of normal cells (Tet –, 26 hrs) and abnormal cells after RNAi induction (Tet +; 18 and 26 
hrs). DNA is shown by DAPI stain (DAPI); phase contrast image (PHASE), and an overlay of the 
DAPI and phase images (MERGE). 
  
Though no analysis has yet been performed to quantify the RNAi-induced 
knockdown of Tb13380 transcripts in the above experiments the timing of the 
growth arrest and subsequent cell death, as well as the nature of the aberrant 
cells that arise, is highly reminiscent of the phenotypes that result from 
TbORC1/CDC6 RNAi in BSF T. brucei cells.  
 
 162
 
Figure 4-18 – FACS profiles of PI-stained cells after Tb13380 RNAi 
Histograms show propidium iodide-stained T. brucei procyclic-form cells after FACS sorting, 
sampled 8 hrs (A), 18 hrs (B), 26 hrs (C) pre- and post - induction of RNAi for Tb13380 (- Tet and + 
Tet ,respectively). The peaks corresponding with cells containing 2C and 4C DNA content are 
indicated, as is the peak position for cells with 8C content; where C represents a haploid DNA 
content 
 
4.9 Characterisation of Tb927.10.7890; another putative 
novel component of the pre-RC machinery in T. 
brucei 
This section will describe preliminary analyses that have been carried out to 
define a role for the T. brucei protein Tb927.10.7890 (hereafter referred to as 
Tb7980 for the purpose of brevity). As earlier mentioned, Tb7980 was identified 
as a putative TbORC1/CDC6 interacting partner by co-immunoprecipitation and 
subsequent mass spectrometry analyses.  
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4.9.1 Confirmation of interaction between Tb7980 and 
TbORC1/CDC6 
4.9.1.1 Cloning of Tb7980-HA tagging construct 
To determine if Tb7980 and TbORC1/CDC6 interact in vivo in PCF cells, the 
Tb7980 DNA sequence was retrieved from the TriTrypDB database 
(http://tritrypdb.org/tritrypdb/), and a construct was generated that allows 
Tb7980 to be expressed as a C-terminal fusion with six copies of the HA epitope 
after integration into the endogenous loci. The strategy for this is as described 
in Section 4.5.2. A 633 bp C-terminal fragment of Tb7980 was PCR-amplified 
with primers CT_OL67/CT_OL68 (Table 2-2) and the PCR product was cloned into 
the restriction sites HindIII and XbaI of the pNAT6HA vector (Figure 4-19). The 
construct was linearised with XhoI, transfected into the TbORC1/CDC6-Myc 
tagged line cell line (Section 4.5) and two phleomycin-resistant clones selected 
that should co-express TbORC1/CDC6-Myc and Tb7980-HA (A and B). As a 
control, the construct was also transfected into WT TREU927 procyclic form cells 
and two clones recovered. In each case, single clones validated for expression of 
the expected proteins were taken for further analysis 
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Figure 4-19 – The pNAT6HA vector for Tb7980-HA epitope tagging 
A C-terminal coding sequence of Tb7980 (633 bp) that was cloned into HindIII and XbaI sites in the 
plasmid after PCR amplification is shown. The XhoI site used for vector linearization to allow 
integration into the Tb7980 locus is also shown. Properties of vectors have been described 
previously (Figure 4-11) 
 
4.9.1.2 Co-immunoprecipitation of Tb7980-HA and TbORC1/CDC6-Myc 
We examined by co-immunoprecipitation whether Tb7980-HA and TbORC1/CDC6-
Myc interact. The procedure to validate the interaction between Tb7980-HA and 
TbORC1/CDC6-Myc was carried out as described for Tb13380-HA and 
TbORC1/CDC6-Myc in Section 4.8.1.2. Expression of both tagged proteins was 
checked by western blot using the corresponding antibodies to the HA and Myc 
tags (Figure 4-20, input lanes).   
As shown on Figure 4-20 (TbORC1/CDC6-Myc IP box), anti-Myc IP of 
TbORC1/CDC6-Myc was successful from the TbORC1/CDC6-Myc/Tb7980-HA 
double expressor cells, as seen by a band at 66 kDa  in the eluate that was 
absent from the Tb7980-HA control (Figure 4-20; TbORC1/CDC6-Myc IP box; anti-
myc panel). The interaction between the proteins was inconclusive when the 
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same eluate was probed with anti-HA antibody, because a band of the size 
expected for Tb7980-HA (~48 kDa) was present in both the eluate from the 
double expressor cell and in the control Tb7980-HA expressor lane (Figure 4-20; 
TbORC1/CDC6-Myc IP box; anti-HA panel). This band most probably results from 
the eluted IgG heavy chain fragment from the anti-myc antibody used for the IP. 
The reciprocal experiment, where IP was used to ‘pull-down’ Tb7980-HA using 
anti-HA antibody from TbORC1/CDC6-Myc/Tb7980-HA double expressor or 
TbORC1/CDC6-Myc single expressor cells, confirmed interaction between the 
two proteins. In Figure 4-20 (Tb7980-HA IP box; anti-HA panel), from the anti-HA 
western blot, a definitive conclusion could not be made about the success of the 
IP of Tb7980-HA from the double expressor, since the same band was present in 
both the control lane as well as the double expressor lane. However, the anti-
Myc blot from the same eluate revealed a band of the expected size (66 KDa) for 
TbORC1/CDC6-Myc from the TbORC1/CDC6-Myc/Tb7980-HA double expressor 
cells; with no such band in the control lane. Thus, with the Tb7980-HA IP an 
interaction with TbORC1/CDC6-Myc was confirmed suggesting that the 
inconclusive results obtained for the TbORC1/CDC6-IP was due to co-localisation 
of the putative antibody band and the eluted immunoprecipitated Tb7980-HA at 
~48 kDa.  
Until the resulting eluates are separated by running the SDS-PAGE for a longer 
period of time on a gradient gel, a definitive conclusion to confirm the previous 
IP-mass spectrometry data of interaction between these proteins cannot be 
reached. However, based on the reciprocal experiment above, it is likely that 
both data would complement each other. To further understand the potential 
role of Tb7980 and determine whether it is essential for viability, its expression 
in bloodstream stage parasites was knocked down using the inducible RNAi 
system described previously (Section 4.8.3). 
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Figure 4-20 – Western blot analysis of the inputs and eluates following co-
immunoprecipitation using anti-HA and anti-myc antibodys 
(A) and (B) show cartoon of epitope-tagged constructs of Tb7980 and TbORC1/CDC6. Whole cell 
extracts from cell lines expressing proteins from both constructs were subjected to co-IP using 
antibodies to the Myc or HA tags. “TbORC1/CDC6-Myc IP Box”: The input and eluate from co-IPs 
from whole cell extracts of a control cell line (7980-HA, expressing Tb7980-HA), and from co-
expressor cell lines expressing Tb7980-HA (7980-HA), and TbORC1/CDC6-Myc (Orc1-Myc), were 
separated on a 10 % SDS-PAGE gel and then transferred to a nylon membrane. This was then 
probed with anti-Myc antibody (anti-myc) or with anti-HA antibody (anti-HA). “Tb7980-HA IP Box”: 
The input and eluate from co-IPs from whole cell extracts of a control cell line (Orc1-myc, 
expressing TbORC1/CDC6-Myc), and from co-expressor cell lines expressing Tb7980-HA (7980-
HA), and TbORC1/CDC6-Myc (Orc1-Myc), were separated on a 10 % SDS-PAGE gel and then 
transferred to a nylon membrane. This was then probed with anti-HA antibody (anti-HA) or with 
anti-Myc antibody (anti-myc). 
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4.9.2 Amino acid sequence analysis of Tb7980 
As earlier mentioned, Tb7980 was identified as one of the potential interacting 
molecular partners of TbORC1/CDC6, including Tb13380. In the preceding 
sections, data has been shown to suggest that indeed the T. brucei machinery 
may have additional divergent factors; Tb13380. We therefore carried out amino 
acid sequence analysis of the putative second factor, Tb7980, to specifically ask 
if obvious ORC motifs could be identified that would justify further biochemical 
characterisation for inclusion into the T. brucei ORC-related family.  
Tb7980 is annotated as a hypothetical protein in TritryDB (http://tritrypdb.org). 
The protein is predicted to be 441 amino acids long and 48.8 kDa in size. Tb7980 
is conserved and syntenic across the sequenced kinetoplastids: orthologues exist 
in all the Tritryps, are annotated as hypothetical proteins and are of a similar 
size. T. cruzi encodes a single protein (Tc00.1047053506247.280) that is 66% 
identical to Tb7980, while L. major encodes a protein (LmjF36.6700) with 44% 
identity to Tb13380. Second iteration psiBLAST searches of the NCBI database 
using the Tb7980 sequence from TriTrypDB as query retrieved no meaningful hits 
with E-value better than the threshold set by the search algorithm. However, 
third iteration BLAST retrieved a number of DNA helicases from bacteria with the 
best hit having an E-value of 7e-25. A rather less convincing, but perhaps 
meaningful, hit was Replication factor C with an E-value of 0.023. In any case 
the output of the BLAST suggested a probable DNA replication function for the 
Tb7980, prompting further bioinformatic amino acid analyses.  
Examination of the Tb7980 amino acid sequence revealed the presence of a 
walker A motif (GxxGxGKT; where x = any amino acid residue), which putatively 
binds nucleotide. Tb7980 has this motif between positions 33 and 40 (inclusive) 
of its primary amino acid sequence. This motif is known to be present in energy 
generating proteins that hydrolyse ATP or GTP (Neuwald et al. 1999). This 
observation is consistent with the fact that ORC members (Orc1, Orc4, and Orc5 
in budding yeasts) possess this key conserved ATP binding element that is crucial 
for regulating their function (Speck et al. 2005). To ask if the functional 
nucleotide binding motif present in the primary sequence could be related to 
the function of the protein, we searched the PHYRE database for related protein 
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structures. To our surprise, the PHYRE search revealed three predictions of 
Tb7980 being structurally similar to Cdc6p from the archaeum Pyrobaculum 
aerophilum (85% precision), archaeal Orc1/Cdc6 from Solfolobus Solfataricus 
(80% precision) and archaeal Orc1/Cdc6 Aeropyrum pernix; lending further 
support for Tb7980 being a T. brucei ORC/CDC6-related factor. To further 
support this finding, CLC Workbench v4 PFAM domain searches also revealed that 
Tb7980 belonged to the AAA+ superfamily of proteins (Figure 4-21), a critical 
feature of the ORC family (Orc1, Orc4 and Orc5) of proteins, except for Orc6 
which lacks the domain (Erzberger & Berger 2006; Speck et al. 2005; Neuwald et 
al. 1999). As shown in Figure 4-21, S. cerevisiae Orc1, Orc5 and Cdc6 proteins 
were also predicted to have the AAA+ motif in which this function has already 
been biochemically characterised and reported (Randell et al. 2006; Speck et al. 
2005; Harvey & Newport 2003). These observations put together may support a 
role for Tb7980 in the formation of an ORC complex formation in T. brucei.  
Although our co-IP experiments were inconclusive, the bioinformatic analyses 
prompted to us to further investigate the role of this protein by RNAi of the gene 
in BSF cells.  
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Figure 4-21 – PFAM domain prediction of Tb13380 compared with selected S. cerevisiae Orc 
and Cdc6 proteins  
Using the “PFAM 100 most common” domain prediction tool in CLC Genomics Workbench v4, 
putative functional domain organisation of Tb7980 (Tb798080 box) is shown relative to the same 
analysis of S. cerevisiae Orc1 (SceOrc1 box), S. cerevisiae Orc5 (SceOrc5 box) and S. cerevisiae 
Cdc6 (SceCdc6 box). An ATPase motif is indicated by AAA (PFAM no. PF00004); tetratricopeptide 
repeats are indicated by TPR1 and TPR2 (PFAM no. PF07719); Radical SAM superfamily is 
indicated by Radical SAM which confer protein-protein interactions and multi-complex formation 
function; ABC transporters indicated by ABC_tran (PFAM no. PF00005); GTPase motif indicated 
by MMR_HRS1 (PFAM no. PF01926); cytochrome b (N-terminal) motif indicated by 
Cytochrom_B_N (PFAM no. PF00033); Helix-turn-helix motif indicated by HTH_3 (PFAM no. 
PF01381); CBS domain indicated by CBS (PFAM no. PF00571) DEAD/DEAH box helicase 
indicated by DEAD (PFAM no. PF00270); Zinc finger, C3HC4 type indicated by zf-C3HC4 (PFAM 
no. PF00097); PFAM numbers (PFAM no.) obtained from the Sanger Institute webpage available 
at (http://pfam.sanger.ac.uk/).  
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4.9.3 RNA interference analysis of Tb7980 in bloodstream form 
cells 
4.9.3.1 Cloning of Tb7980 RNAi construct 
In order to further investigate the role of Tb7980 in vivo, an RNAi approach was 
used. A 446 bp fragment (Figure 4-22) of Tb7980 was amplified by PCR using 
oligonucleotides CT_OL67 and CT_OL68 (Table 2-2), cloned into BglII/HindIII of 
the pZJM dual T7 vector as described in 4.8.3.1 and transfected into the T. 
brucei BSF 427 pLew90-pLew13 cell line. Two independent clones were selected, 
and analysed further for the effect of inducing Tb7980 RNAi.  
 
Figure 4-22 – The pZJM dual T7 vector for Tb7980 RNAi 
A fragment of Tb7980 (446 bp) that was cloned into BglII and HindIII sites in the plasmid, after PCR 
amplification, is shown; Vector properties are same as described previously (Figure 4-15) 
 
4.9.3.2 Effect of TbORC6 RNAi on growth in bloodstream form cells 
Growth curves were generated in the absence or presence of tetracycline, which 
induces expression of the Tb7980 double-stranded RNA. Induction of Tb7980 
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RNAi resulted in a growth defect in BSF cells observable from 18 h post induction 
of RNAi in both clones (Figure 4-23), leading to cell death from 30 hours as 
evidenced by the decreasing cell numbers. These results suggested that Tb7980 
may be essential for viability of BSF T. brucei cells. 
 
Figure 4-23 – Effect of Tb798080 RNAi in bloodstream form cells 
Growth was monitored in bloodstream cell lines in which Tb13380 RNAi was induced (+ Tet, solid 
line) or without induction (-Tet, broken line) for 2 clones; C3 and C4 
 
4.9.3.3 Effect of Tb7980 RNAi on cell morphology in bloodstream form cells 
To determine whether the growth defect observed upon Tb7980 RNAi occurred 
as a result of a cell cycle defect, DNA content was monitored as described in 
Section 4.8.3.3. The results for a single clone after DNA-DAPI staining and 
microscopically counting were very similar to that described for TbORC1/CDC6 
and Tb13380 depletion by RNAi (Sections 3.6and 4.8.3, respectively). As shown 
in Figure 4-24, after RNAi depletion of Tb7980, DAPI staining revealed an 
increase in cells with >2 nuclei and >2 kinetoplast DNA content (>2N2K cells, 
unclassified) from ~ 2% (at 8 hrs post-induction) to 60% (at 24 hrs post induction) 
of the population, with a concomitant decrease in 1N1K cells from ~ 70% to ~ 
20% within the same time period. This cell morphological defect was not 
observed in the control population (uninduced population) where 1N1K cells 
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remained constant constituting 80% of the population between 8 hrs and 24 hrs 
during which the experiment was performed.  
 
Figure 4-24 – Analysis of nuclear and kinetoplast DNA configuration of Tb7980 RNAi cells 
for a single clone 
(A) Microscopic of counting nuclear (N) and kinetoplast (K) DNA content after DAPI staining.  ~ 100 
bloodstream form T. brucei cells were counted at each time point for non RNAi-induced control 
cells (A: 8, 18, 24 hrs; Tet -), or cells depleted in Tb7980 by RNAi (A: 8, 18, 26 hrs; Tet +). (B) 
Images of normal cells (Tet –, 24 hrs) and abnormal cells after RNAi induction (Tet +; 18 and 24 
hrs). DNA is shown by DAPI stain (DAPI); a phase contrast image (PHASE), and an overlay of the 
DAPI and phase images (MERGE). 
 
4.9.3.4 Effect of Tb7980 RNAi on cell cycle 
Analysis of flow cytometry profiles of the Tb7980 RNAi-depleted cells showed 
that the cells re-replicated their nuclei and kinetoplasts, as demonstrated by the 
appearance of 8C peaks with the concomitant disappearance of 2C and 4C peaks 
following induction at 18 and 24 hrs with the uninduced RNAi cells remaining 
unchanged for the same period of time (Figure 4-25). This observation is in 
agreement with the accumulation of multinucleate cells observed from DNA DAPI 
staining experiments.  
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Figure 4-25 – FACS profiles of PI-stained cells after Tb7980 RNAi 
Histograms show propidium iodide-stained T. brucei procyclic-form cells after FACS sorting, 
sampled 8 hrs (A), 18 hrs (B), 26 hrs (C) pre- and post - induction of RNAi for Tb7980 (- Tet and + 
Tet ,respectively). The peaks corresponding with cells containing 2C and 4C DNA content are 
indicated, as is the peak position for cells with 8C content; where C represents a haploid DNA 
content 
 
While analysis to quantify the RNAi-induced knockdown of Tb7980 transcripts or 
protein levels remains to be carried, it is remarkable that in the RNAi analysis of 
Tb7980, the timing of the growth arrest and subsequent cell death, as well as 
the nature of the aberrant cells that arise, is highly reminiscent of the 
phenotypes that result from TbORC1/CDC6 and Tb13380 RNAi in BSF T. brucei 
cells. 
4.10 Discussion 
The aim of this chapter was to investigate if TbORC1/CDC6 is the sole functional 
ORC-related component of the T. brucei pre-replication machinery. To do this, 
targeted IP analysis to test for interactions between known factors, as well as a 
proteomics approach after IP of TbORC1/CDC6, were adopted. These 
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experiments required the generation of tagged variants of the proteins under 
investigation. Ideally, specific antibodies raised and validated against native 
proteins would be employed; hence the tools used here will be justified. An 
overview of the proteomic analysis and subsequent bioinformatic approaches 
used will also be discussed within the context of T. brucei replication initiation 
machinery. To conclude this chapter, our existing hypothesis for what 
constitutes the T. brucei pre-RC machinery will be discussed in relation to the 
novel candidates identified. 
4.10.1 Are in silico approaches for identifying molecular 
interactors sufficient; a case study of the T. brucei DNA 
replication initiation machinery 
Unprecedented advances in DNA sequencing technologies over the last decade 
and the increasing availability of whole genome sequences for various organisms 
has progressively amplified the pace of basic scientific research; reviewed in 
(Metzker 2010). The revolution in DNA sequencing technologies has also 
triggered a steady rise in the development of software and web-based tools that 
facilitate comparative relationships between biological pathways, and even 
between whole organisms; for review see (Chen, Jorgenson, & Cheung 2009). 
Various Bioinformatic tools that help for whole genome or specific comparative 
studies, some freely available and some commercial, are increasingly available 
to the scientific community for studying patterns in evolution of genes, for 
ascribing functions to genes, and for understanding interaction pathways (Chen 
et al. 2009). Inference from the presence or absence of a specific catalogue of 
genes has been used to predict what biological pathways are active or inactive in 
an organism for which experimental information is not available. An example of 
this has been observed in the microsporidium E. cuniculi, which has been 
reported to have lost a number of DNA repair genes (Gill & Fast 2007). 
Nevertheless, to extrapolate function, or absence of function, using homology 
from other organisms might sometimes be misleading due to biological variation. 
Thus, experimental analysis still remains vital to substantiate computer-based 
predictive strategies. 
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With the publication of the genome sequence for T. brucei and related 
kinetoplastids in 2005, it was possible to use a number of these computer-based 
algorithms to search the genome database to predict the function of T. brucei 
proteins based on primary amino acid sequence and overall 3D structural 
homology with those of other organisms. Overall, 9068 ORFs were predicted, and 
those genes (~ 64%) for which obvious homology could not be ascribed to the 
products were annotated as hypothetical proteins (Berriman et al. 2005). Nuclear 
DNA replication initiation in T. brucei provides a good example, as this was a 
poorly studied process with essentially no functional data available prior to the 
release of the whole genome sequence. The TritryDB genome annotation 
indicates that Trypanosoma and Leishmania species possess a simplified ORC 
machinery that is analogous to archaea (Aslett et al. 2010). This hypothesis was 
supported by a recent paper from the lab of M.C. Elias (Godoy et al, 2009). 
Indeed, our own bioinformatic searches identified only one subunit of ORC, and 
found that and other replication initiation proteins, including Cdt1 and CDC7-
DBF4, were ‘missing’ in the these parasites. Given the potential evolutionary 
and therapeutic consequences of such putative novelty, we considered it 
important to experimentally test the bioinformatic hypothesis that the T. brucei 
ORC machinery is structurally and functionally distinct from its mammalian host. 
This led us to generate a number of genetic tools, as discussed below. 
4.10.2 Is TbORC1/CDC6 the helicase (TbMCM) loader in T. 
brucei? 
One fundamental question that was asked in this chapter was whether the 
TbMCM helicase is recruited onto origin DNA in T. brucei by TbORC1/CDC6. With 
no obvious homologue of Cdt1, a verified eukaryotic helicase loader (Chen et al. 
2007; Randell et al. 2006; Tanaka & Diffley 2002), or archaeal WhiP, which might 
function as a helicase loader (Robinson & Bell 2007), present in the genome of T. 
brucei, it seemed possible that a direct interaction between TbORC1/CDC6 and 
TbMCM might mediate this crucial step in replication. Any such interaction would 
be highly novel in eukaryotes, and therefore of mechanistic interest. However, if 
such interaction was detectable further assays (such as in vitro reconstitution) 
would ultimately be needed to corroborate their functionality, since the 
approach we took only asked if a stable interaction was detectable between 
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TbORC1/CDC6 and TbMCM, and could not exclude an indirect interaction via 
additional factors. Nevertheless, stable interaction between ORC and MCM has 
not previously been described in unmodified eukaryotes; except when Cdt1 is 
tethered to Orc1-5 (Chen et al. 2007).   
Studies in bacteria, archaea and eukaryotes (see Section 1.6) suggest that the 
presence of a loading factor is normally crucial for recruitment of helicase onto 
origins, and only in some archaea is this role provided by Orc1/Cdc6 itself 
(Kasiviswanathan et al. 2005; De Felice et al. 2003). In the analysis described 
here, we did not find evidence for ORC1/CDC6 binding to the MCM complex in T. 
brucei. We tested for in vivo interaction between TbORC1/CDC6 and TbMCM3, 
TbMCM6 and TbMCM7, without success. Tests of interaction between 
TbORC1/CDC6 and TbMCM5 or TbMCM4 were not carried out. However, we 
showed also that TbMCM2, TbMCM4, TbMCM6 and TbMCM7 can form a complex 
(see below), so it seems likely that if TbORC1/CDC6 and TbMCM4 were to 
interact, this would have revealed interaction with these other subunits. In S. 
pombe Mcm3 forms a dimer with Mcm5 (Lee & Hurwitz 2000). If this is conserved 
also in T. brucei, the lack of TbORC1/CDC6 interaction with TbMCM3 (albeit only 
tested via IP of TbMCM3-HA) is likely also to rule out interaction with TbMCM5. 
We therefore tentatively conclude that T. brucei recruitment of the replicative 
MCM helicase is not mediated through direct interaction with TbORC1/CDC6. 
However, in the absence of TbMCM5-HA tagged cells, or examination of 
TbORC1/CDC6-TbMCM4 interaction, we cannot formally exclude that these 
subunits mediate interaction. A recent paper has shown that in S. cerevisiae, 
absence of Cdt1 results in reduced levels of Mcm3 and Mcm5, suggesting that the 
helicase loader stabilises these subunits of the MCM complex (Tsakraklides & Bell 
2010). We do not see evidence for low abundance of TbMCM3 in T. brucei, 
suggesting that any evolutionary absence of Cdt1 does not result in constitutive 
loss of this subunit, though again TbMCM5 has not been tested. If TbMCM5 were 
to be of low abundance, and was critical in direct recruitment of TbMCM by 
TbORC1/CDC6, small amounts of the TbMCM subunits examined following IP may 
have been missed. Equally, the analysis has examined interactions in whole cell 
extracts, and it is possible that functional, direct interaction between 
TbORC1/CDC6 and TbMCM is only found in the nucleus, and hence our assay may 
not be sensitive enough to detect this.  
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4.10.3 MCM helicase subunits in T. brucei form typical 
eukaryotic MCM subcomplexes 
Bioinformatic mining of the kinetoplastid genomes shows that they possess all six 
eukaryotic MCM paralogues. The in vivo IP experiments described here show that 
the T. brucei MCM proteins are able to form subcomplexes that appear typical of 
the eukaryotic model described in Section 1.6.3.4. Briefly, in eukaryotes a 
subcomplex of Mcm4/6/7 has been shown to have 3′-5′ helicase activity in vitro 
while addition of Mcm2, Mcm3 and Mcm5 tend to play a regulatory role within 
the hexameric complex (Lee & Hurwitz 2000; Ishimi 1997). From our MCM IPs, 
the presence of TbMCM2/4/6/7 subcomplex in T. brucei was demonstrated. In 
contrast to the co-IP of TbMCM2, TbMCM4, TbMCM6 and TbMCM7, IP of TbMCM3 
did not co-IP any other MCM subunit. This is consistent with the expectation 
from other eukaryotes that TbMCM3 does not always interact with a 
TbMCM2/4/6/7 complex, but is inconsistent with the protein forming a stable 
dimer with TbMCM5. This may indicate a difference from the eukaryotic model, 
but it seems unlikely given the conservation of TbMCM5 in all kinetoplastids and 
its sequence homology with S. cerevisiae Mcm5 (42 % identity between S. 
cerevisiae Mcm5 and TbMCM5 from Leishmania and Trypanosomes).  
Immuno-depletion of Cdt1 from budding yeast extracts results in reduced 
purification yields of Mcm3 and Mcm5, while co-overexpression of Cdt1 improves 
the purification yield of Mcm3 and Mcm5 (Tsakraklides & Bell 2010). These 
results have been interpreted as suggesting that Cdt1 may stabilise Mcm3 and 
Mcm5 in the hexameric complex. The absence of an interaction between 
TbMCM3 and TbMCM5 may therefore be due to limitations in our purification 
protocol to retain a T. brucei Cdt1-like factor during the IP (assuming T. brucei 
has a homologous protein that has been missed in our in silico searches). 
Despite the absence of evidence for a TbMCM3/5 subcomplex, the observation of 
a TbMCM2/4/6/7 complex argues that assembly of a putative T. brucei MCM 
hexameric complex, involving all six protein subunits, follows the eukaryotic 
paradigm (Figure 4-26) 
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Figure 4-26 –Typical eukaryotic subcomplexes in vivo for human MCM proteins 
(A) trimer of human Mcm4/6/7; (B) tetramer of human Mcm2/4/6/7; (C) dimer of human Mcm3/5; 
Arrows indicate direction of interaction of subcomplexes for formation of a heterohexamer. Figure 
adapted from (Yu, Feng, & Liang 2004)  
 
4.10.4 The T. brucei DNA replication initiation machinery: 
complex or simplified? 
From the above data, we have proposed that ‘downstream’ events in pre-RC 
assembly in T. brucei are more eukaryotic than archaeal: we confirm 
bioinformatic predictions that the MCM helicase exists as a complex of distinct 
subunits, and we can find no evidence that this is recruited to origins directly by 
TbORC1/CDC6. With this in mind, below is a discussion of our comparative 
eukaryotic genome mining for the pre-RC machinery in relation to how this aids 
our understanding of T. brucei replication initiation, followed by analysis of the 
novel proteins obtained from IP studies with TbORC1/CDC6. 
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DNA replication is an intricate biological process that involves a series of 
complex reactions tightly regulated at various levels. In humans, from start to 
finish 165 proteins are currently known to be involved DNA replication (Cotterill 
& Kearsey 2009), either acting individually or acting in (sub)complexes. The 
association of ORC, Cdc6, Cdt1, and the MCM complex to form the pre-RC at 
replication origins has been observed in all characterised eukaryotes. In budding 
yeast, for example, in vitro pre-RC assembly has been shown to be a dynamic 
and sequential process where there is ordered loading of ORC and Cdc6, then 
upon recruitment of an Mcm2-7-Cdt1 heptameric complex, there is a 
concomitant offloading of ORC from the pre-RC (Tsakraklides & Bell 2010). These 
results suggest that pre-RC formation is a tightly regulated process and involves 
the concerted participation of all of these factors. What consequences might 
stem from the putative absence of several of these factors in some eukaryotes? 
As shown in Figure 4-1, only some subunits of the ORC family are detected in 
some eukaryotes and in a few (including T. brucei) only a single protein is found 
that is similar to Cdc6 (Orc1/Cdc6). Orc6 and Orc3 appear to be the ORC 
subunits that are most frequently undetected, being absent from genome 
searches of nine of the organisms examined, including representatives of each 
supergroup (Adl et al, 2005) except the Archaeplastida.  Orc2 and Orc4, and to a 
lesser extent Orc5, were more widely detected, either individually or in 
combination. Orc1 was the sole subunit that was universally detected (albeit in 
four cases as a potential ‘hybrid’ with Cdc6). This distribution may not reflect 
presence or absence, but instead the extent to which the sequences of the 
proteins are functionally constrained in evolution. For instance, it may be that 
Orc3 and Orc6 are much diverged in sequence amongst eukaryotes, and 
therefore escape bioinformatic searches using experimentally characterised 
members of the family. Alternatively, some or all of the subunits may truly be 
absent, reflecting later evolutionary formation in some eukaryotes, or loss in 
many.  
There is little functional data to assess if eukaryotic DNA replication could 
initiate if some ORC components were absent (though, clearly, this is possible in 
archaea). Orc6 has been shown to be essential for cell viability in S. cerevisiae 
and to be involved in the recruitment of Cdt1 (Chen et al. 2007), but some 
evidence suggests it could be dispensable in some circumstances. This is because 
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it has been shown not to be required for ORC-DNA binding (Chen et al. 2007; 
Semple et al. 2006; Lee & Bell 1997). The more widespread detection of Orc1, 
Orc2, Orc4 and Orc5 subunits could be explained by the fact that they have each 
been proposed to possess a winged helix domain fold that acts in binding DNA 
(Speck et al. 2005). Moreover, each (except Orc2) are members of the AAA+ 
family of proteins with ATPase activities (Speck et al. 2005), which provides a 
key regulatory component in the complex and in interactions with other factors. 
However, the same motifs are conserved in Orc3, so why then this might be less 
conserved is unclear, though it may indicate that there is some functional 
redundancy within the ‘standard’ six ORC subunits (whose detailed individual 
roles are not yet understood; (Duncker et al. 2009). As stated in the results, the 
absence of some detectable ORC subunits in E. cuniculi, given its relatively close 
relationship with fungi (Gill & Fast 2007; Katinka et al. 2001), may be the 
clearest sign that eukaryotic ORC architecture can diverge from the six-subunit 
paradigm. Ultimately, such questions can only be resolved by biochemical 
structural analysis. Below we described the first attempt to do so in a protozoan 
organism. 
4.10.5 Tb13380 is a bona fide member of the ORC family 
To attempt to ask what proteins interact with TbORC1/CDC6 we adopted the 
strategy of TbORC1/CDC6-Myc IP and identification of interacting factors by 
separation of recovered proteins by gel electrophoresis followed by 
identification by mass spectrometry. As a relative quantitative approach to give 
fold-enrichment would have required optimisation potentially beyond the time-
frame of the project, we utilised this rapid ‘one-step’ protein purification 
approach. A drawback of this technique is that we lost the ability to discriminate 
small levels of enrichment, and/or weak and transient interactors. Another 
drawback is that it is likely that some proteins will bind to the anti-Myc coupled 
beads, rather than to TbORC1/CDC6. By comparing a control WT-IP to the 
TbORC1/CDC6-Myc IP, we were able to filter out these contaminants. Since the 
same amount of beads was used in both the TbORC1/CDC6-Myc-IP and the WT- 
IP, this appeared to be a reliable approach because the same amount of bead 
surface area is exposed to protein extract during experimentation. Nevertheless, 
it is unlikely that all the ~150 proteins that were found specifically in a 
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TbORC1/CDC6 - IP were real interactors; it is necessary to confirm interactions 
by direct co-IP experiments.  
Three putative TbORC1/CDC6 interacting proteins stood out from the above 
analysis as potential ORC-related factors, based on sequence analysis: 
Tb927.10.13380 (or Tb13380), Tb927.10.7980 (or Tb7980) and Tb09.160.3120. 
Functional characterisation of Tb13380 and Tb7980 by RNAi showed highly 
similar phenotypes to those observed following RNAi of TbORC1/CDC6 (chapter 
3), consistent with these proteins acting in the same pathway. Co-IP of Tb13380 
and TbORC1/CDC6 confirmed that the proteins are bona fide interactors. The 
same experiments for TbORC1/CDC6 and Tb7980 were inconclusive, though do 
not rule out interaction. Combining the bioinformatic and experimental data, we 
speculate that at least Tb13380 and TbORC1/CDC6 act together in the initiation 
of DNA replication, and thus Tb13380 is a member of the pre-RC complex in T. 
brucei. 
All ORC protein family members except Orc6 belong to the AAA+ ATPase family 
(Chen et al. 2007), characterised by the presence of Walker A and Walker B 
motifs, and associated sensor 1 and 2 motifs, that are necessary for binding and 
hydrolysing, typically, ATP to ADP (Speck et al. 2005). The Walker A motif 
(consensus, GxxxxGK[T/S]) binds ATP/GTP (Kawakami & Katayama 2010), while 
the Walker B box (consensus, hhhh[D/E]) binds Mg++. Although Tb13380 appears 
to lack canonical Walker A and Walker B motifs, structural prediction algorithms 
predict it to have AAA+ folds, suggesting it belongs to the AAA+ ATPase family. 
We therefore speculate that it is still likely to function as a TbORC family 
member. This assertion is based on similar patterns observed for budding yeasts 
Orc2 and Orc3 proteins. Both proteins may also not be functional ATPases, but 
possess the AAA+ folds characteristic of this protein family (Clarey et al. 2006; 
Speck et al. 2005). Therefore, in T. brucei, ATPase regulation of the pre-RC 
components is likely to focus on TbORC1/CDC6, which possesses clearly 
conserved ATPase domains. It is possible also that ATPase activity, which is 
likely to be used for ORC conformational changes to mediate association and 
disassociation with other pre-RC proteins and with origins (Speck et al. 2005), 
might reside in other ORC factors. One possibility is Tb7980. Though we cannot 
confirm by co-IP that this protein interacts with TbORC1/CDC6, RNAi gives very 
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similar phenotypes and the protein has AAA+ fold homology, though alignment of 
the individual motifs and assigning ORC subunit orthology has proved elusive.  
Based on the evidence presented above, we conclude that the pre-RC machinery 
contains at least one further factor beyond TbORC1/CDC6, encoded by 
Tb10.389.0050 (that we have named Tb13380) and we propose to name TbORC4, 
based on potential orthology with Orc4 in other eukaryotes (Figure 4-27). As yet, 
definitive tests are needed to ask if Tb7980 can also be considered a T. brucei 
pre-RC, and potential ORC, component. Indeed, further experiments to test this 
hypothesis, by detailing the nature of the putative interactions amongst these 
factors and their roles during DNA replication, are needed. 
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Figure 4-27 – Phylogenetic tree of eukaryotic ORC proteins and putative T. brucei ORC 
proteins 
A neighbour-joining phylogenetic tree was generated from the ClustalX alignment in Figure 4-13 
(with exception of DmeOrc4); each line refers to the length of the tree arms and indicates 10 amino 
acid changes per 100 amino acids. Hsa, Homo sapiens; Dme, Drosophila melanogaster; Ath, 
Arabidopsis thaliana; Sce, Saccharomyces cerevisiae; Pfa, Plasmodium falciparum; Ddi, 
Dictyostelium discoideum; Cpa, Cryptosporidium parvum; Tan, Theileria annulata;; Tth, 
Tetrahymena thermophila; Gla, Giardia lamblia;  Ecu, and Encephalitozoon cuniculi ; Tva, 
Trichomonas vaginalis; and Tb, Trypanosoma brucei. Genbank accession numbers are provided 
Appendix 3
 
4.10.6 How is TbORC1/CDC6 recruited to origins in T. brucei? 
A hypothetical mechanism 
This section considers the specific question of how DNA sites along chromosomes 
might be selected to act as origins in T. brucei. In higher eukaryotes, the 
mechanism by which ORC identifies and selects a functional origin locus and 
nucleates it for pre-RC licensing has not been clearly elucidated. Several factors 
 
 184
have been proposed to trigger ORC recognition of origins, although some of 
these ORC binding sites do not eventually function as active origins (Wyrick et 
al. 2001). Some factors that influence ORC binding include: (1) local chromatin 
architecture, e.g. presence of euchromatin (MacAlpine et al. 2010); (2) 
recruitment via other interacting proteins, e.g. EBNA1 (Norseen et al. 2008); (3) 
local sequence elements, e.g. AT-rich sequences in S. cerevisiae (Theis & 
Newlon 1997); CpG islands in mouse embryonic stem cells (Sequeira-Mendes et 
al. 2009); (4) topological properties of DNA, e.g. the presence of negative 
supercoils in Drosophila (Remus, Beall, & Botchan 2004). A more detailed 
discussion of the influence of chromatin and local DNA sequence elements will 
be covered in Chapter 5.  
Recently, in eukaryotic cells three independent reports have proposed an RNA-
dependent mechanism of ORC recruitment to DNA replication origins or to other 
sequences, mediated via interactions with either known RNA-binding proteins or 
interaction with RNA. In the free-living ciliate protozoan Tetrahymena 
thermophila, ORC is targeted to the ribosomal DNA (rDNA) replication origin via 
its interaction with a non-coding fragment of 26S rRNA known as 26T RNA. The 
formation of an RNA-DNA hybrid between the 26T RNA and origin DNA is thought 
to dictate the recruitment of ORC at rDNA origins in these organisms (Donti et al. 
2009; Mohammad et al. 2007). In Epstein-Barr virus, it has been shown that ORC 
binding to origin DNA of an episome (oriP) requires interaction of ORC to a viral 
protein, EBNA1, and this interaction is stabilised by a G-rich RNA sequence, 
suggesting that RNA molecules are involved in the recruitment of ORC in human 
cells (Norseen et al. 2008). In yeast and mammalian cells, the non-coding 
telomeric repeat-containing RNA (TERRA) has been implicated to facilitate TFR2 
recruitment to telomeres via the formation of DNA-RNA hybrids. This interaction 
mediated by TERRA is also thought to enhance the recruitment of ORC to 
telomeres, since ORC interacts with TFR2 (Deng et al. 2009). Given these 
findings, could it also be the case that in T. brucei TbORC1/CDC6 recruitment to 
origins is mediated via an RNA-interaction mechanism? 
Analysis of the TbORC1/CDC6-Myc IP and mass spectrometry data above 
concentrated on putative ORC–like factors that interact with TbORC1/CDC6. 
However, a wider consideration of the proteins recovered, but not so far 
analysed functionally, may provide preliminary evidence that supports RNA-
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dependent recruitment of ORC at replication origins (or to DNA in general) in T. 
brucei. Among the ‘best’ hits (Section 4.7), in silico analyses suggested that four 
proteins (Tb927.6.1120, Tb11.46.0009, Tb927.2.5130, and Tb927.10.9350) 
appeared to have an RNA-associated function. Using Phyre, Tb927.6.1120 (14 
peptide hits) showed homology, at 70 % precision, to a virion RNA polymerase, 
Tb11.46.0009 (5 peptide hits) showed 100 % precision homology with ATP-
dependent RNA helicases, Tb927.2.5130 (3 peptide hits) showed 90 - 95 % 
precision homology to Armadillo/HEAT repeat proteins (Andrade et al. 2001), 
and Tb927.10.9350 (3 peptide hits) showed 60 – 70 % precision homology also to 
Armadillo/HEAT repeat proteins. Whilst this is very preliminary, these 
bioinformatic predictions could suggest TbORC1/CDC6 interaction with a protein 
complex that involves, and perhaps generates, RNA. This is clearly highly 
speculative, but it would be of value to test, thereby asking if RNA mediates 
TbORC1/CDC6 recruitment to replication origins, or underlies further functions 
of the protein in T. brucei.  
4.11 Highlight of major findings 
In summary, the findings in this chapter include: (1) T. brucei ORC1/CDC6 
interacts with at least one other protein (Tb927.10.13380, previously annotated 
as hypothetical) that bears sequence homology with eukaryotic ORC subunits, 
and is likely to act in origin definition and DNA replication initiation; (2) RNAi of 
a further protein (Tb927.10.7980) is consistent with a role in replication, and 
preliminary evidence suggests this may also interact with TbORC1/CDC6; (3) 
TbORC1/CDC6 appears not to interact directly with the TbMCM helicase 
subunits, consistent with previous observations from a number of eukaryotic 
organisms, and contrary to reports in some archaeal species; (4) MCM subunits in 
T. brucei form at least one subcomplex homologous to that previously observed 
for human, yeast, Drosophila, Xenopus and mouse MCM proteins. Taken 
together, these data appears to refute the hypothesis that the DNA replication 
pre-RC machinery in T. brucei is analogous to archaea. Rather, we propose a 
model for TbORC containing least two-components (TbORC1/CDC6 and TbORC4), 
more analogous to the eukaryotic model, suggesting that origin designation is 
not carried out by a single protein as suggested by Godoy et al (Godoy et al. 
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2009). More work is needed to substantiate these proposals, and it remains 
unclear what protein or proteins provide a link between TbORC and TbMCM. 
 
 
 187
5 Genome-wide localisation of TbORC1/CDC6 
DNA binding sites in Trypanosoma brucei 
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5.1 Introduction 
It is well established that the budding yeast S. cerevisiae has a highly conserved 
consensus sequence element that defines origins of DNA replication (Newlon 
1996). Until 2006 only few origins had been characterised in higher eukaryotes 
and the DNA sequences showed no known consensus (Aladjem et al. 2006). Like 
in humans, origin usage and origin specification on chromosomes in mouse, rat 
and chicken, and in the more diverged Drosophila melanogaster and Xenopus 
laevis, appears to be more plastic [see (Aladjem et al. 2006) for a comprehensive 
review]. This observation has led to several suggestions that DNA replication 
origin usage in these organisms may be guided by factors that lie beyond primary 
DNA sequence elements, such as local DNA topology (Remus et al. 2004), local 
chromatin architecture (MacAlpine et al. 2010) and transcriptional regulatory 
units (Sequeira-Mendes et al. 2009), to name just a few. In the past, the 
approaches taken to identify origins in these organisms have been more direct, 
targeting specific loci on chromosomes. Some of these methods include: nascent 
strand abundance for characterisation of origins near the c-MYC genes in HeLa 
cells (Waltz, Trivedi, & Leffak 1996) and the Adenine Phosphoribosyl Transferase 
gene in Chinese Hamster Ovary (CHO) cells (Delgado et al. 1998);  two-
dimensional (2D) gel electrophoresis for characterisation of rDNA loci in Xenopus 
embryos (Hyrien et al. 1995); and single molecule analyses for characterisation of 
rDNA locus in HeLa cells (Lebofsky & Bensimon 2005), among others. From the 
aforementioned approaches, it became evident that the selection and utilisation 
of sites to act as origins of DNA replication could not be limited to specific loci 
as this would not reflect the presence of origins in a global genome context.  
Recently, genome-wide approaches have been adopted and these studies have 
offered new hope for identifying a complete repertoire of DNA replication 
origins for a particular organism, overcoming the potential for variation due to 
factors such as local GC or AT content, gene density, gene architecture, and 
transcriptional activity, which are likely to influence origin usage for specific 
loci when selected and characterised individually (Gilbert 2010; Aladjem 2007). 
Some of these approaches are discussed further below.  
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In this chapter we focus on the origins of DNA replication in T. brucei, since the 
validation that TbORC1/CDC6 acts in replication means it offers the opportunity 
to define these sequences, which has so far not been possible. Although the 
molecular features that define the selection of chromosomal loci to act as 
origins of DNA replication in higher eukaryotic species (Xenopus, Drosophila, and 
humans) remain poorly understood (Aladjem et al. 2006), in bacteria, budding 
yeast and archaea consensus nucleotide sequence elements are preferentially 
selected to act as origins of replication [for review see (Sun and Kong 2010).  
5.2 Results 
5.2.1 Generation and verification of Myc-tagged TbORC1/CDC6 
In order to identify DNA sequences to which TbORC1/CDC6 binds, we chose to 
adopt a chromatin immunoprecipitation (ChIP) approach. To this end, a vector 
for Myc-tagging of TbORC1/CDC6 at the C-terminus was constructed, as 
described in Chapter 4. This was linearised and transfected into TbORC1/CDC6 
+/- mutant PCF TREU927 T. brucei cells. Western blot analysis was carried out to 
confirm expression of TbORC1/CDC6-Myc and to test the specificity of the anti-
Myc antibody used; Southern blotting was carried out to confirm the genotype of 
transformants and demonstrate functionality of the Myc-tagged TbORC1/CDC6 
protein. All these experiments have been described previously in Section 4.5. 
Here, the functionally validated TbORC1/CDC-Myc expressing line was used for 
ChIP experiments to study its interactions with DNA in vivo.  
5.3 Chromatin immunoprecipitation (ChIP) and 
Microarray technology (chip) – [ChIP-chip] 
5.3.1 Description of methodology 
ChIP-chip (also known as ChIP-on-chip) is an in vivo technique that combines the 
isolation of DNA sequences by chromatin immunoprecipitation (ChIP) and their 
subsequent identification via a microarray-based approach (chip). The ultimate 
goal of a ChIP-chip experiment is to query a genome in order to determine what 
DNA sequences a given protein binds (Kim & Ren 2006). A summary of the 
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methodology is shown in Figure 5-1. Briefly, in a ChIP-chip experiment, a cross-
linking step is used to stabilise DNA-protein interactions in cells. The cells are 
lysed and the chromatin is sheared, the target protein is enriched by 
immunoprecipitation using a specific antibody or antiserum, DNA-protein 
interactions are then de-crosslinked, and DNA is purified from proteins and RNA. 
The generate sufficient material for analysis, the purified DNA is PCR-amplified 
and labelled differentially from input DNA (refers to whole genomic DNA that is 
not subjected to ChIP, but treated in the same way as ChIP material prior to IP). 
Both labelled DNAs are then co-hybridised on a microarray (chip), and the ratio 
of ChIP DNA versus input DNA is quantified. For TbORC1/CDC6, we adapted this 
generalised procedure as described below.  
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Figure 5-1 – Workflow overview of a ChIP-chip protocol 
chIP: (1) Crosslink proteins to DNA; (2) Extract and shear crosslinked DNA; (3) Immunoprecipitate 
with specific antibody; (4) Reverse crosslink, PCR-amplify and differentially label DNA. Chip: (5) 
co-hybridize labelled DNA to microarray; (6) Red/Green fluorescence ratio at each position on 
array is proportional to extent of binding. Taken from (Pollack & Iyer 2002) 
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For ChIP in PCF T. brucei cells, an established protocol from the lab of G.A.M 
Cross was adapted (See Materials and Methods for a detailed protocol). Briefly, 
108 PCF cells were fixed with 11 % formaldehyde for 20 min at RT. After cross-
linking, formaldehyde was neutralized by addition of Glycine to a final 
concentration of 125 mM. After five minutes incubation, cells were washed 
twice in ice-cold PBS, lysed and the chromatin was sonicated using a Bioruptor® 
(Diagenode). Insoluble material was removed by centrifugation at 4000 g for 20 
mins at 4°C, and the supernatant diluted. Samples of this material were 
retained as ‘input’ DNA. The sheared chromatin was next incubated with IgG-
coated magnetic beads coupled to a ChIP-validated anti-Myc monoclonal 
antibody (Millipore®) to precipitate TbORC1/CDC6-Myc crosslinked to DNA. As a 
negative control for non-specific factors binding to the beads or antibody, a 
TREU927 wild type cell line (not transfected with the TbORC1/CDC6-Myc 
construct) was treated in exactly the same way. The beads were washed seven 
times, and samples retained as ‘flow through’. IP material was then eluted from 
the beads, the cross-links reversed to separate DNA from protein, and the DNA 
purified using a Qiagen® Gel extraction protocol. Nicks introduced in the DNA 
during sonication were repaired using a Quick Blunting kit from NEB, according 
to manufacturer’s protocol. Contaminating proteins and RNA were purified from 
the ChIP DNA using Proteinase K and RNase A, the DNA was cleaned again using a 
Qiagen® Gel extraction kit, PCR-amplified using a Whole Genome Amplification 
kit (SIGMA) and purified using a PCR purification Kit from Qiagen®. 
5.3.2 Confirmation of chromatin immunoprecipitation by western 
blot 
Prior to the purification of TbORC1/CDC6-Myc ChIP DNA from the crosslinked 
protein-DNA complex, the input sample and ChIP samples were checked by 
western blotting using an antibody to the Myc tag to test if the anti-Myc 
antibody was specific to TbORC1/CDC6-Myc tagged protein, and that the ChIP 
experiment was successful. A 20 μl aliquot was taken from both the input and 
ChIP samples and separated on by 10 % SDS-PAGE (Invitrogen). The gel was 
transferred to a nitrocellulose membrane (GE Healthcare), the membrane was 
probed with an anti-Myc antibody and detected using an ECL western blotting 
detection kit (described in Materials and Methods). 
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The results in Figure 5-2 showed that no band was visible in the samples from 
the TREU927 wild type control cell line where TbORC1/CDC6 is not Myc-tagged, 
while a single band of 66 kDa visible was visible in the input, to some extent in 
the flow through (FT), and in the eluate lanes from the TbORC1/CDC6-Myc cell 
line (Figure 5-2). This indicated that TbORC1/CDC6-Myc could be successfully 
immunoprecipitated from whole cell extract after cross-linking to chromatin and 
sonication, and that the anti-Myc antibody did not cross-react significantly with 
other antigens in the whole cell lysate. From Figure 5-2 it is also apparent that 
not all crosslinked TbORC1/CDC6-Myc bound to the beads, as seen by a band of 
the same size in the flow-through (FT) material.  
 
Figure 5-2 – Western blot of TbORC1/CDC6Myc during chromatin imunoprecipitation (chIP) 
Western blot of whole cell extract after sonication step before IP (input), unbound material (FT), 
and after IP (eluate) using anti-Myc antibody against TbORC1/CDC6-Myc (ORC1/CDC6-MYC IP) 
or in a control cell line (TREU 927 wild type (WT) IP).  
 
5.3.3 Confirmation of chromatin immunoprecipitation by PCR  
After confirmation of TbORC1/CDC6Myc IP by western blot in this chIP protocol, 
DNA was purified and whole genome amplification employed as described above. 
The amount of DNA recovered after this step, from both WT and TbORC1/CDC6-
Myc-tagged input and ChIP material, was measured using a NanoDrop analyser 
and 5 μl of DNA was resolved on a 1.5 % agarose gel, stained with SYBR safe 
(Invitrogen) and imaged with a transilluminator (BioRad). The results showed 
that the purified ChIP and input DNA had a product size range of ~200 bp to ~1 
Kb (Figure 5-3). After quantification by NanoDrop, ~ 5 μg of chIP DNA was sent 
for hybridisation to a custom-designed T. brucei microarray while 100 ng was 
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sent for Solexa sequencing (Illumina). Samples from the WT experiments were 
not sent as the amount of DNA recovered from ChIP and subsequent whole 
genome amplification did not produce sufficient DNA for co-hybridisation on the 
microarray (Figure 5-3). 
 
Figure 5-3 – Purified input and ChIP DNA after whole genome PCR-amplification 
An Image is shown of a 1.5 % agarose gel of purified DNA before (input) and after IP (eluate) using 
a TbORC1/CDC6-Myc cell line (ORC1-MYC) and a control cell line (927 WT). Size markers are 
shown on the far left lane (100 bp ladder). 
 
5.4 Microarray (chip) design, output and data analysis 
This section will cover the analyses of the microarray data post co-hybridisation 
of TbORC1/CDC6-Myc IP (labelled with Cy5) and input sample (labelled with 
Cy3). After co-hybridisation, the data was extracted using NimbleScan software 
and the ratio of ChIP versus input fluorescent intensity signal of the 
corresponding Cy dyes was used to call peaks. This was performed by 
NimBleGen, and part of the data analysis described below was carried out in 
conjunction with L. Marcello (WTCMP, University of Glasgow), a collaborator on 
the DNA replication project. 
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5.4.1 Defining chromosome regions in the context of ChIP-chip 
analysis 
The majority of the T. brucei genome consists of 11 pairs of megabase 
chromosomes (that vary in size from 1 – 6 Mb). The core of the megabase 
chromosomes, which are known to harbour most of the transcribed 
‘housekeeping’ genes, is diploid, while the VSG array-containing subtelomeres 
are aneuploid (Berriman et al. 2005; Melville et al. 1998). Together with these 
megabase chromosomes, the genome is also composed of a few linear 
intermediate size (200-900 kb in length) and ~100 linear minichromosomes (~ 50–
150 kb) (Wickstead et al. 2004; Melville et al. 1998). In this chapter our analysis 
has focused only on the megabase-sized chromosomes since ~95 % of this 
component of the genome has sequence available and was used for our 
microarray design (Berriman et al. 2005). To facilitate data analysis, the genome 
was divided into three categories: chromosome core, subtelomere-proximal and 
VSG array. Whereas the first category comprises housekeeping genes, the second 
has been defined as containing INGI retrotransposon sequences, ESAG genes, VR 
(VSG-related) genes, and retrotransposon hot spot loci (RHS). The third 
category, VSG arrays, has a much more defined structure, consisting mostly of 
tandem repeats of what has been termed a VSG cassette, the fundamental unit 
that is copied into the VSG expression sites by gene conversion during antigenic 
variation (Figure 5-8). The VSG cassette starts at a 70 bp repeat and includes a 
VSG5’ flanking sequence (hereafter referred to as 5’ VSG component), the VSG 
ORF itself, and a VSG 3’ flanking sequence (referred to as 3’ VSG component); 
the latter is in turn flanked by a downstream 70 bp repeat, which become the 
start of the next VSG cassette. With these categories in mind, a program was 
written by L. Marcello in Perl to demarcate the megabase chromosomes into 
“core”, “subtelomere-proximal” and “VSG array” sections. Beginning from one 
chromosome end, genes along the length of each megabase chromosome were 
analysed sequentially and upon arrival at the coordinates of the first VSG along 
the chromosome, a “VSG array” feature would be generated while RHS, VSG-
related and ESAG genes (but not ESAG3, as this is also in VSG arrays) would 
generate a “subtelomere-proximal” feature (referred to as the “subtelomere” 
feature, for short). All hypothetical genes were skipped, and a “core” feature 
generated, which corresponds to the region encompassing all other non-
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hypothetical genes. Gaps were then joined. Some short regions containing 
subtelomeric genes present at strand-switch regions (SSRs) in the core of 
chromosomes were identified, and these correspond with where chromosome 
fusions were shown to have occurred in the past (El Sayed et al. 2005a). These 
were left as having a “subtelomere” feature, even though they are in the core of 
the chromosome. A schematic representation of these features on Chr6, as an 
example, is shown in Figure 5-4. 
 
Figure 5-4 – Demarcation of chromosome features on megabase chromosomes 
(A) Schematic representation of T. brucei chromosome 6 coding sequence. Blue blocks indicate 
genes in directional gene clusters along the chromosome, either in the forward strand (top) or in 
the reverse strand (bottom). (B) Chromosome features predicted by Perl script to demarcate the 
chromosome “core” (blue box), the “subtelomere” (red box), and the “VSG array” (orange box) 
  
5.4.2 Design of Microarray and hybridisation 
Chip design was performed by Roche Diagnostics NimbleGen (USA) using a 
selected set of T. brucei TREU927 DNA sequence files (Appendix 4), obtained 
from the Pathogen Sequencing Group at the Wellcome Trust Sanger Institute 
(Cambridge) and chosen to provide the best coverage possible of megabase 
chromosomes and some examples of telomeric sequences (only Chromosome 1 
and 10 have been assembled in their entirety) (Renauld et al. 2007). The 
NimbleGen Tiling ChIP Service (design ID 19441, design name 
090109_Tbru_LM_CHIP) was used. 385,816 probes were tiled across all unique 
regions of the T. brucei genome at an average spacing of 61 bp. The coverage of 
probes relative to chromosome features described above is as shown on Table 
5-1. 
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Table 5-1 – Probe coverage compared to chromosome architecture (ng = NimbleGEN)  
 
 
Labelling, hybridization and data acquisition was performed by NimbleGen, 
according to standard procedures. Two independent ChIP DNA samples from the 
TbORC1/CDC6myc PCF cell line were evaluated. However, only the input DNA 
from one sample was sent for co-hybridisation - hence the IP sample which did 
not have a corresponding input DNA sample was not analysed further. The 
control ChIP and input DNA samples from 927 WT cells were not sent for co-
hybridisation on the array. The data sets were viewed using NimbleGen 
SignalMap software either as a scaled log2 ratio or as filtered peak data 
generated after normalisation of the log2 ratio data. 
From the NimbleGen ChIP-chip guide, the scaled log2 ratio is defined as “the 
ratio of the input signals for the experimental and test samples that were co-
hybridized to the array. The log2 ratio is computed and scaled to center the 
ratio data around zero. Scaling is performed by subtracting the biweight mean 
for the log2-ratio values for all features on the array from each log2-ratio 
value”. In our case, the experimental sample refers to the input DNA (input) 
while the test sample refers to the ChIP DNA (sample). According to the same 
guide, for peak detection, “the scaled log2 ratio is normalised by searching for 
four or more probes whose signals are above the specified cut-off values, 
ranging from 90% to 15%, using a sliding window of 500 bp. The cut-off values 
are a percentage of a hypothetical maximum, which is the mean + 6[standard 
deviation]. The ratio data is then randomized 20 times to evaluate the 
probability of “false positives”. Each peak is then assigned a false discovery rate 
(FDR) score based on the randomization”. FDR scores ≤ 0.05 indicate the highest 
confidence of binding sites, while FDR scores > 0.2 are generally not considered 
as high confidence binding sites.  
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5.5 TbORC1/CDC6 binding site analysis:  
5.5.1 Chromosomes overview; schematic representation of 
TbORC1/CDC6 binding sites  
After co-hybridisation, data acquisition and analysis by NimbleGen, the scaled 
log2 ratio and the peak data sets were aligned with the annotated genome 
sequence coordinates for ten chromosomes (Chr1-10) from T. brucei strain 
TREU927 using the NimbleGen SignalMap software. The contiguous sequences for 
Chr11 version 4 that was used for probe design is in the process of being 
assembled, hence could not yet be included in the analysis. As shown in Figure 
5-5, for each chromosome, the scaled log2 ratio data is manually adjusted to a 
minimum value of zero on the y-axis to show the fluorescent signal intensity of 
the Cy5-labelled TbORC1/CDC6-Myc ChIP DNA (sample) enrichment relative to 
the fluorescent signal intensity of the Cy3-labelled input DNA (input). Positive 
log2 ratios of Cy5/Cy3 are indicated by peaks and these correspond to a relative 
excess of the DNA in the Cy5-labelled sample, while log2 ratios of Cy5/Cy3 near 
zero correspond to an equal abundance of the Cy5-labelled sample and Cy3-
labelled input DNA (Figure 5-5, log2-ratio sample/input). In Figure 5-5, for each 
chromosome, the middle panel shows the chromosome coding sequence 
(chromosome CDS) with blue boxes representing ORFs for both the forward and 
reverse coding strands above and below a horizontal line, respectively. The 
chromosome CDS coordinates are aligned with the log2 ratios for each probe on 
the array to illustrate the coordinates of loci within chromosome regions where 
Cy5-labelled sample DNA is enriched for on the array. The top panel shows 
assigned peaks (assignment described above) with 0≤FDR score<0.2, which 
indicate putative TbORC1/CDC6 binding sites identified.  The 0.2 FDR score was 
empirically chosen as a cut-off, as many binding sites with an FDR score higher 
than 0.05 still appeared to show a significant, non-random distribution. At FDR 
score < 0.2, 685 binding sites were identified for the ten chromosomes analysed 
while at a more stringent FDR score cut-off (≤ 0.05) a total of 242 binding sites 
were identified. The global distribution pattern of the reduced number of 
binding sites remains unaltered whether the FDR score cut-off is set at 0.05 or at 
0.2 (discussed below). 
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In summary, the results revealed that TbORC1/CDC6 binding within the 
chromosome interior (“core”) localised mainly to regions separating directional 
gene clusters (strand switch regions, SSRs), while the subtelomeric ends of 
chromosomes showed high density clusters of TbORC1/CDC6 binding (Figure 5-5). 
A detailed analysis of binding sites within the chromosome core and chromosome 
ends is described below. 
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Figure 5-5 – Distribution of TbORC1/CDC6 binding sites from ChIP-chip 
TbORC1/CDC6-Myc chIP and control input DNA samples were labelled with Cy5 and Cy3, 
respectively, and co-hybridized to a T. brucei 385K tiled array. Chromosomes 1-10 are shown, not 
to scale. Each chromosome is shown in the same way. Bottom panel: raw data were analysed 
using NimbleScan software and visualised using SignalMap software (NimbleGen) producing 
signal ratio values over a 500 bp sliding window; indicated by (log2-ratio sample/input); the scale 
on the y-axis indicates the ratio of the signals derived from the corresponding co-hybridisation, and 
the x-axis indicates the genomic coordinates of the microarray tiles. Middle panel: Chromosome 
coding sequence (Chromosome CDS) is depicted by blue boxes showing both the forward coding 
strand above (top strand, 1) and the reverse coding strand below (bottom strand, -1) a horizontal 
line. Top panel: a statistical method was used to generate p-value enrichment from the log2 ratio 
data with each probe assigned a false discovery rate (FDR score set here at < 0.2) for assignment 
of peaks which are indicated by vertical red and orange lines (0≤FDR score<0.2); FDR scores ≤ 
0.05 indicate the highest confidence of binding sites are depicted by red vertical lines, while FDR 
scores <0.2 indicate low confidence of binding sitesand are depicted by orange vertical lines. The 
T. brucei chromosome coordinates (bp) are indicated by the numbers at the top 
 
5.5.2 Chromosomes features and TbORC1/CDC6 binding  
A quantitative analysis of TbORC1/CDC6 ChIP-chip data for chromosomes 1 to 10  
(21 Mb in length) was performed on the chromosome features predicted by the 
Perl script described in Section 5.4.1 to investigate the degree of overlap 
between TbORC1/CDC6 occupancy with the three assigned chromosome 
features: “core”, “subtelomere” and “VSG array”. A representative chromosome 
(Chr6) is shown in Figure 5-6A to illustrate the distribution of TbORC1/CDC6 
peaks and the assigned chromosome features are shown beneath it. The results 
revealed that, at a p-value of 0≤FDR score<0.2, a total of 685 TbORC1/CDC6 
putative binding sites were present across the ten chromosomes. The sum of all 
“core” regions,  with a total size of 17.7 Mb and  73 % probe coverage, housed 
40 % (278) of TbORC1/CDC6  binding sites (Figure 5-6B). The “subtelomere” 
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regions, with a total size of 1.1 Mb and 29 % probe coverage, had 12 % (81) 
TbORC1/CDC6 binding sites (Figure 5-6B). The “VSG array” regions, which had a 
total size of 2.1 Mb, and 61 % coverage by array probes, had 48 % (330) of the 
total number of TbORC1/CDC6 binding sites (Figure 5-6B). Within the “core”, 
the spacing of unique binding sites (binding sites that are closer than 2 kb are 
grouped together) is ~ 110 kb, compared with ~ 30 kb within the “subtelomere”, 
and ~ 7kb with the “VSG array”. In total, the putative TbORC1/CDC6 binding 
sites cover a region of 450 kb, which corresponds with ~ 2 % of the genome 
sequence contained within chromosomes 1-10. 
 
 
 
Figure 5-6 – Overlap of TbORC1/CDC6 binding sites and chromosome features 
(A) SignaMap output graphic representation of chromosome 6, showing genome coordinates (top), 
TbORC1/CDC6 binding sites with p-value 0≤FDR score<0.2 indicated by vertical red and orange 
lines, and chromosome forward and reverse coding strands (CDS) indicated by blue boxes above 
and below a horizontal line, respectively. Chromosome features predicted by Perl script to 
demarcate chromosome “core” (blue box), from “subtelomere” (red box) and from “VSG array” 
(orange box) regions are shown. (B) A Pie chart depicting the overlap between TbORC1/CDC6-
associated binding site sequences and Perl script-defined chromosome features (core, 
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subtelomere and VSG array) for Chr1-10 combined; numbers indicate total number of binding sites 
for each region with a corresponding percentage of overlap with features indicated in brackets. 
 
5.5.3 Polycistrons, strand switch regions (SSRs) and 
TbORC1/CDC6 binding 
A quantitative analysis of TbORC1/CDC6 binding within the “core” features of 
Chr1-10 was performed to investigate the degree of overlap with polycistrons 
(on forward or reverse strand) and SSRs (either convergent or divergent). 
Chromosome (Chr) 6 is shown in Figure 5-7A as an example to illustrate the 
distribution of TbORC1/CDC6 binding sites within the chromosomes and their 
relationship with the organisation of the genes in directional gene clusters, 
indicated by the direction of arrows in Figure 5-6B. The results revealed that, 
within the “core” of the ten chromosomes analysed, the forward coding 
polycistrons had a total of 68 (24 %) TbORC1/CDC6 binding sites, while the 
reverse coding polycistrons had a total of 84 (29%) TbORC1/CDC6 binding sites 
(Figure 5-7C). The comparable distribution of binding sites between forward and 
reverse polycistrons is not surprising, as they are functionally equivalent. More 
interestingly, TbORC1/CDC6 binding within the “core” mainly localised to 
divergent SSRs: 114 (38%) binding sites compared to 23 (8%) binding sites for 
convergent SSRs. In nine out of ten chromosomes analysed there are a total of 46 
divergent SSRs, 37 (80%) of which had at least one TbORC1/CDC6 binding site. Of 
the 43 convergent SSRs, only 6 (13%) had TbORC1/CDC6 binding sites. It appears, 
therefore, that TbORC1/CDC6 binding in PCF T. brucei cells appears to favour 
divergent SSRs. 
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Figure 5-7 – Distribution of TbORC1/CDC6 binding sites within polycistrons and strand 
switch regions 
(A) SignaMap output graphic representation of chromosome 6 showing genome coordinates (top), 
TbORC1/CDC6 binding sites with p-value 0≤FDR score<0.2 indicated by vertical red and orange 
lines, and chromosome forward and reverse coding strands (CDS) indicated by blue boxes above 
and below a horizontal line, respectively. (B) The distribution of directional gene clusters on 
chromosome 6. Clusters are boxed to reveal those transcribed from left to right (above) and those 
transcribed from right to left (below); direction of transcription is indicated by black arrows. (C) Pie 
chart depicting the overlap of TbORC1/CDC6-associated binding site sequences with either the 
forward coding polycistron (polycistron, forward strand), the reverse coding polycistron (polycistron, 
reverse strand), or with either convergent strand switches (strand switch, convergent) or divergent 
strand switches (strand switch, divergent) for Chrs 1-10 combined; numbers indicate total number 
of binding sites for each region with a corresponding percentage relating to the total number of core 
binding sites indicated in braces 
 
5.5.4 VSG arrays and TbORC1/CDC6 binding 
A VSG array is defined by a tandemly repeated unit structure as described above 
(section 5.4.1) and illustrated in Figure 5-8A (Barry et al. 2005). To investigate 
any potential relationship between TbORC1/CDC6 binding and the VSG array 
components, a program was written in Perl by L. Marcello to mark out the 
components that make up the VSG array: 70 bp repeat, 5’ VSG component, VSG 
ORF, 3’ VSG component and 70 bp repeat (Figure 2-8A). Overall, across the ten 
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chromosomes analysed, 8.6 % of 70 bp repeat sequence, which had a total size 
of 47 kb, was occupied by TbORC1/CDC6, corresponding with 87 binding sites 
(Figure 5-8B). 14.8 % of 5’ VSG component sequence, which had a total size of 
774 kb, was bound by TbORC1/CDC6 (261 binding sites). 5.2 % of VSG sequence, 
which had a total size of 785 kb, was occupied by TbORC1/CDC6 (112 binding 
sites). Finally, 9.6 % of 3’ VSG component sequence, which had a total size of 
135 kb, was bound by TbORC1/CDC6 (80 binding sites). In summary, the 5’ VSG 
component appeared to be enriched for TbORC1/CDC6 binding; 14.8 % of the 
total feature length overlapped with TbORC1/CDC6 binding sites, ~5 % more than 
any other part of the VSG cassette. Of all the TbORC1/CDC6 binding sites 
predicted to fall within the VSG arrays (540 in total), 48 % mapped to the 5’ VSG 
component. 
 
Figure 5-8 – Schematic representation of a typical VSG array cassette 
(A) VSG array showing a typical cassette structure consisting of 70bp repeat, 5’ VSG component, 
VSG, 3’ VSG component, 70bp repeat. (B) Pie chart depicting the overlap of TbORC1/CDC6-
associated binding site sequences with VSG array components (70bp repeats, 5’ VSG component, 
VSG, and 3’ VSG component) for Chr1-10 combined; numbers indicate total number of binding 
sites for each region with a corresponding percentage of overlap with feature indicated in braces 
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5.5.5 VSG expression sites and TbORC1/CDC6 binding sites 
In Section 3.8.6, we proposed an involvement of TbORC1/CDC6 in the regulation 
of MVSG expression, and perhaps also in BVSG expression. Here, we have used 
Artemis (a bioinformatics software available from the Sanger Institute at 
http://www.sanger.ac.uk/resources/software/artemis/) to manually inspect 
BES and MES for which telomeric sequences are available from the TREU927 
strain, as these were also included into the microarray design. Most of these 
sequences (with the exception of the GUTat10.1 BES and the ES present within 
assembled megabase chromosomes) were obtained from C. Hertz-Fowler (Sanger 
Institute, UK), and represent the best current assembly of TAR-cloned 927 
chromosome ends, which has not been published [for TAR cloning of 
trypanosome telomeres, see Section 3.8.6, and the publication of T. brucei 
Lister 427 chromosome ends (Hertz-Fowler et al. 2008)]. It is important to 
highlight here that in this context when we refer to VSGs, we mean a telomeric 
VSG present at the end of a telomeric expression site, and not to a VSG present 
in the subtelomeric arrays described above. Telomeric VSGs are preceded by a 
much larger tract of 70 bp repeats when compared with VSG array 70 bp 
repeats, and are flanked upstream by ESAGs and pseudogenes (LaCount et al. 
2001) (see Section 3.8.6 for detailed description of a BES). 
5.5.5.1 TbORC1/CDC6 binding to Bloodstream expression sites (BES) 
All the contigs for the analysis of BES and MES used for localising TbORC1/CDC6 
binding sites were obtained from C. Hertz-Fowler, and have not yet been 
published, as they are still in the process of being assembled. We have analysed 
one BES and two ‘pseudo-BESs’, and each of the three will be outlined in turn. 
Before the full genome sequence of T. brucei strain TREU927 was published, the 
DNA sequence of Chr1 had been sequenced and assembled; extending into the 
subtelomeric regions at both ends of the chromosome (Hall et al. 2003). At the 
left subtelomeric end of Chr1 there is a BES promoter that does not seem to be 
part of a canonical BES, as it is divergent in sequence and lacks BES-associated 
ESAG6 and ESAG7 (Hall et al. 2003). Although this subtelomeric end might not 
represent a typical BES (Pham, Rothman, & Gottesdiener 1997), we examined 
the loci for the presence of TbORC1/CDC6 binding sites. The results revealed 
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that TbORC1/CDC6 binding sites in this region do not co-localise with the 
putative promoter elements. Rather, the closest binding sites were located on 
either side of the 70bp repeats, 5-8 kb downstream of the promoter (FDR score = 
0.05; Figure 5-9). No binding sites were found within 90 kb upstream. 
 
Figure 5-9 – TbORC1/CDC6 binding at the left subtelomeric BES of Chromosome 1 left arm 
Signalmap out profile for a contig DNA sequence of the left arm of chromosome 1; All features are 
same as described above (Figure 5-5) except that in this case the location of the promoter for the 
BES is indicated by an arrow, with the direction of transcription shown by the arrow head; red 
vertical bars indicate TbORC1/CDC6 binding sites with FDR score = 0.05.  
 
A TREU927 GUTat10.1-containing BAC-26P8 genomic DNA insert expressing VSG 
10.1 was sequenced by Lacount et al (2001). The 35 kb contig, which is part of 
chromosome 10, spans from 50 bp repeats at one end to telomeric repeats at the 
other end (LaCount et al. 2001). Downstream of the 50 bp repeats are typical BES 
features: a VSG promoter followed by seven ESAG genes (ESAGs 7, 6, 5, 8a, 3, 4 
and 8b), five pseudogenes, 15 kb of 70 bp repeats, a single VSG ORF (10.1), 
followed by telomeric DNA repeats (LaCount et al. 2001). No TbORC1/CDC6 
binding sites were present close to the promoter region, although there are 
probes spanning this region. Six TbORC1/CDC6 binding sites were found 
downstream of the promoter (between 5 and 32 kb away; Figure 5-10), but only 
one out of six has an FDR score of 0.05, the rest being 0.2. The TbORC1/CDC6 
binding site with the highest confidence of binding (FDR score <0.05) in this ES is 
at a pseudo VSG sequence located ~12 kb downstream from the promoter.  
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Figure 5-10 – TbORC1/CDC6 binding within the GUTat10.1 BES contig at the end of 
Chromosome 10 
Signalmap out profile for a 35 kb contig DNA sequence of chromosome 10; All features are same 
as described above (Figure 5-5) except that in this case the location of the promoter for the BES is 
indicated by an arrow, with the direction of transcription shown by the arrow head; red vertical bar 
indicate TbORC1/CDC6 binding sites with FDR score = 0.05 while orange and yellow vertical bars 
indicate TbORC1/CDC6 binding sites with FDR score > 0.05.  
 
A chromosome 8 TAR clone contig was also analysed, which consists of a 
degenerate BES in which a promoter is conserved with downstream ESAGs 
(ESAG6, 5, 4), but lacking a VSG ORF or further ESAGs. The ESAG6 gene present 
in this sequence is a pseudogene, and there is no ESAG7 (L. Marcello, personal 
communication). Examination of this contig revealed two TbORC1/CDC6 binding 
sites, each with a FDR score of 0.2; Figure 5-11). Both binding sites were located 
downstream of promoter, one around 3 kb downstream and the other 
overlapping with ESAG5, which is 6 kb downstream of the promoter 
(interestingly, one of the binding sites in the GUTat 10.1 BES also overlaps with 
ESAG5) 
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Figure 5-11 – TbORC1/CDC6 binding within a BES of Chromosome 8 TAR clone 
Signalmap out profile for a chromosome 8 TAR clone; All features are same as described above 
(Figure 5-5) except that in this case the location of the promoter for the BES is indicated by an 
arrow, with the direction of transcription shown by the arrow head; yellow vertical bars indicate 
TbORC1/CDC6 binding sites with FDR score > 0.05. 
 
5.5.5.2 TbORC1/CDC6 binding to metacyclic expression sites (MES) 
For localising TbORC1/CDC6 binding sites in MESs, we analysed two MES on Chr10 
and Chr11, and two pseudo MES on Chrs. 5 and 6. Again, each of these are 
outlined in turn. 
The left end of Chr10 contains a fully assembled MES, with a promoter and a 
downstream VSG. As in the case for BES promoters, this MES promoter does not 
seem to be bound by TbORC1/CDC6. However, in contrast to the BES, 
TbORC1/CDC6 binding sites appeared much closer to the promoter, the nearest 
only 200 bp downstream and 100 bp upstream. The TbORC1/CDC6 binding sites 
(three in the 6 kb downstream of the promoter and ten within 25 kb upstream) 
all have low FDR scores (<0.05) and in total cover more than half of the 31 kb 
region considered (Figure 5-12).  Within this region the TbORC1/CDC6 binding 
sites overlap with ESAG1, the functional VSG and an upstream pseudo-VSG. 
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Figure 5-12 – TbORC1/CDC6 binding within a MES of Chromosome 10 left arm contig 
Signalmap out profile for a contig DNA sequence of the left arm of chromosome 10 containing a 
MES is shown; All features are same as described above (Figure 5-5) except that in this case the 
location of the promoter for the MES is indicated by an arrow, with the direction of transcription 
shown by the arrow head; red vertical bars indicate TbORC1/CDC6 binding sites with FDR score = 
0.05 
 
The left end of Chr11 also contains a fully assembled MES, although it did not 
display the same level of TbORC1/CDC6 binding as the MES on Chr10: two 
binding sites were observed downstream (2.5 and 3.6 kb from promoter) and 
four upstream (between 5 and 12 kb upstream of promoter), and all exhibited a 
higher FDR score value (0.2), with the exception of the most telomere-proximal 
(overlapping the MVSG; FDR = 0.2). 
Similar patterns were exhibited by two other potential MES (contigs for which 
are incomplete and do not include any potential downstream MVSG) on the left 
ends of both Chr5 and Chr6 (927T6L1A4-11g05.p1k, 6.7 kb; and 927T5L5E3-
1f09.p1k, 13.5 kb). On the Chr5 MES, TbORC1/CDC6 binding sites surrounded the 
promoter in a similar manner to the Chr10 MES (Figure 5-12), ranging from 600 
bp downstream and from 100 bp upstream, although the FDR score values were 
higher (0.2) and the binding site coverage of the contig is not as dense (less than 
20%). Only a single TbORC1/CDC6 binding site, with an FDR score of 0.2, was 
present 3 kb upstream of the Chr.6 MES promoter. In both Chr6 and Chr10 the 
binding sites overlap with ESAG1, whereas in both Chr11 and Chr5 the upstream 
binding sites overlap with ESAG9. 
In summary, not all MES regions appeared to be bound by TbORC1/CDC6 in the 
same way, although similarities between the four putative MES can be drawn. A 
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repeat of the experiment should clarify whether the variability seen is purely 
experimental, or whether it is a stable trait of each locus. 
5.6 Validation of TbORC1/CDC6 binding by quantitative 
real-time PCR  
Although the distinctive pattern of TbORC1/CDC6 binding, localised to SSRs in 
the chromosome cores, suggests that the microarray output is not artefactual or 
random, it is necessary to independently validate the results, and confirm that 
the observed peaks correspond with increased DNA abundance in the ChIP DNA 
relative to input DNA. In order to do this, a qPCR absolute quantification method 
was used for specific loci to determine the amount of ChIP DNA present in the 
samples sent for microarray relative to input DNA. For validation of a divergent 
SSR in the core of Chr1, a predicted TbORC1/CDC6 binding site at position 
281401-284218 was chosen. This had a high confidence value of binding, with an 
FDR score below 0.05.  Primers were designed using the Primer Express software 
(Applied Biosystems) for four loci around the binding site: primer1 
(CT_OL71/CT_OL72) was located upstream of the binding at position 278690-
279050, primer2 and primer3 (CT_OL73/CT_OL74 and CT_OL75/CT_OL76) were 
located within the breadth of the binding site at positions 281498-281930 and 
282686-283145, respectively, and primer4 (CT_OL77/CT_OL78) was located 
downstream of the binding site at position 292478-293045 (Figure 5-13). For 
each primer pair, a qPCR master mix was made according to the following 
recipe: 12.5 µl of SYBR mix (provided in kit), 1.0 µl of each primer (300 nM 
stock), 9.5 µl of dH2O, and 1.0 µl template DNA (concentrations are described 
below) or dH2O for a non-template control. The input and chIP DNA samples used 
for the microarray were used as template DNA for the qPCR. An ABI Prism 7500 
thermocycler was used for the qPCR, as described in manufacturer’s manual. For 
each primer pair, a standard curve was generated at five DNA concentrations (2 
ng, 1 ng, 0.5 ng, 0.25 ng, 0.125 ng, 0 ng) using input DNA as the template. The 
chIP DNA was used as the test sample at two concentrations (1 ng and 0.5 ng) 
and assayed in the same run as the standards. 
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Figure 5-13 – Primer positions for validation of a TbORC1/CDC6 binding site on 
chromosome 1 by qPCR 
Top panel: Signalmap output profile showing TbORC1/CDC6 binding sites on chromosome 1 as 
has been previously shown in Figure 5-5; Middle panel: an enlargement of a selected binding site 
on chromosome 1; Bottom panel: enlargement of the representative raw log2-ratio data for the 
selected binding site, primers used for quantitative PCR are indicated by horizontal red bars 
labelled 1, 2, 3, and 4 to indicated the respective positions of primer1, primer2, primer3, and 
primer4 within the region.   
 
During the qPCR set up, a dissociation step was included at the end of the 
reaction to generate a dissociation curve for each primer pair in order to assess 
the homogeneity of the PCR products and the presence or absence of primer 
dimers, and hence the specificity of the reaction. The dissociation curve showed 
a single uniform peak at 72.5 ◦C for all four primers, confirming that all primers 
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were specific for the chosen loci and there were no secondary products present 
(Figure 5-14). 
 
Figure 5-14 – Dissociation curves for the amplification product of qPCR primers 
The y-axis (derivative) denotes the change in fluorescence, that is, the rate at which amplification 
products are denaturing at a given temperature, shown on the x-axis.  Colours of lines represent 
different detectors for each of the four primers used (explained in text); the horizontal line at y = o 
represents a derivative for distilled water used as a non-template control (lacking any DNA 
substrate). 
 
After the run, the PCR threshold values (CT values) generated for input DNA 
(standard) were used to generate a standard curve. All four standard curves for 
each primer pair had a correlation coefficient (R2 value) of 0.99. Using the 
standard curve for each primer pair, the CT values of both the 1 ng and 0.5 ng 
ChIP DNA were interpolated to determine the absolute amount of DNA present at 
the four loci. 
The quantification of ChIP DNA relative to input DNA showed that for primer2, 
located within the breadth of the predicted TbORC1/CDC6 binding site, qPCR of 
the immunoprecipitated material was five times more efficient for both the 1 ng 
and 0.5 ng samples compared with primer1 and primer4, both of which were 
located outside of the putative binding site (Figure 5-13). Although primer3 is 
also located within the breadth of the chIP-chip filtered peak for TbORC1/CDC6, 
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the unfiltered, scaled log2 ratio data show that there is no enrichment of the 
ChIP DNA relative to input DNA at the specific 60 bp sequence PCR-amplified in 
the qPCR.  This result verifies the location of a TbORC1/CDC6 binding site at this 
locus. 
 
 
Figure 5-15 – ChIP-qPCR validation of TbORC1/CDC6 binding on a strand switch region of 
Chromosome 1 
The mean absolute amount of 1 ng (A) or 0.5 ng (B) of ChIP DNA was compared to total input DNA 
by qPCR for specific loci indicated by primer1, primer2, primer3 and primer4 (see text for details of 
location of primers) on a divergent strand switch region of Chr1. Error bars indicate standard 
deviation of three independent experiments.  
 
5.7 Discussion 
5.7.1 TbORC1/CDC6 binding sites and replication origins in T. 
brucei  
In the last decade, the identification of replication origins in eukaryotes (for 
example in S. pombe and S. cerevisiae) by genome-wide approaches, such as 
using chIP coupled with DNA microarrays, has become more popular (Hayashi et 
al. 2007; Heichinger et al. 2006; Xu et al. 2006; Wyrick et al. 2001). Many of 
these studies, though not all [e.g. (Heichinger et al. 2006)], have exploited the 
concept that the localisation of binding sites of pre-RC components such as ORC 
and MCM proteins would facilitate the identification of origins of DNA 
replication. Using ChIP-chip of ORC and MCM proteins in S. cerevisiae cells, 
Wyrick and colleagues (2001) identified 531 and 443 sites in the genome that 
bound ORC and MCM proteins, respectively, with a confidence level for binding 
of p ≤ 0.025 (Wyrick et al. 2001). Of these loci ~80 % were demonstrated to be 
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origins of replication, by comparing the ORC- and MCM- binding sites with 
positions which had previously been identified to possess ARS activity. In similar 
work by Hayashi et al. (2006), Orc1-chIP and Mcm6-chIP in G1–arrested S. pombe 
cells yielded a total of 460 sites that were occupied by both proteins (Hayashi et 
al. 2007). Using BrdU incorporation coupled with ChIP-chip, the authors showed 
that 307 (67 %) of these binding sites fired early in S-phase while 153 (33 %) of 
them fired late or were inefficient origins, although these loci co-localised with 
pre-RC proteins (Hayashi et al. 2007). The studies described above, as well as 
others (Heichinger et al. 2006), have concluded that the spatial distribution of 
pre-RC proteins correlates with origin usage. However, their eventual selection 
for firing DNA replication is variable. Nevertheless, binding of the pre-RC 
complex is necessary for any sequence to have the potential to function as an 
origin of replication.  
Using the same reasoning, we have used ChIP-chip to map the binding sites for 
the single ORC-related protein that could be identified bioinformatically in T. 
brucei: TbORC1/CDC6. At a stringent confidence interval for binding (p≤0.05) of 
TbORC1/CDC6 with each DNA probe on our array, we identified 242 binding sites 
spanning Chrs 1-10, and at a modest confidence interval (p<0.2) we identified 
685 binding sites.  A direct question that arises is what percentage of these 
binding sites are DNA replication origins in the T. brucei megabase 
chromosomes? At present, we are not able to answer this. A major obstacle has 
been providing experimental validation of these putative binding sites as origins 
of DNA replication in T. brucei. Two-dimensional agarose gel electrophoresis 
(Brewer & Fangman 1987), Short-Nascent strand DNA purification (Cadoret et al. 
2008) coupled with microarray or Solexa Sequencing  and marker frequency 
analysis (Lundgren et al. 2004) have all been attempted, without success to date 
(L. Marcello, Glasgow, and S.D. Bell Lab, Oxford). We are therefore limited in 
this discussion to the confines of available chIP-chip data, and therefore will 
simply to refer to the TbORC1/CDC6-associated DNA sequence loci identified 
here as binding sites, but will consider their potential to act as origins of DNA 
replication.  
In S. pombe, Orc1 and MCM6 binding sites are observed  with an average 
separation of 26.7 kb within the central core of the chromosomes, and are 
enriched at subtelomeres (Hayashi et al. 2007), except in Chr. 3. Using BrdU 
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incorporation coupled with ChIP-chip suggests that replication firing occurs 
differentially, with pre-RC sites in the central core functioning as early firing 
origins in S-phase compared with the subtelomere pre-RC sites, which are late-
firing (Hayashi et al. 2007). The higher density of the subtelomere sites may then 
be needed to ensure efficient replication at the ends of chromosomes. This 
distribution of pre-RC sites throughout most of the S. pombe chromosomes 
appears similar to what we observed here for the distribution of TbORC1/CDC6 
binding sites in the megabase chromosomes of T. brucei. Thus, all TbORC1/CDC6 
binding sites might be replication origins, although we have to demonstrate this 
assertion experimentally. However, it is not clear whether the definition of the 
chromosome core and subtelomere in S. pombe is comparable with the clear 
distinction between the diploid ‘housekeeping’ core and aneuploid, VSG-rich 
subtelomere in T. brucei. Indeed, it is not clear if the relative enrichment we 
see at the T. brucei subtelomeres is comparable, as it is not quantified in S. 
pombe (Hayashi et al. 2007). TbORC1/CDC6 binding sites observed in the T. 
brucei megabase chromosome “core” shower greater dispersion (~110 kb 
between sites) compared with the average separation of 26.7 kb in S. pombe 
chromosome cores (Hayashi et al. 2007). Any such distinctions might reflect 
differences in TbORC1/CDC6 function relative to Orc1 in S. pombe, or they may 
simply reflect differences in the structural organisation of protein coding genes 
in the two organisms (polycistronic for T. brucei and monocistronic for S. 
pombe). If the latter is true, this may indicate that T. brucei nuclear DNA 
replication initiation is consistent with findings in other organisms that suggest 
DNA replication origin distribution and organisation of gene transcription are 
inherently linked (see below).  
As mentioned above, no consensus sequence elements have emerged in the 
characterisation of T. brucei sequences that are able to confer 
extrachromosomal stability to circular plasmids or artificial linear molecules (see 
Section 1.8). Attempts to identify consensus elements for TbORC1/CDC6 binding, 
through comparing the sequences of chIP-chip-derived interaction loci, have not 
to date been successful (L. Marcello, pers. comm.). Though AT-rich regions in 
SSRs that separate directional gene clusters have been shown to confer mitotic 
stability in T. brucei, these have been implicated as having centromeric 
functions (Obado et al. 2007), are GC-rich in T. cruzi (Obado et al. 2005) and, 
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puzzlingly, appear not to confer chromosome stability in a close relative, 
Leishmania (Dubessay et al. 2002). For T. brucei, more importantly, it appears 
that each chromosome possesses a single centromere at an SSR (Obado et al. 
2007), which contrasts with the binding of TbORC1/CDC6 we see to most SSRs 
(~50 % of sites within the chromosome cores). Thus, though centromeres and 
TbORC1/CDC6 binding sites may co-localise in a small number of loci, this is a 
minority of TbORC1/CDC6 sites. Furthermore, finer mapping of both 
TbORC1/CDC6 binding and the elements that dictate centromere activity is 
needed to determine if they share sequence features. Nevertheless, it remains 
possible that the unique architecture of kinetoplastid genomes has constrained 
DNA replication, centromeres and transcription initiation (see below) to localise 
to SSRs and, perhaps, to share functional determinants.  
TbORC1/CDC6 binding sites and transcriptional regulation 
First reported in human cells for the β-globin locus, the link between DNA 
replication and gene transcription is becoming a widespread observation, having 
being reported for a number of other organisms including Drosophila (Sequeira-
Mendes et al. 2009), Xenopus (Danis et al. 2004) and CHO cells (Saha et al. 
2004). Upstream of the β-globin origin of replication, a β-globin Locus Control 
Region (LCR) located proximal to the β-globin promoter was discovered and 
deletion of the LCR resulted in loss of promoter activity, as well as ablation of 
origin activity, suggesting that this origin locus was linked with both replication 
and transcription (Aladjem et al. 1995). In Xenopus and Drosophila embryos, 
prior to the onset of gene transcription, replication origins are more randomly 
dispersed in the genome, but at the onset of transcription become localised to 
intergenic regions (Sasaki et al. 1999; Hyrien et al. 1995). In HeLa and mouse 
embryonic stem cells, the co-localisation of replication origins with CpG islands 
that are in close proximity with promoters is also an emerging paradigm, which 
suggests a global coordination of gene transcription and replication timing 
(Sequeira-Mendes et al. 2009; Cadoret et al. 2008).  
In T. brucei, a similar phenomenon had been hinted at, with the identification of 
a PMS that confers stability to a plasmid or an artificial linear molecule and 
depends on the presence of the PARP promoter in close proximity (Patnaik et al. 
1996; Lee et al. 1995; Patnaik et al. 1994). However, gene transcription in T. 
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brucei and related kinetoplastids is regulated differently from other eukaryotes 
(Clayton 2002). In T. brucei RNA PolII transcribes most protein coding genes 
(with the exception of VSGs) as large, polycistronic units, or directional gene 
clusters (Clayton 2002). Furthermore, the available evidence suggests that 
transcription initiation is largely unregulated and localises upstream of the first 
gene in the transcription unit, though promoters have not been identified. 
Although our microarray-based approach shows no TbORC1/CDC6 binding sites at 
the PARP promoter (as this was masked because it is present in four copies), the 
predominant co-localisation of TbORC1/CDC6 binding sites with divergent SSRs, 
rather than with convergent SSRs, is potentially very interesting. Divergent SSRs 
have been reported to be RNA PolII transcription start sites in T. brucei (Siegel et 
al. 2009), whereas convergent SSRs would be regions where two transcripts 
meet. It is therefore possible that TbORC1/CDC6 binds to RNA PolII transcription 
initiation sites. What aspect of this might be responsible for the binding is 
unclear; it may be that previously unrecognised DNA sequences are shared as 
promoters and as replication origins, or it might be that TbORC1/CDC6 is 
recruited by RNA PolII-associated factors. Alternatively, TbORC1/CDC6 binding 
might reflect chromatin architecture in these SSRs: it may simply be that the 
putative open chromatin allows TbORC1/CDC6 access, or specific chromatin 
modifications might recruit the protein. To date, acetylated histone H4 (residue 
K10), trimethylated histone H3 (residue K4), variants of histones H2A and H2B 
(named H2AZ and H2BV), and the hypermodified base J have been localised, 
predominantly if not exclusively in some cases, at divergent SSRs (Cliffe et al. 
2010; Wright, Siegel, & Cross 2010; Siegel et al. 2009). Consistent with any of 
these suggestions, the localisation of TbORC1/CDC6 binding sites within, and 
equally distributed between, forward and reverse coding strands of polycistronic 
units appeared to colocalise with these chromatin modifications (fine mapping of 
this overlap is awaiting analysis). These sites appear then to be transcription 
start sites with these units, and would therefore share features with the 
divergent SSRs, and do not undermine the putative link between transcription 
initiation and origin specification.  
Verification of the suggestion that TbORC1/CDC6 binds RNA PollII transcription 
start sites will require further work. Most notably, it will be important to fine 
map TbORC1/CDC6 binding sites within divergent SSRs and ask if these overlap, 
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or are neighbours, with features around the RNA polII transcription start sites, 
since some of the SSRs are very large. It will also be important to experimentally 
test if the TbORC1/CDC6 localisation we observed to convergent SSRs is real. We 
also do not know if TbORC1/CDC6 localisation is specific to RNA PolII 
transcription, or may be related to transcription in general: because the rDNA 
arrays are repeated in T. brucei, they are not represented in the microarray, 
and we cannot therefore evaluate if TbORC1/CDC6 binds these RNA Pol I units. 
Though MES and BES are also RNA PolI transcribed, these are inactive in the 
procyclic form cells analysed here. Finally, it is important to consider the 
implications of high density localisation of TbORC1/CDC to the VSG arrays, which 
are thought to be constitutively transcriptionally silent.  
5.7.2 TbORC1/CDC6 binding sites and VSG architecture 
As mentioned earlier, in megabase chromosomes in T. brucei VSGs are located 
either in VSG arrays, which are located within the telomere-distal portion of the 
chromosome (the subtelomere), or in ESs, where they are located in close 
proximity to telomeric repeats (McCulloch 2004). Unlike array VSGs, telomeric 
VSGs can be transcribed if they are present within an active BES or MES (Barry & 
McCulloch 2001). It is thought that the 70 bp repeats in the arrays enhance 
recombination by gene conversion to an active ES. This event is crucial for 
trypanosome survival in the bloodstream of the mammalian host, where the 
parasite is exposed to immune attack (Barry & McCulloch 2001). We have shown 
that TbORC1/CDC6 binding sites are more densely clustered in the VSG arrays 
than in the chromosome cores and that within these arrays TbORC1/CDC6 
preferentially localises to the 5’ VSG component.  In addition, we have 
attempted to map TbORC1/CDC6 binding in the ES that are available from the 
sequencing of the TREU 927 genome to date. Here, we see evidence for binding, 
though not with a clear pattern. We did not find evidence that TbORC1/CDC6 
binds to either promoter [MES and BES promoters are diverged in sequence; 
(Ginger et al. 2002)], but did find localisation upstream and downstream of the 
promoters. Where VSGs were found in the ESs, a definite conclusion about 
preferential localisation of TbORC1/CDC6 with the 5’ component cannot be 
reached as most of the telomeric ends of chromosomes are being assembled.  
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What is the significance of TbORC1/CDC6 subtelomeric localisation? Given the 
lack of transcription in these loci, it is possible that subtelomere localisation 
shares features with the SSRs, which are untranscribed regions between 
transcription units. However, there is no evidence for any transcription initiation 
in the VSG arrays, unlike the SSRs. If TbORC1/CDC6 recruitment to the SSRs was 
due to transcription initiation, a distinct mode of recruitment to the VSG arrays 
must be invoked, perhaps implying that these sites do not represent replication 
origins. This requires experimental testing. It also poses a problem: if replication 
origins are defined by transcription start sites, is replication from origins 
adjacent to the subtelomeres sufficient to duplicate these loci, which can 
represent as much as 75 % of a chromosome (Callejas et al. 2006)? One other 
hypothesis, consistent with the activation of MVSG expression after 
TbORC1/CDC6 RNAi, is that TbORC1/CDC6 binding in the subtelomeres 
contributes to transcriptional repression of VSG expression, via the formation of 
heterochromatin (see Section 3.7 for experimental data to support this). This 
would be consistent with observed roles for ORC components in establishing 
silent chromatin in other organisms. In S. cerevisiae, ORC contributes to 
silencing of the mating type loci (Sasaki & Gilbert 2007) and stress-induced 
repression of further genes (Burhans et al. 2006; Ramachandran et al. 2006). In 
P. falciparum, Orc1 has been shown to associate with Sir2 and to bind 
telomeres, and may have a role in telomeric silencing, including of var genes 
(Mancio-Silva et al. 2008). If this is correct, it remains to be determined how 
TbORC1/CDC6 acts in this way, and how it associates with chromatin. A final 
hypothesis is that TbORC1/CDC6 binding in the VSG arrays might regulate the 
recombination of VSGs into the ES. This remains to be tested, but could be 
related to chromatin-mediated silencing in suppressing such recombination, or it 
may promote recombination via replication.   
5.8 Highlight of major findings 
Here, using chIP coupled with a high resolution tiling array we have determined 
the genomic locations of TbORC1/CDC6 binding on ten of the eleven T. brucei 
megabase chromosomes. In total, up to 685 sites were identified; 278 loci were 
located within the core of chromosomes, 330 in VSG arrays and 81 in 
subtelomeres. We postulate that at least some of these binding sites are likely 
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to function as origins of replication in T. brucei megabase chromosomes. Within 
the chromosome cores, TbORC1/CDC6 binding sites show a significant overlap 
with boundaries of polycistronic transcription units, at putative RNA PolII 
transcription start sites; this may be consistent with a link between DNA 
replication and gene transcription in T. brucei. A significant proportion of 
TbORC1/CDC6 binding sites are present in VSG arrays, consistent with a previous 
observation of the involvement of TbORC1/CDC6 in VSG expression control, and 
thus antigenic variation, in T. brucei. 
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6 Perspectives 
The raison d'être for studying the process of nuclear DNA replication in T. brucei 
is the fundamental importance of the process. Beyond this, two parasite-specific 
features also prompted the investigations described in this thesis: (1) the 
mechanistic architecture of the process of initiation of nuclear DNA replication 
in T. brucei appeared to be simplified; and (2) the central and essential nature 
of the process of DNA replication has allowed the development of new drugs in 
other organisms (such as Ganciclovir and Ciprofloxacin), which might suggest 
that the same could be true for this parasite. 
Bioinformatic, biochemical and genetic studies of yeasts (S. cerevisiae and S. 
pombe) and metazoan cells have implicated at least fourteen proteins (Orc1-
Orc6, Cdc6, Cdt1, Mcm2-Mcm7) as constituting the core machinery required to 
define an initiation event that is necessary to replicate their genetic material; 
DNA (Dutta & Bell 2006). Apart from these protein initiators, much effort over 
the years has also been dedicated to the identification of cis-acting elements 
that the main initiator protein complex, ORC, binds to, otherwise known as 
origins of replication. From this picture, two fundamental questions can be 
asked with respect to nuclear DNA replication initiation in T. brucei: (a) how 
conserved are the parasite initiator factors that define origin of replication 
sequences relative to other eukaryotes; and (b) what defines the sequence 
elements that constitute origins of DNA replication? In this work, we have begun 
to shed light on both of these questions in T. brucei.  
6.1 Interaction of TbORC1/CDC6 with other proteins 
Based on analyses of small subunit ribosomal RNA genes the African trypanosome 
T. brucei has previously been described as a “primitive organism” or “an early 
divergent”, single-celled flagellated parasitic protozoa (Sogin et al. 1989). This 
description is highly compatible with several lines of evidence, which have 
revealed numerous striking and fundamentally distinct biological phenomena 
from yeasts, humans and plants. Examples of these include trans-splicing (Lee & 
Van der Ploeg 1997) and RNA editing (Horton & Landweber 2002). However, 
recent phylogenetic analyses based on morphological and comparative molecular 
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studies, the latter emerging from available whole genome information, suggest 
that T. brucei and associated members of the order Kinetoplastida may not be 
primitive after all (Dacks et al. 2008). Failure of BLAST searches of the T. brucei 
genome to identify clear homologues of Orcs2-6 and Cdt1 have been interpreted 
by at least three publications (Fritz-Laylin et al. 2010; Cavalier-Smith 2010; 
Godoy et al. 2009) as indicating that these genes are absent, leading to the 
hypothesis that DNA replication initiation in T. brucei might be another aspect of 
biology that is divergent. Furthermore, Cavalier-Smith has used this hypothesis 
as a premise, among other considerations, to re-classify the phylum Euglenozoa 
by segregating it from infrakingdom Excavata (Cavalier-Smith 2010). The 
reasoning behind this is that Cavalier-Smith suggests these data indicate that the 
root of the eukaryotic kingdom is between Euglenozoa and all other eukaryotes. 
Prior to the publication of the genome of T. brucei the process of nuclear DNA 
replication initiation in this parasite, and indeed in all kinetoplastids, remained 
largely unexplored, in contrast to the advanced description of mitochondrial 
genome replication (Liu et al. 2005). 
In this work, we have shown by RNAi that TbORC1/CDC6 is an essential protein in 
both BSF and PCF T. brucei. Furthermore, we show that it is involved in cell 
cycle regulation in BSF; it is involved in nuclear DNA replication in PCF; it 
regulates the expression of MVSGs (and perhaps BVSGs); and it interacts with at 
least one other ORC-like trypanosome protein. We provide evidence that this 
protein, which was previously uncharacterised and unidentifiable by 
bioinformatic searches alone, is the T. brucei orthologue of Orc4, and therefore 
name it TbORC4 (Figure 6-1).  
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Figure 6-1 – Model for T. brucei pre-replication complex 
The MCM2-7 complex is loaded onto origin by TbORC1/CDC6 alone (Pre-PhD); and two 
evolutionarily ORC related proteins (TbORC1/CDC6, TbORC4) and possibly Tb927.10.7980 load 
the MCM2-7 complex (Post PhD). 
 
Godoy et al (2009) showed that TbORC1/CDC6 is able to complement S. 
cerevisiae Cdc6 temperature-sensitive mutants, but not Orc1 mutants (Godoy et 
al. 2009). Having identified two more proteins (TbORC4 and Tb927.10.7980) that 
putatively interact with TbORC1/CDC6, and have the same RNAi phenotype in 
BSF as TbORC1/CDC6, the question now is: are any of these proteins able to 
complement yeast Orc1? In other words, is it conceivable that the TbORC1/CDC6 
protein that was considered the sole T. brucei ORC component is actually 
functionally analogous (even orthologous) with Cdc6, and might one of the other 
factors, despite being highly diverged in sequence, provide Orc1 functions?. 
Complementation assays using yeast temperature-sensitive mutants might allow 
this to be addressed. Follow-up experiments will be needed to test if the 
predicted AAA+ folds present in these proteins confer DNA-binding characteristics 
in vitro, or whether their role is in determining the structure and function of 
T.brucei ORC. Expression and purification of all ORC-like proteins and DNA-
binding assays, such as electrophoretic mobility shift assays (EMSA), could test 
this in vitro. Attempts were made early in this PhD to express and purify 
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TbORC1/CDC6 from E. coli, but the protein proved to be very insoluble (data not 
shown). Perhaps, then, its stability is dependent on co-expression with the 
further putative ORC-like factors identified here. 
To understand the architecture of the putative T. brucei ORC, coIP will be 
needed to ask if TbORC4 and Tb927.10.7980 interact with each other, and it will 
be necessary to ask if IP of these proteins reveals yet further ORC components. 
One very distantly related ORC-like factor (Tb09.160.3120) was not examined 
here, and this should be analysed in the same way. Co-localisation experiments 
in vivo to confirm nuclear localisation of the proteins, and to test how they 
interact with TbORC1/CDC6 throughout the cell cycle, should be done to support 
the co-IP experiments already performed. Ultimately, to test if these factors do 
act in origin designation, chromatin-IP experiments coupled with either qPCR or 
hybridisation to the T. brucei microarray needs to be done to analyse genome 
localisation. It remains possible, of course, that these factors do not act 
together as an ORC, but that they associate with TbORC1/CDC6 at specific times 
in the cell cycle, or at specific genomic locations, to modulate the function of 
TbORC1/CDC6. If this were the case, they may provide other T. brucei functions 
(e.g. they might act in VSG regulation), and TbORC1/CDC6 may then be an 
archaeal-like origin designator. 
One drawback in the co-IP experiments performed here has been to distinguish 
between interactions that occurred as a result of binding with the Myc-tag on 
TbORC1/CDC6 and interactions that occurred as a result of binding with 
TbORC1/CDC6 itself. With hindsight, we would have done a Myc-tag only pull-
down experiment to filter any proteins that are common in both IP experiments. 
Since we did not do a Myc-IP mock experiment, a solution will be to exchange 
the tags in the proteins in co-IP experiments. For example, in the co-IP of 
“TbORC4”-HA and TbORC1/CDC6-Myc, an exchange of tags to have “TbORC4”-
myc and TbORC1/CDC6-HA will confirm that indeed the interaction we have 
shown does not occur via the myc tag but via TbORC1/CDC6 and “TbORC4”. This 
procedure should be repeated for all interactors found in the IP-mass 
spectrometry approach. 
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6.2 Interaction of TbORC1/CDC6 with origins 
In S. cerevisiae (Wyrick et al. 2001), S. pombe (Hayashi et al. 2007) and higher 
eukaryotes Orc1 binds to origins of DNA replication and has been used as bait to 
map genome-wide locations of origins. Here, we have used ChIP-chip to create a 
near genome-wide map of TbORC1/CDC6 binding sites. The localisation of these 
binding sites fit with the nuclear architecture of T. brucei chromosomes and 
appears reminiscent of a typical eukaryotic organisation (Hayashi et al. 2007; 
Heichinger et al. 2006). In particular, the localisation of the protein to 
transcription start sites (promoters have not been defined) within the core 
appears to fit with patterns described elsewhere. Higher density localisation to 
to subtelomeric and telomeric regions has also been observed in other 
eukaryotes.  
To complement our ChIP-chip TbORC1/CDC6 localisation data at telomeric and 
subtelomeric loci it would have been desirable to perform mobility shift and 
supershift assays, as well chIP-qPCR and chIP-blot experiments. Interactions of 
TbORC1/CDC6 and TbRAP1 (Yang et al. 2009), TbISW1 (Hughes et al. 2007) and 
TbTRF2 would strongly support a role of TbORC1/CDC6 in transcriptional 
activation at BES and MES in trypanosomes. Co-localisation experiments of 
tagged TbORC1/CDC6 with histone H4k10ac, histone variants H2BV and H2AZ will 
strongly corroborate our hypothesis that DNA replication in T. brucei is linked to 
gene transcription.  
At the moment, we and our collaborators (H. Farr and S.D. Bell; Oxford) have 
not been able to identify origins of DNA replication by a variety of approaches: 
two-dimensional agarose gel electrophoresis, Marker Frequency analysis, and 
Short Nascent Strand synthesis coupled with Solexa sequencing. Currently, 
attempts to use S-phase synchronised cells are on-going and might enrich for 
origins. We are also in the process of characterising TbORC1/CDC6 binding sites 
to see if specific DNA sequence motifs are identifiable. Once this is done, if we 
are able to identify conserved motifs, variable lengths of DNA including these 
motifs could be cloned and targeted to specific locations on chromosomes, or to 
articifial plasmids. Using ChIP, we could then test if TbORC1/CDC6 recognises 
and binds to these sequences. Using 2D gel electrophoresis, we could also ask if 
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origins are fired from these loci. Although these might represent an artificial 
chromosomal context, as other factors such as chromatin organisation are likely 
to affect origin preference, it will confirm that the identified TbORC1/CDC6 
binding sites are even more likely to function as origins in their natural context 
and those specific motifs are likely to define origins in this organism. 
6.3 Closing Remarks 
T. brucei remains a pathogen of major medical, veterinary and economic 
impact. In common with other kinetoplastid parasites, safe and effective drugs 
against T. brucei are still needed, and resistance to the existing drugs is 
increasing (Barrett 2006). DNA replication studies have been instrumental in our 
understanding of the basis of many diseases; for example, cancer can result from 
non-regulated DNA replication. In fact, several drugs (such as Ganciclovir and 
Ciprofloxacin) have been developed targeting aspects of the DNA replication 
mechanism in a number of organisms, including bacteria and viruses. This thesis 
has provided a mechanistic insight into nuclear DNA replication in T. brucei, an 
area in which very little work had been done and it sheds a novel perspective on 
eukaryotic DNA replication strategies. The analysis we have undertaken has 
allowed the identification of potentially diverged factors of the trypanosomatid 
DNA replication apparatus (for example, TbORC4 and, perhaps, Tb927.10.7980), 
which if further characterised may differ sufficiently from that of the host 
(where significant work has been done) to represent targets for the future 
generation of novel therapeutic agents. 
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7 Appendices 
Appendix 1 MCM protein IDs used for BLAST of the TriTryp database 
MCM2 
 
>gi|3912|emb|CAA37615.1| MCM2 [Saccharomyces cerevisiae] 
>gi|602896|emb|CAA54503.1| MCM2 [Saccharomyces cerevisiae] 
>gi|536021|emb|CAA84842.1| MCM2 [Saccharomyces cerevisiae] 
>gi|453237|emb|CAA52635.1| MCM2 [Saccharomyces cerevisiae] 
>gi|20977583|gb|AAM28219.1| DNA replication licensing factor [Danio rerio] 
>gi|157437450|gb|EDO81660.1| MCM2 [Giardia lamblia ATCC 50803] 
>gi|253741552|gb|EES98420.1| MCM2 [Giardia intestinalis ATCC 50581] 
>gi|159118230|ref|XP_001709334.1| MCM2 [Giardia lamblia ATCC 50803] 
>gi|308158142|gb|EFO60951.1| MCM2 [Giardia lamblia P15] 
>gi|3642638|gb|AAC36510.1| MCM2 [Mus musculus] 
>gi|159765762|gb|ABW97990.1| mcm2 [Hemiselmis andersenii] 
>gi|160331215|ref|XP_001712315.1| mcm2 [Hemiselmis andersenii] 
>gi|7299005|gb|AAF54207.1| minichromosome maintenance 2 [Drosophila melanogaster] 
>gi|17137132|ref|NP_477121.1| minichromosome maintenance 2 [Drosophila 
melanogaster] 
>gi|296474646|gb|DAA16761.1| KIAA0030-like [Bos taurus] 
>gi|296491164|gb|DAA33237.1| cyclin L1 [Bos taurus] 
>gi|33356547|ref|NP_004517.2| DNA replication licensing factor MCM2 [Homo sapiens] 
>gi|147898891|ref|NP_001080759.1| DNA replication licensing factor mcm2 [Xenopus 
laevis] 
>gi|585465|sp|P29469.2|MCM2_YEAST RecName: Full=DNA replication licensing factor 
MCM2; AltName: Full=Minichromosome maintenance protein 2 
>gi|172088119|ref|NP_032590.2| DNA replication licensing factor MCM2 [Mus musculus] 
 
MCM3 
 
>gi|21105417|gb|AAM34652.1|AF506208_1 DNA replication licensing factor [Danio 
rerio] 
>gi|829621|gb|AAA80227.1| MCM3 [Xenopus laevis] 
>gi|3953607|dbj|BAA34731.1| MCM3 [Drosophila melanogaster] 
>gi|308162155|gb|EFO64566.1| MCM3 [Giardia lamblia P15] 
>gi|157434045|gb|EDO78280.1| MCM3 [Giardia lamblia ATCC 50803] 
>gi|253742964|gb|EES99567.1| MCM3 [Giardia intestinalis ATCC 50581] 
>gi|159111445|ref|XP_001705954.1| MCM3 [Giardia lamblia ATCC 50803] 
>gi|159766078|gb|ABW98304.1| mcm3 [Hemiselmis andersenii] 
>gi|160331845|ref|XP_001712629.1| mcm3 [Hemiselmis andersenii] 
>gi|7290573|gb|AAF46023.1| minichromosome maintenance 3 [Drosophila melanogaster] 
>gi|24639835|ref|NP_511048.2| minichromosome maintenance 3 [Drosophila 
melanogaster] 
>gi|296474394|gb|DAA16509.1| DNA replication licensing factor MCM3 [Bos taurus] 
>gi|6631095|ref|NP_002379.2| DNA replication licensing factor MCM3 [Homo sapiens] 
>gi|33859484|ref|NP_032589.1| DNA replication licensing factor MCM3 [Mus musculus] 
>gi|19857543|sp|P25205.3|MCM3_HUMAN RecName: Full=DNA replication licensing 
factor MCM3; AltName: Full=DNA polymerase alpha holoenzyme-associated protein P1; 
AltName: Full=P1-MCM3; AltName: Full=RLF subunit beta; AltName: Full=p102 
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>gi|2506834|sp|P25206.2|MCM3_MOUSE RecName: Full=DNA replication licensing 
factor MCM3; AltName: Full=DNA polymerase alpha holoenzyme-associated protein P1; 
AltName: Full=P1-MCM3 
>gi|126822|sp|P24279.1|MCM3_YEAST RecName: Full=DNA replication licensing factor 
MCM3; AltName: Full=Minichromosome maintenance protein 3 
>gi|75334009|sp|Q9FL33.1|MCM3_ARATH RecName: Full=DNA replication licensing 
factor MCM3 homolog; AltName: Full=Minichromosome maintenance protein 3 homolog 
>gi|164448574|ref|NP_001013604.2| DNA replication licensing factor MCM3 [Bos taurus] 
>gi|57530231|ref|NP_001006421.1| DNA replication licensing factor MCM3 [Gallus 
gallus] 
 
MCM4 
 
>gi|259130476|gb|ACV95639.1| MCM4 [Leishmania donovani] 
>gi|2754697|gb|AAC52018.1| MCM4 [Homo sapiens] 
>gi|11761139|dbj|BAA73964.1| MCM4 [Gallus gallus] 
>gi|11862812|dbj|BAB19264.1| MCM4 [Xenopus laevis] 
>gi|308159481|gb|EFO62010.1| MCM4 [Giardia lamblia P15] 
>gi|157436985|gb|EDO81197.1| MCM4 [Giardia lamblia ATCC 50803] 
>gi|253745243|gb|EET01291.1| MCM4 [Giardia intestinalis ATCC 50581] 
>gi|159117302|ref|XP_001708871.1| MCM4 [Giardia lamblia ATCC 50803] 
>gi|159766065|gb|ABW98291.1| mcm4 [Hemiselmis andersenii] 
>gi|160331819|ref|XP_001712616.1| mcm4 [Hemiselmis andersenii] 
>gi|296480668|gb|DAA22783.1| minichromosome maintenance complex component 4 
[Bos taurus] 
>gi|7304207|gb|AAF59242.1| disc proliferation abnormal [Drosophila melanogaster] 
>gi|17137242|ref|NP_477185.1| disc proliferation abnormal [Drosophila melanogaster] 
>gi|33469919|ref|NP_005905.2| DNA replication licensing factor MCM4 [Homo sapiens] 
>gi|33469917|ref|NP_877423.1| DNA replication licensing factor MCM4 [Homo sapiens] 
>gi|255918149|ref|NP_032591.3| DNA replication licensing factor MCM4 [Mus musculus] 
>gi|68571766|sp|P33991.5|MCM4_HUMAN RecName: Full=DNA replication licensing 
factor MCM4; AltName: Full=CDC21 homolog; AltName: Full=P1-CDC21 
>gi|11559506|gb|AAG37988.1|AF083323_1 DNA replication licensing factor MCM4 
[Plasmodium falciparum] 
>gi|115495629|ref|NP_001068626.1| DNA replication licensing factor MCM4 [Bos taurus] 
>gi|54020819|ref|NP_001005655.1| DNA replication licensing factor mcm4 [Xenopus 
(Silurana) tropicalis] 
 
MCM5 
 
>gi|47678565|emb|CAG30403.1| MCM5 [Homo sapiens] 
>gi|109451950|emb|CAK54847.1| MCM5 [synthetic construct] 
>gi|109451374|emb|CAK54548.1| MCM5 [synthetic construct] 
>gi|308158211|gb|EFO60998.1| MCM5 [Giardia lamblia P15] 
>gi|157434121|gb|EDO78355.1| MCM5 [Giardia lamblia ATCC 50803] 
>gi|253748087|gb|EET02444.1| MCM5 [Giardia intestinalis ATCC 50581] 
>gi|159111596|ref|XP_001706029.1| MCM5 [Giardia lamblia ATCC 50803] 
>gi|159765671|gb|ABW97899.1| mcm5 [Hemiselmis andersenii] 
>gi|160331033|ref|XP_001712224.1| mcm5 [Hemiselmis andersenii] 
>gi|7299365|gb|AAF54557.1| minichromosome maintenance 5 [Drosophila melanogaster] 
>gi|24645774|ref|NP_524308.2| minichromosome maintenance 5 [Drosophila 
melanogaster] 
>gi|296487399|gb|DAA29512.1| DNA replication licensing factor MCM5 [Bos taurus] 
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>gi|169144979|emb|CAQ08830.1| minichromosome maintenance complex component 5 
[Homo sapiens] 
>gi|169144978|emb|CAQ08829.1| minichromosome maintenance complex component 5 
[Homo sapiens] 
>gi|23510448|ref|NP_006730.2| DNA replication licensing factor MCM5 [Homo sapiens] 
>gi|46358340|ref|NP_848523.2| DNA replication licensing factor MCM5 [Danio rerio] 
>gi|57525409|ref|NP_001006243.1| DNA replication licensing factor MCM5 [Gallus 
gallus] 
>gi|284413774|ref|NP_001017327.2| DNA replication licensing factor mcm5 [Xenopus 
(Silurana) tropicalis] 
>gi|22347793|gb|AAM95977.1| DNA replication licensing factor Mcm5 [Danio rerio] 
>gi|116248539|sp|Q0V8B7.1|MCM5_BOVIN RecName: Full=DNA replication licensing 
factor MCM5 
 
MCM6 
 
>gi|29725889|gb|AAO89010.1| MCM6 [Saccharomyces cerevisiae] 
>gi|161728849|dbj|BAF94254.1| Mcm6 [Rattus norvegicus] 
>gi|161728828|dbj|BAF94234.1| Mcm6 [Rattus norvegicus] 
>gi|3953609|dbj|BAA34732.1| MCM6 [Drosophila melanogaster] 
>gi|308162402|gb|EFO64801.1| MCM6 [Giardia lamblia P15] 
>gi|157434295|gb|EDO78527.1| MCM6 [Giardia lamblia ATCC 50803] 
>gi|253744910|gb|EET01045.1| MCM6 [Giardia intestinalis ATCC 50581] 
>gi|159111942|ref|XP_001706201.1| MCM6 [Giardia lamblia ATCC 50803] 
>gi|159765901|gb|ABW98128.1| mcm6 [Hemiselmis andersenii] 
>gi|160331492|ref|XP_001712453.1| mcm6 [Hemiselmis andersenii] 
>gi|7290738|gb|AAF46184.1| minichromosome maintenance 6 [Drosophila melanogaster] 
>gi|17530827|ref|NP_511065.1| minichromosome maintenance 6 [Drosophila 
melanogaster] 
>gi|296490539|gb|DAA32652.1| DNA replication licensing factor MCM6 [Bos taurus] 
>gi|2497824|sp|Q14566.1|MCM6_HUMAN RecName: Full=DNA replication licensing 
factor MCM6; AltName: Full=p105MCM 
>gi|7427519|ref|NP_005906.2| DNA replication licensing factor MCM6 [Homo sapiens] 
>gi|6678832|ref|NP_032593.1| DNA replication licensing factor MCM6 [Mus musculus] 
>gi|75026271|sp|Q9V461.1|MCM6_DROME RecName: Full=DNA replication licensing 
factor Mcm6; Short=DmMCM6 
>gi|114052981|ref|NP_001039699.1| DNA replication licensing factor MCM6 [Bos taurus] 
>gi|57529699|ref|NP_001006527.1| DNA replication licensing factor MCM6 [Gallus 
gallus] 
>gi|108860789|sp|Q2KIZ8.1|MCM6_BOVIN RecName: Full=DNA replication licensing 
factor MCM6 
 
MCM7 
 
>gi|54290089|dbj|BAD61056.1| MCM7 [Bombyx mori] 
>gi|20977575|gb|AAM28215.1| DNA replication licensing factor [Danio rerio] 
>gi|3953611|dbj|BAA34733.1| MCM7 [Drosophila melanogaster] 
>gi|308160888|gb|EFO63355.1| MCM7 [Giardia lamblia P15] 
>gi|157434691|gb|EDO78919.1| MCM7 [Giardia lamblia ATCC 50803] 
>gi|253744222|gb|EET00456.1| MCM7 [Giardia intestinalis ATCC 50581] 
>gi|159112730|ref|XP_001706593.1| MCM7 [Giardia lamblia ATCC 50803] 
>gi|159765708|gb|ABW97936.1| mcm7 [Hemiselmis andersenii] 
>gi|160331107|ref|XP_001712261.1| mcm7 [Hemiselmis andersenii] 
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>gi|115908135|ref|XP_001200231.1| PREDICTED: similar to DNA replication licensing 
factor; MCM7, partial [Strongylocentrotus purpuratus] 
>gi|115740038|ref|XP_001180038.1| PREDICTED: similar to DNA replication licensing 
factor; MCM7, partial [Strongylocentrotus purpuratus] 
>gi|7295030|gb|AAF50357.1| minichromosome maintenance 7 [Drosophila melanogaster] 
>gi|17647617|ref|NP_523984.1| minichromosome maintenance 7 [Drosophila 
melanogaster] 
>gi|296472979|gb|DAA15094.1| DNA replication licensing factor MCM7 [Bos taurus] 
>gi|33469968|ref|NP_005907.3| DNA replication licensing factor MCM7 isoform 1 [Homo 
sapiens] 
>gi|33469922|ref|NP_877577.1| DNA replication licensing factor MCM7 isoform 2 [Homo 
sapiens] 
>gi|10242373|ref|NP_032594.1| DNA replication licensing factor MCM7 [Mus musculus] 
>gi|20981696|sp|P33993.4|MCM7_HUMAN RecName: Full=DNA replication licensing 
factor MCM7; AltName: Full=CDC47 homolog; AltName: Full=P1.1-MCM3 
>gi|12230233|sp|O75001.1|MCM7_SCHPO RecName: Full=DNA replication licensing 
factor mcm7; AltName: Full=Minichromosome maintenance protein 7 
>gi|115529274|ref|NP_001020516.2| DNA replication licensing factor MCM7 [Bos taurus] 
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Appendix 2 Gene IDs for Orc4 subunits used to generate ORC4 alignment 
 
>SceOrc4 (P54791) 
>EcuOrc5? (NP_597618)  
>HsaOrc4 (O43929) 
>AthOrc4 (CAE01428) 
>TanOrc4 TA12985 |||hypothetical protein|Theileria annulata|chr 02|||Manual 
>CpaOrc4 cgd2_1550  
>PfaOrc4 PF13_0189 |||hypothetical protein, conserved|Plasmodium falciparum|chr 
13|SANGER||Manual 
>DdiOrc4 DDB0168430 ||||Dictyostelium discoideum|chr 2|||Auto 
>GlaOrc4 ctg02_3 
>TthOrc4 51.m00235 
>TvaOrc4 TVAG_365960 
>DmeOrc4 gi|7291857|gb|AAF47276.1| origin recognition complex subunit 4 [Drosophila 
melanogaster] 
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Appendix 3 Gene IDs of ORC subunits used for generation of phylogenetic 
tree 
>SceOrc1 (P54784) 
>SceOrc2 (P32833) 
>SceOrc3 (P54790) 
>SceOrc4 (P54791) 
>SceOrc5 (P50874) 
>SceOrc6 (P38826) 
>SceCDC6 (NP_012341) 
>EcuOrc1 (NP_597612) 
>EcuOrc2 (NP_586228) 
>EcuOrc5? (NP_597618)  
>EcuCdc6 (XP_955574) 
>HsaOrc1 (Q13415) 
>HsaOrc2 (Q13416) 
>HsaOrc3 (Q9UBD5) 
>HsaOrc4 (O43929) 
>HsaOrc5 (O43913) 
>HsaOrc6 (Q9Y5N6) 
>HsaCDC6 (NP_001245) 
>AthOrc1a (CAD13174) 
>AthOrc2 (Q38899)  
>AthOrc3 (AAT37463) 
>AthOrc4 (CAE01428) 
>AthOrc5 (NP_194720) 
>AthOrc6 (Q9ZVH3) 
>AthCdc6 (CAC81074) 
>TanOrc1 TA04740 |||origin recognition complex protein 1, putative|Theileria annulata|chr 
03|||Manual 
>TanOrc2 TA19765 |||origin recognition complex -like protein, putative|Theileria 
annulata|chr 01|||Manual 
>TanOrc4 TA12985 |||hypothetical protein|Theileria annulata|chr 02|||Manual 
>TanCdc6 TA14555 |||CDC6-like ATPase, putative|Theileria annulata|chr 02|||Manual 
>CpaOrc1 cgd4_4320  
>CpaOrc2 cgd4_1930 
>CpaOrc4 cgd2_1550  
>CpaOrc5 cgd4_430  
>CpaCdc6 cgd7_2310 
>PfaOrc1 PFL0150w |||origin recognition complex 1 protein|Plasmodium falciparum|chr 
12|STANFORD||Manual 
>PfaOrc2 MAL7P1.21 |||origin recognition complex subunit, putative|Plasmodium 
falciparum|chr 7|SANGER||Manual 
>PfaOrc4 PF13_0189 |||hypothetical protein, conserved|Plasmodium falciparum|chr 
13|SANGER||Manual 
>PfaOrc5 PFB0720c |||hypothetical protein, conserved|Plasmodium falciparum|chr 
2|TIGR||Manual 
>PfaCdc6 PFE0155w  
>DdiOrc1 DDB0218435 ||||Dictyostelium discoideum|chr 4|||Auto 
>DdiOrc2 DDB0190652 ||||Dictyostelium discoideum|chr 1|||Auto 
>DdiOrc3 DDB0216767 ||||Dictyostelium discoideum|chr 1|||Auto 
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>DdiOrc4 DDB0168430 ||||Dictyostelium discoideum|chr 2|||Auto 
>DdiOrc5 DDB0191826 |||hypothetical protein|Dictyostelium discoideum|chr 6|||Auto 
>DdiOrc6 DDB0186183 ||||Dictyostelium discoideum|chr 4|||Auto 
>DdiCdc6 DDB0203551 ||||Dictyostelium discoideum|chr 2|||Auto 
>EhiOrc1/Cdc6 224.m00087 hypothetical protein 224.t00013 AAFB01000646 
>EhiOrc2 (XP_651724) 
>GlaOrc1/Cdc6 ctg02_20 
>GlaOrc4 ctg02_3 
>TpsOrc1a |Thaps3|263879|thaps1_ua_kg.chr_12000030 
>TpsOrc1b fgenesh1_pg.C_chr_6000022 [Thaps3:5867] 
>TpsOrc2 jgi|Thaps3|260866|thaps1_ua_kg.chr_1000126 
>TpsCdc6 jgi|Thaps3|8536|fgenesh1_pg.C_chr_10000306 
>TthOrc1 154.m00093 
>TthOrc2 104.m00101 
>TthOrc4 51.m00235 
>TthOrc5 142.m00114 
>TbrORC1/CDC6 (Tb11.02.5110)(EAN79686) 
>TcrORC1/CDC6 (Tc00.1047053511159.20)(XP_806474) 
>LmaORC1/CDC6 (F28.0030)(CAJ04600) 
>TvaOrc1 TVAG_340580 
>TvaCdc6 TVAG_376490 
>TvaOrc2 TVAG_185790 
>TvaOrc4 TVAG_365960 
>Tb09.160.3120  | Trypanosoma brucei TREU927 | hypothetical protein, conserved | 
protein  | length=1018 
>Tb10.389.0050 tbrucei_v5:Tb10.389.0050/Tb927.10.13380 hypothetical protein, 
conserved 
>Tb927.10.7980 hypothetical protein, conserved (Tb10.6k15.2570) 
>DmeOrc1 gi|7304200|gb|AAF59236.1| origin recognition complex subunit 1 [Drosophila 
melanogaster] 
>DmeOrc2 gi|7299828|gb|AAF55006.1| origin recognition complex subunit 2 [Drosophila 
melanogaster] 
>DmeOrc3 gi|5081626|gb|AAD39472.1|AF139062_1 origin recognition complex subunit 
3 [Drosophila melanogaster] 
>DmeOrc4 gi|7291857|gb|AAF47276.1| origin recognition complex subunit 4 [Drosophila 
melanogaster] 
>DmeOrc5 gi|7298101|gb|AAF53340.1| origin recognition complex subunit 5 [Drosophila 
melanogaster] 
>DmeOrc6 gi|7303844|gb|AAF58890.1| origin recognition complex subunit 6 [Drosophila 
melanogaster] 
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Appendix 4 Genome files for microarray 
 
 
core files length No. contigs content
Tb927_01_May08_v4.embl.gz 1 1064672 1
Tb927_02_May08_v4.embl.gz 1 1193648 1
Tb927_03_May08_v4.embl.gz 1 1653225 1
Tb927_04_May08_v4.embl.gz 1 1590432 1
Tb927_05_May08_v4.embl.gz 1 1608198 1
Tb927_06_May08_v4.embl.gz 1 1618915 1
Tb927_07_May08_v4.embl.gz 1 2205233 1
Tb927_08_May08_v4.embl.gz 1 2481190 1
TRYP9.cons27OCT08.gz 1 3542885 2
Tb927_10_May08_v4.embl.gz 1 4054025 1
Tb927_11_chain1_contigs_v5.fas.gz 1 4489688 14
Tb927_11_chain2_contigs_v5.fas.gz 1 272620 3
Tb927_11_chain3_contigs_v5.fas.gz 1 131299 3
25906030
Subtelomeric sequences
Chr5h_5K5.fas 1 158740 1 Chr5
BAC26D11_v3.embl.gz 1 142770 1 Chr5 TbAT locus
chr8h_27P2.fas 1 146393 1 Chr8
Tb927_11_Xhomologue_contigs_v5.fas.gz 1 580726 2
Tb927_11_Yhomologue_contigs_v5.fas.gz 1 429803 2
Tb927_11_chain1_LHEhomologue_contigs_v5.fas.gz 1 14898 1
Tb927_09_remaining_6Kb_v5.fas.gz 1 522210 30
Tb927_10_remaining_v4.embl.gz 1 865254 32
2860794
Telomeric sequences
Tb927_2L_I5_contigs1-6.embl 1 139208 6 BES-like
Tb927_2R_3E10_contigs2-4.embl 1 72378 3
Tb927_4R_I8_Mar08.fas.gz 1 62719 1
927T5L5E3-1f09.p1k 1 13474 1 Contains MES
Tb927_5R_1F2_contigsv1.fas 1 187762 8 Contains VSGs
Tb927_6L_1A4_contigsv2_2-16.embl 1 157939 15 Contains MES
Tb927_8R_1F6_contigsv3.fas.gz 1 57306 3 Contains part of BES
AC087700_GUTat telo35k.fas 1 35726 1 BES pt2
AC087701_GUTat telo75k.fas 1 75311 1 BES pt1
801823
total 30 29568647 140  
 
Remaining core regions from table above 
 
TRYP9.cons27OCT08.gz 
fasta_record          1 3472654    tryp_IXb-180h05.q1ka TRYP9.0.3648     
fasta_record    3472655 3542885    tryp_IXb-293e04.p1c TRYP9.0.85070     
 
Tb927_11_chain1_contigs_v5.fas.gz. . . . . . . . . . . . . . . . Oct 
28 17:51   1348K  
fasta_record          1  163188    J21197Cg06.q1k TRYP11P7.0.20100     
fasta_record     163189  176390    GTRYP_6322_6323-1a02.w2k6322 
TRYP11P6.0.9973     
fasta_record     176391  296585    tryp_XI-874e08.p1k 
TRYP11P4.0.5290     
fasta_record     296586  433652    tryp_XI-890e12.p1k 
TRYP11P4.0.3259     
 
237 
fasta_record     433653  568587    TP7d2Lh12.p1k TRYP11P4.0.8510     
fasta_record     568588 1417114    tryp_XI-491d08.p1ka 
TRYP11P3.0.16673     
fasta_record    1417115 1712115    tryp_XI-463c04.p1k 
TRYP11P5.0.2016     
fasta_record    1712116 1835124    TP25A10Ea02.p1k TRYP11P6.0.6601     
fasta_record    1835125 2215864    TP27I12Cf01.p1k TRYP11P7.0.8359     
fasta_record    2215865 2321151    tryp_XI-924a01.p1k 
TRYP11P2.0.1650     
fasta_record    2321152 2586020    tryp_XI-976a09.q2k95 
TRYP11P9.0.4907     
fasta_record    2586021 3036733    tryp_XI-330a07.q1k 
TRYP11P1.0.10229     
fasta_record    3036734 3252777    TP2H24Gb03.q1k TRYP11P1.0.16681     
fasta_record    3252778 4489688    tryp_XI-419d08.q2kA161 
TRYP11P8.0.24064     
 
Tb927_11_chain2_contigs_v5.fas.gz. . .  . . . . Oct 28 17:51     84K  
fasta_record         1  69920    tryp_XI-428a01.p1ka TRYP11P6.0.1     
fasta_record     69921 233603    tryp_XI-1074f04.q1k TRYP11P8.0.642     
fasta_record    233604 272620    TP48c6Fh07.q1k TRYP11P6.0.11240     
  
Tb927_11_chain3_contigs_v5.fas.gz. . .. . . . . Oct 28 17:51     40K 
fasta_record         1  59030    tryp_XI-496g08.q1k TRYP11P7.0.16684     
fasta_record     59031  80079    TP46e1Ca07.p2k2166 TRYP11P2.0.624     
fasta_record     80080 131299    tryp_XI-371e06.p2k5133 
TRYP11P7.0.20739 
 
 
Subtelomeric sequences  
 
Tb927_11_Xhomologue_contigs_v5.fas.gz. .  . . . Oct 28 17:51    176K  
fasta_record         1 494177    tryp_XI-322b06.p1k TRYP11P8.0.18497     
f
 
asta_record    494178 580726    TP27G7Ah06.q1k TRYP11P7.0.11531     
Tb927_11_Yhomologue_contigs_v5.fas.gz. . . .  . Oct 28 17:51    130K  
fasta_record         1 353602    TP3g7Hh01.q1k TRYP11P5.0.17854     
fasta_record    353603 429803    J22763Jb08.q1k TRYP11P7.0.20742     
 
Tb927_11_chain1_LHEhomologue_contigs_v5.fas.gz . Oct 28 17:51   5041   
>tryp_XI-157e02.p1c TRYP11P7.0.22752    14898bp 
 
Tb927_09_remaining_6Kb_v5.fas.gz 
fasta_record         1 105076    TP26P4-10b07.q1k TRYP9.0.81996     
fasta_record    105077 180962    tryp_IXb-68c09.p1c TRYP9.0.21459     
fasta_record    180963 223982    tryp_IXb-314f06.q1c TRYP9.0.83811     
fasta_record    223983 266768    TP26P4-2d02.q1k TRYP9.0.79194     
fasta_record    266769 292726    TP3F6-6h08.p1k TRYP9.0.87204     
fasta_record    292727 310765    tryp_IXb-337a08.q1c TRYP9.0.84971     
fasta_record    310766 328359    tryp_IXa-9g07.q1c TRYP9.0.1357     
fasta_record    328360 342142    tryp_IXb-90d08.q1c TRYP9.0.78174     
fasta_record    342143 355876    Tp_ends-40b06.q1k TRYP9.0.79877     
fasta_record    355877 367812    tryp_IXb-385f12.p1c TRYP9.0.2975     
fasta_record    367813 379071    tryp_IXb-186g06.p1c TRYP9.0.87714     
fasta_record    379072 390112    tryp_IXb-354h01.q1c TRYP9.0.78353     
fasta_record    390113 399888    tryp_IXb-292h05.q1c TRYP9.0.85916     
fasta_record    399889 409641    tryp_IXa-2f12.q1c TRYP9.0.86440     
fasta_record    409642 418193    tryp_IXa-17f02.q1c TRYP9.0.23707     
fasta_record    418194 426201    tryp_IXa-23c06.p1c TRYP9.0.88680     
fasta_record    426202 434149    tryp_IXb-360b06.p1c TRYP9.0.80492     
fasta_record    434150 441974    TP23e5-1g01.q1k TRYP9.0.80678     
fasta_record    441975 449812    TP28J11-2b06.p1k TRYP9.0.87973     
fasta_record    449813 457591    tryp_IXa-3h12.p1c TRYP9.0.23660     
fasta_record    457592 464617    TP30EO1-1e08.p1k TRYP9.0.77746     
fasta_record    464618 471380    tryp_IXb-75h06.q1c TRYP9.0.22760     
 
238 
fasta_record    471381 478026    tryp_IXa-2c04.p1ka TRYP9.0.84936     
fasta_record    478027 484639    tryp_IXb-211e12.p1c TRYP9.0.587     
fasta_record    484640 491215    tryp_IXb-215c04.p1c TRYP9.0.1028     
fasta_record    491216 497664    TP8h5-He11.p1k TRYP9.0.20543     
fasta_record    497665 503873    TP22C17-5h06.p1c TRYP9.0.23356     
fasta_record    503874 510074    tryp_IXb-380g06.q1c TRYP9.0.197     
fasta_record    510075 516231    tryp_IXa-33d02.p1c TRYP9.0.887     
f
 
asta_record    516232 522210    TP22C17-3a09.p1c TRYP9.0.81626     
Tb927_10_remaining_v4.embl.gz 
source               1  26266    /origid="TP3F6-6f06.p1k"   
source           26267  40256    /origid="TP3F6-6h01.p1k"   
source           40257  51590    /origid="TPB1C9-1a08.q1k"   
source           51591  66283    /origid="Tp_ends-39g01.p1k"  no 
probes (repeats) 
source           66284  79243    /origid="tryp_X-106b08.p1c"  no 
probes (repeats) 
source           79244  89400    /origid="tryp_X-149c07.p1c"   
source           89401 101769    /origid="tryp_X-149e07.q1c"  no 
probes (repeats) 
source          101770 119545    /origid="tryp_X-155h05.q1c"   
source          119546 142206    /origid="tryp_X-174f04.q1c"   
source          142207 161636    /origid="tryp_X-179b07.p1c"   
source          161637 187665    /origid="tryp_X-188b09.p2kB601"   
source          187666 212557    /origid="tryp_X-206a03.p1c"   
source          212558 255431    /origid="tryp_X-220a01.q1c"   
source          255432 267898    /origid="tryp_X-232f09.q1c"   
source          267899 329822    /origid="tryp_X-254c10.q1c"   
source          329823 341021    /origid="tryp_X-264e11.p1c"   
source          341022 351266    /origid="tryp_X-275g09.p1c"  no 
probes (repeats) 
source          351267 382388    /origid="tryp_X-276b11.q1c"   
source          382389 424917    /origid="tryp_X-284f09.p1c"  no 
probes (repeats) 
source          424918 489696    /origid="tryp_X-302f11.q1ca"  first 
part no probes (repeats) 
source          489697 506672    /origid="tryp_X-313e04.q2kB520"   
source          506673 596326    /origid="tryp_X-324h11.p1k"   
source          596327 628954    /origid="tryp_X-333c11.p1c"  no 
probes (repeats) 
source          628955 644712    /origid="tryp_X-36a02.p1c"   
source          644713 661218    /origid="tryp_X-423d07.p2kB114"   
source          661219 676570    /origid="tryp_X-432f03.p2kB42"   
source          676571 723138    /origid="tryp_X-448g06.q1c"   
source          723139 738015    /origid="tryp_X-46d09.q1c"  no 
probes [4 VSG pseudogenes) 
source          738016 750267    /origid="tryp_X-48f04.q1c"   
source          750268 784033    /origid="tryp_X-50f09.p2kB193"   
source          784034 799211    /origid="tryp_X-54d09.q1c"   
source          799212 815787    /origid="tryp_X-68d04.q1c"   
source          815788 865254    /origid="tryp_X-76f06.p1c"   
 
 
Telomeric sequences  
Tb927_2L_I5_contigs1-6.embl 
fasta_record         1  54822    T927_IIL_1-5Id10.p1k T927_IIL_1-
5.0.2758     
fasta_record     54823  81466    T927_IIL_1-5R2c11.p1k T927_IIL_1-
5.0.2268     
fasta_record     81467 101891    T927_IIL_1-5X2b11.p1k T927_IIL_1-
5.0.421     
fasta_record    101892 116892    T927_IIL_1-5Q2d08.p1k T927_IIL_1-
5.0.1360     
fasta_record    116893 128227    T927_IIL_1-5Rf06.q1k T927_IIL_1-
5.0.3699     
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fasta_record    128228 139208    T927_IIL_1-5J2f08.p1k T927_IIL_1-
5.0.567     
 
 
Tb927_2R_3E10_contigs2-4.embl  
fasta_record        1 10409    T927_IIR_3E10-21b10.p1k 
T927_IIR_3E10.0.1545     
fasta_record    10410 66030    T927_IIR_3E10-17e04.p1k 
T927_IIR_3E10.0.193     
fasta_record    66031 72378    T927_IIR_3E10-17b02.p1k 
T927_IIR_3E10.0.52     
 
Tb927_4R_I8_Mar08.fas.gz 
T
 
927_teloIVR-33d07.q1k VSG 
927T5L5E3-1f09.p1k 
 
Tb927_5R_1F2_contigsv1.fas 
fasta_record         1  44726    927T8R1F2-42e01.q1k 
T927_VIIIR_1F2.0.2493    VSG 
fasta_record     44727  85990    927T8R1F2-20c07.p1k 
T927_VIIIR_1F2.0.3343    VSG 
fasta_record     85991 108895    927T8R1F2-36f11.q1k 
T927_VIIIR_1F2.0.44    VSG 
fasta_record    108896 125319    927T8R1F2-28d06.p1k 
T927_VIIIR_1F2.0.2049    VSG 
fasta_record    125320 139229    927T8R1F2-3b02.q1k 
T927_VIIIR_1F2.0.773    VSG 
fasta_record    139230 151329    927T8R1F2-15c03.p1k 
T927_VIIIR_1F2.0.1225    VSG 
fasta_record    151330 161698    927T8R1F2-24g09.q1k 
T927_VIIIR_1F2.0.1616    VSG 
fasta_record    161699 171605    927T8R1F2-4g03.p1k 
T927_VIIIR_1F2.0.1534    VSG 
fasta_record    171606 180650    927T8R1F2-21g02.p1k 
T927_VIIIR_1F2.0.1101    VSG 
fasta_record    180651 187762    927T8R1F2-26c08.q1k 
T927_VIIIR_1F2.0.1910    VSG 
 
 
fasta_record         1  28228    927T6L1A4-32a11.q1k 
T927_VIL_1A4.0.2730     
fasta_record     28229  44806    927T6L1A4-5f05.p1k 
T927_VIL_1A4.0.2278     
fasta_record     44807  58655    927T6L1A4-18g07.p1k 
T927_VIL_1A4.0.2688     
fasta_record     58656  69790    927T6L1A4-41b09.p1k 
T927_VIL_1A4.0.1138     
fasta_record     69791  80379    927T6L1A4-27e05.p1k 
T927_VIL_1A4.0.1863     
fasta_record     80380  90443    927T6L1A4-1b06.q1k 
T927_VIL_1A4.0.112     
fasta_record     90444 100171    927T6L1A4-34b05.p1k 
T927_VIL_1A4.0.3798     
fasta_record    100172 108329    927T6L1A4-19a02.p1k 
T927_VIL_1A4.0.2545     
fasta_record    108330 116251    927T6L1A4-14c03.q1k 
T927_VIL_1A4.0.4023     
fasta_record    116252 123690    927T6L1A4-4e05.q1k 
T927_VIL_1A4.0.2369     
fasta_record    123691 130886    927T6L1A4-8f11.q1k 
T927_VIL_1A4.0.1651     
fasta_record    130887 138006    927T6L1A4-6e08.p1k 
T927_VIL_1A4.0.1500     
 
240 
fasta_record    138007 145046    927T6L1A4-18f03.p1k 
T927_VIL_1A4.0.3117     
fasta_record    145047 151666    927T6L1A4-16h06.p1k 
T927_VIL_1A4.0.805     
fasta_record    151667 157939    927T6L1A4-11g05.p1k 
T927_VIL_1A4.0.2549    # 
 
Tb927_8R_1F6_contigsv3.fas.gz 
fasta_record        1 40608    927T5R1F6-1h06.q1k T927_VR_1F6.0.51    
BES hit VSG (pseudo?) 
fasta_record    40609 52165    927T5R1F6-11f02.p1k 
T927_VR_1F6.0.1000    VSG 
fasta_record    52166 57306    927T5R1F6-2a08.q1k T927_VR_1F6.0.746   
VSG 
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